No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 1azcA, 0.8207, 1.51, 0.161, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
2, 1azbB, 0.8205, 1.51, 0.161, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
3, 1azbA, 0.8205, 1.51, 0.161, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
4, 1azcB, 0.8204, 1.51, 0.161, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
5, 1uriA, 0.8202, 1.63, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY GLN
6, 2azaA, 0.8200, 1.61, 0.161, 129, 124, STRUCTURE OF AZURIN FROM ALCALIGENES DENITRIFICANS. REFINEMENT AT 1.8 ANGSTROMS RESOLUTION AND COMPARISON OF THE TWO CRYSTALLOGRAPHICALLY INDEPENDENT MOLECULES
7, 1aizB, 0.8195, 1.53, 0.161, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
8, 1aizA, 0.8195, 1.55, 0.161, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
9, 1dyzA, 0.8192, 1.63, 0.137, 129, 124, OXIDISED AZURIN II FROM ALCALIGENES XYLOSOXIDANS
10, 1dz0A, 0.8190, 1.64, 0.137, 129, 124, REDUCED AZURIN II FROM ALCALIGENES XYLOSOXIDANS
11, 1uriB, 0.8186, 1.50, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY GLN
12, 1a4aA, 0.8180, 1.63, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT 16 DEGREES CELSIUS
13, 2azaB, 0.8176, 1.61, 0.161, 129, 124, STRUCTURE OF AZURIN FROM ALCALIGENES DENITRIFICANS. REFINEMENT AT 1.8 ANGSTROMS RESOLUTION AND COMPARISON OF THE TWO CRYSTALLOGRAPHICALLY INDEPENDENT MOLECULES
14, 2ccwA, 0.8158, 1.71, 0.137, 129, 124, CRYSTAL STRUCTURE OF AZURIN II AT ATOMIC RESOLUTION (1.13 ANGSTROM)
15, 1a4aB, 0.8158, 1.57, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT 16 DEGREES CELSIUS
16, 1a4bA, 0.8157, 1.59, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
17, 1rkrA, 0.8155, 1.63, 0.161, 129, 124, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
18, 1rkrD, 0.8147, 1.65, 0.161, 129, 124, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
19, 1cuoA, 0.8147, 1.56, 0.177, 129, 124, CRYSTAL STRUCTURE ANALYSIS OF ISOMER-2 AZURIN FROM METHYLOMONAS J
20, 1rkrC, 0.8145, 1.65, 0.161, 129, 124, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
21, 1rkrB, 0.8140, 1.65, 0.161, 129, 124, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
22, 1a4cB, 0.8140, 1.55, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
23, 1a4bB, 0.8136, 1.59, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
24, 1uatA, 0.8120, 1.64, 0.177, 129, 124, THE SIGNIFICANCE OF THE FLEXIBLE LOOP IN THE AZURIN (AZ-ISO2) FROM THE OBLIGATE METHYLOTROPH METHYLOMONAS SP. STRAIN J
25, 1a4cA, 0.8110, 1.66, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
26, 1a4cD, 0.8107, 1.70, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
27, 1a4cC, 0.8100, 1.79, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
28, 4ko5B, 0.8082, 1.50, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48L/V95I/Y108F)
29, 2tsbA, 0.8073, 1.47, 0.131, 128, 122, AZURIN MUTANT M121A-AZIDE
30, 4hz1D, 0.8071, 1.52, 0.138, 128, 123, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
31, 2oj1B, 0.8067, 1.57, 0.138, 128, 123, DISULFIDE-LINKED DIMER OF AZURIN N42C/M64E DOUBLE MUTANT
32, 1nwpA, 0.8065, 1.52, 0.138, 128, 123, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
33, 6mjtB, 0.8063, 1.66, 0.154, 128, 123, AZURIN 122F/124W/126RE 
34, 2tsaA, 0.8061, 1.48, 0.131, 128, 122, AZURIN MUTANT M121A
35, 3azuD, 0.8059, 1.70, 0.138, 128, 123, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
36, 2tsbD, 0.8058, 1.71, 0.130, 128, 123, AZURIN MUTANT M121A-AZIDE
37, 1jzjA, 0.8053, 1.59, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN OS(BPY)2(IM)(HIS83)
38, 3iboC, 0.8052, 1.57, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
39, 3azuA, 0.8052, 1.49, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
40, 2tsaD, 0.8050, 1.72, 0.130, 128, 123, AZURIN MUTANT M121A
41, 2oj1A, 0.8050, 1.58, 0.138, 128, 123, DISULFIDE-LINKED DIMER OF AZURIN N42C/M64E DOUBLE MUTANT
42, 2h47C, 0.8047, 1.62, 0.106, 128, 123, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEPHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 1)
43, 4ko6C, 0.8045, 1.61, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
44, 1nwoA, 0.8035, 1.60, 0.130, 128, 123, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
45, 4ko6B, 0.8034, 1.61, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
46, 3ugeD, 0.8033, 1.50, 0.139, 128, 122, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
47, 1nwpB, 0.8033, 1.56, 0.130, 128, 123, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
48, 1e5zD, 0.8033, 1.73, 0.138, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
49, 6gyiB, 0.8031, 1.49, 0.148, 127, 122, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
50, 1nwoB, 0.8031, 1.59, 0.130, 128, 123, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
51, 1jvoJ, 0.8030, 1.74, 0.138, 128, 123, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
52, 6gyiC, 0.8029, 1.70, 0.138, 128, 123, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
53, 5azuD, 0.8029, 1.73, 0.138, 128, 123, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
54, 1jvoD, 0.8029, 1.74, 0.138, 128, 123, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
55, 4ko5A, 0.8028, 1.60, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48L/V95I/Y108F)
56, 1jvoG, 0.8027, 1.74, 0.138, 128, 123, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
57, 1jvoE, 0.8027, 1.74, 0.138, 128, 123, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
58, 1gr7B, 0.8027, 1.37, 0.149, 125, 121, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
59, 1jvoC, 0.8026, 1.74, 0.138, 128, 123, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
60, 1jvoL, 0.8025, 1.74, 0.138, 128, 123, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
61, 1e5yD, 0.8025, 1.73, 0.138, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
62, 1vlxD, 0.8024, 1.75, 0.138, 128, 123, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
63, 1jzeA, 0.8024, 1.66, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN RU(BPY)2(IM)(HIS83)
64, 6mjrC, 0.8023, 1.75, 0.154, 128, 123, AZURIN 122W/124F/126RE 
65, 1jvoB, 0.8023, 1.75, 0.138, 128, 123, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
66, 1gr7A, 0.8023, 1.57, 0.148, 126, 122, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
67, 1jziA, 0.8022, 1.66, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN RE(PHEN)(CO)3(HIS83)
68, 4hz1A, 0.8021, 1.53, 0.139, 127, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
69, 2i7sD, 0.8021, 1.63, 0.138, 128, 123, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
70, 1jvoI, 0.8021, 1.75, 0.138, 128, 123, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
71, 1gr7D, 0.8020, 1.59, 0.148, 126, 122, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
72, 1gr7C, 0.8020, 1.38, 0.149, 125, 121, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
73, 3fswB, 0.8019, 1.71, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
74, 1jvoH, 0.8019, 1.75, 0.138, 128, 123, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
75, 1jvoA, 0.8019, 1.75, 0.138, 128, 123, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
76, 1vlxC, 0.8018, 1.71, 0.138, 128, 123, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
77, 1etjC, 0.8018, 1.51, 0.139, 128, 122, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
78, 4kobD, 0.8017, 1.63, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
79, 2iaaC, 0.8017, 1.70, 0.106, 128, 123, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEPHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 2)
80, 2h3xF, 0.8015, 1.65, 0.114, 128, 123, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 3)
81, 2h3xC, 0.8015, 1.65, 0.114, 128, 123, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 3)
82, 1e65D, 0.8014, 1.76, 0.138, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
83, 3ugeA, 0.8013, 1.74, 0.138, 128, 123, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
84, 1jvoF, 0.8013, 1.76, 0.146, 128, 123, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
85, 1e5zB, 0.8013, 1.80, 0.138, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
86, 1jvoK, 0.8012, 1.76, 0.138, 128, 123, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
87, 1ilsD, 0.8012, 1.74, 0.138, 128, 123, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
88, 1e5zC, 0.8012, 1.69, 0.138, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
89, 1jziB, 0.8011, 1.68, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN RE(PHEN)(CO)3(HIS83)
90, 5azuC, 0.8010, 1.70, 0.138, 128, 123, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
91, 5azuB, 0.8010, 1.80, 0.138, 128, 123, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
92, 4mfhC, 0.8010, 1.64, 0.138, 128, 123, CRYSTAL STRUCTURE OF M121G AZURIN
93, 4ko9D, 0.8010, 1.65, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
94, 1e65C, 0.8010, 1.71, 0.138, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
95, 4qlwA, 0.8009, 1.52, 0.131, 128, 122, AZURIN MUTANT M121E WITH IRON
96, 1jzhA, 0.8009, 1.67, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN RU(TPY)(BPY)(HIS83)
97, 4azuD, 0.8008, 1.75, 0.138, 128, 123, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
98, 2xv3A, 0.8008, 1.71, 0.137, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED PH5.3
99, 2azuB, 0.8008, 1.55, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
100, 3ugeC, 0.8007, 1.72, 0.138, 128, 123, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
101, 3azuC, 0.8007, 1.53, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
102, 4ko7D, 0.8006, 1.60, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
103, 6mjsA, 0.8005, 1.62, 0.154, 128, 123, AZURIN 122W/124W/126RE 
104, 4kobC, 0.8005, 1.61, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
105, 4ko9C, 0.8005, 1.63, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
106, 3jtbD, 0.8004, 1.70, 0.138, 128, 123, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
107, 2tsaB, 0.8004, 1.54, 0.131, 128, 122, AZURIN MUTANT M121A
108, 4ko6A, 0.8002, 1.62, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
109, 1ezlD, 0.8002, 1.59, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
110, 1e5yC, 0.8002, 1.74, 0.138, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
111, 2tsbC, 0.8001, 1.54, 0.131, 128, 122, AZURIN MUTANT M121A-AZIDE
112, 1r1cA, 0.8001, 1.76, 0.171, 128, 123, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
113, 1nzrD, 0.8001, 1.75, 0.138, 128, 123, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
114, 1i53A, 0.8001, 1.69, 0.138, 128, 123, RE(I)-TRICARBONLY DIIMINE (Q107H)) AZURIN
115, 6gyiD, 0.8000, 1.51, 0.148, 127, 122, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
116, 1jzjB, 0.8000, 1.75, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN OS(BPY)2(IM)(HIS83)
117, 1etjD, 0.8000, 1.76, 0.130, 128, 123, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
118, 2idfA, 0.7999, 1.67, 0.138, 128, 123, P. AERUGINOSA AZURIN N42C/M64E DOUBLE MUTANT BMME-LINKED DIMER
119, 1e5yB, 0.7999, 1.81, 0.138, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
120, 2tsbB, 0.7998, 1.55, 0.131, 128, 122, AZURIN MUTANT M121A-AZIDE
121, 2tsaC, 0.7998, 1.55, 0.131, 128, 122, AZURIN MUTANT M121A
122, 1e5zA, 0.7998, 1.53, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
123, 4kobA, 0.7997, 1.64, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
124, 1azrD, 0.7997, 1.76, 0.138, 128, 123, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
125, 1aznA, 0.7997, 1.53, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
126, 6iavA, 0.7996, 1.52, 0.148, 127, 122, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
127, 3iboB, 0.7996, 1.65, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
128, 2idfB, 0.7996, 1.67, 0.138, 128, 123, P. AERUGINOSA AZURIN N42C/M64E DOUBLE MUTANT BMME-LINKED DIMER
129, 1azrC, 0.7996, 1.72, 0.138, 128, 123, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
130, 1e65A, 0.7995, 1.54, 0.139, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
131, 1xb8A, 0.7994, 1.56, 0.139, 127, 122, ZN SUBSTITUTED FORM OF D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
132, 4azuC, 0.7993, 1.74, 0.138, 128, 123, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
133, 4azuB, 0.7993, 1.79, 0.138, 128, 123, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
134, 2azuD, 0.7993, 1.77, 0.138, 128, 123, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
135, 3azuB, 0.7992, 1.55, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
136, 2gi0A, 0.7992, 1.69, 0.138, 128, 123, CRYSTAL STRUCTURE OF CU(I) PHE114PRO AZURIN MUTANT
137, 1joiA, 0.7992, 1.77, 0.130, 128, 123, STRUCTURE OF PSEUDOMONAS FLUORESCENS HOLO AZURIN
138, 1ezlA, 0.7992, 1.53, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
139, 1e67B, 0.7992, 1.78, 0.138, 128, 123, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
140, 1vlxB, 0.7991, 1.79, 0.138, 128, 123, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
141, 1i53B, 0.7991, 1.67, 0.138, 128, 123, RE(I)-TRICARBONLY DIIMINE (Q107H)) AZURIN
142, 1xb6A, 0.7990, 1.66, 0.146, 128, 123, THE K24R MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
143, 1iluK, 0.7990, 1.58, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
144, 1e67C, 0.7990, 1.73, 0.146, 128, 123, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
145, 5azuA, 0.7989, 1.55, 0.139, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
146, 3u25B, 0.7989, 1.54, 0.156, 127, 122, CRYSTAL STRUCTURE OF P. AERUGINOAS AZURIN CONTAINING A TYR-HIS HYDROGEN BONDED PAIR
147, 3fszA, 0.7989, 1.73, 0.137, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM)
148, 2i7sB, 0.7989, 1.63, 0.146, 128, 123, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
149, 2azuC, 0.7989, 1.56, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
150, 2azuA, 0.7989, 1.54, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
151, 1jzgA, 0.7989, 1.70, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA REDUCED AZURIN (CU1+) RU(TPY)(PHEN) (HIS83)
152, 1jzfA, 0.7989, 1.70, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA OXIDIZED AZURIN(CU2+) RU(TPY)(PHEN) (HIS83)
153, 1e5yA, 0.7989, 1.54, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
154, 4ko9A, 0.7988, 1.66, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
155, 1xb3A, 0.7988, 1.66, 0.138, 128, 123, THE D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
156, 4k9jA, 0.7987, 1.55, 0.148, 127, 122, STRUCTURE OF RE(CO)3(47-DIMETHYL-PHEN)(THR126HIS)(LYS122TRP) (HIS83GLU)(TRP48PHE)(TYR72PHE)(TYR108PHE)AZCU(II) A RHENIUM MODIFIED AZURIN MUTANT
157, 1e67D, 0.7987, 1.77, 0.138, 128, 123, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
158, 6mjsB, 0.7986, 1.43, 0.157, 126, 121, AZURIN 122W/124W/126RE 
159, 3jt2A, 0.7986, 1.78, 0.138, 128, 123, CU(II) N47S/M121L VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
160, 1ag0A, 0.7986, 1.67, 0.130, 128, 123, STRUCTURE OF CYS 112 ASP AZURIN FROM PSEUDOMONAS AERUGINOSA
161, 6iavC, 0.7985, 1.54, 0.148, 127, 122, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
162, 4ko7C, 0.7985, 1.68, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
163, 3jtbB, 0.7985, 1.75, 0.146, 128, 123, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
164, 2ghzA, 0.7985, 1.70, 0.138, 128, 123, CRYSTAL STRUCTURE OF AZURIN PHE114PRO MUTANT
165, 1nzrC, 0.7985, 1.74, 0.138, 128, 123, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
166, 1ag0B, 0.7985, 1.67, 0.130, 128, 123, STRUCTURE OF CYS 112 ASP AZURIN FROM PSEUDOMONAS AERUGINOSA
167, 3jt2B, 0.7984, 1.78, 0.138, 128, 123, CU(II) N47S/M121L VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
168, 3ft0B, 0.7984, 1.74, 0.137, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED
169, 3ft0A, 0.7984, 1.74, 0.137, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED
170, 1nzrB, 0.7984, 1.79, 0.146, 128, 123, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
171, 1jvlB, 0.7984, 1.69, 0.146, 128, 123, AZURIN DIMER COVALENTLY CROSSLINKED THROUGH BIS- MALEIMIDOMETHYLETHER
172, 1jvlA, 0.7984, 1.69, 0.146, 128, 123, AZURIN DIMER COVALENTLY CROSSLINKED THROUGH BIS- MALEIMIDOMETHYLETHER
173, 4ko7B, 0.7983, 1.68, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
174, 4jknC, 0.7983, 1.78, 0.138, 128, 123, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
175, 3ugeB, 0.7983, 1.80, 0.138, 128, 123, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
176, 2i7sC, 0.7983, 1.67, 0.138, 128, 123, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
177, 4jknB, 0.7982, 1.75, 0.138, 128, 123, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
178, 2xv3B, 0.7982, 1.75, 0.137, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED PH5.3
179, 6mjrA, 0.7981, 1.73, 0.154, 128, 123, AZURIN 122W/124F/126RE 
180, 5i28G, 0.7981, 1.65, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
181, 1ilsC, 0.7981, 1.75, 0.130, 128, 123, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
182, 6iavB, 0.7980, 1.53, 0.148, 127, 122, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
183, 5i26A, 0.7979, 1.66, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM I
184, 4hz1C, 0.7979, 1.57, 0.139, 127, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
185, 1ilsB, 0.7979, 1.57, 0.131, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
186, 1etjB, 0.7979, 1.77, 0.138, 128, 123, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
187, 4qlwC, 0.7978, 1.78, 0.130, 128, 123, AZURIN MUTANT M121E WITH IRON
188, 4jknA, 0.7978, 1.55, 0.139, 128, 122, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
189, 3jtbA, 0.7977, 1.77, 0.138, 128, 123, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
190, 1azrB, 0.7977, 1.80, 0.138, 128, 123, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
191, 4mfhB, 0.7976, 1.68, 0.130, 128, 123, CRYSTAL STRUCTURE OF M121G AZURIN
192, 1e65B, 0.7976, 1.79, 0.138, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
193, 5i28J, 0.7975, 1.67, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
194, 4ko6D, 0.7975, 1.69, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
195, 2gi0B, 0.7975, 1.72, 0.138, 128, 123, CRYSTAL STRUCTURE OF CU(I) PHE114PRO AZURIN MUTANT
196, 1vlxA, 0.7975, 1.56, 0.139, 128, 122, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
197, 1xb8C, 0.7974, 1.44, 0.149, 126, 121, ZN SUBSTITUTED FORM OF D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
198, 1bexB, 0.7974, 1.78, 0.138, 128, 123, STRUCTURE OF RUTHENIUM-MODIFIED PSEUDOMONAS AERUGINOSA AZURIN
199, 6mjsD, 0.7973, 1.44, 0.157, 126, 121, AZURIN 122W/124W/126RE 
200, 1iluA, 0.7973, 1.59, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
201, 3fszB, 0.7972, 1.75, 0.137, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM)
202, 3fpyA, 0.7972, 1.68, 0.122, 128, 123, AZURIN C112D/M121L
203, 3iboD, 0.7971, 1.68, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
204, 1etjA, 0.7971, 1.57, 0.139, 128, 122, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
205, 1aznB, 0.7971, 1.56, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
206, 6gyiA, 0.7970, 1.54, 0.139, 127, 122, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
207, 4azuA, 0.7970, 1.56, 0.148, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
208, 2i7sA, 0.7970, 1.68, 0.138, 128, 123, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
209, 1iluI, 0.7970, 1.59, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
210, 1ezlB, 0.7970, 1.81, 0.138, 128, 123, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
211, 1bexA, 0.7968, 1.79, 0.138, 128, 123, STRUCTURE OF RUTHENIUM-MODIFIED PSEUDOMONAS AERUGINOSA AZURIN
212, 4mfhA, 0.7967, 1.69, 0.130, 128, 123, CRYSTAL STRUCTURE OF M121G AZURIN
213, 2ghzB, 0.7967, 1.73, 0.138, 128, 123, CRYSTAL STRUCTURE OF AZURIN PHE114PRO MUTANT
214, 1iluM, 0.7967, 1.58, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
215, 3jtbC, 0.7966, 1.78, 0.138, 128, 123, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
216, 1r1cD, 0.7966, 1.66, 0.154, 128, 123, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
217, 1e67A, 0.7966, 1.56, 0.148, 128, 122, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
218, 4ko9B, 0.7965, 1.68, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
219, 4ko7A, 0.7964, 1.71, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
220, 2i7oA, 0.7964, 1.67, 0.138, 128, 123, STRUCTURE OF RE(47-DIMETHYL-PHEN)(THR124HIS)(LYS122TRP)(HIS83GLN) AZCU(II) A RHENIUM MODIFIED AZURIN MUTANT
221, 1iluD, 0.7964, 1.59, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
222, 1ilsA, 0.7964, 1.56, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
223, 4kobB, 0.7963, 1.68, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
224, 3u25A, 0.7963, 1.58, 0.148, 127, 122, CRYSTAL STRUCTURE OF P. AERUGINOAS AZURIN CONTAINING A TYR-HIS HYDROGEN BONDED PAIR
225, 5i28P, 0.7961, 1.71, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
226, 3fswD, 0.7961, 1.56, 0.139, 127, 122, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
227, 2fnwB, 0.7961, 1.81, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/M109H-AZURIN RE(PHEN)(CO)3
228, 6iavD, 0.7960, 1.54, 0.139, 127, 122, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
229, 1iluE, 0.7958, 1.60, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
230, 4bwwB, 0.7957, 1.73, 0.131, 127, 122, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
231, 1nzrA, 0.7956, 1.57, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
232, 1iluH, 0.7956, 1.61, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
233, 1iluL, 0.7955, 1.62, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
234, 4bwwA, 0.7954, 1.72, 0.131, 127, 122, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
235, 3fq1A, 0.7954, 1.72, 0.122, 128, 123, AZURIN C112D/M121I
236, 1azrA, 0.7954, 1.58, 0.139, 128, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
237, 4jknD, 0.7953, 1.59, 0.139, 128, 122, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
238, 6mjsC, 0.7952, 1.39, 0.158, 125, 120, AZURIN 122W/124W/126RE 
239, 5i28A, 0.7952, 1.71, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
240, 4qlwB, 0.7952, 1.76, 0.130, 128, 123, AZURIN MUTANT M121E WITH IRON
241, 2hxaB, 0.7950, 1.65, 0.148, 127, 122, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH3.5
242, 4bwwD, 0.7949, 1.74, 0.139, 127, 122, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
243, 6mjtA, 0.7947, 1.82, 0.154, 128, 123, AZURIN 122F/124W/126RE 
244, 1iluF, 0.7947, 1.59, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
245, 5i28N, 0.7946, 1.72, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
246, 5i28D, 0.7945, 1.72, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
247, 4kocA, 0.7945, 1.74, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I/Y108F)
248, 1iluB, 0.7945, 1.61, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
249, 1iluG, 0.7944, 1.62, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
250, 5i28H, 0.7943, 1.72, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
251, 4bwwC, 0.7942, 1.74, 0.131, 127, 122, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
252, 6mjrD, 0.7939, 1.84, 0.154, 128, 123, AZURIN 122W/124F/126RE 
253, 5i26B, 0.7939, 1.69, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM I
254, 1aznC, 0.7937, 1.83, 0.146, 128, 123, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
255, 5i28K, 0.7936, 1.73, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
256, 1r1cB, 0.7936, 1.83, 0.163, 128, 123, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
257, 1iluC, 0.7935, 1.63, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
258, 3iboA, 0.7934, 1.70, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
259, 5i28E, 0.7932, 1.72, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
260, 1aznD, 0.7930, 1.61, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
261, 3fqyA, 0.7928, 1.75, 0.130, 128, 123, AZURIN C112D
262, 5i28C, 0.7927, 1.75, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
263, 2fnwA, 0.7926, 1.71, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/M109H-AZURIN RE(PHEN)(CO)3
264, 3ay2B, 0.7925, 1.67, 0.107, 126, 122, CRYSTAL STRUCTURE OF NEISSERIAL AZURIN
265, 5i28M, 0.7924, 1.75, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
266, 3ay2A, 0.7922, 1.67, 0.107, 126, 122, CRYSTAL STRUCTURE OF NEISSERIAL AZURIN
267, 4qlwD, 0.7921, 1.87, 0.138, 128, 123, AZURIN MUTANT M121E WITH IRON
268, 6mjrB, 0.7920, 1.90, 0.154, 128, 123, AZURIN 122W/124F/126RE 
269, 5i28O, 0.7917, 1.76, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
270, 5i28I, 0.7917, 1.76, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
271, 4hz1B, 0.7917, 1.68, 0.139, 127, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
272, 5i28B, 0.7915, 1.76, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
273, 5i28F, 0.7913, 1.73, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
274, 3in0C, 0.7911, 1.85, 0.130, 128, 123, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
275, 1ov8C, 0.7911, 1.64, 0.180, 139, 122, AURACYANIN B STRUCTURE IN SPACE GROUP P65
276, 2iweA, 0.7909, 1.82, 0.138, 128, 123, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
277, 1xb6B, 0.7909, 1.74, 0.138, 128, 123, THE K24R MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
278, 1ov8B, 0.7909, 1.65, 0.180, 139, 122, AURACYANIN B STRUCTURE IN SPACE GROUP P65
279, 5i28L, 0.7908, 1.75, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
280, 1ov8A, 0.7908, 1.65, 0.180, 139, 122, AURACYANIN B STRUCTURE IN SPACE GROUP P65
281, 1r1cC, 0.7906, 1.92, 0.154, 128, 123, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
282, 1ov8D, 0.7906, 1.65, 0.180, 139, 122, AURACYANIN B STRUCTURE IN SPACE GROUP P65
283, 3fq2A, 0.7903, 1.76, 0.130, 128, 123, AZURIN C112D/M121F
284, 3np3A, 0.7902, 1.77, 0.130, 128, 123, C112D/M121E PSEUDOMONAS AERUGINOSA AZURIN
285, 1qhqA, 0.7902, 1.66, 0.180, 139, 122, AURACYANIN A BLUE COPPER PROTEIN FROM THE GREEN THERMOPHILIC PHOTOSYNTHETIC BACTERIUM CHLOROFLEXUS AURANTIACUS
286, 1ezlC, 0.7896, 1.94, 0.138, 128, 123, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
287, 3np4A, 0.7894, 1.78, 0.122, 128, 123, C112D/M121E PSEUDOMONAS AERUGINOSA AZURIN
288, 3in2A, 0.7893, 1.85, 0.138, 128, 123, CRYSTAL STRUCTURE OF THE N47S/M121L VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
289, 4hhgA, 0.7891, 1.72, 0.156, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN RUH107NO YOH109
290, 1xb3B, 0.7890, 1.78, 0.138, 128, 123, THE D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
291, 4hhwB, 0.7888, 1.70, 0.156, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H124NO YOH122
292, 3in0A, 0.7888, 1.66, 0.131, 128, 122, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
293, 3fswA, 0.7888, 1.64, 0.139, 127, 122, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
294, 2iweJ, 0.7888, 1.88, 0.130, 128, 123, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
295, 2iweG, 0.7887, 1.87, 0.138, 128, 123, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
296, 2hx8B, 0.7883, 1.73, 0.148, 127, 122, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH5
297, 2n0mA, 0.7875, 1.90, 0.106, 130, 123, THE SOLUTION STRUCTURE OF THE SOLUBLE FORM OF THE LIPID-MODIFIED AZURIN FROM NEISSERIA GONORRHOEAE
298, 2iweD, 0.7874, 1.89, 0.130, 128, 123, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
299, 4hipB, 0.7863, 1.75, 0.156, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H126NO YOH109
300, 3in0B, 0.7862, 1.90, 0.138, 128, 123, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
301, 1azuA, 0.7862, 1.56, 0.140, 126, 121, STRUCTURAL FEATURES OF AZURIN AT 2.7 ANGSTROMS RESOLUTION
302, 2hx7B, 0.7861, 1.74, 0.148, 127, 122, CRYSTAL STRUCTURE OF CU(II) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM
303, 4hipA, 0.7860, 1.73, 0.148, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H126NO YOH109
304, 2hxaA, 0.7860, 1.51, 0.150, 125, 120, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH3.5
305, 4hhwA, 0.7857, 1.86, 0.148, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H124NO YOH122
306, 4wkxB, 0.7856, 1.80, 0.122, 128, 123, REVERSIBLE S-NITROSYLATION IN AN ENGINEERED MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN WITH RED COPPER SITE
307, 3n2jK, 0.7856, 2.00, 0.138, 128, 123, AZURIN H117G OXIDIZED FORM
308, 3in0D, 0.7855, 1.70, 0.139, 128, 122, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
309, 3n2jE, 0.7854, 2.00, 0.138, 128, 123, AZURIN H117G OXIDIZED FORM
310, 5i26D, 0.7851, 1.77, 0.132, 126, 121, AZURIN T30R1 CRYSTAL FORM I
311, 2hx9A, 0.7850, 1.52, 0.150, 124, 120, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH4
312, 3n2jL, 0.7848, 2.03, 0.138, 128, 123, AZURIN H117G OXIDIZED FORM
313, 2hx9B, 0.7846, 1.70, 0.149, 125, 121, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH4
314, 2hx8A, 0.7846, 1.52, 0.150, 125, 120, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH5
315, 3n2jD, 0.7843, 2.04, 0.138, 128, 123, AZURIN H117G OXIDIZED FORM
316, 5i26C, 0.7842, 1.47, 0.143, 124, 119, AZURIN T30R1 CRYSTAL FORM I
317, 3n2jF, 0.7842, 1.82, 0.139, 128, 122, AZURIN H117G OXIDIZED FORM
318, 3n2jB, 0.7832, 1.99, 0.146, 128, 123, AZURIN H117G OXIDIZED FORM
319, 3n2jJ, 0.7822, 1.98, 0.138, 128, 123, AZURIN H117G OXIDIZED FORM
320, 3n2jI, 0.7821, 2.00, 0.146, 128, 123, AZURIN H117G OXIDIZED FORM
321, 3n2jH, 0.7817, 2.04, 0.146, 128, 123, AZURIN H117G OXIDIZED FORM
322, 3n2jA, 0.7814, 1.85, 0.139, 128, 122, AZURIN H117G OXIDIZED FORM
323, 3n2jG, 0.7813, 1.84, 0.139, 128, 122, AZURIN H117G OXIDIZED FORM
324, 4wkxA, 0.7809, 1.86, 0.130, 128, 123, REVERSIBLE S-NITROSYLATION IN AN ENGINEERED MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN WITH RED COPPER SITE
325, 3n2jC, 0.7809, 2.01, 0.146, 128, 123, AZURIN H117G OXIDIZED FORM
326, 2hx7A, 0.7805, 1.56, 0.150, 125, 120, CRYSTAL STRUCTURE OF CU(II) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM
327, 4qktB, 0.7800, 1.75, 0.132, 125, 121, AZURIN MUTANT M121EM44K WITH COPPER
328, 4qktA, 0.7765, 1.78, 0.132, 125, 121, AZURIN MUTANT M121EM44K WITH COPPER
329, 1cc3B, 0.7755, 2.15, 0.136, 130, 125, PURPLE CUA CENTER
330, 2aanA, 0.7752, 1.54, 0.185, 123, 119, AURACYANIN A: A BLUE COPPER PROTEIN FROM THE GREEN THERMOPHILIC PHOTOSYNTHETIC BACTERIUMCHLOROFLEXUS AURANTIACUS
331, 2ftaC, 0.7749, 1.60, 0.143, 124, 119, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
332, 2ftaD, 0.7738, 1.41, 0.145, 122, 117, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
333, 3fswC, 0.7708, 1.64, 0.151, 124, 119, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
334, 1cc3A, 0.7707, 2.27, 0.136, 130, 125, PURPLE CUA CENTER
335, 2ftaB, 0.7699, 1.59, 0.144, 123, 118, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
336, 2ftaA, 0.7698, 1.46, 0.145, 122, 117, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
337, 3oqrA, 0.7660, 1.75, 0.126, 123, 119, C112D/M121E AZURIN PH 10.0
338, 2ft7A, 0.7630, 1.57, 0.145, 122, 117, STRUCTURE OF CU(I)AZURIN AT PH 6 WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPM
339, 2ft8A, 0.7623, 1.58, 0.145, 122, 117, STRUCTURE OF CU(I)AZURIN PH8 WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPM
340, 2ft6A, 0.7623, 1.57, 0.145, 122, 117, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPM
341, 2xv0A, 0.7572, 1.91, 0.142, 125, 120, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM) CHEMICALLY REDUCED PH4.8
342, 2xv2A, 0.7516, 1.99, 0.142, 124, 120, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM) CHEMICALLY REDUCED PH4.2
343, 3fs9A, 0.7496, 2.01, 0.133, 125, 120, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM)
344, 3fsaA, 0.7444, 2.01, 0.134, 122, 119, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM); CHEMICALLY REDUCED.
345, 5yt7C, 0.7093, 1.72, 0.128, 130, 109, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
346, 5yt7B, 0.7071, 1.64, 0.128, 132, 109, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
347, 5yt7A, 0.7058, 1.73, 0.119, 133, 109, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
348, 5yt7D, 0.7050, 1.79, 0.128, 133, 109, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
349, 3fsvA, 0.6699, 2.09, 0.112, 118, 107, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAHAAAM)
350, 2yqbA, 0.6492, 2.09, 0.223, 454, 103, STRUCTURE OF P93A VARIANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.4 A RESOLUTION
351, 3zbmA, 0.6488, 2.09, 0.214, 455, 103, STRUCTURE OF M92A VARIANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII
352, 6fjaA, 0.6487, 2.10, 0.214, 455, 103, CRYSTAL STRUCTURE OF T2D THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
353, 5ocfA, 0.6484, 2.09, 0.214, 455, 103, CRYSTAL STRUCTURE OF NITRIC OXIDE BOUND TO THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
354, 5oboA, 0.6484, 2.10, 0.214, 456, 103, CRYSTAL STRUCTURE OF NITRITE BOUND D97N MUTANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
355, 3ziyA, 0.6482, 2.10, 0.214, 457, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE  FROM RALSTONIA PICKETTII AT 1.01 A RESOLUTION
356, 5ocbA, 0.6480, 2.10, 0.214, 453, 103, CRYSTAL STRUCTURE OF NITRIC OXIDE BOUND D97N MUTANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
357, 1e30A, 0.6480, 2.20, 0.171, 153, 105, CRYSTAL STRUCTURE OF THE MET148GLN MUTANT OF RUSTICYANIN AT 1.5 ANGSTROM RESOLUTION
358, 6f1qA, 0.6479, 2.11, 0.214, 456, 103, CRYSTAL STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII IN I213 SPACE GROUP 
359, 4ax3C, 0.6478, 2.11, 0.214, 455, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
360, 4ax3D, 0.6474, 2.11, 0.214, 457, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
361, 4ax3B, 0.6470, 2.12, 0.214, 455, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
362, 4ax3A, 0.6463, 2.12, 0.214, 456, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
363, 1ndrB, 0.6461, 2.09, 0.214, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
364, 1ndrA, 0.6461, 2.09, 0.214, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
365, 1ndsA, 0.6460, 2.09, 0.214, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A SUBSTRATE BOUND BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
366, 1ndrC, 0.6460, 2.09, 0.214, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
367, 2avfE, 0.6457, 2.10, 0.233, 315, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
368, 1ndsC, 0.6457, 2.09, 0.214, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A SUBSTRATE BOUND BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
369, 1ndsB, 0.6457, 2.09, 0.214, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A SUBSTRATE BOUND BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
370, 2avfC, 0.6451, 2.09, 0.233, 316, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
371, 1gy2B, 0.6448, 2.22, 0.171, 155, 105, CRYSTAL STRUCTURE OF MET148LEU RUSTICYANIN
372, 1gs6X, 0.6448, 2.12, 0.233, 336, 103, CRYSTAL STRUCTURE OF M144A MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
373, 1a8zA, 0.6448, 2.21, 0.181, 153, 105, STRUCTURE DETERMINATION OF A 16.8KDA COPPER PROTEIN RUSTICYANIN AT 2.1A RESOLUTION USING ANOMALOUS SCATTERING DATA WITH DIRECT METHODS
374, 2vm4A, 0.6447, 2.12, 0.243, 334, 103, STRUCTURE OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE IN SPACE GROUP R3 - 2 OF 2
375, 2vm3A, 0.6446, 2.12, 0.243, 333, 103, STRUCTURE OF ALCALIGENES XYLOSOXIDANS IN SPACE GROUP R3 - 1 OF 2
376, 1gs8A, 0.6445, 2.11, 0.243, 336, 103, CRYSTAL STRUCTURE OF  MUTANT D92N ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
377, 1wa1X, 0.6444, 2.12, 0.243, 335, 103, CRYSTAL STRUCTURE OF H313Q MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
378, 2vw6B, 0.6443, 2.13, 0.243, 334, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 3 OF 3
379, 2jfcF, 0.6443, 2.11, 0.223, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
380, 2jfcA, 0.6443, 2.11, 0.223, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
381, 2cakA, 0.6443, 2.20, 0.181, 154, 105, 1.27ANGSTROM STRUCTURE OF RUSTICYANIN FROM THIOBACILLUS FERROOXIDANS
382, 1oe1A, 0.6443, 2.11, 0.243, 335, 103, ATOMIC RESOLUTION STRUCTURE OF THE WILDTYPE NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
383, 1ndtA, 0.6443, 2.12, 0.243, 336, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
384, 1hauA, 0.6443, 2.12, 0.243, 336, 103, X-RAY STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE AT HIGH PH AND IN COPPER FREE FORM AT 1.9 A RESOLUTION
385, 5b1kA, 0.6442, 2.12, 0.243, 334, 103, CRYSTAL STRUCTURE OF THE CHLORIDE-BOUND FORM OF BLUE COPPER NITRITE REDUCTASE
386, 2zooA, 0.6442, 2.15, 0.223, 438, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM PSEUDOALTEROMONAS HALOPLANKTIS TAC125
387, 2xxfA, 0.6442, 2.11, 0.243, 335, 103, CU METALLATED H254F MUTANT OF NITRITE REDUCTASE
388, 2vw4B, 0.6442, 2.13, 0.243, 333, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 2 OF 3
389, 1waeA, 0.6442, 2.13, 0.243, 334, 103, CRYSTAL STRUCTURE OF H129V MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
390, 1wa0X, 0.6442, 2.12, 0.243, 335, 103, CRYSTAL STRUCTURE OF W138H MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
391, 1gs7A, 0.6442, 2.11, 0.243, 336, 103, CRYSTAL STRUCTURE OF H254F MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
392, 1a3zA, 0.6442, 2.23, 0.181, 150, 105, REDUCED RUSTICYANIN AT 1.9 ANGSTROMS
393, 5onyA, 0.6441, 2.13, 0.243, 335, 103, AS-ISOLATED RESTING STATE COPPER NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS
394, 4cspF, 0.6441, 2.12, 0.243, 335, 103, STRUCTURE OF THE F306C MUTANT OF NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS
395, 2xxfB, 0.6441, 2.11, 0.243, 335, 103, CU METALLATED H254F MUTANT OF NITRITE REDUCTASE
396, 1oe2A, 0.6441, 2.11, 0.243, 334, 103, ATOMIC RESOLUTION STRUCTURE OF D92E MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
397, 1hawA, 0.6441, 2.13, 0.243, 336, 103, X-RAY STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE AT HIGH PH AND IN COPPER FREE FORM AT 1.9A RESOLUTION
398, 1e30B, 0.6441, 2.27, 0.171, 153, 105, CRYSTAL STRUCTURE OF THE MET148GLN MUTANT OF RUSTICYANIN AT 1.5 ANGSTROM RESOLUTION
399, 2xwzA, 0.6439, 2.12, 0.243, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
400, 2vw7A, 0.6439, 2.13, 0.243, 335, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 1 OF 3
401, 2vw6A, 0.6439, 2.13, 0.243, 333, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 3 OF 3
402, 2nrdA, 0.6439, 2.12, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
403, 2jfcD, 0.6439, 2.12, 0.223, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
404, 1oe3A, 0.6439, 2.12, 0.243, 335, 103, ATOMIC RESOLUTION STRUCTURE OF  HALF APO  NIR
405, 4cspA, 0.6438, 2.13, 0.243, 335, 103, STRUCTURE OF THE F306C MUTANT OF NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS
406, 2xwzF, 0.6438, 2.12, 0.233, 334, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
407, 2xwzD, 0.6438, 2.12, 0.233, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
408, 1nibB, 0.6438, 2.12, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
409, 1mzzC, 0.6438, 2.13, 0.214, 334, 103, CRYSTAL STRUCTURE OF MUTANT (M182T)OF NITRITE REDUCTASE
410, 5onxA, 0.6437, 2.13, 0.243, 335, 103, RESTING STATE COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY
411, 2xx0A, 0.6437, 2.11, 0.243, 335, 103, STRUCTURE OF THE N90S-H254F MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
412, 2vw4A, 0.6437, 2.13, 0.243, 333, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 2 OF 3
413, 2afnC, 0.6437, 2.12, 0.233, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AND A COPPER SITE MUTANT M150E THAT CONTAINS ZINC
414, 2xx0B, 0.6436, 2.11, 0.243, 336, 103, STRUCTURE OF THE N90S-H254F MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
415, 2bp0B, 0.6436, 2.13, 0.233, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
416, 1nieA, 0.6436, 2.13, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
417, 1et7A, 0.6436, 2.13, 0.233, 339, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE HIS255ASP MUTANT FROM ALCALIGENES FAECALIS S-6
418, 1bq5A, 0.6436, 2.12, 0.243, 333, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS GIFU 1051
419, 4cszA, 0.6435, 2.13, 0.243, 335, 103, STRUCTURE OF F306C MUTANT OF NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS WITH NITRITE BOUND
420, 2xxgC, 0.6435, 2.13, 0.243, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
421, 2xx1A, 0.6435, 2.13, 0.243, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
422, 2vw7B, 0.6435, 2.13, 0.243, 334, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 1 OF 3
423, 2bo0A, 0.6435, 2.12, 0.233, 335, 103, CRYSTAL STRUCTURE OF THE C130A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
424, 1ntdA, 0.6435, 2.12, 0.223, 336, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE MUTANT M150E THAT CONTAINS ZINC
425, 1nicA, 0.6435, 2.13, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
426, 2zonC, 0.6434, 2.13, 0.243, 334, 103, CRYSTAL STRUCTURE OF ELECTRON TRANSFER COMPLEX OF NITRITE REDUCTASE WITH CYTOCHROME C
427, 1wa2X, 0.6433, 2.13, 0.243, 334, 103, CRYSTAL STRUCTURE OF H313Q MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE WITH NITRITE BOUND
428, 1kcbA, 0.6433, 2.13, 0.233, 333, 103, CRYSTAL STRUCTURE OF A NO-FORMING NITRITE REDUCTASE MUTANT: AN ANALOG OF A TRANSITION STATE IN ENZYMATIC REACTION
429, 1et8A, 0.6433, 2.13, 0.233, 339, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE HIS255ASN MUTANT FROM ALCALIGENES FAECALIS
430, 2bp8B, 0.6432, 2.14, 0.233, 335, 103, M144Q STRUCTURE OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
431, 1rzqC, 0.6432, 2.12, 0.223, 332, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH5.0
432, 5ofhA, 0.6431, 2.13, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.15MGY 
433, 5i6pA, 0.6431, 2.13, 0.233, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 27.60 MGY
434, 5f7bA, 0.6431, 2.13, 0.233, 336, 103, RESTING STATE STRUCTURE OF CUNIR FORM ALCALIGENES FAECALIS DETERMINED AT 293 K
435, 2zonA, 0.6431, 2.13, 0.243, 334, 103, CRYSTAL STRUCTURE OF ELECTRON TRANSFER COMPLEX OF NITRITE REDUCTASE WITH CYTOCHROME C
436, 2xx1F, 0.6431, 2.13, 0.233, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
437, 1gy1A, 0.6431, 2.23, 0.181, 154, 105, CRYSTAL STRUCTURES OF SER86ASP AND MET148LEU RUSTICYANIN
438, 5ogfA, 0.6430, 2.13, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.27MGY 
439, 5og6A, 0.6430, 2.13, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.24MGY 
440, 5og3A, 0.6430, 2.13, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.15MGY 
441, 5b1jA, 0.6430, 2.13, 0.243, 334, 103, CRYSTAL STRUCTURE OF THE ELECTRON-TRANSFER COMPLEX OF COPPER NITRITE REDUCTASE WITH A CUPREDOXIN
442, 2xwzE, 0.6430, 2.13, 0.243, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
443, 1rcyA, 0.6430, 2.23, 0.181, 151, 105, RUSTICYANIN (RC) FROM THIOBACILLUS FERROOXIDANS
444, 6gb8A, 0.6429, 2.14, 0.233, 333, 103, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: SMALL CELL POLYMORPH DATASET 1 
445, 5d4iA, 0.6429, 2.13, 0.233, 334, 103, INTACT NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY
446, 2zonB, 0.6429, 2.13, 0.243, 334, 103, CRYSTAL STRUCTURE OF ELECTRON TRANSFER COMPLEX OF NITRITE REDUCTASE WITH CYTOCHROME C
447, 2jfcB, 0.6429, 2.13, 0.233, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
448, 1j9rC, 0.6429, 2.13, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED D98N AFNIR
449, 5og5A, 0.6428, 2.13, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.21MGY 
450, 5og2A, 0.6428, 2.14, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.09MGY 
451, 5n8hA, 0.6428, 2.14, 0.233, 333, 103, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 240K. DATASET 3.
452, 3h56A, 0.6428, 2.13, 0.223, 335, 103, MET150LEU/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
453, 2xwzB, 0.6428, 2.13, 0.243, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
454, 1rzqB, 0.6428, 2.13, 0.233, 328, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH5.0
455, 1rzpC, 0.6428, 2.13, 0.233, 332, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH6.2
456, 1nidA, 0.6428, 2.14, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
457, 6gcgA, 0.6427, 2.14, 0.233, 333, 103, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: LARGE POLYMORPH DATASET 15 
458, 5ue6F, 0.6427, 2.14, 0.223, 307, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
459, 5oggA, 0.6427, 2.14, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.30MGY 
460, 5og4A, 0.6427, 2.14, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.18MGY 
461, 5ofgA, 0.6427, 2.14, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.06MGY 
462, 5n8gA, 0.6427, 2.14, 0.233, 333, 103, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 240K. DATASET 2.
463, 5i6oA, 0.6427, 2.14, 0.233, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 20.70 MGY
464, 2jfcE, 0.6427, 2.14, 0.233, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
465, 2dv6D, 0.6427, 2.15, 0.223, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
466, 2bp8A, 0.6427, 2.14, 0.233, 335, 103, M144Q STRUCTURE OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
467, 1niaB, 0.6427, 2.13, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
468, 6gbbA, 0.6426, 2.14, 0.233, 333, 103, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: LARGE CELL POLYMORPH DATASET 1 
469, 5n8fA, 0.6426, 2.14, 0.233, 333, 103, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 240K. DATASET 1.
470, 5f7aA, 0.6426, 2.13, 0.233, 336, 103, NITRITE COMPLEX STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS DETERMINED AT 293 K
471, 2xxgA, 0.6426, 2.14, 0.243, 334, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
472, 1nibA, 0.6426, 2.13, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
473, 1niaC, 0.6426, 2.13, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
474, 1j9rB, 0.6426, 2.13, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED D98N AFNIR
475, 6gtiA, 0.6425, 2.14, 0.233, 333, 103, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 5.0 
476, 1nifA, 0.6425, 2.14, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
477, 1nibC, 0.6425, 2.13, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
478, 1gy2A, 0.6425, 2.27, 0.171, 155, 105, CRYSTAL STRUCTURE OF MET148LEU RUSTICYANIN
479, 6gtjA, 0.6424, 2.14, 0.233, 333, 103, NEUTRON CRYSTAL STRUCTURE FOR COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT 1.8 A RESOLUTION 
480, 5ue6C, 0.6424, 2.15, 0.223, 310, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
481, 5offA, 0.6424, 2.14, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.03MGY 
482, 5i6nA, 0.6424, 2.14, 0.233, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 11.73 MGY
483, 2vn3A, 0.6424, 2.14, 0.233, 336, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
484, 2jfcC, 0.6424, 2.13, 0.233, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
485, 2calA, 0.6424, 2.25, 0.171, 153, 105, CRYSTAL STRUCTURE OF HIS143MET RUSTICYANIN
486, 2bwdA, 0.6424, 2.14, 0.233, 334, 103, ATOMIC RESOLUTION STRUCTURE OF ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE WITH ENDOGENOUSLY BOUND NITRITE AND NO
487, 2bp0A, 0.6424, 2.14, 0.233, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
488, 2afnB, 0.6424, 2.13, 0.233, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AND A COPPER SITE MUTANT M150E THAT CONTAINS ZINC
489, 2afnA, 0.6424, 2.13, 0.233, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AND A COPPER SITE MUTANT M150E THAT CONTAINS ZINC
490, 6gtkA, 0.6423, 2.14, 0.233, 333, 103, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 5.5 
491, 4yscA, 0.6423, 2.14, 0.233, 336, 103, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
492, 1j9tC, 0.6423, 2.14, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED H255N AFNIR
493, 6gtlA, 0.6422, 2.15, 0.233, 333, 103, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 6.0 
494, 5tb7A, 0.6422, 2.15, 0.223, 312, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP P212121
495, 2fjsC, 0.6422, 2.13, 0.233, 336, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY REDUCED WILD TYPE NITRITE REDUCTASE FROM A. FAECALIS
496, 2bw5A, 0.6422, 2.15, 0.233, 334, 103, ATOMIC RESOLUTION STRUCTURE OF NO-BOUND ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE
497, 2b08B, 0.6422, 2.14, 0.223, 336, 103, REDUCED ACETAMIDE-BOUND M150G NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
498, 6gbyA, 0.6421, 2.14, 0.233, 333, 103, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: NON- POLYMORPH SEPARATED DATASET 1 
499, 5tb7C, 0.6421, 2.16, 0.223, 311, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP P212121
500, 5i6lA, 0.6421, 2.14, 0.233, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 2.76 MGY
501, 5i6kA, 0.6421, 2.14, 0.233, 334, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 0.69 MGY
502, 2ppdC, 0.6421, 2.13, 0.223, 336, 103, OXIDIZED H145A MUTANT OF AFNIR BOUND TO NITRIC OXIDE
503, 1snrC, 0.6421, 2.13, 0.233, 336, 103, NITRIC OXIDE BOUND TO CU NITRITE REDUCTASE
504, 1rzpB, 0.6421, 2.14, 0.233, 328, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH6.2
505, 1npnB, 0.6421, 2.13, 0.223, 336, 103, CRYSTAL STRUCTURE OF A COPPER RECONSTITUTED H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
506, 1mzzA, 0.6421, 2.15, 0.214, 334, 103, CRYSTAL STRUCTURE OF MUTANT (M182T)OF NITRITE REDUCTASE
507, 1kbwC, 0.6421, 2.15, 0.223, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
508, 1kbvA, 0.6421, 2.15, 0.223, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
509, 1gy1B, 0.6421, 2.27, 0.181, 154, 105, CRYSTAL STRUCTURES OF SER86ASP AND MET148LEU RUSTICYANIN
510, 6gtnA, 0.6420, 2.15, 0.233, 333, 103, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 6.5 
511, 5ue6I, 0.6420, 2.15, 0.223, 311, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
512, 5i6mA, 0.6420, 2.15, 0.233, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 7.59 MGY
513, 2xwzC, 0.6420, 2.14, 0.243, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
514, 2b08C, 0.6420, 2.14, 0.223, 336, 103, REDUCED ACETAMIDE-BOUND M150G NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
515, 1npjB, 0.6420, 2.13, 0.223, 336, 103, CRYSTAL STRUCTURE OF H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
516, 1niaA, 0.6420, 2.14, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
517, 1kbwF, 0.6420, 2.15, 0.223, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
518, 1kbwB, 0.6420, 2.16, 0.223, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
519, 1j9tB, 0.6420, 2.14, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED H255N AFNIR
520, 1j9sB, 0.6420, 2.14, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED H255N AFNIR
521, 1et5A, 0.6420, 2.14, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE ASP98ASN MUTANT FROM ALCALIGENES FAECALIS S-6
522, 1kbwE, 0.6419, 2.16, 0.223, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
523, 1kbwA, 0.6419, 2.16, 0.223, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
524, 6gsqA, 0.6418, 2.15, 0.233, 333, 103, OXIDISED COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY 
525, 5ofdA, 0.6418, 2.15, 0.233, 333, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
526, 5d4jB, 0.6418, 2.14, 0.233, 336, 103, CHLORIDE-BOUND FORM OF A COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALS
527, 5d4iC, 0.6418, 2.15, 0.233, 334, 103, INTACT NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY
528, 2ppfC, 0.6418, 2.14, 0.233, 336, 103, REDUCED MUTANT D98N OF AFNIR EXPOSED TO NITRIC OXIDE
529, 2ppeC, 0.6418, 2.13, 0.223, 336, 103, REDUCED H145A MUTANT OF AFNIR EXPOSED TO NO
530, 2ppaC, 0.6418, 2.14, 0.233, 336, 103, ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR BOUND TO NITROUS OXIDE
531, 2ppaB, 0.6418, 2.14, 0.233, 337, 103, ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR BOUND TO NITROUS OXIDE
532, 1npnC, 0.6418, 2.14, 0.223, 336, 103, CRYSTAL STRUCTURE OF A COPPER RECONSTITUTED H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
533, 1mzzB, 0.6418, 2.15, 0.214, 334, 103, CRYSTAL STRUCTURE OF MUTANT (M182T)OF NITRITE REDUCTASE
534, 1l9qB, 0.6418, 2.14, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257L VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
535, 1l9pB, 0.6418, 2.14, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257G VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIES S-6
536, 5ofcA, 0.6417, 2.15, 0.233, 334, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 21.65MGY 
537, 5f7aB, 0.6417, 2.14, 0.233, 337, 103, NITRITE COMPLEX STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS DETERMINED AT 293 K
538, 2pp9C, 0.6417, 2.13, 0.233, 336, 103, NITRATE BOUND WILD TYPE OXIDIZED AFNIR
539, 1sjmC, 0.6417, 2.14, 0.233, 336, 103, NITRITE BOUND COPPER CONTAINING NITRITE REDUCTASE
540, 1l9pC, 0.6417, 2.14, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257G VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIES S-6
541, 1l9oB, 0.6417, 2.14, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257A VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
542, 1kbwD, 0.6417, 2.16, 0.223, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
543, 1as8B, 0.6417, 2.14, 0.233, 336, 103, STRUCTURE OF NITRITE BOUND TO REDUCED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
544, 6gt0A, 0.6416, 2.15, 0.233, 333, 103, NITRITE-BOUND COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY 
545, 5tb7B, 0.6416, 2.16, 0.223, 311, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP P212121
546, 5f7bB, 0.6416, 2.14, 0.233, 337, 103, RESTING STATE STRUCTURE OF CUNIR FORM ALCALIGENES FAECALIS DETERMINED AT 293 K
547, 5b1jB, 0.6416, 2.13, 0.243, 334, 103, CRYSTAL STRUCTURE OF THE ELECTRON-TRANSFER COMPLEX OF COPPER NITRITE REDUCTASE WITH A CUPREDOXIN
548, 3h4fB, 0.6416, 2.14, 0.233, 336, 103, MET62LEU VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECLIS
549, 2y1aA, 0.6416, 2.15, 0.233, 332, 103, CRYSTAL STRUCTURE OF ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE WITH BOUND NO
550, 2pp7C, 0.6416, 2.14, 0.233, 336, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR (ACETATE BOUND)
551, 1zdsC, 0.6416, 2.14, 0.223, 336, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH ACETAMIDE BOUND
552, 1rzqA, 0.6416, 2.15, 0.233, 328, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH5.0
553, 1n70A, 0.6416, 2.16, 0.223, 334, 103, THE CRYSTAL STRUCTURE OF NITRITE REDUCTASE MUTANT HIS287ALA FROM RHODOBACTER SPHAEROIDES
554, 1l9oC, 0.6416, 2.14, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257A VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
555, 1j9tA, 0.6416, 2.15, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED H255N AFNIR
556, 1as8C, 0.6416, 2.14, 0.233, 336, 103, STRUCTURE OF NITRITE BOUND TO REDUCED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
557, 1aq8B, 0.6416, 2.14, 0.233, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE REDUCED WITH ASCORBATE
558, 5ue6H, 0.6415, 2.16, 0.223, 310, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
559, 5d4iB, 0.6415, 2.14, 0.233, 341, 103, INTACT NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY
560, 5d4hC, 0.6415, 2.14, 0.233, 339, 103, HIGH-RESOLUTION NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SYNCHROTRON RADIATION CRYSTALLOGRAPHY
561, 3h4hB, 0.6415, 2.14, 0.233, 334, 103, MET94THR/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
562, 2ppcC, 0.6415, 2.14, 0.233, 336, 103, OXIDIZED WILD TYPE AFNIR EXPOSED TO NO (NITRITE BOUND)
563, 2fjsB, 0.6415, 2.14, 0.233, 337, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY REDUCED WILD TYPE NITRITE REDUCTASE FROM A. FAECALIS
564, 2e86C, 0.6415, 2.14, 0.233, 336, 103, AZIDE BOUND TO COPPER CONTAINING NITRITE REDUCTASE FROM A. FAECALIS S- 2 6
565, 2bwiA, 0.6415, 2.15, 0.233, 334, 103, ATOMIC RESOLUTION STRUCTURE OF NITRITE -SOAKED ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE
566, 1npjC, 0.6415, 2.14, 0.223, 336, 103, CRYSTAL STRUCTURE OF H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
567, 1l9rC, 0.6415, 2.15, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257M VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
568, 1l9rB, 0.6415, 2.14, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257M VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
569, 1l9qC, 0.6415, 2.14, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257L VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
570, 1kbvD, 0.6415, 2.16, 0.223, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
571, 1as8A, 0.6415, 2.14, 0.233, 336, 103, STRUCTURE OF NITRITE BOUND TO REDUCED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
572, 1as7B, 0.6415, 2.14, 0.233, 337, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
573, 5f7bC, 0.6414, 2.14, 0.233, 336, 103, RESTING STATE STRUCTURE OF CUNIR FORM ALCALIGENES FAECALIS DETERMINED AT 293 K
574, 5f7aC, 0.6414, 2.14, 0.233, 336, 103, NITRITE COMPLEX STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS DETERMINED AT 293 K
575, 5d4hB, 0.6414, 2.14, 0.233, 341, 103, HIGH-RESOLUTION NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SYNCHROTRON RADIATION CRYSTALLOGRAPHY
576, 5d4hA, 0.6414, 2.14, 0.233, 337, 103, HIGH-RESOLUTION NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SYNCHROTRON RADIATION CRYSTALLOGRAPHY
577, 2ppdB, 0.6414, 2.14, 0.223, 337, 103, OXIDIZED H145A MUTANT OF AFNIR BOUND TO NITRIC OXIDE
578, 2pp9B, 0.6414, 2.14, 0.233, 337, 103, NITRATE BOUND WILD TYPE OXIDIZED AFNIR
579, 2pp8C, 0.6414, 2.14, 0.233, 336, 103, FORMATE BOUND TO OXIDIZED WILD TYPE AFNIR
580, 2pp8B, 0.6414, 2.14, 0.233, 336, 103, FORMATE BOUND TO OXIDIZED WILD TYPE AFNIR
581, 2dv6C, 0.6414, 2.16, 0.223, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
582, 1l9sC, 0.6414, 2.14, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257T VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
583, 5of8A, 0.6413, 2.15, 0.233, 333, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
584, 2ppfB, 0.6413, 2.14, 0.233, 337, 103, REDUCED MUTANT D98N OF AFNIR EXPOSED TO NITRIC OXIDE
585, 2ppeB, 0.6413, 2.14, 0.223, 337, 103, REDUCED H145A MUTANT OF AFNIR EXPOSED TO NO
586, 2fjsA, 0.6413, 2.15, 0.233, 336, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY REDUCED WILD TYPE NITRITE REDUCTASE FROM A. FAECALIS
587, 2e86B, 0.6413, 2.14, 0.233, 337, 103, AZIDE BOUND TO COPPER CONTAINING NITRITE REDUCTASE FROM A. FAECALIS S- 2 6
588, 2bw4A, 0.6413, 2.15, 0.233, 334, 103, ATOMIC RESOLUTION STRUCTURE OF RESTING STATE OF THE ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE
589, 1sjmB, 0.6413, 2.14, 0.233, 336, 103, NITRITE BOUND COPPER CONTAINING NITRITE REDUCTASE
590, 1kbvF, 0.6413, 2.16, 0.223, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
591, 1j9qC, 0.6413, 2.14, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED D98N AFNIR
592, 1as7C, 0.6413, 2.14, 0.233, 337, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
593, 1as6C, 0.6413, 2.14, 0.233, 335, 103, STRUCTURE OF NITRITE BOUND TO OXIDIZED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
594, 6gt2A, 0.6412, 2.15, 0.233, 333, 103, REDUCED COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY 
595, 5ofeA, 0.6412, 2.15, 0.233, 334, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
596, 5of7A, 0.6412, 2.15, 0.233, 334, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
597, 4yscB, 0.6412, 2.14, 0.233, 336, 103, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
598, 3h4fC, 0.6412, 2.14, 0.233, 336, 103, MET62LEU VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECLIS
599, 2ppeA, 0.6412, 2.15, 0.223, 336, 103, REDUCED H145A MUTANT OF AFNIR EXPOSED TO NO
600, 2pp8A, 0.6412, 2.14, 0.233, 336, 103, FORMATE BOUND TO OXIDIZED WILD TYPE AFNIR
601, 2dv6B, 0.6412, 2.16, 0.223, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
602, 1zdsB, 0.6412, 2.15, 0.223, 336, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH ACETAMIDE BOUND
603, 1snrB, 0.6412, 2.14, 0.233, 337, 103, NITRIC OXIDE BOUND TO CU NITRITE REDUCTASE
604, 1l9tC, 0.6412, 2.15, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257V VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
605, 1l9tB, 0.6412, 2.14, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257V VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
606, 1kbvC, 0.6412, 2.16, 0.223, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
607, 1j9sC, 0.6412, 2.15, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED H255N AFNIR
608, 1aq8C, 0.6412, 2.14, 0.233, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE REDUCED WITH ASCORBATE
609, 5ue6B, 0.6411, 2.16, 0.223, 310, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
610, 5d4jC, 0.6411, 2.15, 0.233, 336, 103, CHLORIDE-BOUND FORM OF A COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALS
611, 5akrA, 0.6411, 2.16, 0.233, 337, 103, ATOMIC RESOLUTION STRUCTURE OF NITRITE BOUND STATE OF THE ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE AT 0.87 A RESOLUTION
612, 4yscC, 0.6411, 2.15, 0.233, 335, 103, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
613, 2pp7B, 0.6411, 2.15, 0.233, 337, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR (ACETATE BOUND)
614, 2dv6F, 0.6411, 2.15, 0.223, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
615, 1kbvE, 0.6411, 2.16, 0.223, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
616, 5ue6E, 0.6410, 2.16, 0.223, 310, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
617, 5ue6D, 0.6410, 2.16, 0.223, 309, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
618, 3h4hC, 0.6410, 2.14, 0.233, 334, 103, MET94THR/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
619, 2ppdA, 0.6410, 2.15, 0.223, 336, 103, OXIDIZED H145A MUTANT OF AFNIR BOUND TO NITRIC OXIDE
620, 2ppcB, 0.6410, 2.15, 0.233, 337, 103, OXIDIZED WILD TYPE AFNIR EXPOSED TO NO (NITRITE BOUND)
621, 1l9sB, 0.6410, 2.15, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257T VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
622, 1j9qB, 0.6410, 2.14, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED D98N AFNIR
623, 1as6B, 0.6410, 2.14, 0.233, 336, 103, STRUCTURE OF NITRITE BOUND TO OXIDIZED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
624, 3h4fA, 0.6409, 2.14, 0.233, 336, 103, MET62LEU VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECLIS
625, 1j9sA, 0.6409, 2.15, 0.223, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED H255N AFNIR
626, 1j9rA, 0.6409, 2.15, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED D98N AFNIR
627, 1as7A, 0.6409, 2.15, 0.233, 337, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
628, 1as6A, 0.6409, 2.14, 0.223, 335, 103, STRUCTURE OF NITRITE BOUND TO OXIDIZED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
629, 2pp9A, 0.6408, 2.14, 0.233, 336, 103, NITRATE BOUND WILD TYPE OXIDIZED AFNIR
630, 2p80C, 0.6408, 2.15, 0.233, 336, 103, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN NITRITE REDUCTASE AND PSEUDOAZURIN FROM A. FAECALIS
631, 2dv6A, 0.6408, 2.16, 0.223, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
632, 1npjA, 0.6408, 2.15, 0.223, 336, 103, CRYSTAL STRUCTURE OF H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
633, 5of6A, 0.6407, 2.16, 0.233, 334, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
634, 5d4jA, 0.6407, 2.15, 0.233, 335, 103, CHLORIDE-BOUND FORM OF A COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALS
635, 4yseB, 0.6407, 2.15, 0.233, 337, 103, HIGH RESOLUTION SYNCHROTRON STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
636, 2ppfA, 0.6407, 2.15, 0.233, 336, 103, REDUCED MUTANT D98N OF AFNIR EXPOSED TO NITRIC OXIDE
637, 2ppaA, 0.6407, 2.15, 0.233, 336, 103, ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR BOUND TO NITROUS OXIDE
638, 2b08A, 0.6407, 2.15, 0.223, 335, 103, REDUCED ACETAMIDE-BOUND M150G NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
639, 1snrA, 0.6407, 2.15, 0.233, 336, 103, NITRIC OXIDE BOUND TO CU NITRITE REDUCTASE
640, 1rzpA, 0.6407, 2.16, 0.233, 328, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH6.2
641, 2p80B, 0.6406, 2.15, 0.233, 336, 103, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN NITRITE REDUCTASE AND PSEUDOAZURIN FROM A. FAECALIS
642, 1npnA, 0.6406, 2.15, 0.223, 336, 103, CRYSTAL STRUCTURE OF A COPPER RECONSTITUTED H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
643, 1kbvB, 0.6406, 2.16, 0.223, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
644, 2ppcA, 0.6405, 2.15, 0.233, 336, 103, OXIDIZED WILD TYPE AFNIR EXPOSED TO NO (NITRITE BOUND)
645, 2pp7A, 0.6405, 2.15, 0.233, 336, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR (ACETATE BOUND)
646, 2dy2A, 0.6405, 2.15, 0.223, 329, 103, NITRITE REDUCTASE PH 6.0
647, 1zdqC, 0.6405, 2.15, 0.223, 336, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH METHYLSULFANYL METHANE BOUND
648, 1l9rA, 0.6405, 2.16, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257M VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
649, 1j9qA, 0.6405, 2.15, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED D98N AFNIR
650, 5ue6G, 0.6404, 2.17, 0.223, 314, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
651, 5n8iA, 0.6404, 2.16, 0.233, 334, 103, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 100K REFERENCE DATASET.
652, 1zdqB, 0.6404, 2.15, 0.223, 336, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH METHYLSULFANYL METHANE BOUND
653, 1sjmA, 0.6404, 2.15, 0.233, 335, 103, NITRITE BOUND COPPER CONTAINING NITRITE REDUCTASE
654, 1l9pA, 0.6404, 2.16, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257G VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIES S-6
655, 4yseA, 0.6403, 2.15, 0.233, 337, 103, HIGH RESOLUTION SYNCHROTRON STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
656, 2dv6E, 0.6403, 2.16, 0.223, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
657, 1l9tA, 0.6403, 2.16, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257V VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
658, 1aq8A, 0.6403, 2.15, 0.233, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE REDUCED WITH ASCORBATE
659, 2e86A, 0.6402, 2.15, 0.233, 336, 103, AZIDE BOUND TO COPPER CONTAINING NITRITE REDUCTASE FROM A. FAECALIS S- 2 6
660, 2dwtA, 0.6401, 2.17, 0.223, 329, 103, CU-CONTAINING NITRITE REDUCTASE AT PH 6.0 WITH BOUND NITRITE
661, 1l9qA, 0.6401, 2.16, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257L VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
662, 1l9oA, 0.6401, 2.16, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257A VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
663, 1l9sA, 0.6400, 2.16, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257T VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
664, 3h4hA, 0.6399, 2.16, 0.223, 334, 103, MET94THR/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
665, 5ue6A, 0.6397, 2.17, 0.223, 314, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
666, 2p80A, 0.6397, 2.16, 0.233, 335, 103, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN NITRITE REDUCTASE AND PSEUDOAZURIN FROM A. FAECALIS
667, 2xx1D, 0.6396, 2.20, 0.243, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
668, 1zdsA, 0.6396, 2.16, 0.223, 335, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH ACETAMIDE BOUND
669, 1zdqA, 0.6391, 2.16, 0.214, 335, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH METHYLSULFANYL METHANE BOUND
670, 4knuD, 0.6386, 2.16, 0.248, 285, 101, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
671, 4knsB, 0.6385, 2.16, 0.238, 285, 101, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
672, 5zl1D, 0.6383, 1.87, 0.170, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
673, 5zl1C, 0.6383, 1.87, 0.170, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
674, 5zl1A, 0.6383, 1.87, 0.170, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
675, 4knsC, 0.6382, 1.98, 0.240, 285, 100, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
676, 5zl1B, 0.6380, 1.88, 0.170, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
677, 4knuB, 0.6380, 2.17, 0.238, 285, 101, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
678, 4yseC, 0.6379, 2.18, 0.233, 337, 103, HIGH RESOLUTION SYNCHROTRON STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
679, 4knuF, 0.6378, 2.17, 0.238, 285, 101, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
680, 2xx1E, 0.6378, 2.21, 0.243, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
681, 5of5A, 0.6377, 2.20, 0.233, 333, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 
682, 2xx1B, 0.6376, 2.21, 0.243, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
683, 2xx1C, 0.6375, 2.20, 0.243, 334, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
684, 4knuA, 0.6374, 2.17, 0.238, 285, 101, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
685, 4knsA, 0.6369, 2.18, 0.238, 285, 101, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
686, 4knuC, 0.6364, 1.71, 0.232, 285, 99, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
687, 4knuE, 0.6363, 2.19, 0.238, 285, 101, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
688, 4kntB, 0.6363, 2.18, 0.238, 285, 101, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA PH 8.5
689, 4knsD, 0.6363, 1.71, 0.232, 285, 99, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
690, 4knsF, 0.6359, 1.72, 0.222, 285, 99, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
691, 4knsE, 0.6359, 2.02, 0.240, 285, 100, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
692, 4kntA, 0.6352, 1.72, 0.232, 285, 99, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA PH 8.5
693, 4kntC, 0.6351, 1.72, 0.232, 285, 99, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA PH 8.5
694, 4q89A, 0.6312, 2.73, 0.104, 501, 106, CRYSTAL STRUCTURE OF THE COTA NATIVE ENZYME
695, 1curA, 0.6304, 2.30, 0.183, 155, 104, REDUCED RUSTICYANIN NMR
696, 4q8bA, 0.6301, 2.74, 0.104, 499, 106, THE CRYSTAL STRUCTURE OF COTA LACCASE COMPLEXED WITH SINAPIC ACID
697, 3gyrJ, 0.6292, 2.80, 0.142, 587, 106, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
698, 2bhfA, 0.6289, 2.75, 0.104, 504, 106, 3D STRUCTURE OF THE REDUCED FORM OF COTA
699, 2avfA, 0.6288, 2.31, 0.238, 314, 101, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
700, 2avfB, 0.6285, 2.52, 0.235, 316, 102, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
701, 1of0A, 0.6282, 2.76, 0.104, 502, 106, CRYSTAL STRUCTURE OF BACILLUS SUBTILIS COTA AFTER 1H SOAKING WITH EBS
702, 2avfD, 0.6280, 2.47, 0.235, 320, 102, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
703, 1gskA, 0.6280, 2.76, 0.104, 502, 106, CRYSTAL STRUCTURE OF COTA AN ENDOSPORE COAT PROTEIN FROM BACILLUS SUBTILIS
704, 5zlmA, 0.6279, 2.76, 0.104, 502, 106, MUTATION IN THE TRINUCLEAR SITE OF COTA-LACCASE: H491C MUTANT; PH 8.0 
705, 2x87A, 0.6278, 2.76, 0.104, 504, 106, CRYSTAL STRUCTURE OF THE RECONSTITUTED COTA
706, 4q8bB, 0.6277, 2.77, 0.104, 499, 106, THE CRYSTAL STRUCTURE OF COTA LACCASE COMPLEXED WITH SINAPIC ACID
707, 4akqA, 0.6277, 2.76, 0.104, 505, 106, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: E498D MUTANT
708, 4a67A, 0.6277, 2.76, 0.104, 504, 106, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: D116E MUTANT
709, 4yvnA, 0.6276, 2.77, 0.104, 505, 106, CRYSTAL STRUCTURE OF COTA LACCASE COMPLEXED WITH ABTS AT A NOVEL BINDING SITE
710, 4a68A, 0.6276, 2.75, 0.104, 502, 106, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: D116N MUTANT
711, 3zdwA, 0.6276, 2.76, 0.104, 502, 106, SUBSTRATE AND DIOXYGEN BINDING TO THE ENDOSPORE COAT LACCASE COTA FROM BACILLUS SUBTILIS
712, 1w8eA, 0.6276, 2.76, 0.104, 505, 106, 3D STRUCTURE OF COTA INCUBATED WITH HYDROGEN PEROXIDE
713, 1w6wA, 0.6276, 2.76, 0.104, 502, 106, 3D STRUCTURE OF COTA INCUBATED WITH SODIUM AZIDE
714, 4akpA, 0.6275, 2.76, 0.104, 504, 106, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE:E498T MUTANT
715, 2x88A, 0.6275, 2.76, 0.104, 504, 106, CRYSTAL STRUCTURE OF HOLOCOTA
716, 5zljA, 0.6274, 2.76, 0.104, 503, 106, CRYSTAL STRUCTURE OF COTA NATIVE ENZYME; PH8.0 
717, 2wsdA, 0.6274, 2.77, 0.104, 504, 106, PROXIMAL MUTATIONS AT THE TYPE 1 CU SITE OF COTA-LACCASE: I494A MUTANT
718, 5zllA, 0.6273, 2.76, 0.104, 503, 106, MUTATION IN THE TRINUCLEAR SITE OF COTA-LACCASE: H493C MUTANT; PH 8.0 
719, 4akoA, 0.6273, 2.76, 0.104, 505, 106, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: E498L MUTANT
720, 4yvuA, 0.6272, 2.76, 0.104, 506, 106, CRYSTAL STRUCTURE OF COTA NATIVE ENZYME IN THE ACID CONDITION PH5.6
721, 4a66A, 0.6272, 2.75, 0.113, 501, 106, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: D116A MUTANT
722, 1w6lA, 0.6272, 2.76, 0.104, 503, 106, 3D STRUCTURE OF COTA INCUBATED WITH CUCL2
723, 6iqyB, 0.6270, 2.42, 0.078, 536, 102, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
724, 5zd7B, 0.6270, 2.42, 0.078, 536, 102, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
725, 4q89B, 0.6269, 2.78, 0.104, 499, 106, CRYSTAL STRUCTURE OF THE COTA NATIVE ENZYME
726, 3x1gA, 0.6267, 1.78, 0.214, 296, 98, H294M MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS SHOWING TWO COORDINATION GEOMETRIES AT THE T2CU SITE
727, 3x1fA, 0.6265, 1.79, 0.214, 296, 98, H294M MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
728, 6iqyA, 0.6264, 2.42, 0.078, 536, 102, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
729, 5zd7A, 0.6264, 2.42, 0.078, 536, 102, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
730, 4ysaA, 0.6264, 1.77, 0.214, 294, 98, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
731, 5zlkA, 0.6263, 2.77, 0.104, 506, 106, MUTATION IN THE TRINUCLEAR SITE OF COTA-LACCASE: H493A MUTANT; PH 8.0 
732, 5ytlA, 0.6260, 1.79, 0.214, 294, 98, CRYSTAL STRUCTURE OF GEOBACILLUS THERMODENITRIFICANS COPPER-CONTAINING NITRITE REDUCTASE DETERMINED WITH AN ANAEROBICALLY MANIPULATED CRYSTAL 
733, 3x1nA, 0.6258, 1.78, 0.204, 298, 98, NITRITE-BOUND THERMOSTABLE COPPER NITRITE REDUCTASE AT 320 K
734, 4zk8A, 0.6257, 1.79, 0.214, 294, 98, COPPER-CONTAINING NITRITE REDUCTASE FROM THERMOPHILIC BACTERIUM GEOBACILLUS THERMODENITRIFICANS (RE-REFINED)
735, 4ysrA, 0.6257, 1.80, 0.214, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 16.6 MGY
736, 4yspA, 0.6257, 1.80, 0.214, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 8.32 MGY
737, 4yssA, 0.6256, 1.80, 0.214, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 16.7 MGY
738, 4ysuA, 0.6255, 1.80, 0.214, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 25.0 MGY
739, 4ystA, 0.6255, 1.80, 0.214, 294, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 24.9 MGY
740, 4ysqA, 0.6255, 1.80, 0.214, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 8.38 MGY
741, 5ytnA, 0.6253, 1.80, 0.204, 298, 98, C135A MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS IN COMPLEX WITH PEROXIDE 
742, 3x1eA, 0.6252, 1.80, 0.214, 295, 98, STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS WITHOUT CHLORIDE
743, 4ysoA, 0.6251, 1.80, 0.214, 295, 98, COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 0.064 MGY
744, 5ytmA, 0.6250, 1.81, 0.204, 298, 98, C135A MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS DETERMINED BY IN-OUSE SOURCE 
745, 3wniA, 0.6250, 1.80, 0.214, 298, 98, 1.50 A RESOLUTION CRYSTAL STRUCTURE OF DIOXYGEN BOUND COPPER- CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
746, 3wnjA, 0.6249, 1.80, 0.214, 298, 98, 1.20 A RESOLUTION CRYSTAL STRUCTURE OF DIOXYGEN BOUND COPPER- CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
747, 3wiaG, 0.6249, 1.81, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
748, 3wiaD, 0.6249, 1.81, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
749, 3wiaC, 0.6247, 1.80, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
750, 3wiaA, 0.6247, 1.81, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
751, 3wkpA, 0.6245, 1.81, 0.204, 295, 98, C135A MUTANT OF GEOBACILLUS THERMODENITRIFICANS COPPER-CONTAINING NITRITE REDUCTASE IN COMPLEX WITH NITRITE
752, 2j5wA, 0.6243, 3.17, 0.176, 1029, 108, CERULOPLASMIN REVISITED: STRUCTURAL AND FUNCTIONAL ROLES OF VARIOUS METAL CATION BINDING SITES
753, 4enzA, 0.6242, 3.19, 0.176, 1029, 108, STRUCTURE OF HUMAN CERULOPLASMIN AT 2.6 A RESOLUTION
754, 3wiaB, 0.6241, 1.81, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
755, 1qniE, 0.6241, 1.91, 0.186, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
756, 1qniB, 0.6240, 1.91, 0.196, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
757, 1qniA, 0.6240, 1.91, 0.186, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
758, 3wiaH, 0.6236, 1.82, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
759, 3wiaF, 0.6233, 1.82, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
760, 3wiaE, 0.6232, 1.82, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
761, 1qniC, 0.6232, 1.92, 0.196, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
762, 1qniD, 0.6228, 1.93, 0.186, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
763, 1fwxC, 0.6224, 1.95, 0.186, 590, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS
764, 1qniF, 0.6222, 1.93, 0.196, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
765, 1fwxA, 0.6222, 1.96, 0.186, 591, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS
766, 4e9xC, 0.6221, 2.27, 0.190, 316, 100, MULTICOPPER OXIDASE MGLAC (DATA3)
767, 4e9wC, 0.6221, 2.26, 0.190, 316, 100, MULTICOPPER OXIDASE MGLAC (DATA2)
768, 4e9yC, 0.6218, 2.27, 0.190, 316, 100, MULTICOPPER OXIDASE MGLAC (DATA4)
769, 4e9vC, 0.6216, 2.26, 0.190, 316, 100, MULTICOPPER OXIDASE MGLAC (DATA1)
770, 4e9vA, 0.6216, 2.29, 0.190, 317, 100, MULTICOPPER OXIDASE MGLAC (DATA1)
771, 2zwnC, 0.6216, 2.27, 0.190, 316, 100, CRYSTAL STRUCTURE OF THE NOVEL TWO-DOMAIN TYPE LACCASE FROM A METAGENOME
772, 4e9yA, 0.6215, 2.29, 0.190, 317, 100, MULTICOPPER OXIDASE MGLAC (DATA4)
773, 4e9xA, 0.6215, 2.29, 0.190, 317, 100, MULTICOPPER OXIDASE MGLAC (DATA3)
774, 4e9wA, 0.6215, 2.29, 0.190, 317, 100, MULTICOPPER OXIDASE MGLAC (DATA2)
775, 2zwnA, 0.6215, 2.29, 0.190, 317, 100, CRYSTAL STRUCTURE OF THE NOVEL TWO-DOMAIN TYPE LACCASE FROM A METAGENOME
776, 4bdvA, 0.6209, 2.87, 0.142, 612, 106, CRYSTAL STRUCTURE OF A TRUNCATED B-DOMAIN HUMAN FACTOR VIII
777, 3gdcB, 0.6209, 2.27, 0.180, 285, 100, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE
778, 3gdcA, 0.6205, 2.32, 0.180, 288, 100, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE
779, 5z1xB, 0.6204, 2.75, 0.155, 495, 103, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA SP. RSD1 
780, 5z1xA, 0.6204, 2.75, 0.155, 495, 103, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA SP. RSD1 
781, 5z22A, 0.6202, 2.75, 0.155, 494, 103, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA SP. RSD1 
782, 3gdcC, 0.6202, 2.26, 0.180, 286, 100, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE
783, 2iwfA, 0.6199, 1.90, 0.208, 590, 96, RESTING FORM OF PINK NITROUS OXIDE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
784, 2iwkA, 0.6197, 1.91, 0.208, 590, 96, INHIBITOR-BOUND FORM OF NITROUS OXIDE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT 1.7 ANGSTROM RESOLUTION
785, 1fwxB, 0.6196, 1.89, 0.187, 589, 96, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS
786, 3wiaI, 0.6194, 1.80, 0.206, 272, 97, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
787, 2iwfB, 0.6194, 1.90, 0.208, 590, 96, RESTING FORM OF PINK NITROUS OXIDE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
788, 1fwxD, 0.6193, 1.90, 0.187, 588, 96, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS
789, 2iwkB, 0.6191, 1.92, 0.208, 590, 96, INHIBITOR-BOUND FORM OF NITROUS OXIDE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT 1.7 ANGSTROM RESOLUTION
790, 5i5mB, 0.6189, 1.95, 0.144, 576, 97, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE CA2+-RECONSTITUTED FORM
791, 5ehfA, 0.6185, 2.58, 0.127, 497, 102, LACCASE FROM ANTRODIELLA FAGINEA
792, 5i5mA, 0.6184, 1.95, 0.144, 575, 97, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE CA2+-RECONSTITUTED FORM
793, 3kw7A, 0.6184, 2.76, 0.146, 502, 103, CRYSTAL STRUCTURE OF LACB FROM TRAMETES SP. AH28-2
794, 2zwnB, 0.6184, 2.34, 0.190, 316, 100, CRYSTAL STRUCTURE OF THE NOVEL TWO-DOMAIN TYPE LACCASE FROM A METAGENOME
795, 3t6vC, 0.6181, 2.78, 0.136, 495, 103, CRYSTAL STRUCTURE OF LACCASE FROM STECCHERINUM OCHRACEUM
796, 6rkzB, 0.6180, 2.03, 0.214, 586, 98, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM II 
797, 4e9yB, 0.6178, 2.34, 0.190, 316, 100, MULTICOPPER OXIDASE MGLAC (DATA4)
798, 4e9xB, 0.6178, 2.34, 0.190, 316, 100, MULTICOPPER OXIDASE MGLAC (DATA3)
799, 3kw7B, 0.6178, 2.77, 0.146, 502, 103, CRYSTAL STRUCTURE OF LACB FROM TRAMETES SP. AH28-2
800, 3g5wA, 0.6177, 2.31, 0.160, 318, 100, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
801, 4e9wB, 0.6175, 2.35, 0.190, 316, 100, MULTICOPPER OXIDASE MGLAC (DATA2)
802, 4e9vB, 0.6175, 2.35, 0.190, 316, 100, MULTICOPPER OXIDASE MGLAC (DATA1)
803, 1kyaD, 0.6172, 2.75, 0.136, 499, 103, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
804, 3v9cA, 0.6171, 2.76, 0.117, 499, 103, TYPE-2 CU-DEPLETED FUNGUS LACCASE FROM TRAMETES HIRSUTA AT LOW DOSE OF IONIZATION RADIATION
805, 1kyaC, 0.6171, 2.75, 0.136, 499, 103, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
806, 1kyaB, 0.6171, 2.75, 0.136, 499, 103, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
807, 1kyaA, 0.6170, 2.75, 0.136, 499, 103, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
808, 3pxlA, 0.6169, 2.77, 0.117, 499, 103, TYPE-2 CU-DEPLETED FUNGUS LACCASE FROM TRAMETES HIRSUTA
809, 6rikA, 0.6168, 2.39, 0.149, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. THIRTEENTH STRUCTURE OF THE SERIES WITH 5200 KGY DOSE. 
810, 3g5wE, 0.6168, 2.32, 0.160, 318, 100, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
811, 3t6xC, 0.6167, 2.63, 0.147, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (20 percent DOSE)
812, 3t6wB, 0.6167, 2.63, 0.147, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (10 percent DOSE)
813, 6rilA, 0.6166, 2.39, 0.149, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FOURTEENTH STRUCTURE OF THE SERIES WITH 5600 KGY DOSE (DATA WAS COLLECTED AFTER REFREEZING). 
814, 6ri2A, 0.6166, 2.40, 0.149, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. TWENTIETH STRUCTURE OF THE SERIES WITH 4065 KGY DOSE. 
815, 6rhpA, 0.6166, 2.39, 0.149, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. TWENTY FIRST STRUCTURE OF THE SERIES WITH 4415 KGY DOSE (COLLECTED AFTER REFREEZING). 
816, 6rhoA, 0.6166, 2.39, 0.149, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. TWENTIETH STRUCTURE OF THE SERIES WITH 4065 KGY DOSE. 
817, 6riiA, 0.6165, 2.39, 0.149, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FOURTH STRUCTURE OF THE SERIES WITH 1200 KGY DOSE. 
818, 6ri8A, 0.6165, 2.39, 0.149, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. THIRD STRUCTURE OF THE SERIES WITH 800 KGY DOSE. 
819, 6ri6A, 0.6165, 2.39, 0.149, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. SECOND STRUCTURE OF THE SERIES WITH 400 KGY DOSE. 
820, 6ri4A, 0.6165, 2.39, 0.149, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FIRST STRUCTURE OF THE SERIES WITH 13 KGY DOSE. 
821, 3divA, 0.6165, 2.78, 0.126, 497, 103, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA MAXIMA AT 1.76A RESOLUTION
822, 6rhrA, 0.6164, 2.39, 0.149, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FIRST STRUCTURE OF THE SERIES WITH 15 KGY DOSE. 
823, 6rhiA, 0.6164, 2.39, 0.149, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. NINTH STRUCTURE OF THE SERIES WITH 1215 KGY DOSE. 
824, 6rhhA, 0.6164, 2.39, 0.149, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. THIRD STRUCTURE OF THE SERIES WITH 315 KGY DOSE. 
825, 6rgpA, 0.6164, 2.39, 0.149, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. SECOND STRUCTURE OF THE SERIES WITH 165 KGY DOSE. 
826, 3t6zA, 0.6164, 2.42, 0.149, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (60 percent DOSE)
827, 6ri0A, 0.6163, 2.39, 0.149, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. NINTH STRUCTURE OF THE SERIES WITH 1215 KGY DOSE. 
828, 6rhuA, 0.6163, 2.39, 0.149, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. SECOND STRUCTURE OF THE SERIES WITH 165 KGY DOSE. 
829, 6rghA, 0.6163, 2.39, 0.149, 499, 101, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. FIRST STRUCTURE OF THE SERIES WITH 15 KGY DOSE. 
830, 5micA, 0.6163, 2.40, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 13-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 363 MIN.
831, 5e9nA, 0.6163, 2.39, 0.149, 495, 101, STECCHERINUM MURASHKINSKYI LACCASE AT 0.95 RESOLUTION
832, 3t71B, 0.6163, 2.63, 0.147, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (90 percent DOSE)
833, 3g5wD, 0.6163, 2.34, 0.160, 318, 100, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
834, 6rhxA, 0.6162, 2.39, 0.149, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. THIRD STRUCTURE OF THE SERIES WITH 315 KGY DOSE. 
835, 5migA, 0.6162, 2.40, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 16-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 453 MIN. THE CRYSTAL WAS QUICK REFREEZING BEFORE THIS DATA COLLECTION.
836, 5mieA, 0.6162, 2.40, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 15-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 423 MIN.
837, 5midA, 0.6162, 2.40, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 14-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 393 MIN.
838, 5miaA, 0.6162, 2.40, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 11-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 303 MIN.
839, 5mi2A, 0.6162, 2.40, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 10-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 273 MIN.
840, 5mi1A, 0.6162, 2.40, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 9-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 243 MIN.
841, 5mhyA, 0.6162, 2.40, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE SEVENTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 183 MIN.
842, 5mejA, 0.6162, 2.40, 0.149, 499, 101, STRUCTURAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI. FIRST STRUCTURE OF THE SERIES WITH 3 MIN TOTAL X-RAY EXPOSITION TIME.
843, 3t6vA, 0.6162, 2.40, 0.139, 495, 101, CRYSTAL STRUCTURE OF LACCASE FROM STECCHERINUM OCHRACEUM
844, 2h5uA, 0.6162, 2.78, 0.136, 497, 103, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA MAXIMA AT 1.9A RESOLUTION
845, 1v10A, 0.6162, 2.81, 0.136, 487, 103, STRUCTURE OF RIGIDOPORUS LIGNOSUS LACCASE FROM HEMIHEDRALLY TWINNED CRYSTALS
846, 6rl0D, 0.6161, 2.01, 0.216, 581, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM I 
847, 5mibA, 0.6161, 2.40, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 12-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 333 MIN.
848, 5mhzA, 0.6161, 2.40, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 8-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 213 MIN.
849, 5mhxA, 0.6161, 2.40, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE SIXTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 153 MIN.
850, 5mhwA, 0.6161, 2.40, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE FIFTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 123 MIN.
851, 5mhvA, 0.6161, 2.40, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE FOURTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 93 MIN.
852, 5mhuA, 0.6161, 2.40, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE THIRD STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 63 MIN.
853, 5mewA, 0.6161, 2.40, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI. SECOND STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 33 MIN.
854, 3t71C, 0.6161, 2.64, 0.147, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (90 percent DOSE)
855, 3g5wC, 0.6161, 2.33, 0.160, 318, 100, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
856, 3t6zC, 0.6158, 2.40, 0.139, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (60 percent DOSE)
857, 3t6vB, 0.6158, 2.43, 0.139, 495, 101, CRYSTAL STRUCTURE OF LACCASE FROM STECCHERINUM OCHRACEUM
858, 3t6xA, 0.6157, 2.41, 0.139, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (20 percent DOSE)
859, 3t6wA, 0.6157, 2.41, 0.139, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (10 percent DOSE)
860, 3g5wF, 0.6157, 2.34, 0.160, 318, 100, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
861, 3t71A, 0.6156, 2.41, 0.139, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (90 percent DOSE)
862, 3g5wB, 0.6156, 2.34, 0.160, 318, 100, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
863, 2fqdA, 0.6155, 2.60, 0.127, 464, 102, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
864, 6rl0A, 0.6154, 2.03, 0.227, 584, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM I 
865, 3t6wC, 0.6154, 2.42, 0.139, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (10 percent DOSE)
866, 3t6zB, 0.6152, 2.45, 0.149, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (60 percent DOSE)
867, 2uxtA, 0.6151, 2.46, 0.108, 422, 102, SUFI PROTEIN FROM ESCHERICHIA COLI
868, 6rl0B, 0.6150, 2.02, 0.227, 584, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM I 
869, 2xybA, 0.6150, 2.79, 0.136, 497, 103, CRYSTAL STRUCTURE OF A FULLY FUNCTIONAL LACCASE FROM THE LIGNINOLYTIC FUNGUS PYCNOPORUS CINNABARINUS
870, 2hzhA, 0.6149, 2.79, 0.136, 499, 103, CRYSTAL STRUCTURE OF LACCASE FROM CORIOLUS ZONATUS AT 2.6 A RESOLUTION
871, 3x1bB, 0.6148, 2.62, 0.108, 500, 102, CRYSTAL STRUCTURE OF LACCASE FROM LENTINUS SP. AT 1.8 A RESOLUTION
872, 6rl0C, 0.6147, 2.01, 0.227, 582, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM I 
873, 3fpxA, 0.6147, 2.62, 0.118, 499, 102, NATIVE FUNGUS LACCASE FROM TRAMETES HIRSUTA
874, 3t6xB, 0.6146, 2.43, 0.139, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (20 percent DOSE)
875, 3sbpF, 0.6146, 2.02, 0.216, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
876, 2fqgA, 0.6146, 2.61, 0.127, 464, 102, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
877, 5lduA, 0.6144, 2.80, 0.117, 499, 103, RECOMBINANT HIGH-REDOX POTENTIAL LACCASE FROM BASIDIOMYCETE TRAMETES HIRSUTA
878, 3gyrE, 0.6144, 2.08, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
879, 2fqfA, 0.6143, 2.61, 0.127, 465, 102, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
880, 5b7mB, 0.6141, 2.63, 0.127, 464, 102, STRUCTURE OF PERDEUTERATED CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
881, 5b7eA, 0.6140, 2.61, 0.127, 477, 102, STRUCTURE OF PERDEUTERATED CUEO
882, 1n68A, 0.6140, 2.65, 0.127, 464, 102, COPPER BOUND TO THE MULTICOPPER OXIDASE CUEO
883, 3sbrA, 0.6139, 2.06, 0.216, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
884, 3sbpG, 0.6139, 2.03, 0.216, 585, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
885, 3gyrG, 0.6139, 2.08, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
886, 2fqeA, 0.6139, 2.62, 0.127, 463, 102, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
887, 3x1bA, 0.6138, 2.43, 0.109, 500, 101, CRYSTAL STRUCTURE OF LACCASE FROM LENTINUS SP. AT 1.8 A RESOLUTION
888, 3sbqB, 0.6138, 2.03, 0.216, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P65 CRYSTAL FORM
889, 3sbpA, 0.6138, 2.06, 0.216, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
890, 6rkzA, 0.6137, 2.02, 0.216, 586, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM II 
891, 5b7mC, 0.6137, 2.64, 0.127, 462, 102, STRUCTURE OF PERDEUTERATED CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
892, 3sbpH, 0.6137, 2.02, 0.216, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
893, 3gyrL, 0.6137, 2.07, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
894, 4uanB, 0.6136, 2.38, 0.109, 270, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Q WITH DEPLETED TYPE-2 COPPER ION
895, 4uahB, 0.6136, 2.39, 0.109, 271, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99N WITH DEPLETED TYPE-2 COPPER ION
896, 3gyrF, 0.6136, 2.08, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
897, 3gyrD, 0.6136, 2.07, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
898, 3gyrC, 0.6136, 2.08, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
899, 3gyrA, 0.6136, 2.09, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
900, 5n4lA, 0.6135, 2.45, 0.198, 1034, 101, RAT CERULOPLASMIN TRIGONAL FORM
901, 4ejxA, 0.6135, 2.28, 0.190, 1034, 100, STRUCTURE OF CERULOPLASMIN-MYELOPEROXIDASE COMPLEX
902, 3gyrB, 0.6135, 2.08, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
903, 3sbrG, 0.6134, 2.06, 0.227, 585, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
904, 3gyrK, 0.6134, 2.08, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
905, 3gyrH, 0.6134, 2.08, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
906, 5nq9A, 0.6133, 2.82, 0.126, 497, 103, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM II MONOCLINIC
907, 3sbpD, 0.6133, 2.05, 0.227, 588, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
908, 3pauA, 0.6133, 2.61, 0.127, 464, 102, CUEO IN THE RESTING OXIDIZED STATE
909, 3gyrI, 0.6133, 2.08, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
910, 3sbrD, 0.6132, 2.04, 0.227, 588, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
911, 2qt6A, 0.6132, 2.80, 0.146, 498, 103, CRYSTAL STRUCTURE DETERMINATION OF A BLUE LACCASE FROM LENTINUS TIGRINUS
912, 4uanC, 0.6131, 2.39, 0.109, 272, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Q WITH DEPLETED TYPE-2 COPPER ION
913, 1gycA, 0.6131, 2.80, 0.136, 499, 103, CRYSTAL STRUCTURE DETERMINATION AT ROOM TEMPERATURE OF A LACCASE FROM TRAMETES VERSICOLOR IN ITS OXIDISED FORM CONTAINING A FULL COMPLEMENT OF COPPER IONS
914, 3sbpB, 0.6130, 2.06, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
915, 4wtqB, 0.6129, 2.40, 0.109, 269, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT M295L
916, 5nq8A, 0.6126, 2.82, 0.126, 497, 103, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM II
917, 3sbrE, 0.6126, 2.02, 0.237, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
918, 3nsfA, 0.6125, 2.64, 0.127, 480, 102, APO FORM OF THE MULTICOPPER OXIDASE CUEO
919, 2qt6B, 0.6125, 2.81, 0.146, 498, 103, CRYSTAL STRUCTURE DETERMINATION OF A BLUE LACCASE FROM LENTINUS TIGRINUS
920, 4wtqA, 0.6124, 2.40, 0.109, 270, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT M295L
921, 3sbrF, 0.6124, 2.04, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
922, 3sbpE, 0.6124, 2.03, 0.237, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
923, 6hbeC, 0.6123, 2.28, 0.214, 427, 98, CU-CONTAINING NITRITE REDUCTASE (NIRK) FROM THERMUS SCOTODUCTUS SA-01 
924, 4w1tB, 0.6123, 2.40, 0.109, 269, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Y WITH DEPLETED TYPE-2 COPPER ION
925, 3sbrH, 0.6123, 2.04, 0.216, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
926, 3sbrC, 0.6123, 2.07, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
927, 1kcwA, 0.6123, 2.30, 0.180, 1017, 100, X-RAY CRYSTAL STRUCTURE OF HUMAN CERULOPLASMIN AT 3.0 ANGSTROMS
928, 4wtqC, 0.6122, 2.40, 0.109, 269, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT M295L
929, 3sbpC, 0.6122, 2.06, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
930, 3pavA, 0.6121, 2.68, 0.127, 466, 102, THE REDUCED FORM OF CUEO
931, 5o4qA, 0.6120, 2.22, 0.130, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
932, 4uahA, 0.6120, 2.40, 0.109, 272, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99N WITH DEPLETED TYPE-2 COPPER ION
933, 3sbqA, 0.6120, 2.04, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P65 CRYSTAL FORM
934, 6hbeA, 0.6119, 2.30, 0.214, 425, 98, CU-CONTAINING NITRITE REDUCTASE (NIRK) FROM THERMUS SCOTODUCTUS SA-01 
935, 6hbeB, 0.6118, 2.30, 0.214, 425, 98, CU-CONTAINING NITRITE REDUCTASE (NIRK) FROM THERMUS SCOTODUCTUS SA-01 
936, 4w1tA, 0.6118, 2.40, 0.109, 272, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Y WITH DEPLETED TYPE-2 COPPER ION
937, 4hakA, 0.6118, 2.65, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT E506A
938, 2yxwA, 0.6118, 2.65, 0.127, 440, 102, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
939, 5nq9C, 0.6116, 2.84, 0.126, 497, 103, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM II MONOCLINIC
940, 1kv7A, 0.6116, 2.65, 0.127, 463, 102, CRYSTAL STRUCTURE OF CUEO A MULTI-COPPER OXIDASE FROM E. COLI INVOLVED IN COPPER HOMEOSTASIS
941, 5n0kA, 0.6115, 2.30, 0.200, 1034, 100, RAT CERULOPLASMIN ORTHORHOMBIC FORM
942, 3sbrB, 0.6115, 2.06, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
943, 5b7mA, 0.6114, 2.69, 0.127, 463, 102, STRUCTURE OF PERDEUTERATED CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
944, 4x4kA, 0.6112, 2.26, 0.143, 525, 98, STRUCTURE OF LACCASE FROM BOTRYTIS ACLADA WITH FULL COPPER CONTENT
945, 3t9wA, 0.6112, 2.43, 0.149, 270, 101, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116
946, 3nsyA, 0.6112, 2.67, 0.127, 465, 102, THE MULTI-COPPER OXIDASE CUEO WITH SIX MET TO SER MUTATIONS (M358S M361SM362SM364SM366SM368S)
947, 3nscA, 0.6112, 2.67, 0.127, 470, 102, C500S MUTANT OF CUEO BOUND TO CU(II)
948, 6im8A, 0.6111, 2.67, 0.127, 469, 102, CUEO-PM2 MULTICOPPER OXIDASE 
949, 2hrgA, 0.6111, 2.78, 0.147, 496, 102, CRYSTAL STRUCTURE OF BLUE LACCASE FROM TRAMETES TROGII COMPLEXED WITH P-METHYLBENZOATE
950, 5lm8A, 0.6110, 2.24, 0.153, 549, 98, CRYSTAL STRUCTURE OF A LACCASE-LIKE MULTICOPPER OXIDASE MCOG FROM FROM ASPERGILLUS NIGER
951, 4halA, 0.6110, 2.66, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT E506I
952, 3ta4D, 0.6110, 2.45, 0.149, 273, 101, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116 COMPLEXED WITH 1-(34- DIMETHOXYPHENYL)-2-(2-METHOXYPHENOXY)-13-DIHYDROXYPROPANE
953, 5o4qJ, 0.6109, 2.24, 0.130, 280, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
954, 4e9tA, 0.6109, 2.66, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO (DATA6)
955, 4m3hA, 0.6107, 2.42, 0.109, 269, 101, CRYSTAL STRUCTURE OF SMALL LACCASE SSL1 FROM STREPTOMYCES SVICEUS
956, 4e9rA, 0.6107, 2.66, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO (DATA4)
957, 2yxwB, 0.6107, 2.64, 0.127, 444, 102, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
958, 4e9sA, 0.6106, 2.66, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO (DATA5)
959, 4a2dA, 0.6106, 2.78, 0.137, 495, 102, CORIOLOPSIS GALLICA LACCASE T2 COPPER DEPLETED AT PH  4.5
960, 1pf3A, 0.6106, 2.67, 0.127, 463, 102, CRYSTAL STRUCTURE OF THE M441L MUTANT OF THE MULTICOPPER OXIDASE CUEO
961, 4m3hB, 0.6105, 2.42, 0.109, 269, 101, CRYSTAL STRUCTURE OF SMALL LACCASE SSL1 FROM STREPTOMYCES SVICEUS
962, 4e9qA, 0.6105, 2.66, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO (DATA2)
963, 4uanA, 0.6104, 2.41, 0.109, 276, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Q WITH DEPLETED TYPE-2 COPPER ION
964, 4nerA, 0.6104, 2.67, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO (DATA1)
965, 3uaeA, 0.6104, 2.66, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA6)
966, 3nt0A, 0.6104, 2.68, 0.127, 468, 102, C500S (T1D) MUTANT OF CUEO SOAKED IN AND BOUND TO CU(I)
967, 2yxvA, 0.6104, 2.67, 0.127, 444, 102, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
968, 5gnoA, 0.6103, 2.70, 0.127, 463, 102, STRUCTURE OF MULTICOPPER OXIDASE CUEO - SIGNAL PEPTIDE-FREE
969, 5b7fA, 0.6103, 2.70, 0.127, 463, 102, STRUCTURE OF CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
970, 3uadA, 0.6103, 2.66, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA5)
971, 3uacA, 0.6103, 2.66, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA4)
972, 4w1tC, 0.6102, 2.41, 0.109, 276, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Y WITH DEPLETED TYPE-2 COPPER ION
973, 4uahC, 0.6101, 2.41, 0.109, 276, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99N WITH DEPLETED TYPE-2 COPPER ION
974, 3qqxA, 0.6101, 2.68, 0.127, 474, 102, REDUCED NATIVE INTERMEDIATE OF THE MULTICOPPER OXIDASE CUEO
975, 3od3A, 0.6101, 2.67, 0.127, 488, 102, CUEO AT 1.1 A RESOLUTION INCLUDING RESIDUES IN PREVIOUSLY DISORDERED REGION
976, 4a2hA, 0.6100, 2.78, 0.137, 495, 102, CRYSTAL STRUCTURE OF LACCASE FROM CORIOLOPSIS GALLICA PH 7.0
977, 3uabA, 0.6099, 2.67, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA2)
978, 2hrhA, 0.6099, 2.84, 0.146, 496, 103, CRYSTAL STRUCTURE OF BLUE LACCASE FROM TRAMETES TROGII
979, 5ys5A, 0.6098, 2.56, 0.129, 457, 101, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE CUEO G304K MUTANT WITH SEVEN COPPER IONS 
980, 2yxvB, 0.6098, 2.65, 0.127, 440, 102, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
981, 4jhvA, 0.6097, 2.85, 0.136, 496, 103, T2-DEPLETED LACCASE FROM CORIOLOPSIS CAPERATA
982, 3uaaA, 0.6097, 2.66, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA1)
983, 6im9A, 0.6095, 2.55, 0.129, 490, 101, MDM2 BOUND CUEO-PM2 SENSOR 
984, 5anhA, 0.6094, 2.88, 0.146, 496, 103, CRYSTAL STRUCTURE OF LACCASE FROM BASIDIOMYCETE PM1 (CECT 2971)
985, 4a2eA, 0.6094, 2.79, 0.137, 495, 102, CRYSTAL STRUCTURE OF A CORIOLOPSIS GALLICA LACCASE AT 1.7 A RESOLUTION PH 5.5
986, 3nsdA, 0.6094, 2.69, 0.127, 462, 102, SILVER BOUND TO THE MULTICOPPER OXIDASE CUEO (UNTAGGED)
987, 3j2qA, 0.6094, 3.04, 0.151, 630, 106, MODEL OF MEMBRANE-BOUND FACTOR VIII ORGANIZED IN 2D CRYSTALS
988, 3cdzA, 0.6094, 3.04, 0.151, 630, 106, CRYSTAL STRUCTURE OF HUMAN FACTOR VIII
989, 2uxvB, 0.6094, 2.54, 0.108, 422, 102, SUFI PROTEIN FROM ESCHERICHIA COLI
990, 5nq7A, 0.6093, 2.68, 0.127, 497, 102, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM I
991, 3fu9B, 0.6091, 2.40, 0.141, 559, 99, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (20 MIN) WITH 26- DIMETHOXYPHENOL
992, 4ef3A, 0.6088, 2.74, 0.127, 466, 102, MULTICOPPER OXIDASE CUEO (CITRATE BUFFER)
993, 5ys1A, 0.6087, 2.57, 0.129, 461, 101, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE CUEO G304K MUTANT 
994, 4a2gA, 0.6087, 2.86, 0.136, 495, 103, CORIOLOPSIS GALLICA LACCASE COLLECTED AT 8.98 KEV
995, 3dkhA, 0.6085, 2.40, 0.141, 558, 99, L559A MUTANT OF MELANOCARPUS ALBOMYCES LACCASE
996, 4a2fA, 0.6084, 2.70, 0.137, 495, 102, CORIOLOPSIS GALLICA LACCASE COLLECTED AT 12.65 KEV
997, 4jhuA, 0.6082, 2.70, 0.137, 496, 102, T2-DEPLETED LACCASE FROM CORIOLOPSIS CAPERATA SOAKED WITH CUCL
998, 6evgA, 0.6080, 2.63, 0.088, 444, 102, STRUCTURAL AND FUNCTIONAL CHARACTERISATION OF A BACTERIAL LACCASE-LIKE MULTI-COPPER OXIDASE CUEO FROM LIGNIN-DEGRADING BACTERIUM OCHROBACTRUM SP. WITH OXIDASE ACTIVITY TOWARDS LIGNIN MODEL COMPOUNDS AND LIGNOSULFONATE 
999, 5anhB, 0.6078, 2.71, 0.147, 496, 102, CRYSTAL STRUCTURE OF LACCASE FROM BASIDIOMYCETE PM1 (CECT 2971)
1000, 3ta4E, 0.6074, 2.27, 0.150, 267, 100, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116 COMPLEXED WITH 1-(34- DIMETHOXYPHENYL)-2-(2-METHOXYPHENOXY)-13-DIHYDROXYPROPANE
1001, 5anhC, 0.6072, 2.54, 0.149, 496, 101, CRYSTAL STRUCTURE OF LACCASE FROM BASIDIOMYCETE PM1 (CECT 2971)
1002, 1gw0B, 0.6070, 2.41, 0.141, 559, 99, CRYSTAL STRUCTURE OF LACCASE FROM MELANOCARPUS ALBOMYCES IN FOUR COPPER FORM
1003, 5n4lB, 0.6068, 2.27, 0.190, 1034, 100, RAT CERULOPLASMIN TRIGONAL FORM
1004, 2uxvA, 0.6068, 2.66, 0.108, 422, 102, SUFI PROTEIN FROM ESCHERICHIA COLI
1005, 5i5iB, 0.6060, 1.58, 0.151, 537, 93, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE APP FORM
1006, 3cdzB, 0.6059, 2.40, 0.141, 631, 99, CRYSTAL STRUCTURE OF HUMAN FACTOR VIII
1007, 5a7eA, 0.6055, 2.84, 0.137, 495, 102, CRYSTALLOGRAPHIC STRUCTURAL DETERMINATION OF A TRIGONAL LACCASE FROM CORIOLOPSIS GALLICA (CGL) TO 1.5 A RESOLUTION
1008, 2r7eB, 0.6054, 2.22, 0.143, 644, 98, CRYSTAL STRUCTURE ANALYSIS OF COAGULATION FACTOR VIII
1009, 5i5iA, 0.6049, 1.61, 0.151, 539, 93, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE APP FORM
1010, 4bdvB, 0.6045, 2.41, 0.152, 606, 99, CRYSTAL STRUCTURE OF A TRUNCATED B-DOMAIN HUMAN FACTOR VIII
1011, 2vmjA, 0.6035, 2.19, 0.237, 326, 97, TYPE 1 COPPER-BINDING LOOP OF NITRITE REDUCTASE MUTANT: 130- CAPEGMVPWHVVSGM-144 TO 130-CTPHPFM-136
1012, 3j2qB, 0.6028, 2.47, 0.141, 631, 99, MODEL OF MEMBRANE-BOUND FACTOR VIII ORGANIZED IN 2D CRYSTALS
1013, 6im7A, 0.6024, 2.35, 0.131, 461, 99, CUEO-12.1 MULTICOPPER OXIDASE 
1014, 2xllC, 0.6024, 2.50, 0.100, 533, 100, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
1015, 2r7eA, 0.6024, 2.72, 0.108, 693, 102, CRYSTAL STRUCTURE ANALYSIS OF COAGULATION FACTOR VIII
1016, 3j2sB, 0.6018, 2.49, 0.141, 631, 99, MEMBRANE-BOUND FACTOR VIII LIGHT CHAIN
1017, 3ta4F, 0.6000, 2.57, 0.228, 282, 101, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116 COMPLEXED WITH 1-(34- DIMETHOXYPHENYL)-2-(2-METHOXYPHENOXY)-13-DIHYDROXYPROPANE
1018, 3zx1A, 0.5999, 2.57, 0.186, 471, 102, MULTICOPPER OXIDASE FROM CAMPYLOBACTER JEJUNI: A METALLO-OXIDASE
1019, 4ysdA, 0.5994, 2.50, 0.192, 299, 99, ROOM TEMPERATURE STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
1020, 1hfuA, 0.5993, 2.58, 0.119, 500, 101, TYPE-2 CU-DEPLETED LACCASE FROM COPRINUS CINEREUS AT 1.68 A RESOLUTION
1021, 5k8dA, 0.5992, 2.53, 0.100, 611, 100, CRYSTAL STRUCTURE OF RFVIIIFC
1022, 6iqxA, 0.5987, 2.92, 0.075, 535, 106, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; AEROBICALLY PREPARED 
1023, 3abgA, 0.5986, 2.55, 0.100, 508, 100, X-RAY CRYSTAL ANALYSIS OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA AT 2.3 ANGSTROM RESOLUTION USING A TWIN CRYSTAL
1024, 6iqzA, 0.5985, 2.94, 0.075, 535, 106, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - WILD TYPE 
1025, 5zd6A, 0.5985, 2.94, 0.075, 535, 106, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - WILD TYPE 
1026, 6iqxB, 0.5983, 2.93, 0.075, 535, 106, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; AEROBICALLY PREPARED 
1027, 5jrrA, 0.5975, 2.67, 0.186, 439, 102, CRYSTAL STRUCTURE OF NATIVE LACCASE FROM THERMUS THERMOPHILUS HB27
1028, 5k5kA, 0.5973, 2.67, 0.186, 439, 102, CRYSTAL STRUCTURE OF LACCASSE FROM THERMUS THERMOPHILUS HB27 (ASCORBIC ACID 10 MIN)
1029, 3wkqA, 0.5973, 2.52, 0.192, 299, 99, COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS IN COMPLEX WITH FORMATE
1030, 5k84A, 0.5971, 2.68, 0.186, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (SODIUM NITRATE 10 MIN)
1031, 5afaA, 0.5970, 2.68, 0.186, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 COMPLEXED WITH AG CRYSTAL OF THE HOLOENZYME SOAKED FOR 30 M IN 5 MM AGNO3 AT 278 K.
1032, 1a65A, 0.5969, 2.59, 0.119, 504, 101, TYPE-2 CU-DEPLETED LACCASE FROM COPRINUS CINEREUS
1033, 5jx9A, 0.5968, 2.68, 0.186, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CU(II)- CYCLOPHANES 5 MIN)
1034, 2yaoA, 0.5967, 2.68, 0.186, 437, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (50.0-62.5 PERCENT DOSE)
1035, 5k7aA, 0.5966, 2.68, 0.186, 439, 102, CRYSTAL STRUCTURE OF LACCASE FRON THERMUS THERMOPHILUS HB27 (SODIUM NITRATE 1.5 MIN)
1036, 2yarA, 0.5965, 2.69, 0.186, 436, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (87.5-100.0 PERCENT DOSE)
1037, 2yaeA, 0.5965, 2.68, 0.186, 438, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27(0.0-12.5 PERCENT DOSE)
1038, 2yapA, 0.5964, 2.68, 0.186, 437, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (62.5-75.0 PERCENT DOSE)
1039, 2yafA, 0.5964, 2.68, 0.186, 438, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (12.5-25.0 PERCENT DOSE)
1040, 5k15A, 0.5963, 2.68, 0.186, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CU2PO 8 MIN)
1041, 2yamA, 0.5963, 2.69, 0.186, 436, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (37.5-50.0 PERCENT DOSE)
1042, 2xu9A, 0.5963, 2.68, 0.186, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27
1043, 5k0dA, 0.5962, 2.69, 0.186, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CU(II)- CYCLOPHANES 3 MIN)
1044, 5g3cA, 0.5962, 2.69, 0.186, 435, 102, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS TERMOPHILUS MULTICOPPER OXIDASE
1045, 5g3hA, 0.5961, 2.69, 0.186, 438, 102, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1046, 5g3eA, 0.5961, 2.69, 0.186, 437, 102, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1047, 5g3dA, 0.5961, 2.69, 0.186, 438, 102, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CCASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1048, 2yahA, 0.5961, 2.69, 0.186, 436, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (25.0-37.5 PERCENT DOSE)
1049, 2yaqA, 0.5960, 2.69, 0.186, 436, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (75.0-87.5 PERCENT DOSE)
1050, 5k3kA, 0.5959, 2.69, 0.186, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CUSO4 20 MIN)
1051, 2xllD, 0.5959, 2.93, 0.085, 533, 106, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
1052, 2xllB, 0.5959, 2.93, 0.085, 533, 106, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
1053, 2xllA, 0.5959, 2.93, 0.085, 533, 106, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
1054, 2xuwA, 0.5943, 2.70, 0.186, 437, 102, CRYSTAL STRUCTURE OF APOLACCASE FROM THERMUS THERMOPHILUS HB27
1055, 3wi9A, 0.5937, 2.46, 0.194, 303, 98, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS KAUSTOPHILUS
1056, 6s0oA, 0.5921, 2.64, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
1057, 5lwxA, 0.5921, 2.60, 0.153, 554, 98, CRYSTAL STRUCTURE OF THE H253D MUTANT OF MCOG FROM ASPERGILLUS NIGER
1058, 5o3kI, 0.5919, 2.80, 0.168, 275, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1059, 5o4iA, 0.5918, 2.63, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1060, 6rhqF, 0.5917, 2.63, 0.170, 276, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
1061, 6rh9A, 0.5915, 2.64, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1062, 5o4iK, 0.5915, 2.64, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1063, 6rhqA, 0.5914, 2.64, 0.170, 282, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
1064, 6fc7L, 0.5913, 2.64, 0.170, 276, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1065, 6rh9F, 0.5912, 2.62, 0.170, 276, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1066, 6fc7I, 0.5912, 2.63, 0.170, 281, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1067, 5o4iD, 0.5911, 2.64, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1068, 5o3kB, 0.5910, 2.63, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1069, 6fc7C, 0.5909, 2.66, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1070, 5o3kA, 0.5909, 2.62, 0.170, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1071, 6fc7D, 0.5908, 2.64, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1072, 5o4qC, 0.5906, 2.68, 0.170, 275, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1073, 6rh9B, 0.5904, 2.67, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1074, 6fc7E, 0.5904, 2.63, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1075, 6rh9I, 0.5903, 2.63, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1076, 6fc7H, 0.5903, 2.65, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1077, 5o4qD, 0.5903, 2.66, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1078, 5o4iG, 0.5902, 2.65, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1079, 5o3kD, 0.5902, 2.65, 0.170, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1080, 6fdjE, 0.5901, 2.83, 0.168, 277, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1081, 6fdjB, 0.5901, 2.65, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1082, 5o4iJ, 0.5901, 2.65, 0.170, 279, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1083, 5o4iC, 0.5901, 2.65, 0.170, 277, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1084, 3sqrA, 0.5901, 2.75, 0.141, 539, 99, CRYSTAL STRUCTURE OF LACCASE FROM BOTRYTIS ACLADA AT 1.67 A RESOLUTION
1085, 6rhqC, 0.5900, 2.65, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
1086, 5o4qG, 0.5900, 2.65, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1087, 5o3kJ, 0.5900, 2.65, 0.170, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1088, 5lwwA, 0.5899, 2.64, 0.153, 550, 98, CRYSTAL STRUCTURE OF A LACCASE-LIKE MULTICOPPER OXIDASE MCOG FROM ASPERGILLUS NIGER BOUND TO ZINC
1089, 3cg8A, 0.5899, 2.66, 0.170, 270, 100, LACCASE FROM STREPTOMYCES COELICOLOR
1090, 6rh9L, 0.5898, 2.64, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1091, 5o4qF, 0.5898, 2.65, 0.170, 275, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1092, 3v9eA, 0.5898, 2.76, 0.152, 539, 99, STRUCTURE OF THE L499M MUTANT OF THE LACCASE FROM B.ACLADA
1093, 6rhqE, 0.5897, 2.66, 0.170, 282, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
1094, 6rh9K, 0.5897, 2.69, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1095, 5o4qL, 0.5897, 2.70, 0.170, 275, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1096, 6rh9H, 0.5896, 2.67, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1097, 5o4qB, 0.5896, 2.65, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1098, 5o4iE, 0.5896, 2.68, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1099, 6s0oF, 0.5895, 2.68, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
1100, 6rh9J, 0.5895, 2.66, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1101, 6rh9D, 0.5895, 2.67, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1102, 6rh9G, 0.5894, 2.67, 0.170, 279, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1103, 6fc7G, 0.5894, 2.65, 0.170, 281, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1104, 5o4iI, 0.5894, 2.65, 0.170, 275, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1105, 2avfF, 0.5894, 2.81, 0.143, 323, 98, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
1106, 6s0oD, 0.5893, 2.66, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
1107, 6fdjA, 0.5893, 2.66, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1108, 6fc7J, 0.5893, 2.65, 0.170, 281, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1109, 5g3bA, 0.5893, 2.70, 0.188, 437, 101, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE: THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1110, 5o4qH, 0.5892, 2.70, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1111, 5lhlD, 0.5892, 2.68, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
1112, 5g3fA, 0.5892, 2.70, 0.188, 437, 101, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1113, 5o4qE, 0.5891, 2.70, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1114, 5o3kG, 0.5891, 2.65, 0.170, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1115, 5g3gA, 0.5891, 2.70, 0.188, 437, 101, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1116, 5o4qI, 0.5890, 2.66, 0.170, 275, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1117, 6fdjL, 0.5889, 2.67, 0.170, 276, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1118, 6fdjF, 0.5889, 2.65, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1119, 5lhlE, 0.5889, 2.67, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
1120, 5lhlC, 0.5889, 2.71, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
1121, 6s0oB, 0.5888, 2.66, 0.170, 280, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
1122, 6rhqD, 0.5888, 2.66, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
1123, 5o3kE, 0.5888, 2.65, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1124, 4ai7A, 0.5888, 2.77, 0.186, 437, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 COMPLEXED WITH HG CRYSTAL OF THE APOENZYME SOAKED FOR 2 H IN 5 MM HGCL2 AT 278 K.
1125, 6fc7A, 0.5887, 2.67, 0.170, 281, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1126, 5mkmA, 0.5887, 2.66, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
1127, 6fdjI, 0.5886, 2.65, 0.170, 276, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1128, 6s0oE, 0.5885, 2.67, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
1129, 6fdjC, 0.5885, 2.67, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1130, 6fdjD, 0.5884, 2.88, 0.168, 278, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1131, 6fc7K, 0.5884, 2.66, 0.170, 282, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1132, 5o4qK, 0.5884, 2.67, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1133, 5lhlA, 0.5884, 2.68, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
1134, 6rh9E, 0.5883, 2.67, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1135, 6fc7B, 0.5883, 2.66, 0.170, 281, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1136, 4n8uC, 0.5883, 2.67, 0.170, 275, 100, TWO-DOMAIN LACCASE FROM STREPTOMYCES VIRIDOCHROMOGENES AT 2.4 A RESOLUTION AC629
1137, 5mkmE, 0.5882, 2.66, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
1138, 3cg8B, 0.5882, 2.68, 0.170, 272, 100, LACCASE FROM STREPTOMYCES COELICOLOR
1139, 1zpuB, 0.5882, 2.62, 0.140, 529, 100, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1140, 6rh9C, 0.5881, 2.71, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1141, 5mkmF, 0.5881, 2.68, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
1142, 5mkmB, 0.5881, 2.66, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
1143, 5lhlF, 0.5881, 2.69, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
1144, 5lhlB, 0.5881, 2.67, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
1145, 6fdjG, 0.5880, 2.67, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1146, 5o3kF, 0.5880, 2.70, 0.170, 276, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1147, 5o4iH, 0.5879, 2.67, 0.170, 277, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1148, 5o4iB, 0.5879, 2.69, 0.170, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1149, 5o3kC, 0.5879, 2.65, 0.170, 277, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1150, 3aw5A, 0.5879, 2.72, 0.170, 438, 100, STRUCTURE OF A MULTICOPPER OXIDASE FROM THE HYPERTHERMOPHILIC ARCHAEON PYROBACULUM AEROPHILUM
1151, 2xvbA, 0.5879, 2.78, 0.186, 438, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 COMPLEXED WITH HG CRYSTAL OF THE APOENZYME SOAKED FOR 5 MIN. IN 5 MM HGCL2 AT 278 K.
1152, 5o4iF, 0.5878, 2.67, 0.170, 277, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1153, 5o3kL, 0.5878, 2.67, 0.170, 276, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1154, 5mkmC, 0.5878, 2.67, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
1155, 4najA, 0.5878, 2.69, 0.170, 279, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES LIVIDANS AC1709 IN COMPLEX WITH AZIDE AFTER 90 MIN SOAKING
1156, 4gybA, 0.5878, 2.69, 0.170, 279, 100, TWO-DOMAIN LACCASE FROM STREPTOMYCES LIVIDANS AT 2.4 A RESOLUTION AC1709
1157, 3abgB, 0.5878, 2.91, 0.066, 518, 106, X-RAY CRYSTAL ANALYSIS OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA AT 2.3 ANGSTROM RESOLUTION USING A TWIN CRYSTAL
1158, 1zpuD, 0.5877, 2.63, 0.140, 529, 100, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1159, 6fdjH, 0.5876, 2.66, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1160, 1zpuF, 0.5876, 2.63, 0.140, 529, 100, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1161, 1zpuC, 0.5876, 2.63, 0.140, 529, 100, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1162, 1zpuA, 0.5876, 2.63, 0.140, 529, 100, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1163, 5o3kK, 0.5875, 2.67, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1164, 5o3kH, 0.5875, 2.67, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1165, 1zpuE, 0.5875, 2.63, 0.140, 529, 100, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1166, 4nb7A, 0.5874, 2.70, 0.170, 280, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES LIVIDANS AC1709 IN COMPLEX WITH AZIDE AFTER 180 MIN SOAKING
1167, 6rhqB, 0.5873, 2.68, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
1168, 5o4iL, 0.5873, 2.68, 0.170, 280, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1169, 4n8uA, 0.5873, 2.69, 0.170, 275, 100, TWO-DOMAIN LACCASE FROM STREPTOMYCES VIRIDOCHROMOGENES AT 2.4 A RESOLUTION AC629
1170, 6fc7F, 0.5872, 2.67, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1171, 4n8uB, 0.5872, 2.69, 0.170, 276, 100, TWO-DOMAIN LACCASE FROM STREPTOMYCES VIRIDOCHROMOGENES AT 2.4 A RESOLUTION AC629
1172, 6fdjK, 0.5871, 2.66, 0.170, 276, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1173, 4gxfB, 0.5871, 2.69, 0.170, 279, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1174, 2dwsA, 0.5870, 2.97, 0.111, 328, 99, CU-CONTAINING NITRITE REDUCTASE AT PH 8.4 WITH BOUND NITRITE
1175, 4gxfA, 0.5869, 2.69, 0.170, 279, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1176, 4gxfC, 0.5867, 2.70, 0.170, 279, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1177, 3cg8C, 0.5867, 2.70, 0.170, 272, 100, LACCASE FROM STREPTOMYCES COELICOLOR
1178, 4m3hC, 0.5865, 2.72, 0.170, 270, 100, CRYSTAL STRUCTURE OF SMALL LACCASE SSL1 FROM STREPTOMYCES SVICEUS
1179, 4gy4B, 0.5864, 2.72, 0.170, 278, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1180, 1aozB, 0.5864, 2.67, 0.163, 552, 98, REFINED CRYSTAL STRUCTURE OF ASCORBATE OXIDASE AT 1.9 ANGSTROMS RESOLUTION
1181, 1aozA, 0.5864, 2.64, 0.163, 552, 98, REFINED CRYSTAL STRUCTURE OF ASCORBATE OXIDASE AT 1.9 ANGSTROMS RESOLUTION
1182, 5mkmD, 0.5863, 2.72, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
1183, 3tbcA, 0.5862, 2.72, 0.170, 279, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM COMPLEXED WITH ACETOVANILLONE.
1184, 6fdjJ, 0.5861, 2.68, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1185, 4gy4A, 0.5860, 2.72, 0.170, 276, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1186, 1aspA, 0.5860, 2.65, 0.153, 552, 98, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
1187, 6s0oC, 0.5859, 2.69, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
1188, 3tbcC, 0.5859, 2.69, 0.170, 277, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM COMPLEXED WITH ACETOVANILLONE.
1189, 4gy4C, 0.5858, 2.71, 0.170, 278, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1190, 3tbbB, 0.5858, 2.72, 0.170, 278, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM.
1191, 3tbbC, 0.5857, 2.69, 0.170, 277, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM.
1192, 3kw8A, 0.5857, 2.71, 0.170, 273, 100, TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR AT 2.3 A RESOLUTION
1193, 3tasA, 0.5856, 2.70, 0.170, 300, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A
1194, 1zv2A, 0.5856, 2.48, 0.125, 328, 96, CU-CONTAINING NITRITE REDUCTASE
1195, 1aspB, 0.5853, 2.67, 0.153, 552, 98, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
1196, 3tbcB, 0.5852, 2.70, 0.170, 278, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM COMPLEXED WITH ACETOVANILLONE.
1197, 3tbbA, 0.5850, 2.74, 0.170, 279, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM.
1198, 3tasC, 0.5850, 2.71, 0.170, 300, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A
1199, 2a3tA, 0.5848, 2.98, 0.111, 328, 99, CU-CONTAINING NITRITE REDUCTASE
1200, 1asoB, 0.5848, 2.68, 0.163, 552, 98, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
1201, 3tasB, 0.5847, 2.71, 0.170, 301, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A
1202, 1asoA, 0.5846, 2.46, 0.155, 552, 97, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
1203, 1asqB, 0.5844, 2.69, 0.163, 552, 98, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
1204, 1mzyA, 0.5843, 2.86, 0.122, 331, 98, CRYSTAL STRUCTURE OF NITRITE REDUCTASE
1205, 1asqA, 0.5843, 2.67, 0.153, 552, 98, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
1206, 2ih8B, 0.5823, 3.17, 0.160, 559, 100, A LOW-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARPUS ALBOMYCES LACCASE
1207, 2ih8A, 0.5822, 3.17, 0.160, 559, 100, A LOW-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARPUS ALBOMYCES LACCASE
1208, 3dkhB, 0.5821, 3.16, 0.160, 558, 100, L559A MUTANT OF MELANOCARPUS ALBOMYCES LACCASE
1209, 6f5kA, 0.5819, 3.18, 0.130, 557, 100, CRYSTAL STRUCTURE OF LACCASE FROM MYCELIOPHTHORA THERMOPHILA 
1210, 2ih9B, 0.5819, 3.18, 0.160, 559, 100, A HIGH-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARBUS ALBOMYCES LACCASE
1211, 2q9oB, 0.5818, 3.17, 0.160, 558, 100, NEAR-ATOMIC RESOLUTION STRUCTURE OF A MELANOCARPUS ALBOMYCES LACCASE
1212, 1gw0A, 0.5818, 3.19, 0.160, 559, 100, CRYSTAL STRUCTURE OF LACCASE FROM MELANOCARPUS ALBOMYCES IN FOUR COPPER FORM
1213, 2ih9A, 0.5817, 3.18, 0.160, 559, 100, A HIGH-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARBUS ALBOMYCES LACCASE
1214, 3fu7A, 0.5816, 3.19, 0.160, 558, 100, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (4 SEC) WITH 26- DIMETHOXYPHENOL
1215, 3fu7B, 0.5814, 3.20, 0.160, 559, 100, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (4 SEC) WITH 26- DIMETHOXYPHENOL
1216, 3fu8A, 0.5813, 3.18, 0.160, 558, 100, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (10 SEC) WITH 26- DIMETHOXYPHENOL
1217, 2q9oA, 0.5813, 3.17, 0.160, 558, 100, NEAR-ATOMIC RESOLUTION STRUCTURE OF A MELANOCARPUS ALBOMYCES LACCASE
1218, 3ppsA, 0.5811, 3.05, 0.152, 564, 99, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1219, 3ppsD, 0.5810, 3.05, 0.152, 564, 99, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1220, 3fu8B, 0.5809, 3.20, 0.160, 558, 100, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (10 SEC) WITH 26- DIMETHOXYPHENOL
1221, 2wo3B, 0.5809, 2.99, 0.045, 142, 110, CRYSTAL STRUCTURE OF THE EPHA4-EPHRINA2 COMPLEX
1222, 3ppsB, 0.5797, 3.22, 0.150, 564, 100, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1223, 3ppsC, 0.5791, 3.05, 0.152, 564, 99, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1224, 3fu9A, 0.5782, 2.92, 0.163, 559, 98, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (20 MIN) WITH 26- DIMETHOXYPHENOL
1225, 3qpkA, 0.5773, 2.81, 0.144, 559, 97, PROBING OXYGEN CHANNELS IN MELANOCARPUS ALBOMYCES LACCASE
1226, 3qpkB, 0.5771, 2.81, 0.144, 559, 97, PROBING OXYGEN CHANNELS IN MELANOCARPUS ALBOMYCES LACCASE
1227, 4m4rF, 0.5759, 3.11, 0.027, 138, 111, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1228, 3pnrB, 0.5753, 3.79, 0.043, 129, 115, STRUCTURE OF PBICP-C IN COMPLEX WITH FALCIPAIN-2
1229, 4f7kB, 0.5751, 2.71, 0.122, 373, 98, CRYSTAL STRUCTURE OF LAC15 FROM A MARINE MICROBIAL METAGENOME
1230, 4f7kA, 0.5744, 2.72, 0.122, 377, 98, CRYSTAL STRUCTURE OF LAC15 FROM A MARINE MICROBIAL METAGENOME
1231, 4l0pB, 0.5738, 3.16, 0.027, 139, 111, STRUCTURE OF THE HUMAN EPHA3 RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH EPHRIN-A5
1232, 4m4rD, 0.5735, 3.18, 0.027, 140, 111, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1233, 3ehbB, 0.5716, 2.33, 0.149, 252, 94, A D-PATHWAY MUTATION DECOUPLES THE PARACOCCUS DENITRIFICANS CYTOCHROME C OXIDASE BY ALTERING THE SIDE CHAIN ORIENTATION OF A DISTANT CONSERVED GLUTAMATE
1234, 1ibzA, 0.5715, 1.69, 0.213, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1235, 1ic0E, 0.5714, 1.70, 0.213, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1236, 5sydB, 0.5713, 1.78, 0.169, 131, 89, CIRCULARLY PERMUTATED AZURIN (CPAZ) BASED ON P. AERUGINOSA AZURIN SEQUENCE
1237, 1ibzB, 0.5713, 1.97, 0.211, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1238, 6ci0D, 0.5710, 2.36, 0.117, 257, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH E101A (II) MUTATION 
1239, 1ibyA, 0.5709, 1.87, 0.211, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1240, 1ar1B, 0.5708, 2.36, 0.149, 252, 94, STRUCTURE AT 2.7 ANGSTROM RESOLUTION OF THE PARACOCCUS DENITRIFICANS TWO-SUBUNIT CYTOCHROME C OXIDASE COMPLEXED WITH AN ANTIBODY FV FRAGMENT
1241, 1ic0C, 0.5707, 1.71, 0.213, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1242, 3hb3B, 0.5705, 2.35, 0.149, 252, 94, HIGH RESOLUTION CRYSTAL STRUCTURE OF PARACOCCUS DENITRIFICANS CYTOCHROME C OXIDASE
1243, 3omnD, 0.5704, 2.37, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION IN THE REDUCED STATE
1244, 3om3B, 0.5704, 2.38, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION IN THE REDUCED STATE
1245, 3omiD, 0.5703, 2.37, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION
1246, 3omaD, 0.5703, 2.37, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION
1247, 3om3D, 0.5703, 2.37, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION IN THE REDUCED STATE
1248, 2gsmD, 0.5703, 2.37, 0.117, 256, 94, CATALYTIC CORE (SUBUNITS I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES
1249, 2gsmB, 0.5702, 2.37, 0.117, 256, 94, CATALYTIC CORE (SUBUNITS I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES
1250, 1ibyB, 0.5701, 1.95, 0.211, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1251, 3omiB, 0.5700, 2.38, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION
1252, 1qleB, 0.5699, 2.34, 0.149, 252, 94, CRYO-STRUCTURE OF THE PARACOCCUS DENITRIFICANS FOUR-SUBUNIT CYTOCHROME C OXIDASE IN THE COMPLETELY OXIDIZED STATE COMPLEXED WITH AN ANTIBODY FV FRAGMENT
1253, 3omaB, 0.5698, 2.38, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION
1254, 3fyiD, 0.5698, 2.38, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE BOUND WITH CYANIDE
1255, 3fyeD, 0.5698, 2.37, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE
1256, 3dtuD, 0.5698, 2.37, 0.117, 258, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES COMPLEXED WITH DEOXYCHOLIC ACID
1257, 6ci0B, 0.5697, 2.38, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH E101A (II) MUTATION 
1258, 1ibyC, 0.5697, 1.95, 0.211, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1259, 4m4rB, 0.5696, 3.20, 0.027, 141, 111, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1260, 1ikoP, 0.5696, 3.23, 0.055, 141, 110, CRYSTAL STRUCTURE OF THE MURINE EPHRIN-B2 ECTODOMAIN
1261, 3fyeB, 0.5695, 2.38, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE
1262, 3omnB, 0.5693, 2.38, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION IN THE REDUCED STATE
1263, 3fyiB, 0.5692, 2.39, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE BOUND WITH CYANIDE
1264, 3d12E, 0.5691, 3.02, 0.066, 141, 106, CRYSTAL STRUCTURES OF NIPAH VIRUS G ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH ITS RECEPTOR EPHRIN-B3
1265, 1m56B, 0.5691, 2.38, 0.117, 260, 94, STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTOR SPHAEROIDES (WILD TYPE)
1266, 1ic0D, 0.5691, 1.80, 0.213, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1267, 1ic0B, 0.5690, 1.77, 0.213, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1268, 5wehB, 0.5688, 2.41, 0.117, 254, 94, CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE
1269, 4m4rH, 0.5688, 3.23, 0.027, 138, 111, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1270, 3dtuB, 0.5685, 2.39, 0.117, 259, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES COMPLEXED WITH DEOXYCHOLIC ACID
1271, 1m56H, 0.5683, 2.39, 0.117, 260, 94, STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTOR SPHAEROIDES (WILD TYPE)
1272, 1ibzC, 0.5676, 1.66, 0.205, 110, 88, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1273, 1m57H, 0.5674, 2.40, 0.117, 260, 94, STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES (EQ(I-286) MUTANT))
1274, 1ibzD, 0.5673, 1.84, 0.213, 112, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1275, 5wehH, 0.5672, 2.43, 0.117, 253, 94, CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE
1276, 1m57B, 0.5672, 2.40, 0.117, 260, 94, STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES (EQ(I-286) MUTANT))
1277, 1ibyD, 0.5670, 1.81, 0.213, 112, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1278, 1ic0F, 0.5662, 1.68, 0.205, 110, 88, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1279, 3mx0D, 0.5661, 3.16, 0.028, 138, 109, CRYSTAL STRUCTURE OF EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN-A5
1280, 5sydA, 0.5657, 1.85, 0.170, 130, 88, CIRCULARLY PERMUTATED AZURIN (CPAZ) BASED ON P. AERUGINOSA AZURIN SEQUENCE
1281, 6hu9b, 0.5652, 2.43, 0.138, 236, 94, III2-IV2 MITOCHONDRIAL RESPIRATORY SUPERCOMPLEX FROM S. CEREVISIAE 
1282, 3mx0B, 0.5652, 3.25, 0.027, 138, 110, CRYSTAL STRUCTURE OF EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN-A5
1283, 5i5jB, 0.5649, 1.35, 0.141, 529, 85, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE REDUCED APO FORM
1284, 5i5jA, 0.5648, 1.35, 0.153, 531, 85, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE REDUCED APO FORM
1285, 4bkfD, 0.5643, 3.08, 0.075, 141, 106, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRINB3
1286, 4bkfC, 0.5643, 3.08, 0.075, 141, 106, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRINB3
1287, 3d12B, 0.5643, 3.08, 0.075, 141, 106, CRYSTAL STRUCTURES OF NIPAH VIRUS G ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH ITS RECEPTOR EPHRIN-B3
1288, 6hu9n, 0.5633, 2.44, 0.138, 236, 94, III2-IV2 MITOCHONDRIAL RESPIRATORY SUPERCOMPLEX FROM S. CEREVISIAE 
1289, 2uxtB, 0.5632, 2.48, 0.105, 420, 95, SUFI PROTEIN FROM ESCHERICHIA COLI
1290, 1ic0A, 0.5628, 1.78, 0.216, 110, 88, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1291, 1shxA, 0.5626, 3.25, 0.027, 138, 110, EPHRIN A5 LIGAND STRUCTURE
1292, 4w9zA, 0.5622, 2.42, 0.128, 138, 94, CRYSTAL STRUCTURE OF THE PERIPLASMIC DOMAIN OF SUBUNIT II OF CYTOCHROME OXIDASE (COXB) OF BRADYRHIZOBIUM JAPONICUM
1293, 3heiB, 0.5620, 2.98, 0.057, 132, 105, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1294, 2wo2B, 0.5618, 3.22, 0.055, 136, 109, CRYSTAL STRUCTURE OF THE EPHA4-EPHRINB2 COMPLEX
1295, 5z62B, 0.5603, 2.44, 0.138, 227, 94, STRUCTURE OF HUMAN CYTOCHROME C OXIDASE 
1296, 4f2fA, 0.5603, 1.68, 0.149, 100, 87, CRYSTAL STRUCTURE OF THE METAL BINDING DOMAIN (MBD) OF THE STREPTOCOCCUS PNEUMONIAE D39 CU(I) EXPORTING P-TYPE ATPASE COPA WITH CU(I)
1297, 1shwA, 0.5599, 3.18, 0.037, 138, 109, EPHB2 / EPHRINA5 COMPLEX STRUCTURE
1298, 5x1bO, 0.5597, 2.43, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE AT 20 NSEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1299, 5b1bO, 0.5593, 2.43, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE AT 1.6 ANGSTROM RESOLUTION
1300, 3abkO, 0.5593, 2.43, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE NO-BOUND FULLY REDUCED STATE (50K)
1301, 3heiJ, 0.5591, 3.02, 0.057, 132, 105, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1302, 1shxB, 0.5591, 3.29, 0.027, 138, 110, EPHRIN A5 LIGAND STRUCTURE
1303, 6j8mO, 0.5589, 2.46, 0.117, 226, 94, LOW-DOSE STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE DETERMINED USING 30 KEV X-RAY 
1304, 5b3sO, 0.5589, 2.46, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)
1305, 3ag4O, 0.5589, 2.44, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE ION-BOUND FULLY REDUCED STATE AT 100 K
1306, 3ag3O, 0.5587, 2.44, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K
1307, 3ag2O, 0.5587, 2.45, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K
1308, 2x11B, 0.5587, 3.19, 0.037, 138, 109, CRYSTAL STRUCTURE OF THE COMPLETE EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN A5 RECEPTOR BINDING DOMAIN
1309, 5zcpO, 0.5586, 2.46, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1310, 5zcqO, 0.5585, 2.46, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 10 MM AZIDE SOLUTION FOR 2 DAYS 
1311, 5z86O, 0.5584, 2.46, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 3 DAYS 
1312, 5b1aO, 0.5584, 2.47, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION
1313, 3wg7O, 0.5584, 2.46, 0.117, 226, 94, A 1.9 ANGSTROM RADIATION DAMAGE FREE X-RAY STRUCTURE OF LARGE (420KDA) PROTEIN BY FEMTOSECOND CRYSTALLOGRAPHY
1314, 5zcoO, 0.5583, 2.47, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 2 MM AZIDE SOLUTION FOR 2 DAYS 
1315, 2y69O, 0.5582, 2.47, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE RE-REFINED WITH MOLECULAR OXYGEN
1316, 5xdqO, 0.5581, 2.47, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE WITH PH 7.3 AT 1.77 ANGSTROM RESOLUTION
1317, 6nmfO, 0.5580, 2.48, 0.117, 226, 94, SFX STRUCTURE OF REDUCED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1318, 5z85O, 0.5580, 2.47, 0.117, 226, 94, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE ANOTHER BATCH CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1319, 3asoO, 0.5580, 2.47, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 0.9 ANGSTROM WAVELENGTH
1320, 3abmO, 0.5580, 2.46, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (200-S X-RAY EXPOSURE DATASET)
1321, 5z84O, 0.5579, 2.47, 0.117, 226, 94, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS 
1322, 1v55O, 0.5579, 2.46, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY REDUCED STATE
1323, 5x1fO, 0.5578, 2.45, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE WITHOUT PUMP LASER IRRADIATION AT 278K
1324, 3x2qO, 0.5578, 2.47, 0.117, 226, 94, X-RAY STRUCTURE OF CYANIDE-BOUND BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 2.0 ANGSTROM RESOLUTION
1325, 3ag1O, 0.5578, 2.47, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 280 K
1326, 5xdxO, 0.5577, 2.44, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE REDUCED STATE WITH PH 7.3 AT 1.99 ANGSTROM RESOLUTION
1327, 3ag3B, 0.5577, 2.47, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K
1328, 2eikO, 0.5577, 2.45, 0.117, 226, 94, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1329, 1v54O, 0.5577, 2.47, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1330, 5x19O, 0.5576, 2.46, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE AT 100 MICRO SEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1331, 5waub, 0.5576, 2.45, 0.117, 226, 94, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SYNCHROTRON X-RAY CRYSTALLOGRAPHY AT 100 K
1332, 3asnO, 0.5576, 2.47, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 1.7470 ANGSTROM WAVELENGTH
1333, 3abkB, 0.5575, 2.47, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE NO-BOUND FULLY REDUCED STATE (50K)
1334, 2eikB, 0.5575, 2.46, 0.117, 226, 94, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1335, 1v55B, 0.5575, 2.46, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY REDUCED STATE
1336, 5w97b, 0.5574, 2.47, 0.117, 226, 94, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SERIAL FEMTOSECOND X-RAY CRYSTALLOGRAPHY AT ROOM TEMPERATURE
1337, 5iy5O, 0.5574, 2.47, 0.117, 226, 94, ELECTRON TRANSFER COMPLEX OF CYTOCHROME C AND CYTOCHROME C OXIDASE AT 2.0 ANGSTROM RESOLUTION
1338, 2zxwO, 0.5574, 2.48, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (1-S X- RAY EXPOSURE DATASET)
1339, 2eijO, 0.5574, 2.46, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1340, 1ocrO, 0.5574, 2.47, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1341, 2dyrO, 0.5573, 2.48, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1342, 1v54B, 0.5573, 2.48, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1343, 5wauB, 0.5571, 2.48, 0.117, 226, 94, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SYNCHROTRON X-RAY CRYSTALLOGRAPHY AT 100 K
1344, 3ag1B, 0.5571, 2.47, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 280 K
1345, 2eijB, 0.5571, 2.47, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1346, 6nknO, 0.5570, 2.49, 0.117, 226, 94, TIME-RESOLVED SFX STRUCTURE OF THE PR INTERMEDIATE OF CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1347, 5z86B, 0.5570, 2.49, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 3 DAYS 
1348, 2eilO, 0.5570, 2.48, 0.117, 226, 94, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1349, 1ocrB, 0.5570, 2.48, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1350, 6j8mB, 0.5569, 2.50, 0.117, 226, 94, LOW-DOSE STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE DETERMINED USING 30 KEV X-RAY 
1351, 5b3sB, 0.5569, 2.50, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)
1352, 3ag4B, 0.5569, 2.48, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE ION-BOUND FULLY REDUCED STATE AT 100 K
1353, 2dyrB, 0.5569, 2.48, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1354, 6nmpO, 0.5568, 2.48, 0.117, 226, 94, SFX STRUCTURE OF OXIDIZED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1355, 3wg7B, 0.5568, 2.50, 0.117, 226, 94, A 1.9 ANGSTROM RADIATION DAMAGE FREE X-RAY STRUCTURE OF LARGE (420KDA) PROTEIN BY FEMTOSECOND CRYSTALLOGRAPHY
1356, 5z85B, 0.5567, 2.50, 0.117, 226, 94, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE ANOTHER BATCH CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1357, 5x1bB, 0.5567, 2.47, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE AT 20 NSEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1358, 2eilB, 0.5567, 2.48, 0.117, 226, 94, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1359, 6nmfB, 0.5566, 2.49, 0.117, 226, 94, SFX STRUCTURE OF REDUCED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1360, 5z84B, 0.5566, 2.50, 0.117, 226, 94, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS 
1361, 3abmB, 0.5566, 2.50, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (200-S X-RAY EXPOSURE DATASET)
1362, 3ablO, 0.5566, 2.48, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (15-S X-RAY EXPOSURE DATASET)
1363, 2eimO, 0.5566, 2.47, 0.117, 226, 94, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1364, 2eimB, 0.5566, 2.47, 0.117, 226, 94, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1365, 5zcqB, 0.5565, 2.50, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 10 MM AZIDE SOLUTION FOR 2 DAYS 
1366, 5zcpB, 0.5565, 2.50, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1367, 5xtiWD, 0.5565, 2.50, 0.117, 227, 94, struct.pdbx_descriptor              
1368, 5xtiUA, 0.5565, 2.50, 0.117, 227, 94, struct.pdbx_descriptor              
1369, 5xthUA, 0.5565, 2.50, 0.117, 227, 94, struct.pdbx_descriptor              
1370, 5lufy, 0.5565, 2.50, 0.117, 227, 94, CRYO-EM OF BOVINE RESPIRASOME
1371, 5gupVB, 0.5565, 2.50, 0.117, 227, 94, 
1372, 5gpnIB, 0.5565, 2.50, 0.117, 227, 94, 
1373, 3ag2B, 0.5565, 2.47, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K
1374, 2ybbM, 0.5565, 2.50, 0.117, 227, 94, FITTED MODEL FOR BOVINE  MITOCHONDRIAL SUPERCOMPLEX I1III2IV1 BY SINGLE PARTICLE CRYO-EM (EMD-1876)
1375, 2einB, 0.5565, 2.49, 0.117, 226, 94, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1376, 2dysO, 0.5565, 2.48, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE MODIFIED BY DCCD
1377, 1occO, 0.5565, 2.50, 0.117, 227, 94, STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1378, 1occB, 0.5565, 2.50, 0.117, 227, 94, STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1379, 5zcoB, 0.5564, 2.50, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 2 MM AZIDE SOLUTION FOR 2 DAYS 
1380, 5iy5B, 0.5564, 2.50, 0.117, 226, 94, ELECTRON TRANSFER COMPLEX OF CYTOCHROME C AND CYTOCHROME C OXIDASE AT 2.0 ANGSTROM RESOLUTION
1381, 3x2qB, 0.5564, 2.50, 0.117, 226, 94, X-RAY STRUCTURE OF CYANIDE-BOUND BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 2.0 ANGSTROM RESOLUTION
1382, 2occO, 0.5564, 2.50, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1383, 2dysB, 0.5564, 2.48, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE MODIFIED BY DCCD
1384, 5x1fB, 0.5563, 2.48, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE WITHOUT PUMP LASER IRRADIATION AT 278K
1385, 5xdqB, 0.5562, 2.50, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE WITH PH 7.3 AT 1.77 ANGSTROM RESOLUTION
1386, 2zxwB, 0.5562, 2.50, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (1-S X- RAY EXPOSURE DATASET)
1387, 2occB, 0.5562, 2.50, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1388, 5b1bB, 0.5561, 2.48, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE AT 1.6 ANGSTROM RESOLUTION
1389, 2y69B, 0.5561, 2.50, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE RE-REFINED WITH MOLECULAR OXYGEN
1390, 2einO, 0.5561, 2.49, 0.117, 226, 94, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1391, 3asoB, 0.5560, 2.50, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 0.9 ANGSTROM WAVELENGTH
1392, 5xdxB, 0.5559, 2.48, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE REDUCED STATE WITH PH 7.3 AT 1.99 ANGSTROM RESOLUTION
1393, 5x19B, 0.5559, 2.48, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE AT 100 MICRO SEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1394, 5b1aB, 0.5559, 2.50, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION
1395, 3heiL, 0.5559, 3.11, 0.065, 132, 107, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1396, 3heiN, 0.5558, 3.10, 0.065, 132, 107, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1397, 1ocoO, 0.5558, 2.50, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN CARBON MONOXIDE-BOUND STATE
1398, 1oczO, 0.5557, 2.51, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN AZIDE-BOUND STATE
1399, 3asnB, 0.5555, 2.50, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 1.7470 ANGSTROM WAVELENGTH
1400, 1oczB, 0.5555, 2.52, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN AZIDE-BOUND STATE
1401, 1ocoB, 0.5555, 2.50, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN CARBON MONOXIDE-BOUND STATE
1402, 6nknB, 0.5554, 2.51, 0.117, 226, 94, TIME-RESOLVED SFX STRUCTURE OF THE PR INTERMEDIATE OF CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1403, 5w97B, 0.5554, 2.50, 0.117, 226, 94, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SERIAL FEMTOSECOND X-RAY CRYSTALLOGRAPHY AT ROOM TEMPERATURE
1404, 3ablB, 0.5554, 2.51, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (15-S X-RAY EXPOSURE DATASET)
1405, 6nmpB, 0.5552, 2.51, 0.117, 226, 94, SFX STRUCTURE OF OXIDIZED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1406, 4uf7C, 0.5542, 3.30, 0.064, 138, 109, GHANAIAN HENIPAVIRUS (GH-M74A) ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN EPHRINB2
1407, 3gxuB, 0.5540, 3.37, 0.046, 138, 109, CRYSTAL STRUCTURE OF EPH RECEPTOR AND EPHRIN COMPLEX
1408, 3czuB, 0.5532, 3.14, 0.085, 130, 106, CRYSTAL STRUCTURE OF THE HUMAN EPHRIN A2- EPHRIN A1 COMPLEX
1409, 3heiH, 0.5530, 3.19, 0.047, 132, 107, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1410, 3heiD, 0.5529, 3.11, 0.057, 132, 105, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1411, 3heiP, 0.5528, 3.16, 0.047, 132, 107, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1412, 4uf7E, 0.5521, 3.37, 0.055, 139, 110, GHANAIAN HENIPAVIRUS (GH-M74A) ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN EPHRINB2
1413, 3heiF, 0.5521, 3.09, 0.057, 132, 105, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1414, 4bkaC, 0.5516, 3.36, 0.027, 136, 110, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRIN A5
1415, 1kgyE, 0.5516, 3.08, 0.084, 138, 107, CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX
1416, 4bk5C, 0.5511, 3.37, 0.027, 136, 110, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRIN A5 (AMINE-METHYLATED SAMPLE)
1417, 4f2eA, 0.5508, 1.73, 0.163, 98, 86, CRYSTAL STRUCTURE OF THE STREPTOCOCCUS PNEUMONIAE D39 COPPER CHAPERONE CUPA WITH CU(I)
1418, 3mbwB, 0.5506, 3.02, 0.049, 127, 103, CRYSTAL STRUCTURE OF THE HUMAN EPHRIN A2 LBD AND CRD DOMAINS IN COMPLEX WITH EPHRIN A1
1419, 1kgyH, 0.5494, 3.34, 0.083, 138, 108, CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX
1420, 4txvB, 0.5476, 2.76, 0.128, 142, 94, CRYSTAL STRUCTURE OF THE MIXED DISULFIDE INTERMEDIATE BETWEEN THIOREDOXIN-LIKE TLPAS(C110S) AND SUBUNIT II OF CYTOCHROME C OXIDASE COXBPD (C233S)
1421, 2vsmB, 0.5475, 3.30, 0.064, 137, 109, NIPAH VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
1422, 1kgyG, 0.5474, 3.20, 0.093, 138, 107, CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX
1423, 2mryA, 0.5471, 1.82, 0.151, 98, 86, NMR SOLUTION STRUCTURE OF COPPER BINDING PROTEIN IN THE APO FORM
1424, 1kgyF, 0.5462, 3.37, 0.074, 138, 108, CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX
1425, 6giqb, 0.5456, 2.58, 0.149, 235, 94, SACCHAROMYCES CEREVISIAE RESPIRATORY SUPERCOMPLEX III2IV 
1426, 4txvD, 0.5444, 2.56, 0.140, 133, 93, CRYSTAL STRUCTURE OF THE MIXED DISULFIDE INTERMEDIATE BETWEEN THIOREDOXIN-LIKE TLPAS(C110S) AND SUBUNIT II OF CYTOCHROME C OXIDASE COXBPD (C233S)
1427, 2vskD, 0.5436, 3.17, 0.057, 131, 105, HENDRA VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
1428, 2vskB, 0.5425, 3.03, 0.048, 131, 104, HENDRA VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
1429, 2hleB, 0.5370, 3.27, 0.086, 133, 105, STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE EPHB4-EPHRINB2 PROTEIN PROTEIN INTERACTION AND RECEPTOR SPECIFICITY.
1430, 1ayrC, 0.5367, 3.56, 0.029, 368, 103, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1431, 1ayrA, 0.5364, 3.47, 0.029, 368, 103, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1432, 2hb0B, 0.5318, 4.00, 0.095, 355, 116, CRYSTAL STRUCTURE OF CFAE THE ADHESIVE SUBUNIT OF CFA/I FIMBRIA OF ENTEROTOXIGENIC ESCHERICHIA COLI
1433, 3ugxA, 0.5309, 3.53, 0.029, 369, 102, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1434, 1jerA, 0.5299, 3.14, 0.153, 110, 98, CUCUMBER STELLACYANIN CU2+ PH 7.0
1435, 1zshA, 0.5295, 3.62, 0.058, 354, 104, CRYSTAL STRUCTURE OF BOVINE ARRESTIN-2 IN COMPLEX WITH INOSITOL HEXAKISPHOSPHATE (IP6)
1436, 4jqiA, 0.5283, 3.67, 0.067, 353, 104, STRUCTURE OF ACTIVE BETA-ARRESTIN1 BOUND TO A G PROTEIN-COUPLED RECEPTOR PHOSPHOPEPTIDE
1437, 3p2dB, 0.5282, 3.65, 0.039, 352, 103, CRYSTAL STRUCTURE OF ARRESTIN-3 REVEALS THE BASIS OF THE DIFFERENCE IN RECEPTOR BINDING BETWEEN TWO NON-VISUAL SUBTYPES
1438, 1g4rA, 0.5276, 3.62, 0.049, 353, 103, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1439, 1cf1D, 0.5276, 3.61, 0.029, 368, 102, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1440, 1zglP, 0.5263, 3.70, 0.083, 242, 108, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
1441, 3p2dA, 0.5262, 3.71, 0.038, 354, 104, CRYSTAL STRUCTURE OF ARRESTIN-3 REVEALS THE BASIS OF THE DIFFERENCE IN RECEPTOR BINDING BETWEEN TWO NON-VISUAL SUBTYPES
1442, 1zglT, 0.5259, 3.69, 0.083, 226, 108, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
1443, 3vacB, 0.5257, 4.24, 0.051, 356, 118, CRYSTAL STRUCTURE OF THE CFA/I ENTEROTOXIGENIC E. COLI ADHESIN CFAE MUTANT G168D
1444, 3f83A, 0.5257, 4.14, 0.034, 508, 117, STRUCTURE OF FUSION COMPLEX OF THE MINOR PILIN CFAE AND MAJOR PILIN CFAB OF CFA/I PILI FROM ETEC E. COLI
1445, 3ugxC, 0.5256, 3.44, 0.030, 358, 100, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1446, 1jxgB, 0.5251, 2.61, 0.133, 100, 90, THE 1.6 A RESOLUTION CRYSTAL STRUCTURE OF A MUTANT POPLAR PLASTOCYANIN BEARING A 21-25 ENGENEERED DISULFIDE BRIDGE
1447, 5fc9B, 0.5249, 2.01, 0.172, 95, 87, NOVEL PURPLE CUPREDOXIN FROM NITROSOPUMILUS MARITIMUS
1448, 3vacA, 0.5249, 4.24, 0.051, 356, 118, CRYSTAL STRUCTURE OF THE CFA/I ENTEROTOXIGENIC E. COLI ADHESIN CFAE MUTANT G168D
1449, 1rmfH, 0.5248, 3.90, 0.089, 216, 112, STRUCTURES OF A MONOCLONAL ANTI-ICAM-1 ANTIBODY R6.5 FRAGMENT AT 2.8 ANGSTROMS RESOLUTION
1450, 1ayrD, 0.5247, 3.45, 0.030, 363, 100, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1451, 1ayrB, 0.5246, 3.45, 0.030, 363, 100, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1452, 1ylbB, 0.5245, 2.50, 0.135, 99, 89, NMR SOLUTION STRUCTURE OF THE REDUCED SPINACH PLASTOCYANIN
1453, 6c6qF, 0.5242, 3.85, 0.083, 113, 109, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR 
1454, 5j7yZB, 0.5241, 2.71, 0.118, 227, 93, 
1455, 5j4zZB, 0.5241, 2.71, 0.118, 227, 93, 
1456, 5fc9A, 0.5239, 2.15, 0.182, 95, 88, NOVEL PURPLE CUPREDOXIN FROM NITROSOPUMILUS MARITIMUS
1457, 5fc9D, 0.5238, 2.05, 0.172, 95, 87, NOVEL PURPLE CUPREDOXIN FROM NITROSOPUMILUS MARITIMUS
1458, 5fc9C, 0.5235, 2.03, 0.172, 95, 87, NOVEL PURPLE CUPREDOXIN FROM NITROSOPUMILUS MARITIMUS
1459, 4n0cG, 0.5235, 3.81, 0.093, 197, 108, 42F3 TCR PCPE3/H-2LD COMPLEX
1460, 3q48A, 0.5234, 2.88, 0.125, 194, 96, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA CUPB2 CHAPERONE
1461, 2hb0A, 0.5232, 4.15, 0.060, 356, 117, CRYSTAL STRUCTURE OF CFAE THE ADHESIVE SUBUNIT OF CFA/I FIMBRIA OF ENTEROTOXIGENIC ESCHERICHIA COLI
1462, 6e47G, 0.5228, 3.80, 0.083, 112, 108, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR AND GLYCOCHENODEOXYCHOLIC ACID 
1463, 1cf1B, 0.5228, 3.46, 0.030, 360, 100, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1464, 4mxqC, 0.5227, 3.76, 0.093, 199, 108, 42F3 TCR PCPC5/H-2LD COMPLEX
1465, 1kiuO, 0.5227, 2.82, 0.074, 205, 95, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1466, 1kiuM, 0.5227, 2.82, 0.074, 205, 95, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1467, 1kiuK, 0.5227, 2.82, 0.074, 205, 95, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1468, 1kiuI, 0.5227, 2.82, 0.074, 205, 95, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1469, 7pcyA, 0.5225, 2.60, 0.122, 98, 90, THE CRYSTAL STRUCTURE OF PLASTOCYANIN FROM A GREEN ALGA ENTEROMORPHA PROLIFERA
1470, 2wtrB, 0.5224, 3.48, 0.050, 367, 100, FULL LENGTH ARRESTIN2
1471, 2wtrA, 0.5222, 3.73, 0.058, 356, 104, FULL LENGTH ARRESTIN2
1472, 4n5eC, 0.5217, 3.80, 0.093, 199, 108, 42F3 TCR PCPA12/H-2LD COMPLEX
1473, 1jsyA, 0.5217, 3.52, 0.058, 358, 103, CRYSTAL STRUCTURE OF BOVINE ARRESTIN-2
1474, 3uguA, 0.5215, 3.57, 0.040, 345, 101, CRYSTAL STRUCTURE OF P44 (SPLICE VARIANT OF VISUAL ARRESTIN)
1475, 4ydjH, 0.5214, 4.13, 0.088, 238, 113, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 44- VRC13.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
1476, 3m4eB, 0.5213, 4.09, 0.062, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1477, 1zglR, 0.5212, 3.74, 0.083, 238, 108, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
1478, 3gd1C, 0.5208, 3.50, 0.059, 345, 101, STRUCTURE OF AN ARRESTIN/CLATHRIN COMPLEX REVEALS A NOVEL CLATHRIN BINDING DOMAIN THAT MODULATES RECEPTOR TRAFFICKING
1479, 3tfkC, 0.5207, 3.89, 0.111, 201, 108, 42F3-P4B10/H2-LD
1480, 6e48F, 0.5206, 3.73, 0.083, 113, 109, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR AND LITHOCHOLIC ACID 
1481, 3m4eD, 0.5206, 3.98, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1482, 3tpuA, 0.5205, 3.79, 0.093, 205, 108, 42F3 P5E8/H2-LD COMPLEX
1483, 3m4eC, 0.5205, 4.08, 0.062, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1484, 4zrgA, 0.5204, 3.45, 0.030, 343, 100, VISUAL ARRESTIN MUTANT - R175E
1485, 2ckbC, 0.5204, 3.78, 0.102, 202, 108, STRUCTURE OF THE 2C/KB/DEV8 COMPLEX
1486, 2ckbA, 0.5204, 3.78, 0.102, 202, 108, STRUCTURE OF THE 2C/KB/DEV8 COMPLEX
1487, 4grlD, 0.5203, 3.70, 0.148, 257, 108, CRYSTAL STRUCTURE OF A AUTOIMMUNE TCR-MHC COMPLEX
1488, 3ugxD, 0.5203, 3.48, 0.030, 348, 100, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1489, 7ahlF, 0.5202, 3.86, 0.055, 293, 109, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1490, 3m4eG, 0.5202, 4.09, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1491, 1zglV, 0.5202, 3.75, 0.083, 242, 108, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
1492, 4n0cC, 0.5201, 3.82, 0.093, 195, 108, 42F3 TCR PCPE3/H-2LD COMPLEX
1493, 4mbrA, 0.5200, 3.95, 0.081, 316, 111, 3.65 ANGSTROM CRYSTAL STRUCTURE OF SERINE-RICH REPEAT PROTEIN (SRR2) FROM STREPTOCOCCUS AGALACTIAE
1494, 3m4eA, 0.5200, 4.09, 0.062, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1495, 3m2lA, 0.5200, 4.11, 0.062, 293, 112, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1496, 1cf1A, 0.5200, 3.51, 0.030, 373, 101, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1497, 6bj2E, 0.5199, 3.60, 0.104, 241, 106, TCR589 IN COMPLEX WITH HIV(POL448-456)/HLA-B35 
1498, 3m4dB, 0.5199, 4.11, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1499, 1jxgA, 0.5198, 2.52, 0.146, 100, 89, THE 1.6 A RESOLUTION CRYSTAL STRUCTURE OF A MUTANT POPLAR PLASTOCYANIN BEARING A 21-25 ENGENEERED DISULFIDE BRIDGE
1500, 6mi2A, 0.5197, 3.71, 0.065, 209, 107, STRUCTURE OF THE HUMAN 4-1BB / UTOMILUMAB FAB COMPLEX 
1501, 3m4dF, 0.5197, 4.10, 0.062, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1502, 5whzH, 0.5196, 3.70, 0.037, 341, 109, PGDM1400-10E8V4 CODV FAB
1503, 4rqqH, 0.5196, 3.57, 0.057, 240, 106, CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1504, 3tpuM, 0.5196, 3.80, 0.093, 204, 108, 42F3 P5E8/H2-LD COMPLEX
1505, 1ws7A, 0.5196, 3.07, 0.135, 107, 96, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
1506, 3tpuC, 0.5195, 3.78, 0.093, 204, 108, 42F3 P5E8/H2-LD COMPLEX
1507, 3m4dC, 0.5195, 4.09, 0.062, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1508, 2pltA, 0.5195, 2.72, 0.143, 98, 91, STRUCTURE DETERMINATION OF PLASTOCYANIN FROM A CRYSTAL SPECIMEN WITH HEMIHEDRAL TWINNING FRACTION OF ONE-HALF
1509, 3m3rC, 0.5194, 4.10, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1510, 5x31A, 0.5193, 2.48, 0.138, 125, 87, PSEUDOAZURIN FROM ALCALIGENES FAECALIS (SPACE GROUP P65)
1511, 3m4eF, 0.5192, 3.88, 0.073, 293, 110, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1512, 1ws7D, 0.5192, 2.99, 0.137, 105, 95, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
1513, 4rqqB, 0.5191, 3.65, 0.047, 239, 107, CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1514, 3m4dD, 0.5191, 4.11, 0.062, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1515, 3m4dA, 0.5191, 4.10, 0.062, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1516, 3ugxB, 0.5189, 3.50, 0.030, 352, 100, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1517, 1ws8A, 0.5189, 2.87, 0.138, 104, 94, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
1518, 6rcuB, 0.5188, 3.69, 0.065, 222, 107, PFRH5 BOUND TO MONOCLONAL ANTIBODIES R5.004 AND R5.016 
1519, 6d49B, 0.5188, 3.88, 0.092, 126, 109, CELL SURFACE RECEPTOR IN COMPLEX WITH LIGAND AT 1.80-A RESOLUTION 
1520, 3m3rB, 0.5188, 4.00, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1521, 6dzrL, 0.5187, 3.98, 0.092, 218, 109, CRYSTAL STRUCTURE OF H38C2 K99R MUTATION 
1522, 4yhdG, 0.5187, 4.09, 0.080, 281, 112, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1523, 6cphE, 0.5186, 3.63, 0.085, 244, 106, CRYSTAL STRUCTURE OF A TCR 
1524, 5tv1A, 0.5186, 3.49, 0.050, 337, 101, ACTIVE ARRESTIN-3 WITH INOSITOL HEXAKISPHOSPHATE
1525, 2j7lA, 0.5186, 3.22, 0.143, 210, 98, E.COLI P PILUS CHAPERONE PAPD IN COMPLEX WITH A PILUS BIOGENESIS INHIBITOR PILICIDE 2C
1526, 3m4dE, 0.5185, 4.00, 0.072, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1527, 3m2lD, 0.5185, 3.98, 0.072, 293, 111, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1528, 4p24A, 0.5184, 3.93, 0.073, 292, 110, PORE FORMING TOXIN
1529, 3m2lE, 0.5184, 3.99, 0.072, 293, 111, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1530, 1g4mA, 0.5184, 3.40, 0.059, 356, 101, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1531, 5aooB, 0.5183, 3.87, 0.038, 314, 105, X-RAY STRUCTURE OF A HUMAN KOBUVIRUS: AICHI VIRUS A (AIV)
1532, 3m2lB, 0.5183, 4.12, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1533, 7ahlD, 0.5182, 4.21, 0.080, 293, 113, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1534, 4mayD, 0.5182, 3.74, 0.148, 255, 108, CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX
1535, 3pl6D, 0.5182, 3.72, 0.148, 257, 108, STRUCTURE OF AUTOIMMUNE TCR HY.1B11 IN COMPLEX WITH HLA-DQ1 AND MBP 85-99
1536, 3m3rG, 0.5182, 3.98, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1537, 3m3rA, 0.5182, 4.00, 0.072, 293, 111, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1538, 6dfqB, 0.5180, 3.73, 0.075, 239, 107, MOUSE DIABETOGENIC TCR I.29 
1539, 5x31B, 0.5180, 2.34, 0.128, 125, 86, PSEUDOAZURIN FROM ALCALIGENES FAECALIS (SPACE GROUP P65)
1540, 4mvbC, 0.5180, 3.71, 0.103, 199, 107, 42F3 PCPB7/H-2LD COMPLEX
1541, 4dp5X, 0.5180, 2.63, 0.124, 99, 89, THE 1.88 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN B AT PH 8.0
1542, 3tpuG, 0.5180, 3.80, 0.102, 202, 108, 42F3 P5E8/H2-LD COMPLEX
1543, 3m2lG, 0.5180, 3.93, 0.073, 293, 110, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1544, 4dp1X, 0.5179, 2.62, 0.124, 99, 89, THE 1.35 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN B AT PH 4.0
1545, 6c74A, 0.5177, 3.76, 0.084, 111, 107, CRYSTAL STRUCTURE OF MURINE CD300LF IN COMPLEX WITH PHOSPHOCHOLINE 
1546, 4ydjA, 0.5177, 4.12, 0.088, 238, 113, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 44- VRC13.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
1547, 4rqqD, 0.5176, 3.64, 0.047, 237, 107, CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1548, 3to4D, 0.5176, 3.84, 0.056, 243, 107, STRUCTURE OF MOUSE VALPHA14VBETA2-MOUSECD1D-ALPHA-GALACTOSYLCERAMIDE
1549, 3m4dG, 0.5175, 4.00, 0.072, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1550, 3m3rF, 0.5175, 4.00, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1551, 1ag6A, 0.5175, 2.61, 0.135, 99, 89, PLASTOCYANIN FROM SPINACH
1552, 6cqrJ, 0.5174, 3.63, 0.085, 245, 106, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1553, 4dp2X, 0.5174, 2.63, 0.124, 99, 89, THE 1.8 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN B AT PH 6.0
1554, 5fflA, 0.5173, 3.84, 0.074, 113, 108, CRYSTAL STRUCTURE OF MOUSE CD300LF AT 1.6 ANGSTROMS RESOLUTION.
1555, 2cdeD, 0.5173, 3.65, 0.065, 244, 107, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
1556, 7ahlA, 0.5172, 4.00, 0.072, 293, 111, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1557, 3m3rE, 0.5172, 4.00, 0.072, 293, 111, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1558, 3m3rD, 0.5172, 4.00, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1559, 6d49A, 0.5171, 3.88, 0.093, 126, 108, CELL SURFACE RECEPTOR IN COMPLEX WITH LIGAND AT 1.80-A RESOLUTION 
1560, 4uduB, 0.5171, 3.71, 0.103, 238, 107, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN E IN COMPLEX WITH A T CELL RECEPTOR
1561, 1oowA, 0.5171, 2.62, 0.135, 99, 89, THE CRYSTAL STRUCTURE OF THE SPINACH PLASTOCYANIN DOUBLE MUTANT G8D/L12E GIVES INSIGHT INTO ITS LOW REACTIVITY TOWARDS PHOTOSYSTEM 1 AND CYTOCHROME F
1562, 5or7C, 0.5170, 3.87, 0.083, 111, 108, ATOMIC STRUCTURE OF THE MURINE NOROVIRUS PROTRUDING DOMAIN AND SCD300LF RECEPTOR COMPLEX
1563, 1ws8D, 0.5170, 2.86, 0.129, 103, 93, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
1564, 5w0pA, 0.5169, 3.62, 0.020, 847, 101, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1565, 4ms8C, 0.5169, 3.72, 0.103, 196, 107, 42F3 TCR PCPB9/H-2LD COMPLEX
1566, 7ahlE, 0.5168, 3.91, 0.073, 293, 110, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1567, 4dp0X, 0.5168, 2.65, 0.124, 99, 89, THE 1.5 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN B AT PH 4.0
1568, 4yhdE, 0.5167, 4.13, 0.071, 268, 112, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1569, 2zpkI, 0.5167, 3.89, 0.064, 207, 109, CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE
1570, 6dfqF, 0.5166, 3.68, 0.075, 238, 106, MOUSE DIABETOGENIC TCR I.29 
1571, 6cqrE, 0.5166, 3.64, 0.085, 245, 106, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1572, 5k93A, 0.5166, 3.28, 0.143, 210, 98, PAPD WILD-TYPE CHAPERONE
1573, 3ujjH, 0.5166, 3.74, 0.056, 230, 108, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 4025 IN COMPLEX WITH CON A PEPTIDE
1574, 3anzG, 0.5166, 3.94, 0.064, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1575, 4p24E, 0.5165, 3.88, 0.082, 291, 110, PORE FORMING TOXIN
1576, 1hklH, 0.5165, 3.60, 0.085, 217, 106, FREE AND LIGANDED FORM OF AN ESTEROLYTIC CATALYTIC ANTIBODY
1577, 1g6rC, 0.5165, 3.86, 0.102, 202, 108, A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
1578, 7ahlB, 0.5164, 4.06, 0.080, 293, 112, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1579, 6pcyA, 0.5164, 2.65, 0.135, 99, 89, CRYSTAL STRUCTURE ANALYSES OF REDUCED (CUI) POPLAR PLASTOCYANIN AT SIX PH VALUES
1580, 3anzY, 0.5164, 3.94, 0.064, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1581, 1gafH, 0.5164, 3.83, 0.082, 217, 110, 48G7 HYBRIDOMA LINE FAB COMPLEXED WITH HAPTEN 5-(PARA- NITROPHENYL PHOSPHONATE)-PENTANOIC ACID
1582, 7ahlC, 0.5162, 4.01, 0.072, 293, 111, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1583, 1kdiA, 0.5162, 2.54, 0.159, 102, 88, REDUCED FORM OF PLASTOCYANIN FROM DRYOPTERIS CRASSIRHIZOMA
1584, 6e48G, 0.5161, 3.84, 0.075, 111, 107, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR AND LITHOCHOLIC ACID 
1585, 5swzJ, 0.5161, 3.68, 0.113, 240, 106, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1586, 4zsoB, 0.5161, 3.86, 0.082, 218, 110, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6 A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30 AND AN INHIBITORY ANTIBODY
1587, 4pcyA, 0.5161, 2.65, 0.135, 99, 89, CRYSTAL STRUCTURE ANALYSES OF REDUCED (CUI) POPLAR PLASTOCYANIN AT SIX PH VALUES
1588, 5swzE, 0.5160, 3.76, 0.112, 240, 107, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1589, 4elmF, 0.5160, 3.72, 0.104, 224, 106, CRYSTAL STRUCTURE OF THE MOUSE CD1D-LYSOSULFATIDE-HY19.3 TCR COMPLEX
1590, 3jabQ, 0.5160, 3.92, 0.064, 221, 110, DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR PDE6
1591, 3jabH, 0.5160, 3.92, 0.064, 221, 110, DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR PDE6
1592, 3anzK, 0.5160, 3.95, 0.064, 295, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1593, 12e8H, 0.5160, 3.92, 0.064, 221, 110, 2E8 FAB FRAGMENT
1594, 5w0pC, 0.5159, 3.62, 0.020, 849, 101, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1595, 5lvcb, 0.5159, 4.04, 0.056, 289, 107, AICHI VIRUS 1: EMPTY PARTICLE
1596, 4oiiI, 0.5158, 4.10, 0.088, 217, 113, WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB
1597, 4oiiH, 0.5158, 4.10, 0.088, 217, 113, WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB
1598, 4dp4X, 0.5158, 2.52, 0.146, 99, 89, THE 1.54 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN B AT PH 6.0
1599, 2oslH, 0.5158, 3.95, 0.090, 224, 111, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
1600, 1hxmH, 0.5158, 3.94, 0.127, 230, 110, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1601, 6d4aB, 0.5157, 3.84, 0.083, 124, 108, CELL SURFACE RECEPTOR WITH BOUND LIGAND AT 1.75-A RESOLUTION 
1602, 5k93B, 0.5157, 3.28, 0.143, 210, 98, PAPD WILD-TYPE CHAPERONE
1603, 4yhdA, 0.5157, 4.02, 0.072, 281, 111, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1604, 4p24D, 0.5157, 3.89, 0.082, 292, 110, PORE FORMING TOXIN
1605, 2xwtA, 0.5157, 3.76, 0.065, 215, 108, CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A BLOCKING TYPE TSHR AUTOANTIBODY
1606, 1g4mB, 0.5157, 3.43, 0.059, 357, 101, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1607, 7ahlG, 0.5156, 4.01, 0.072, 293, 111, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1608, 6d48H, 0.5156, 3.69, 0.085, 124, 106, CELL SURFACE RECEPTOR 
1609, 4nhuA, 0.5156, 3.74, 0.093, 197, 107, THE M33 TCR P3M33L/H-2 LD COMPLEX
1610, 4elkA, 0.5156, 3.81, 0.093, 199, 107, CRYSTAL STRUCTURE OF THE HY19.3 TYPE II NKT TCR
1611, 4dp8X, 0.5156, 2.49, 0.148, 99, 88, THE 1.07 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN A AT PH 4.0
1612, 3pcyA, 0.5156, 2.48, 0.148, 99, 88, THE CRYSTAL STRUCTURE OF MERCURY-SUBSTITUTED POPLAR PLASTOCYANIN AT 1.9-ANGSTROMS RESOLUTION
1613, 3m2lC, 0.5156, 3.95, 0.081, 293, 111, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1614, 3anzW, 0.5156, 3.95, 0.064, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1615, 3anzD, 0.5156, 3.95, 0.064, 295, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1616, 1kdjA, 0.5156, 2.56, 0.159, 102, 88, OXIDIZED FORM OF PLASTOCYANIN FROM DRYOPTERIS CRASSIRHIZOMA
1617, 6b5pH, 0.5155, 3.88, 0.073, 212, 109, STRUCTURE OF PFCSP PEPTIDE 20 WITH HUMAN ANTIBODY CIS42
1618, 5zv3H, 0.5155, 3.65, 0.085, 219, 106, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-28.1 IN COMPLEX WITH ITS TAU PEPTIDE 
1619, 4elmH, 0.5155, 3.61, 0.105, 211, 105, CRYSTAL STRUCTURE OF THE MOUSE CD1D-LYSOSULFATIDE-HY19.3 TCR COMPLEX
1620, 4ei5H, 0.5155, 3.78, 0.093, 230, 107, CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1
1621, 4dp6X, 0.5155, 2.53, 0.146, 99, 89, THE 1.67 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN B AT PH 8.0
1622, 3uttJ, 0.5155, 3.79, 0.073, 245, 109, 1E6-A*0201-ALWGPDPAAA COMPLEX TRICLINIC
1623, 3anzZ, 0.5155, 3.95, 0.064, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1624, 3anzN, 0.5155, 3.95, 0.064, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1625, 5j06D, 0.5154, 3.84, 0.093, 212, 107, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 3 -SIALYLLACTOSE
1626, 4z7vF, 0.5154, 3.64, 0.076, 243, 105, L3-12 COMPLEX
1627, 4p24F, 0.5154, 3.88, 0.082, 290, 110, PORE FORMING TOXIN
1628, 3anzb, 0.5154, 3.95, 0.064, 295, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1629, 3anzF, 0.5154, 3.95, 0.064, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1630, 1hxmF, 0.5154, 4.05, 0.134, 230, 112, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1631, 1afvH, 0.5154, 3.79, 0.092, 220, 109, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
1632, 6b5tH, 0.5153, 3.90, 0.064, 211, 109, STRUCTURE OF PFCSP PEPTIDE 29 WITH HUMAN ANTIBODY CIS42
1633, 4ei6D, 0.5153, 3.69, 0.104, 241, 106, STRUCTURE OF XV19 VALPHA1-VBETA16 TYPE-II NATURAL KILLER T CELL RECEPTOR
1634, 4ei5D, 0.5153, 3.68, 0.094, 242, 106, CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1
1635, 4dwhC, 0.5153, 2.88, 0.084, 201, 95, STRUCTURE OF THE MAJOR TYPE 1 PILUS SUBUNIT FIMA BOUND TO THE FIMC (2.5 A RESOLUTION)
1636, 3cm9S, 0.5153, 3.70, 0.064, 585, 109, SOLUTION STRUCTURE OF HUMAN SIGA2
1637, 3anzR, 0.5153, 3.95, 0.064, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1638, 3anzA, 0.5153, 3.95, 0.064, 295, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1639, 1lcsA, 0.5153, 4.53, 0.059, 205, 118, RECEPTOR-BINDING DOMAIN FROM SUBGROUP B FELINE LEUKEMIA VIRUS
1640, 1iuzA, 0.5153, 2.64, 0.133, 98, 90, PLASTOCYANIN
1641, 6fxnO, 0.5152, 3.77, 0.056, 215, 107, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1642, 6d48F, 0.5152, 3.92, 0.065, 125, 107, CELL SURFACE RECEPTOR 
1643, 5swzT, 0.5152, 3.69, 0.113, 239, 106, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1644, 3njhD, 0.5152, 3.36, 0.122, 122, 98, D37A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS.
1645, 3anzV, 0.5152, 3.95, 0.064, 295, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1646, 3anzO, 0.5152, 4.02, 0.063, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1647, 3anzM, 0.5152, 3.95, 0.064, 295, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1648, 1i7zA, 0.5152, 3.76, 0.095, 219, 105, ANTIBODY GNC92H2 BOUND TO LIGAND
1649, 1eajA, 0.5152, 3.81, 0.064, 124, 109, DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN AT 1.35 ANGSTROM RESOLUTION
1650, 1afvK, 0.5152, 3.79, 0.092, 220, 109, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
1651, 6dc9L, 0.5151, 3.92, 0.084, 215, 107, FAB/EPITOPE COMPLEX OF HUMAN CHIMERIC MONOCLONAL ANTIBODY H4E6 TARGETING A PHOSPHORYLATED TAU EPITOPE. 
1652, 6cqnE, 0.5151, 3.66, 0.085, 244, 106, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1653, 4ei6B, 0.5151, 3.65, 0.095, 244, 105, STRUCTURE OF XV19 VALPHA1-VBETA16 TYPE-II NATURAL KILLER T CELL RECEPTOR
1654, 3jwnI, 0.5151, 2.80, 0.096, 198, 94, COMPLEX OF FIMC FIMF FIMG AND FIMH
1655, 3anzT, 0.5151, 3.95, 0.064, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1656, 3anzQ, 0.5151, 3.95, 0.064, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1657, 2cdeB, 0.5151, 3.68, 0.065, 244, 107, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
1658, 1a4kB, 0.5151, 4.05, 0.071, 219, 112, DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE
1659, 5e8eB, 0.5150, 3.85, 0.055, 228, 110, CRYSTAL STRUCTURE OF THROMBIN BOUND TO AN EXOSITE 1-SPECIFIC IGA FAB
1660, 4tnwX, 0.5150, 3.69, 0.084, 224, 107, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1661, 3m2lF, 0.5150, 4.08, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1662, 3anza, 0.5150, 3.95, 0.064, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1663, 3anzX, 0.5150, 3.95, 0.064, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1664, 3anzS, 0.5150, 3.95, 0.064, 295, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1665, 3anzI, 0.5150, 3.95, 0.064, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1666, 2xg4A, 0.5150, 3.32, 0.143, 216, 98, E. COLI P PILUS CHAPERONE-SUBUNIT COMPLEX PAPD-PAPH BOUND TO PILUS BIOGENESIS INHIBITOR PILICIDE 2C
1667, 6d4aA, 0.5149, 3.79, 0.083, 123, 108, CELL SURFACE RECEPTOR WITH BOUND LIGAND AT 1.75-A RESOLUTION 
1668, 3anzH, 0.5149, 3.95, 0.064, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1669, 1sujA, 0.5149, 3.27, 0.030, 363, 99, X-RAY CRYSTAL STRUCTURE OF AMBYSTOMA TIGRINUM CONE ARRESTIN
1670, 1pdkA, 0.5149, 3.17, 0.133, 215, 98, PAPD-PAPK CHAPERONE-PILUS SUBUNIT COMPLEX FROM E.COLI P PILUS
1671, 5npjA, 0.5148, 3.76, 0.065, 232, 107, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN JFH1 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
1672, 4ki5C, 0.5148, 4.01, 0.064, 218, 110, CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99
1673, 3anzP, 0.5148, 3.95, 0.064, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1674, 3anzC, 0.5148, 3.96, 0.064, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1675, 2ntfB, 0.5148, 3.95, 0.072, 222, 111, CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N- ACYL-L-HOMOSERINE LACTONE ANALOG
1676, 1oaxJ, 0.5148, 3.83, 0.074, 122, 108, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE
1677, 1oaxH, 0.5148, 3.83, 0.074, 122, 108, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE
1678, 1f5wA, 0.5148, 3.91, 0.064, 124, 110, DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN
1679, 3vxqA, 0.5147, 3.74, 0.112, 204, 107, H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10
1680, 6aniI, 0.5146, 3.95, 0.081, 214, 111, COLTUXIMAB FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
1681, 5w0pD, 0.5146, 3.63, 0.020, 773, 101, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1682, 4elkD, 0.5146, 3.76, 0.104, 242, 106, CRYSTAL STRUCTURE OF THE HY19.3 TYPE II NKT TCR
1683, 6erxO, 0.5145, 3.77, 0.056, 215, 107, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1684, 5yslE, 0.5145, 3.70, 0.084, 210, 107, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
1685, 5pcyA, 0.5145, 2.51, 0.148, 99, 88, CRYSTAL STRUCTURE ANALYSES OF REDUCED (CUI) POPLAR PLASTOCYANIN AT SIX PH VALUES
1686, 4tnwU, 0.5145, 3.70, 0.084, 221, 107, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1687, 4p4kD, 0.5145, 3.63, 0.095, 241, 105, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTO IMMUNITY
1688, 4mnqE, 0.5145, 3.71, 0.075, 240, 107, TCR-PEPTIDE SPECIFICITY OVERRIDES AFFINITY ENHANCING TCR-MHC INTERACTIONS
1689, 4dwhA, 0.5145, 2.89, 0.084, 197, 95, STRUCTURE OF THE MAJOR TYPE 1 PILUS SUBUNIT FIMA BOUND TO THE FIMC (2.5 A RESOLUTION)
1690, 4dp7X, 0.5145, 2.50, 0.148, 99, 88, THE 1.08 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN A AT PH 4.0
1691, 2ypvH, 0.5145, 3.77, 0.083, 215, 108, CRYSTAL STRUCTURE OF THE MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN IN COMPLEX WITH A BACTERICIDAL ANTIBODY
1692, 2pcfA, 0.5145, 2.59, 0.146, 99, 89, THE COMPLEX OF CYTOCHROME F AND PLASTOCYANIN DETERMINED WITH PARAMAGNETIC NMR. BASED ON THE STRUCTURES OF CYTOCHROME F AND PLASTOCYANIN 10 STRUCTURES
1693, 2bz7A, 0.5145, 2.70, 0.157, 102, 89, OXIDIZED AND REDUCED STRUCTURES OF A MUTANT PLASTOCYANIN OF FERN
1694, 6cqqI, 0.5144, 3.84, 0.084, 200, 107, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1695, 5swzO, 0.5144, 3.77, 0.112, 241, 107, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1696, 4dpaX, 0.5144, 2.51, 0.148, 99, 88, THE 1.05 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN A AT PH 6.0
1697, 3sdcD, 0.5144, 3.75, 0.056, 239, 107, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-GLOBOTRIHEXOSYLCERAMIDE
1698, 1za3A, 0.5144, 3.79, 0.085, 213, 106, THE CRYSTAL STRUCTURE OF THE YSD1 FAB BOUND TO DR5
1699, 6fupA, 0.5143, 3.80, 0.130, 202, 108, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1700, 5tilK, 0.5143, 4.18, 0.099, 118, 111, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2 DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE V3P AND T-CELL RECEPTOR P14
1701, 3hujH, 0.5143, 3.72, 0.084, 245, 107, CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
1702, 5iblH, 0.5142, 3.69, 0.065, 216, 107, HUMAN ANTIBODY 6639 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 X-181
1703, 3sqbC, 0.5142, 2.84, 0.096, 200, 94, STRUCTURE OF THE MAJOR TYPE 1 PILUS SUBUNIT FIMA BOUND TO THE FIMC CHAPERONE
1704, 3qpqJ, 0.5142, 3.88, 0.091, 216, 110, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
1705, 2op4H, 0.5142, 3.83, 0.100, 217, 110, CRYSTAL STRUCTURE OF QUORUM-QUENCHING ANTIBODY 1G9
1706, 2ntfH, 0.5142, 3.96, 0.072, 222, 111, CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N- ACYL-L-HOMOSERINE LACTONE ANALOG
1707, 2d7tL, 0.5142, 3.95, 0.093, 110, 107, CRYSTAL STRUCTURE OF HUMAN ANTI POLYHYDROXYBUTYRATE ANTIBODY FV
1708, 3ri5I, 0.5141, 3.71, 0.075, 199, 107, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
1709, 2bzcA, 0.5141, 2.55, 0.159, 102, 88, OXIDIZED AND REDUCED STRUCTURES OF A MUTANT PLASTOCYANIN OF FERN
1710, 1tkwA, 0.5141, 2.51, 0.148, 99, 88, THE TRANSIENT COMPLEX OF POPLAR PLASTOCYANIN WITH TURNIP CYTOCHROME F DETERMINED WITH PARAMAGNETIC NMR
1711, 3anzU, 0.5140, 4.02, 0.063, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1712, 1plcA, 0.5140, 2.51, 0.148, 99, 88, ACCURACY AND PRECISION IN PROTEIN CRYSTAL STRUCTURE ANALYSIS: RESTRAINED LEAST-SQUARES REFINEMENT OF THE CRYSTAL STRUCTURE OF POPLAR PLASTOCYANIN AT 1.33 ANGSTROMS RESOLUTION
1713, 1klfK, 0.5140, 2.89, 0.074, 205, 95, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1714, 1bypA, 0.5140, 2.67, 0.135, 99, 89, E43KD44K DOUBLE MUTANT PLASTOCYANIN FROM SILENE
1715, 5j06B, 0.5139, 3.94, 0.093, 215, 108, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 3 -SIALYLLACTOSE
1716, 4jzjA, 0.5139, 3.89, 0.046, 214, 109, CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX
1717, 3dpaA, 0.5139, 3.42, 0.141, 218, 99, CRYSTAL STRUCTURE OF CHAPERONE PROTEIN PAPD REVEALS AN IMMUNOGLOBULIN FOLD
1718, 3anzB, 0.5139, 4.03, 0.063, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1719, 1oauJ, 0.5139, 3.83, 0.083, 122, 108, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH DNP-SER (IMMUNISING HAPTEN)
1720, 1oauH, 0.5139, 3.83, 0.083, 122, 108, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH DNP-SER (IMMUNISING HAPTEN)
1721, 1ngqH, 0.5139, 4.01, 0.080, 215, 112, N1G9 (IGG1-LAMBDA) FAB FRAGMENT
1722, 1klfO, 0.5139, 2.89, 0.074, 205, 95, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1723, 1klfM, 0.5139, 2.89, 0.074, 205, 95, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1724, 1klfI, 0.5139, 2.89, 0.074, 205, 95, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1725, 1a5fH, 0.5139, 3.80, 0.065, 212, 108, FAB FRAGMENT OF A MONOCLONAL ANTI-E-SELECTIN ANTIBODY
1726, 5ikcH, 0.5138, 3.86, 0.074, 214, 108, X-RAY STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN IN COMPLEX WITH FAB
1727, 5iblC, 0.5138, 3.61, 0.066, 216, 106, HUMAN ANTIBODY 6639 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 X-181
1728, 4z7vH, 0.5138, 3.68, 0.075, 242, 106, L3-12 COMPLEX
1729, 4r7nD, 0.5138, 4.01, 0.084, 211, 107, FAB C2E3
1730, 4j2qB, 0.5138, 3.76, 0.040, 346, 101, CRYSTAL STRUCTURE OF C-TERMINALLY TRUNCATED ARRESTIN REVEALS MECHANISM OF ARRESTIN ACTIVATION
1731, 1n7mL, 0.5138, 3.98, 0.063, 216, 111, GERMLINE 7G12 WITH N-METHYLMESOPORPHYRIN
1732, 1g6rA, 0.5138, 3.75, 0.103, 202, 107, A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
1733, 6cqrI, 0.5137, 3.84, 0.084, 201, 107, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1734, 6cqqD, 0.5137, 3.84, 0.084, 200, 107, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1735, 5xcqA, 0.5137, 4.01, 0.045, 166, 110, CRYSTAL STRUCTURE OF P20.1 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
1736, 5swsE, 0.5137, 3.75, 0.113, 239, 106, CRYSTAL STRUCTURE OF NP2-B17 TCR-H2DB-NP COMPLEX
1737, 4ei5C, 0.5137, 3.83, 0.093, 201, 107, CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1
1738, 4amkH, 0.5137, 3.74, 0.083, 215, 108, FAB FRAGMENT OF ANTIPORPHRIN ANTIBODY 13G10
1739, 3njkA, 0.5137, 3.32, 0.112, 122, 98, D116A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS AT PH5.5
1740, 3iyoB, 0.5137, 4.17, 0.055, 468, 109, CRYO-EM MODEL OF VIRION-SIZED HEV VIRION-SIZED CAPSID
1741, 3iyoA, 0.5137, 4.17, 0.055, 468, 109, CRYO-EM MODEL OF VIRION-SIZED HEV VIRION-SIZED CAPSID
1742, 3hujF, 0.5137, 3.66, 0.085, 242, 106, CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
1743, 3anzE, 0.5137, 4.03, 0.063, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1744, 1ngpH, 0.5137, 3.92, 0.090, 215, 111, N1G9 (IGG1-LAMBDA) FAB FRAGMENT COMPLEXED WITH (4-HYDROXY-3- NITROPHENYL) ACETATE
1745, 6eh5B, 0.5136, 3.70, 0.085, 244, 106, 003 HUMAN T-CELL RECEPTOR SPECIFIC FOR HIV GAG EPITOPE SLYNTVATL CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-A*0201 
1746, 4tnwV, 0.5136, 3.70, 0.084, 224, 107, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1747, 4dzbB, 0.5136, 3.98, 0.100, 244, 110, MUCOSAL-ASSOCIATED INVARIANT T CELL RECEPTOR VALPHA7.2JALPHA33-VBETA2
1748, 4dpcX, 0.5136, 2.52, 0.148, 99, 88, THE 1.06 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN A AT PH 8.0
1749, 4a6yH, 0.5136, 3.97, 0.098, 215, 112, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3
1750, 3t2nH, 0.5136, 3.89, 0.056, 203, 108, HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY
1751, 3sqbA, 0.5136, 2.86, 0.096, 191, 94, STRUCTURE OF THE MAJOR TYPE 1 PILUS SUBUNIT FIMA BOUND TO THE FIMC CHAPERONE
1752, 3anzJ, 0.5136, 4.02, 0.063, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1753, 4tnwF, 0.5135, 3.70, 0.084, 221, 107, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1754, 4qrrE, 0.5135, 3.61, 0.086, 241, 105, CRYSTAL STRUCTURE OF HLA B*3501-IPS IN COMPLEX WITH A DELTA-BETA TCR CLONE 12 TCR
1755, 4dpbX, 0.5135, 2.52, 0.148, 99, 88, THE 1.00 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN A AT PH 8.0
1756, 3jwnC, 0.5135, 3.05, 0.083, 199, 96, COMPLEX OF FIMC FIMF FIMG AND FIMH
1757, 2pcyA, 0.5135, 2.51, 0.148, 99, 88, THE CRYSTAL STRUCTURE OF POPLAR APOPLASTOCYANIN AT 1.8- ANGSTROMS RESOLUTION. THE GEOMETRY OF THE COPPER-BINDING SITE IS CREATED BY THE POLYPEPTIDE
1758, 2cdfB, 0.5135, 3.64, 0.075, 244, 107, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE-SPECIFIC T CELL RECEPTORS (TCR 5E)
1759, 1l4iA, 0.5135, 2.83, 0.074, 189, 94, CRYSTAL STRUCTURE OF THE PERIPLASMIC CHAPERONE SFAE
1760, 4dp9X, 0.5134, 2.52, 0.148, 99, 88, THE 1.00 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN A AT PH 6.0
1761, 3vwjD, 0.5134, 3.69, 0.085, 241, 106, TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-C20:2 COMPLEX
1762, 3tjhC, 0.5134, 3.83, 0.112, 201, 107, 42F3-P3A1/H2-LD COMPLEX
1763, 3anzL, 0.5134, 4.03, 0.054, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1764, 2xg5A, 0.5134, 3.34, 0.143, 216, 98, E. COLI P PILUS CHAPERONE-SUBUNIT COMPLEX PAPD-PAPH BOUND TO PILUS BIOGENESIS INHIBITOR PILICIDE 5D
1765, 2qadD, 0.5134, 3.99, 0.071, 229, 112, STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4
1766, 1pndA, 0.5134, 2.52, 0.148, 99, 88, ACCURACY AND PRECISION IN PROTEIN CRYSTAL STRUCTURE ANALYSIS: TWO INDEPENDENT REFINEMENTS OF THE STRUCTURE OF POPLAR PLASTOCYANIN AT 173K
1767, 6gk8H, 0.5133, 3.77, 0.084, 222, 107, CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY DMCBTAU-28.1; DOUBLE MUTANT (S32R; E35K) OF CBTAU-28.1; IN COMPLEX WITH TAU PEPTIDE A7731 (RESIDUES 52-71) 
1768, 6dfqD, 0.5133, 3.71, 0.075, 237, 106, MOUSE DIABETOGENIC TCR I.29 
1769, 4tnwI, 0.5133, 3.70, 0.084, 222, 107, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1770, 4r7dB, 0.5133, 3.98, 0.084, 211, 107, FAB HU 15C1
1771, 4m62M, 0.5133, 3.93, 0.076, 113, 105, ONTOGENY OF RECOGNITION SPECIFICITY AND FUNCTIONALITY FOR THE ANTI-HIV NEUTRALIZING ANTIBODY 4E10
1772, 4gg8F, 0.5133, 3.80, 0.084, 244, 107, IMMUNE RECEPTOR
1773, 4a6yB, 0.5133, 3.97, 0.099, 214, 111, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3
1774, 3t2nI, 0.5133, 3.89, 0.056, 205, 108, HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY
1775, 3scmD, 0.5133, 3.74, 0.056, 239, 107, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-ISOGLOBOTRIHEXOSYLCERAMIDE
1776, 3rhwI, 0.5133, 3.74, 0.075, 199, 107, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
1777, 2y06H, 0.5133, 4.01, 0.080, 215, 112, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE GDPRPSYISHLL
1778, 2qadH, 0.5133, 3.99, 0.071, 229, 112, STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4
1779, 1i7zC, 0.5133, 3.82, 0.094, 219, 106, ANTIBODY GNC92H2 BOUND TO LIGAND
1780, 1hxmC, 0.5133, 3.80, 0.093, 206, 107, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1781, 1hxmB, 0.5133, 4.13, 0.143, 230, 112, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1782, 1byoA, 0.5133, 2.67, 0.135, 99, 89, WILD-TYPE PLASTOCYANIN FROM SILENE
1783, 6fuqA, 0.5132, 3.79, 0.139, 202, 108, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1784, 6eh4E, 0.5132, 3.71, 0.085, 244, 106, 003 HUMAN T-CELL RECEPTOR SPECIFIC FOR HIV GAG EPITOPE SLYNTVATL CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-A*0201 
1785, 5epmA, 0.5132, 3.86, 0.100, 218, 110, CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT
1786, 5bs0E, 0.5132, 3.71, 0.104, 241, 106, MAGE-A3 REACTIVE TCR IN COMPLEX WITH TITIN EPITOPE IN HLA-A1
1787, 4yhdD, 0.5132, 4.11, 0.090, 282, 111, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1788, 4gg8B, 0.5132, 3.80, 0.084, 244, 107, IMMUNE RECEPTOR
1789, 3ra7M, 0.5132, 3.88, 0.085, 211, 106, BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY
1790, 3phoA, 0.5132, 3.90, 0.103, 216, 107, CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH PSBP
1791, 1pncA, 0.5132, 2.52, 0.148, 99, 88, ACCURACY AND PRECISION IN PROTEIN CRYSTAL STRUCTURE ANALYSIS: TWO INDEPENDENT REFINEMENTS OF THE STRUCTURE OF POPLAR PLASTOCYANIN AT 173K
1792, 6fr5B, 0.5131, 3.70, 0.085, 244, 106, HA1.7 TCR STUDY OF CDR LOOP FLEXIBILITY 
1793, 6dfsB, 0.5131, 3.69, 0.075, 241, 106, MOUSE TCR I.29 IN COMPLEX WITH IAG7-P8E9E6SS 
1794, 5ihbB, 0.5131, 3.87, 0.102, 214, 108, STRUCTURE OF THE IMMUNE RECEPTOR CD33
1795, 4z7uH, 0.5131, 3.59, 0.087, 244, 104, S13 COMPLEX
1796, 4r7nB, 0.5131, 4.01, 0.084, 211, 107, FAB C2E3
1797, 4elkC, 0.5131, 3.81, 0.093, 203, 107, CRYSTAL STRUCTURE OF THE HY19.3 TYPE II NKT TCR
1798, 4b0mM, 0.5131, 3.00, 0.095, 212, 95, COMPLEX OF THE CAF1AN USHER DOMAIN CAF1M CHAPERONE AND CAF1 SUBUNIT FROM YERSINIA PESTIS
1799, 3riaI, 0.5131, 3.81, 0.074, 199, 108, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
1800, 1qppA, 0.5131, 3.34, 0.133, 207, 98, CRYSTAL STRUCTURES OF SELF CAPPING PAPD CHAPERONE HOMODIMERS
1801, 6q3sD, 0.5130, 3.72, 0.131, 203, 107, ENGINEERED HUMAN HLA_A2 MHC CLASS I MOLECULE IN COMPLEX WITH TCR AND SV9 PEPTIDE 
1802, 6erxD, 0.5130, 3.77, 0.056, 215, 107, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1803, 5jqdD, 0.5130, 3.93, 0.055, 214, 110, ANTIBODY FAB FRAGMENT
1804, 4zsoD, 0.5130, 4.04, 0.089, 219, 112, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6 A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30 AND AN INHIBITORY ANTIBODY
1805, 4p4kH, 0.5130, 3.65, 0.086, 239, 105, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTO IMMUNITY
1806, 4p24G, 0.5130, 4.08, 0.071, 292, 112, PORE FORMING TOXIN
1807, 4j3oC, 0.5130, 3.02, 0.083, 199, 96, CRYSTAL STRUCTURE OF THE FIMD USHER TRAVERSED BY THE PILUS TIP COMPLEX ASSEMBLY COMPOSED OF FIMC:FIMF:FIMG:FIMH
1808, 3na9H, 0.5130, 3.81, 0.056, 225, 108, CRYSTAL STRUCTURE OF FAB15
1809, 6avgE, 0.5129, 3.72, 0.085, 245, 106, CRYSTAL STRUCTURE OF THE KFJ37 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
1810, 5ks9H, 0.5129, 3.68, 0.086, 240, 105, BEL502-DQ8-GLIA-ALPHA1 COMPLEX
1811, 5k59A, 0.5129, 4.19, 0.080, 292, 113, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
1812, 4nhuC, 0.5129, 3.70, 0.094, 199, 106, THE M33 TCR P3M33L/H-2 LD COMPLEX
1813, 4hqqH, 0.5129, 3.71, 0.065, 215, 107, CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58
1814, 3vxsD, 0.5129, 3.79, 0.112, 204, 107, THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(6L) PEPTIDE
1815, 2w07A, 0.5129, 3.22, 0.122, 215, 98, STRUCTURAL DETERMINANTS OF POLYMERIZATION REACTIVITY OF THE P PILUS ADAPTOR SUBUNIT PAPF
1816, 1oarJ, 0.5129, 3.93, 0.073, 122, 110, FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED
1817, 1oarH, 0.5129, 3.93, 0.073, 122, 110, FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED
1818, 1a4jH, 0.5129, 3.92, 0.064, 217, 110, DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR
1819, 6ol5B, 0.5128, 3.91, 0.103, 213, 107, STRUCTURE OF IGLB12 FAB IN COMPLEX WITH ANTI-IDIOTYPE IB3 FAB 
1820, 6furC, 0.5128, 3.80, 0.139, 202, 108, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1821, 5yslC, 0.5128, 3.93, 0.073, 210, 110, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
1822, 5yslA, 0.5128, 3.94, 0.072, 211, 111, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
1823, 5jo4C, 0.5128, 3.77, 0.075, 221, 107, ANTIBODY FAB FRAGMENT COMPLEX
1824, 4x6cG, 0.5128, 3.70, 0.094, 201, 106, CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR
1825, 4j2qA, 0.5128, 3.64, 0.030, 340, 100, CRYSTAL STRUCTURE OF C-TERMINALLY TRUNCATED ARRESTIN REVEALS MECHANISM OF ARRESTIN ACTIVATION
1826, 3g6jE, 0.5128, 3.98, 0.065, 214, 107, C3B IN COMPLEX WITH A C3B SPECIFIC FAB
1827, 2po6D, 0.5128, 3.73, 0.084, 244, 107, CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
1828, 1hxmE, 0.5128, 3.84, 0.084, 206, 107, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1829, 6cqrD, 0.5127, 3.83, 0.084, 200, 107, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1830, 5t5fH, 0.5127, 3.86, 0.100, 212, 110, NEISSERIA MENINGITIDIS FACTOR H BINDING PROTEIN IN COMPLEX WITH MONOCLONAL ANTIBODY JAR5
1831, 4yhdB, 0.5127, 4.07, 0.081, 283, 111, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1832, 4gg6H, 0.5127, 3.78, 0.075, 243, 107, PROTEIN COMPLEX
1833, 3d34B, 0.5127, 3.46, 0.079, 215, 101, STRUCTURE OF THE F-SPONDIN DOMAIN OF MINDIN
1834, 2zg3A, 0.5127, 4.00, 0.092, 210, 109, CRYSTAL STRUCTURE OF TWO N-TERMINAL DOMAINS OF NATIVE SIGLEC-5 IN COMPLEX WITH 3 -SIALYLLACTOSE
1835, 2j2zA, 0.5127, 3.34, 0.143, 216, 98, X-RAY STRUCTURE OF THE CHAPERONE PAPD IN COMPLEX WITH THE PILUS TERMINATOR SUBUNIT PAPH AT 2.3 ANGSTROM RESOLUTION
1836, 1ws7B, 0.5127, 2.92, 0.129, 103, 93, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
1837, 6mi2D, 0.5126, 4.00, 0.073, 210, 110, STRUCTURE OF THE HUMAN 4-1BB / UTOMILUMAB FAB COMPLEX 
1838, 6b5rH, 0.5126, 4.02, 0.054, 211, 111, STRUCTURE OF PFCSP PEPTIDE 21 WITH HUMAN ANTIBODY CIS42
1839, 6am5E, 0.5126, 3.63, 0.075, 242, 106, CRYSTAL STRUCTURE OF DMF5 TCR BOUND TO HLA-A2 PRESENTING SYNTHETIC PEPTIDE SMLGIGIVPV 
1840, 5yxnB, 0.5126, 3.74, 0.084, 241, 107, A T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HEPATITIS C VIRUS NS3 PEPTIDE (KLVALGINAV) 
1841, 5m00G, 0.5126, 3.88, 0.111, 187, 108, CRYSTAL STRUCTURE OF MURINE P14 TCR COMPLEX WITH H-2DB AND Y4A MODIFIED GP33 PEPTIDE FROM LCMV
1842, 4gg6F, 0.5126, 3.78, 0.075, 243, 107, PROTEIN COMPLEX
1843, 4ei5G, 0.5126, 3.82, 0.093, 172, 107, CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1
1844, 3sjvI, 0.5126, 3.64, 0.086, 197, 105, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
1845, 3q5yD, 0.5126, 3.67, 0.114, 238, 105, V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES
1846, 3q48B, 0.5126, 2.74, 0.129, 186, 93, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA CUPB2 CHAPERONE
1847, 2xzqH, 0.5126, 3.82, 0.082, 215, 110, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE YQLRPNAETLRF
1848, 6fxnD, 0.5125, 3.78, 0.047, 215, 107, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1849, 5nmeE, 0.5125, 3.72, 0.066, 242, 106, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTVATL
1850, 3q13A, 0.5125, 3.46, 0.069, 235, 101, THE STRUCTURE OF THE CA2+-BINDING GLYCOSYLATED F-SPONDIN DOMAIN OF F- SPONDIN A C2-DOMAIN VARIANT FROM EXTRACELLULAR MATRIX
1851, 3d34A, 0.5125, 3.46, 0.089, 211, 101, STRUCTURE OF THE F-SPONDIN DOMAIN OF MINDIN
1852, 6fr9A, 0.5124, 3.80, 0.139, 202, 108, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1853, 6dfqH, 0.5124, 3.70, 0.075, 234, 106, MOUSE DIABETOGENIC TCR I.29 
1854, 6aniH, 0.5124, 4.00, 0.081, 216, 111, COLTUXIMAB FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
1855, 5nmeJ, 0.5124, 3.78, 0.065, 241, 107, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTVATL
1856, 5ks9F, 0.5124, 3.68, 0.086, 240, 105, BEL502-DQ8-GLIA-ALPHA1 COMPLEX
1857, 5k59B, 0.5124, 4.21, 0.080, 293, 113, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
1858, 5brzE, 0.5124, 3.70, 0.104, 241, 106, MAGE-A3 REACTIVE TCR IN COMPLEX WITH MAGE-A3 IN HLA-A1
1859, 4m43H, 0.5124, 4.22, 0.088, 219, 113, CRYSTAL STRUCTURE OF ANTI-RABIES GLYCOPROTEIN FAB 523-11
1860, 4ei6C, 0.5124, 3.69, 0.095, 189, 105, STRUCTURE OF XV19 VALPHA1-VBETA16 TYPE-II NATURAL KILLER T CELL RECEPTOR
1861, 3iyoD, 0.5124, 3.93, 0.067, 461, 105, CRYO-EM MODEL OF VIRION-SIZED HEV VIRION-SIZED CAPSID
1862, 1hxmD, 0.5124, 4.08, 0.143, 230, 112, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1863, 6d48E, 0.5123, 3.77, 0.084, 125, 107, CELL SURFACE RECEPTOR 
1864, 6amuE, 0.5123, 3.63, 0.085, 241, 106, CRYSTAL STRUCTURE OF DMF5 TCR BOUND TO HLA-A2 PRESENTING SYNTHETIC PEPTIDE MMWDRGLGMM 
1865, 5nmdD, 0.5123, 3.78, 0.075, 242, 107, TCR SPECIFIC FOR HLA A02 PRESENTING HIV EPITOPE SLYNTVATL
1866, 5ksbH, 0.5123, 3.60, 0.087, 241, 104, T15-DQ8.5-GLIA-GAMMA1 COMPLEX
1867, 4l5fL, 0.5123, 3.84, 0.104, 213, 106, CRYSTAL STRUCTURE OF DENV1-E106 FAB BOUND TO DENV-1 ENVELOPE PROTEIN DIII
1868, 3vxrD, 0.5123, 3.79, 0.112, 194, 107, THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(WT) PEPTIDE
1869, 3qi9D, 0.5123, 3.77, 0.065, 239, 107, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-PHOSPHOTIDYLINOSITOL WITH MOUSE VALPHA14-VBETA6 2A3-D NKT TCR
1870, 3qeuB, 0.5123, 3.61, 0.085, 238, 106, THE CRYSTAL STRUCTURE OF TCR DMF5
1871, 2y07H, 0.5123, 3.95, 0.072, 215, 111, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE PPYPAWHAPGNI
1872, 2uy7E, 0.5123, 3.35, 0.143, 216, 98, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
1873, 6dkpE, 0.5122, 3.58, 0.086, 242, 105, THE COMPLEX AMONG DMF5(ALPHA-D26Y; ALPHA-Y50A;BETA-L98W) TCR; HUMAN CLASS I MHC HLA-A2 AND MART-1(26-35)(A27L) PEPTIDE 
1874, 5j0bB, 0.5122, 3.96, 0.101, 214, 109, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 6 -SIALYLLACTOSE
1875, 4alaL, 0.5122, 4.01, 0.103, 212, 107, STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
1876, 3uttI, 0.5122, 3.67, 0.105, 199, 105, 1E6-A*0201-ALWGPDPAAA COMPLEX TRICLINIC
1877, 3rfzC, 0.5122, 2.93, 0.084, 201, 95, CRYSTAL STRUCTURE OF THE FIMD USHER BOUND TO ITS COGNATE FIMC:FIMH SUBSTRATE
1878, 3qdgE, 0.5122, 3.59, 0.086, 242, 105, THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
1879, 2zg2A, 0.5122, 3.99, 0.092, 214, 109, CRYSTAL STRUCTURE OF TWO N-TERMINAL DOMAINS OF NATIVE SIGLEC-5
1880, 2po6H, 0.5122, 3.74, 0.084, 244, 107, CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
1881, 1hxmA, 0.5122, 3.84, 0.084, 206, 107, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1882, 5yhlH, 0.5121, 3.97, 0.080, 223, 112, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY. 
1883, 5nmgE, 0.5121, 3.74, 0.066, 242, 106, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYFNTIAVL
1884, 4grmD, 0.5121, 3.61, 0.075, 243, 106, THE CRYSTAL STRUCTURE OF THE HIGH AFFINITY TCR A6
1885, 4cadE, 0.5121, 3.84, 0.065, 220, 108, MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1
1886, 3qeqD, 0.5121, 3.77, 0.143, 194, 105, THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
1887, 2zg1A, 0.5121, 4.02, 0.092, 208, 109, CRYSTAL STRUCTURE OF TWO N-TERMINAL DOMAINS OF SIGLEC-5 IN COMPLEX WITH 6 -SIALYLLACTOSE
1888, 2y36H, 0.5121, 4.00, 0.098, 215, 112, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL)- ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE DLWTTAIPTIPS
1889, 1oayH, 0.5121, 3.99, 0.082, 121, 110, ANTIBODY MULTISPECIFICITY MEDIATED BY CONFORMATIONAL DIVERSITY
1890, 6dc9M, 0.5120, 4.00, 0.084, 215, 107, FAB/EPITOPE COMPLEX OF HUMAN CHIMERIC MONOCLONAL ANTIBODY H4E6 TARGETING A PHOSPHORYLATED TAU EPITOPE. 
1891, 5nyxN, 0.5120, 3.76, 0.076, 210, 105, HUMAN FAB FRAGMENT 5H2 AGAINST NHBA FROM NEISSERIA MENINGITIDIS 
1892, 5ec2A, 0.5120, 4.18, 0.071, 219, 113, KCSA WITH V76ESTER+G77DA MUTATIONS
1893, 4z7uF, 0.5120, 3.73, 0.085, 244, 106, S13 COMPLEX
1894, 4r7dN, 0.5120, 4.00, 0.084, 211, 107, FAB HU 15C1
1895, 4m6nH, 0.5120, 4.04, 0.072, 213, 111, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 6.5
1896, 3of6C, 0.5120, 3.97, 0.109, 243, 110, HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE
1897, 3of6B, 0.5120, 3.79, 0.102, 242, 108, HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE
1898, 1cf1C, 0.5120, 3.41, 0.040, 380, 100, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1899, 6d48G, 0.5119, 3.92, 0.093, 124, 107, CELL SURFACE RECEPTOR 
1900, 5w23H, 0.5119, 3.93, 0.064, 219, 109, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
1901, 5nmdB, 0.5119, 3.87, 0.074, 242, 108, TCR SPECIFIC FOR HLA A02 PRESENTING HIV EPITOPE SLYNTVATL
1902, 5m01G, 0.5119, 3.88, 0.111, 188, 108, CRYSTAL STRUCTURE OF MURINE P14 TCR/ H-2DB COMPLEX WITH PA MODIFIED GP33 PEPTIDE FROM LCMV
1903, 4z95L, 0.5119, 3.87, 0.085, 214, 106, FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA 5 -5(DT)-P- 3 
1904, 4tnwG, 0.5119, 3.98, 0.073, 222, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1905, 4i3rH, 0.5119, 4.25, 0.080, 228, 112, CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P3221
1906, 4elkB, 0.5119, 3.84, 0.093, 242, 107, CRYSTAL STRUCTURE OF THE HY19.3 TYPE II NKT TCR
1907, 3njmA, 0.5119, 3.34, 0.113, 122, 97, P117A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS.
1908, 1klfG, 0.5119, 2.89, 0.074, 205, 95, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1909, 1klfE, 0.5119, 2.89, 0.074, 205, 95, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1910, 1klfA, 0.5119, 2.89, 0.074, 205, 95, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1911, 1byoB, 0.5119, 2.68, 0.135, 99, 89, WILD-TYPE PLASTOCYANIN FROM SILENE
1912, 12e8P, 0.5119, 4.03, 0.063, 221, 111, 2E8 FAB FRAGMENT
1913, 6nz7L, 0.5118, 3.81, 0.094, 214, 106, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 429 B01 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968 
1914, 5i1lH, 0.5118, 3.80, 0.074, 225, 108, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV4-1
1915, 4r7nH, 0.5118, 3.92, 0.085, 211, 106, FAB C2E3
1916, 3ulvF, 0.5118, 4.12, 0.098, 217, 112, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)
1917, 2vxvH, 0.5118, 3.76, 0.047, 222, 107, CRYSTAL STRUCTURE OF HUMAN IGG ABT-325 FAB FRAGMENT
1918, 1klfC, 0.5118, 2.89, 0.074, 205, 95, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1919, 6idgL, 0.5117, 3.80, 0.123, 217, 106, ANTIBODY 64M-5 FAB IN COMPLEX WITH DT(6-4)T 
1920, 6e47F, 0.5117, 3.80, 0.085, 109, 106, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR AND GLYCOCHENODEOXYCHOLIC ACID 
1921, 5ywyH, 0.5117, 3.97, 0.080, 223, 112, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY. 
1922, 5u6fA, 0.5117, 3.67, 0.079, 288, 101, BACTERIAL ADHESIN FROM MOBILUNCUS MULIERIS CONTAINING INTRAMOLECULAR DISULFIDE; ISOPEPTIDE; AND ESTER BOND CROSS-LINKS (SPACE GROUP P21) 
1923, 5jhlL, 0.5117, 3.96, 0.104, 211, 106, CRYSTAL STRUCTURE OF ZIKA VIRUS ENVELOPE PROTEIN IN COMPLEX WITH A FLAVIVIRUS BROADLY-PROTECTIVE ANTIBODY
1924, 5ikcB, 0.5117, 3.76, 0.065, 210, 107, X-RAY STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN IN COMPLEX WITH FAB
1925, 5dgyB, 0.5117, 3.61, 0.020, 673, 100, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
1926, 4zwjB, 0.5117, 3.61, 0.020, 673, 100, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
1927, 4z8fL, 0.5117, 3.88, 0.085, 214, 106, FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA 5 -P5(DT)P- 3 
1928, 3g6jG, 0.5117, 3.98, 0.075, 214, 107, C3B IN COMPLEX WITH A C3B SPECIFIC FAB
1929, 2uy7A, 0.5117, 3.37, 0.143, 216, 98, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
1930, 6fxnH, 0.5116, 3.79, 0.047, 216, 107, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1931, 5udcH, 0.5116, 3.86, 0.055, 217, 109, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
1932, 5tkjJ, 0.5116, 3.98, 0.099, 211, 111, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
1933, 5dgyA, 0.5116, 3.67, 0.020, 833, 101, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
1934, 4zwjA, 0.5116, 3.67, 0.020, 833, 101, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
1935, 3uzqA, 0.5116, 4.05, 0.055, 234, 110, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 1 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
1936, 3utsE, 0.5116, 3.88, 0.073, 246, 109, 1E6-A*0201-ALWGPDPAAA COMPLEX MONOCLINIC
1937, 3q5yA, 0.5116, 3.67, 0.114, 240, 105, V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES
1938, 3mltB, 0.5116, 3.93, 0.064, 219, 109, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
1939, 3hi6Y, 0.5116, 3.95, 0.075, 209, 107, CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
1940, 3ffcE, 0.5116, 3.76, 0.102, 247, 108, CRYSTAL STRUCTURE OF CF34 TCR IN COMPLEX WITH HLA-B8/FLR
1941, 3bn9E, 0.5116, 3.94, 0.075, 211, 107, CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2
1942, 1oayJ, 0.5116, 3.94, 0.082, 121, 110, ANTIBODY MULTISPECIFICITY MEDIATED BY CONFORMATIONAL DIVERSITY
1943, 5w0kL, 0.5115, 4.00, 0.112, 210, 107, CRYSTAL STRUCTURE OF EBV GHGL/CL40/GP42 N-DOMAIN
1944, 5u5oA, 0.5115, 3.65, 0.079, 287, 101, BACTERIAL ADHESIN FROM MOBILUNCUS MULIERIS CONTAINING INTRAMOLECULAR DISULFIDE; ISOPEPTIDE; AND ESTER BOND CROSS-LINKS (SPACE GROUP P1) 
1945, 4apqD, 0.5115, 3.78, 0.056, 240, 107, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-SULFATIDE
1946, 3vxmD, 0.5115, 3.89, 0.111, 198, 108, THE COMPLEX BETWEEN C1-28 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE
1947, 3u9pL, 0.5115, 3.99, 0.093, 212, 107, CRYSTAL STRUCTURE OF MURINE SIDEROCALIN IN COMPLEX WITH AN FAB FRAGMENT
1948, 3qeuE, 0.5115, 3.57, 0.086, 243, 105, THE CRYSTAL STRUCTURE OF TCR DMF5
1949, 3qdjE, 0.5115, 3.59, 0.086, 242, 105, THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
1950, 2uy6A, 0.5115, 3.36, 0.143, 216, 98, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
1951, 2adiA, 0.5115, 3.83, 0.113, 211, 106, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH BARIUM
1952, 1tefA, 0.5115, 2.70, 0.135, 99, 89, CRYSTAL STRUCTURE OF THE SPINACH PLASTOCYANIN MUTANTS G8D/K30C/T69C AND K30C/T69C- A STUDY OF THE EFFECT ON CRYSTAL PACKING AND THERMOSTABILITY FROM THE INTRODUCTION OF A NOVEL DISULFIDE BOND
1953, 1ncaH, 0.5115, 3.92, 0.037, 221, 109, REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
1954, 1mwaA, 0.5115, 4.00, 0.091, 202, 110, 2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX
1955, 6nz7I, 0.5114, 3.87, 0.094, 214, 106, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 429 B01 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968 
1956, 6avfA, 0.5114, 3.80, 0.132, 202, 106, CRYSTAL STRUCTURE OF THE KFJ5 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
1957, 5yslG, 0.5114, 3.83, 0.073, 210, 109, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
1958, 5nmgJ, 0.5114, 3.75, 0.066, 241, 106, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYFNTIAVL
1959, 5hyjE, 0.5114, 3.88, 0.073, 246, 109, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA
1960, 5do2L, 0.5114, 4.00, 0.084, 214, 107, COMPLEX STRUCTURE OF MERS-RBD BOUND WITH 4C2 ANTIBODY
1961, 4yhdC, 0.5114, 4.03, 0.073, 279, 110, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1962, 4u6hA, 0.5114, 3.87, 0.073, 217, 109, VACCINIA L1/M12B9-FAB COMPLEX
1963, 4jfhE, 0.5114, 3.92, 0.119, 244, 109, HIGH AFFINITY ALPHA24-BETA17 T CELL RECEPTOR FOR A2 HLA-MELANOMA PEPTIDE COMPLEX
1964, 3q5yB, 0.5114, 3.74, 0.123, 238, 106, V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES
1965, 2zpkH, 0.5114, 3.93, 0.055, 207, 109, CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE
1966, 1z9sA, 0.5114, 3.01, 0.096, 196, 94, CRYSTAL STRUCTURE OF THE NATIVE CHAPERONE:SUBUNIT:SUBUNIT CAF1M:CAF1:CAF1 COMPLEX
1967, 1s5hB, 0.5114, 4.06, 0.071, 219, 112, POTASSIUM CHANNEL KCSA-FAB COMPLEX T75C MUTANT IN K+
1968, 6erxH, 0.5113, 3.79, 0.047, 216, 107, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1969, 6dfjL, 0.5113, 3.76, 0.095, 214, 105, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z021 BOUND TO DENV-1 ENVELOPE PROTEIN DIII 
1970, 4r7nN, 0.5113, 4.03, 0.075, 211, 107, FAB C2E3
1971, 4jzjH, 0.5113, 3.96, 0.063, 215, 111, CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX
1972, 4jm0B, 0.5113, 3.92, 0.119, 183, 109, STRUCTURE OF HUMAN CYTOMEGALOVIRUS IMMUNE MODULATOR UL141
1973, 3rifJ, 0.5113, 3.82, 0.073, 200, 109, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
1974, 3qpqH, 0.5113, 3.96, 0.099, 215, 111, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
1975, 3ffcJ, 0.5113, 3.77, 0.102, 247, 108, CRYSTAL STRUCTURE OF CF34 TCR IN COMPLEX WITH HLA-B8/FLR
1976, 2vl5B, 0.5113, 3.96, 0.112, 217, 107, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
1977, 2nr6E, 0.5113, 3.86, 0.123, 211, 106, CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
1978, 1py0A, 0.5113, 2.59, 0.126, 122, 87, CRYSTAL STRUCTURE OF E51C/E54C PSAZ FROM A.FAECALIS WITH CLANP PROBE
1979, 1hxmG, 0.5113, 3.84, 0.084, 206, 107, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1980, 6cqnD, 0.5112, 3.86, 0.084, 200, 107, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1981, 6cqlE, 0.5112, 3.69, 0.085, 244, 106, CRYSTAL STRUCTURE OF A TCR 
1982, 5yxuB, 0.5112, 3.67, 0.075, 242, 106, AN AFFINITY ENHANCED T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HCV NS3 PEPTIDE KLVALGINAV 
1983, 5w5xH, 0.5112, 3.98, 0.082, 211, 110, CRYSTAL STRUCTURE OF BAXP168G IN COMPLEX WITH AN ACTIVATING ANTIBODY 
1984, 5tkjD, 0.5112, 3.96, 0.099, 211, 111, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
1985, 5nmfJ, 0.5112, 3.80, 0.075, 240, 107, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTIATL
1986, 5c07J, 0.5112, 3.80, 0.093, 246, 107, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING YQFGPDFPIA
1987, 4r7nT, 0.5112, 4.02, 0.084, 211, 107, FAB C2E3
1988, 4r7nF, 0.5112, 3.93, 0.094, 211, 106, FAB C2E3
1989, 4pb9L, 0.5112, 3.77, 0.105, 216, 105, STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-FRANCISELLA TULARENSIS GROEL ANTIBODY AB64
1990, 4p3dL, 0.5112, 3.90, 0.113, 218, 106, MT1-MMP:FAB COMPLEX (FORM II)
1991, 4odtL, 0.5112, 3.88, 0.085, 214, 106, FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15 IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE
1992, 4mxvE, 0.5112, 3.94, 0.103, 211, 107, STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB
1993, 3vwjC, 0.5112, 3.82, 0.113, 193, 106, TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-C20:2 COMPLEX
1994, 3q5yC, 0.5112, 3.76, 0.123, 239, 106, V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES
1995, 3idyL, 0.5112, 3.97, 0.075, 214, 107, CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13 SPACE GROUP C2221
1996, 3idyC, 0.5112, 3.97, 0.075, 214, 107, CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13 SPACE GROUP C2221
1997, 3bn9C, 0.5112, 3.93, 0.075, 210, 107, CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2
1998, 1zeaH, 0.5112, 3.98, 0.073, 209, 110, STRUCTURE OF THE ANTI-CHOLERA TOXIN ANTIBODY FAB FRAGMENT TE33 IN COMPLEX WITH A D-PEPTIDE
1999, 1ws7C, 0.5112, 2.93, 0.129, 103, 93, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
2000, 6fn1C, 0.5111, 4.04, 0.090, 225, 111, ZOSUQUIDAR AND UIC2 FAB COMPLEX OF HUMAN-MOUSE CHIMERIC ABCB1 (ABCB1HM)
2001, 6c08B, 0.5111, 4.00, 0.084, 215, 107, ZEBRAFISH SLC38A9 WITH ARGININE BOUND IN THE CYTOSOL OPEN STATE 
2002, 6by3A, 0.5111, 4.18, 0.071, 219, 113, OPEN AND CONDUCTIVE CONFORMATION OF KCSA-T75A MUTANT 
2003, 5tkjA, 0.5111, 3.96, 0.099, 211, 111, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
2004, 4qokE, 0.5111, 3.95, 0.100, 244, 110, STRUCTURAL BASIS FOR INEFFECTIVE T-CELL RESPONSES TO MHC ANCHOR RESIDUE IMPROVED HETEROCLITIC PEPTIDES
2005, 4mwfA, 0.5111, 3.85, 0.064, 223, 110, STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C
2006, 4l3eE, 0.5111, 3.59, 0.086, 242, 105, THE COMPLEX BETWEEN HIGH AFFINITY TCR DMF5(ALPHA-D26YBETA-L98W) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
2007, 4al8H, 0.5111, 3.78, 0.083, 212, 109, STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
2008, 3utpE, 0.5111, 3.62, 0.114, 246, 105, 1E6 TCR SPECIFIC FOR HLA-A*0201-ALWGPDPAAA
2009, 3rfzF, 0.5111, 2.94, 0.084, 201, 95, CRYSTAL STRUCTURE OF THE FIMD USHER BOUND TO ITS COGNATE FIMC:FIMH SUBSTRATE
2010, 3pqyT, 0.5111, 3.63, 0.105, 240, 105, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
2011, 3bwuC, 0.5111, 2.87, 0.096, 200, 94, CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF FIMD (N-TERMINAL DOMAIN FIMDN) WITH FIMC AND THE N-TERMINALLY TRUNCATED PILUS SUBUNIT FIMF (FIMFT)
2012, 2zahA, 0.5111, 4.11, 0.038, 296, 104, X-RAY STRUCTURE OF MELON NECROTIC SPOT VIRUS
2013, 2jelH, 0.5111, 4.01, 0.062, 218, 112, JEL42 FAB/HPR COMPLEX
2014, 2e7lA, 0.5111, 3.81, 0.103, 112, 107, STRUCTURE OF A HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
2015, 6fy3X, 0.5110, 3.78, 0.056, 178, 107, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-3D; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
2016, 5wk2H, 0.5110, 4.00, 0.081, 217, 111, CRYSTAL STRUCTURE OF ANTI-CCL17 ANTIBODY M116
2017, 5b4mD, 0.5110, 3.95, 0.104, 218, 106, CRYSTAL STRUCTURE OF AN FAB AGAINST HUMAN INFLUENZA A
2018, 4x8jB, 0.5110, 3.90, 0.113, 214, 106, CRYSTAL STRUCTURE OF MURINE 12F4 FAB MONOCLONAL ANTIBODY AGAINST ADAMTS5
2019, 4am0H, 0.5110, 3.86, 0.082, 214, 110, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
2020, 2uylN, 0.5110, 4.01, 0.072, 213, 111, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2021, 6dfxJ, 0.5109, 3.70, 0.076, 237, 105, HUMAN DIABETOGENIC TCR T1D3 IN COMPLEX WITH DQ8-P8E9E PEPTIDE 
2022, 6cqqE, 0.5109, 3.95, 0.083, 244, 109, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
2023, 5vkhA, 0.5109, 4.08, 0.071, 219, 112, CLOSED CONFORMATION OF KCSA Y82A-F103A MUTANT
2024, 4ztpL, 0.5109, 3.88, 0.105, 216, 105, FAB STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION
2025, 3vxqB, 0.5109, 3.74, 0.094, 242, 106, H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10
2026, 3vwkD, 0.5109, 3.71, 0.085, 242, 106, TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-4 DEOXY-ALPHA- GALACTOSYLCERAMIDE COMPLEX
2027, 3sdaD, 0.5109, 3.78, 0.056, 239, 107, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
2028, 3m4eE, 0.5109, 4.12, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
2029, 2vl5C, 0.5109, 4.01, 0.108, 218, 111, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
2030, 1xedA, 0.5109, 3.51, 0.087, 111, 103, CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR PIGR
2031, 1l7iL, 0.5109, 3.77, 0.086, 214, 105, CRYSTAL STRUCTURE OF THE ANTI-ERBB2 FAB2C4
2032, 6bzuH, 0.5108, 3.99, 0.112, 215, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
2033, 5menE, 0.5108, 3.72, 0.065, 240, 107, HUMAN LEUKOCYTE ANTIGEN A02 PRESENTING ILAKFLHWL IN COMPLEX WITH COGNATE T-CELL RECEPTOR
2034, 5fkaB, 0.5108, 3.80, 0.084, 240, 107, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN E IN COMPLEX WITH A T CELL RECEPTOR
2035, 4ww1A, 0.5108, 3.69, 0.095, 197, 105, CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV21-TRAJ8 AND BETA CHAIN-TRBV7-8
2036, 4r7dJ, 0.5108, 4.02, 0.084, 212, 107, FAB HU 15C1
2037, 4lciH, 0.5108, 3.78, 0.056, 120, 107, ANTI CANINE CD28 ANTIBODY 1C6
2038, 3sjvS, 0.5108, 3.64, 0.124, 197, 105, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
2039, 3sdxF, 0.5108, 3.73, 0.084, 242, 107, CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
2040, 3qjfB, 0.5108, 3.91, 0.073, 240, 109, CRYSTAL STRUCTURE OF THE 2B4 TCR
2041, 3gi9H, 0.5108, 4.12, 0.080, 217, 112, CRYSTAL STRUCTURE OF APCT TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
2042, 2cdeF, 0.5108, 3.78, 0.065, 244, 108, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
2043, 2b1hH, 0.5108, 3.90, 0.065, 226, 108, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG29 PEPTIDE
2044, 1uweU, 0.5108, 3.90, 0.112, 213, 107, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
2045, 1tegA, 0.5108, 2.71, 0.135, 99, 89, CRYSTAL STRUCTURE OF THE SPINACH PLASTOCYANIN MUTANTS G8D/K30C/T69C AND K30C/T69C- A STUDY OF THE EFFECT ON CRYSTAL PACKING AND THERMOSTABILITY FROM THE INTRODUCTION OF A NOVEL DISULFIDE BOND
2046, 1qpxA, 0.5108, 3.12, 0.082, 206, 97, CRYSTAL STRUCTURES OF SELF-CAPPING PAPD CHAPERONE HOMODIMERS
2047, 1p2cD, 0.5108, 3.98, 0.112, 211, 107, CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY
2048, 1kcsL, 0.5108, 3.92, 0.113, 214, 106, CRYSTAL STRUCTURE OF ANTIBODY PC282 IN COMPLEX WITH PS1 PEPTIDE
2049, 6cqlD, 0.5107, 3.87, 0.084, 200, 107, CRYSTAL STRUCTURE OF A TCR 
2050, 5m02G, 0.5107, 3.84, 0.112, 187, 107, CRYSTAL STRUCTURE OF MURINE P14 TCR / H-2DB WITH PF MODIFIED GP33 PEPTIDE FROM LCMV
2051, 5ksaD, 0.5107, 3.69, 0.076, 242, 105, BEL602-DQ8.5-GLIA-GAMMA1 COMPLEX
2052, 5e2vL, 0.5107, 3.80, 0.086, 216, 105, ANTI-TAU AT8 FAB WITH DOUBLY PHOSPHORYLATED TAU PEPTIDE
2053, 5dgyC, 0.5107, 3.62, 0.020, 789, 100, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
2054, 4zwjC, 0.5107, 3.62, 0.020, 789, 100, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
2055, 4kroC, 0.5107, 3.86, 0.094, 211, 106, NANOBODY/VHH DOMAIN EGA1 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR
2056, 3rifI, 0.5107, 3.84, 0.073, 192, 109, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2057, 3of6A, 0.5107, 3.80, 0.102, 240, 108, HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE
2058, 2ntsP, 0.5107, 3.69, 0.076, 240, 105, CRYSTAL STRUCTURE OF SEK-HVB5.1
2059, 2b1aH, 0.5107, 3.90, 0.065, 226, 108, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG1033 PEPTIDE
2060, 1e4xI, 0.5107, 4.02, 0.082, 217, 110, CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
2061, 6fxnM, 0.5106, 3.80, 0.047, 215, 107, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
2062, 6cqqJ, 0.5106, 3.96, 0.083, 244, 109, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
2063, 6cd2A, 0.5106, 3.43, 0.141, 215, 99, CRYSTAL STRUCTURE OF THE PAPC USHER BOUND TO THE CHAPERONE-ADHESIN PAPD-PAPG 
2064, 6bfsL, 0.5106, 3.87, 0.094, 212, 106, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
2065, 5xovJ, 0.5106, 3.76, 0.084, 245, 107, CRYSTAL STRUCTURE OF PEPTIDE-HLA-A24 BOUND TO S19-2 V-DELTA/V-BETA TCR
2066, 5nyxL, 0.5106, 3.71, 0.077, 211, 104, HUMAN FAB FRAGMENT 5H2 AGAINST NHBA FROM NEISSERIA MENINGITIDIS 
2067, 5lxaH, 0.5106, 4.05, 0.054, 238, 111, CRYSTAL STRUCTURE OF HUMAN ADIPONECTIN RECEPTOR 2 IN COMPLEX WITH A C18 FREE FATTY ACID AT 3.0 ANGSTROM RESOLUTION
2068, 5epmE, 0.5106, 3.90, 0.100, 218, 110, CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT
2069, 4kq4L, 0.5106, 3.80, 0.143, 214, 105, CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO7357
2070, 3vxqD, 0.5106, 3.92, 0.128, 204, 109, H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10
2071, 3sddC, 0.5106, 3.93, 0.148, 189, 108, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-LACTOSYLCERAMIDE
2072, 3p11L, 0.5106, 3.99, 0.075, 211, 107, ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAINS I-III OF THE HER3 EXTRACELLULAR REGION
2073, 3arfC, 0.5106, 3.91, 0.148, 203, 108, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-C20:2
2074, 2dweA, 0.5106, 4.18, 0.071, 219, 113, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN RB+
2075, 1fl5L, 0.5106, 3.77, 0.105, 217, 105, THE UNLIGANDED GERMLINE PRECURSOR TO THE SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4.
2076, 6fy0I, 0.5105, 3.77, 0.065, 216, 107, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-16H; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
2077, 6avuL, 0.5105, 3.90, 0.113, 211, 106, HUMAN ALPHA-V BETA-3 INTEGRIN (OPEN CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
2078, 5w1vO, 0.5105, 3.77, 0.084, 243, 107, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
2079, 5sx4L, 0.5105, 3.92, 0.075, 213, 107, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3.
2080, 5cckH, 0.5105, 4.01, 0.064, 224, 109, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 BROADLY NEUTRALIZING ANTIBODY 3BC315 FAB
2081, 4uujA, 0.5105, 4.21, 0.071, 219, 113, POTASSIUM CHANNEL KCSA-FAB WITH TETRAHEXYLAMMONIUM
2082, 4kphL, 0.5105, 3.61, 0.126, 209, 103, STRUCTURE OF THE FAB FRAGMENT OF N62 A PROTECTIVE MONOCLONAL ANTIBODY TO THE NONREDUCING END OF FRANCISELLA TULARENSIS O-ANTIGEN
2083, 4am0F, 0.5105, 3.95, 0.104, 212, 106, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
2084, 3gi8L, 0.5105, 3.97, 0.093, 220, 107, CRYSTAL STRUCTURE OF APCT K158A TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
2085, 2p7tA, 0.5105, 4.18, 0.071, 219, 113, CRYSTAL STRUCTURE OF KCSA MUTANT
2086, 2oslA, 0.5105, 4.06, 0.089, 221, 112, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
2087, 2hjfA, 0.5105, 4.07, 0.071, 219, 112, POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRABUTYLAMMONIUM (TBA)
2088, 1r3iH, 0.5105, 4.18, 0.071, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN RB+
2089, 1oazH, 0.5105, 4.02, 0.081, 122, 111, IGE FV SPE7 COMPLEXED WITH A RECOMBINANT THIOREDOXIN
2090, 1fj1A, 0.5105, 3.98, 0.084, 213, 107, LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
2091, 1clzL, 0.5105, 3.86, 0.113, 219, 106, IGG FAB (IGG3 KAPPA) FRAGMENT (MBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER
2092, 6eqaE, 0.5104, 3.75, 0.102, 244, 108, HLA CLASS I HISTOCOMPATIBILITY ANTIGEN 
2093, 6bzuB, 0.5104, 3.98, 0.112, 216, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
2094, 6bpaC, 0.5104, 3.95, 0.103, 212, 107, PLASMODIUM VIVAX RETICULOCYTE BINDING PROTEIN 2B (PVRBP2B) BOUND TO MONOCLONAL ANTIBODY 3E9 
2095, 5xajE, 0.5104, 3.79, 0.056, 215, 107, STRUCTURAL MIMICRY OF THE DENGUE VIRUS ENVELOPE GLYCOPROTEIN REVEALED BY THE CRYSTALLOGRAPHIC STUDY OF AN IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX.
2096, 5tkjG, 0.5104, 3.98, 0.099, 208, 111, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
2097, 5i15H, 0.5104, 3.78, 0.056, 213, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV1-39
2098, 5d8jH, 0.5104, 4.06, 0.098, 216, 112, DEVELOPMENT OF A THERAPEUTIC MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT TYPE 2 DIABETES.
2099, 5c0bE, 0.5104, 3.80, 0.093, 247, 107, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDFPTI
2100, 5az2L, 0.5104, 3.99, 0.084, 213, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 9E5 A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR HUMAN EPIREGULIN
2101, 4r7nL, 0.5104, 4.05, 0.084, 211, 107, FAB C2E3
2102, 4q6iL, 0.5104, 3.90, 0.113, 218, 106, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
2103, 4am0C, 0.5104, 3.88, 0.082, 211, 110, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
2104, 3ri5G, 0.5104, 3.84, 0.073, 200, 109, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
2105, 3l95L, 0.5104, 3.88, 0.095, 212, 105, CRYSTAL STRUCTURE OF THE HUMAN NOTCH1 NEGATIVE REGULATORY REGION (NRR) BOUND TO THE FAB FRAGMENT OF AN ANTAGONIST ANTIBODY
2106, 3hg1E, 0.5104, 3.94, 0.100, 244, 110, GERMLINE-GOVERNED RECOGNITION OF A CANCER EPITOPE BY AN IMMUNODOMINANT HUMAN T CELL RECEPTOR
2107, 3dxaO, 0.5104, 3.65, 0.094, 244, 106, CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN
2108, 2adjA, 0.5104, 3.97, 0.112, 211, 107, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH CALCIUM
2109, 1yuhH, 0.5104, 4.03, 0.098, 218, 112, FAB FRAGMENT
2110, 1ngxL, 0.5104, 3.89, 0.094, 213, 106, CHIMERIC GERMLINE FAB 7G12 WITH JEFFAMINE FRAGMENT BOUND
2111, 1nezG, 0.5104, 4.06, 0.045, 122, 111, THE CRYSTAL STRUCTURE OF A TL/CD8AA COMPLEX AT 2.1A RESOLUTION:IMPLICATIONS FOR MEMORY T CELL GENERATION CO-RECEPTOR PREFERENCE AND AFFINITY
2112, 1ncbL, 0.5104, 3.97, 0.131, 214, 107, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
2113, 1kj2E, 0.5104, 3.50, 0.069, 117, 102, MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
2114, 1fytD, 0.5104, 3.87, 0.138, 198, 109, CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR INFLUENZA HA ANTIGEN PEPTIDE AND MHC CLASS II MOLECULE HLA-DR1
2115, 1ahwE, 0.5104, 4.01, 0.081, 214, 111, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
2116, 6dwcA, 0.5103, 3.88, 0.113, 217, 106, STRUCTURE OF THE APO 4497 ANTIBODY FAB FRAGMENT 
2117, 6cjkA, 0.5103, 3.81, 0.085, 216, 106, ANTI HIV FAB 10A 
2118, 5nmfE, 0.5103, 3.78, 0.066, 239, 106, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTIATL
2119, 4r7dF, 0.5103, 4.01, 0.084, 211, 107, FAB HU 15C1
2120, 4oduB, 0.5103, 3.93, 0.084, 212, 107, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15
2121, 4j1uC, 0.5103, 3.87, 0.094, 213, 106, CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
2122, 3vxsE, 0.5103, 3.75, 0.084, 242, 107, THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(6L) PEPTIDE
2123, 3phqA, 0.5103, 3.93, 0.103, 216, 107, CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH KDO
2124, 3hagA, 0.5103, 4.11, 0.065, 468, 108, CRYSTAL STRUCTURE OF THE HEPATITIS E VIRUS-LIKE PARTICLE
2125, 3dggD, 0.5103, 3.96, 0.082, 215, 110, CRYSTAL STRUCTURE OF FABOX108
2126, 3ardC, 0.5103, 3.92, 0.148, 202, 108, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-3 DEOXY-ALPHA- GALACTOSYLCERAMIDE
2127, 2nr6C, 0.5103, 3.86, 0.132, 211, 106, CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
2128, 2b4cL, 0.5103, 3.88, 0.085, 215, 106, CRYSTAL STRUCTURE OF HIV-1 JR-FL GP120 CORE PROTEIN CONTAINING THE THIRD VARIABLE REGION (V3) COMPLEXED WITH CD4 AND THE X5 ANTIBODY
2129, 1rzgC, 0.5103, 3.78, 0.064, 213, 109, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D
2130, 1p2cA, 0.5103, 3.99, 0.112, 212, 107, CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY
2131, 1ngxA, 0.5103, 3.89, 0.094, 213, 106, CHIMERIC GERMLINE FAB 7G12 WITH JEFFAMINE FRAGMENT BOUND
2132, 1dbkH, 0.5103, 3.84, 0.064, 219, 110, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
2133, 6fy0H, 0.5102, 3.77, 0.065, 226, 107, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-16H; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
2134, 6avrL, 0.5102, 3.90, 0.113, 211, 106, HUMAN ALPHA-V BETA-3 INTEGRIN (INTERMEDIATE CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
2135, 6avqL, 0.5102, 3.90, 0.113, 211, 106, THE THERAPEUTIC ANTIBODY LM609 SELECTIVELY INHIBITS LIGAND BINDING TO HUMAN ALPHA-V BETA-3 INTEGRIN VIA STERIC HINDRANCE
2136, 6avgD, 0.5102, 3.77, 0.093, 245, 107, CRYSTAL STRUCTURE OF THE KFJ37 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
2137, 5wk3Q, 0.5102, 3.99, 0.081, 221, 111, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
2138, 5o14L, 0.5102, 3.94, 0.075, 212, 107, CO-CRYSTAL STRUCTURE OF A CROSS-REACTIVE BACTERICIDAL HUMAN ANTIBODY TARGETING MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN
2139, 5npjB, 0.5102, 3.97, 0.064, 232, 110, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN JFH1 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
2140, 4x7tB, 0.5102, 3.96, 0.075, 218, 107, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 2
2141, 4wo4D, 0.5102, 3.84, 0.102, 242, 108, THE MOLECULAR BASES OF DELTA/ALPHA BETA T CELL-MEDIATED ANTIGEN RECOGNITION.
2142, 4r7nJ, 0.5102, 3.93, 0.085, 211, 106, FAB C2E3
2143, 4q6iA, 0.5102, 3.90, 0.113, 218, 106, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
2144, 3wxwH, 0.5102, 3.71, 0.066, 119, 106, CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 2
2145, 2vl5A, 0.5102, 4.01, 0.108, 218, 111, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
2146, 2n7bA, 0.5102, 3.90, 0.101, 145, 109, SOLUTION STRUCTURE OF THE HUMAN SIGLEC-8 LECTIN DOMAIN IN COMPLEX WITH 6 SULFO SIALYL LEWISX
2147, 2b3iA, 0.5102, 2.83, 0.154, 97, 91, NMR SOLUTION STRUCTURE OF PLASTOCYANIN FROM THE PHOTOSYNTHETIC PROKARYOTE PROCHLOROTHRIX HOLLANDICA (19 STRUCTURES)
2148, 1ws8B, 0.5102, 2.95, 0.129, 103, 93, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
2149, 1cicB, 0.5102, 3.86, 0.091, 217, 110, IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
2150, 9pcyA, 0.5101, 2.70, 0.146, 99, 89, HIGH-RESOLUTION SOLUTION STRUCTURE OF REDUCED FRENCH BEAN PLASTOCYANIN AND COMPARISON WITH THE CRYSTAL STRUCTURE OF POPLAR PLASTOCYANIN
2151, 6dg2A, 0.5101, 3.88, 0.109, 217, 110, ANTIGEN BINDING FRAGMENT OF THE PAN-EBOLAVIRUS MONOCLONAL ANTIBODY 6D6 
2152, 6dfxH, 0.5101, 3.70, 0.076, 237, 105, HUMAN DIABETOGENIC TCR T1D3 IN COMPLEX WITH DQ8-P8E9E PEPTIDE 
2153, 6by2A, 0.5101, 4.19, 0.071, 219, 113, CLOSED AND DEEP-INACTIVATED CONFORMATION OF KCSA-T75A MUTANT 
2154, 5x2qK, 0.5101, 3.98, 0.103, 216, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH GLYCINE
2155, 5x2pL, 0.5101, 3.98, 0.103, 217, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMATE
2156, 5x0tB, 0.5101, 3.77, 0.133, 213, 105, CRYSTAL STRUCTURE OF CD147 C2 DOMAIN IN COMPLEX WITH FAB OF ITS MONOCLONAL ANTIBODY 6H8
2157, 5npiA, 0.5101, 3.96, 0.064, 232, 110, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN J4 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
2158, 5ebmA, 0.5101, 4.17, 0.088, 218, 113, KCSA T75G MUTANT IN THE NONCONDUCTIVE STATE
2159, 4ww2A, 0.5101, 3.96, 0.102, 203, 108, CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV21-TRAJ8 BETA CHAIN- TRBV7-8 ANTIGEN-PRESENTING GLYCOPROTEIN CD1D AND BETA-2- MICROGLOBULIN
2160, 4r7nP, 0.5101, 4.06, 0.084, 211, 107, FAB C2E3
2161, 4r7dP, 0.5101, 4.02, 0.084, 211, 107, FAB HU 15C1
2162, 4pj8D, 0.5101, 3.77, 0.103, 243, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV20 TCR
2163, 4am0E, 0.5101, 3.88, 0.082, 212, 110, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
2164, 3stzA, 0.5101, 4.19, 0.071, 219, 113, KCSA POTASSIUM CHANNEL MUTANT Y82C WITH NITROXIDE SPIN LABEL
2165, 3sddD, 0.5101, 3.88, 0.056, 238, 108, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-LACTOSYLCERAMIDE
2166, 3qpqD, 0.5101, 3.97, 0.099, 218, 111, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
2167, 3qh3B, 0.5101, 3.73, 0.084, 245, 107, THE CRYSTAL STRUCTURE OF TCR A6
2168, 3opzI, 0.5101, 3.82, 0.056, 220, 107, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
2169, 3fo1A, 0.5101, 3.95, 0.104, 216, 106, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT)
2170, 2oz4L, 0.5101, 3.99, 0.103, 214, 107, STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION
2171, 2itcA, 0.5101, 4.17, 0.071, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN SODIUM CHLORIDE
2172, 1rjlB, 0.5101, 3.99, 0.081, 221, 111, STRUCTURE OF THE COMPLEX BETWEEN OSPB-CT AND BACTERICIDAL FAB-H6831
2173, 1qppB, 0.5101, 3.36, 0.133, 212, 98, CRYSTAL STRUCTURES OF SELF CAPPING PAPD CHAPERONE HOMODIMERS
2174, 1mjjA, 0.5101, 4.04, 0.084, 218, 107, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG
2175, 1fj1C, 0.5101, 3.98, 0.084, 213, 107, LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
2176, 6ncpB, 0.5100, 3.83, 0.075, 212, 106, CRYSTAL STRUCTURE OF HIV-1 BROADLY NEUTRALIZING ANTIBODY ACS202 
2177, 6fumA, 0.5100, 3.82, 0.147, 202, 109, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2178, 6dwaA, 0.5100, 3.92, 0.112, 217, 107, STRUCTURE OF THE 4497 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
2179, 6c08E, 0.5100, 4.03, 0.084, 215, 107, ZEBRAFISH SLC38A9 WITH ARGININE BOUND IN THE CYTOSOL OPEN STATE 
2180, 5xovH, 0.5100, 3.76, 0.084, 245, 107, CRYSTAL STRUCTURE OF PEPTIDE-HLA-A24 BOUND TO S19-2 V-DELTA/V-BETA TCR
2181, 5x0tD, 0.5100, 3.78, 0.133, 213, 105, CRYSTAL STRUCTURE OF CD147 C2 DOMAIN IN COMPLEX WITH FAB OF ITS MONOCLONAL ANTIBODY 6H8
2182, 5w0kF, 0.5100, 4.05, 0.112, 212, 107, CRYSTAL STRUCTURE OF EBV GHGL/CL40/GP42 N-DOMAIN
2183, 5npiB, 0.5100, 4.02, 0.063, 233, 111, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN J4 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
2184, 5cmaA, 0.5100, 4.02, 0.084, 213, 107, ANTI-B7-H3 MONOCLONAL ANTIBODY CH8H9 FAB FRAGMENT
2185, 5c0cE, 0.5100, 3.94, 0.073, 247, 110, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDWIVA
2186, 4ywgM, 0.5100, 3.96, 0.094, 215, 106, CRYSTAL STRUCTURE OF 830A IN COMPLEX WITH V1V2
2187, 4xzuA, 0.5100, 4.05, 0.063, 213, 111, CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY
2188, 4x7sL, 0.5100, 3.94, 0.084, 218, 107, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 1
2189, 4u6hC, 0.5100, 3.87, 0.073, 217, 109, VACCINIA L1/M12B9-FAB COMPLEX
2190, 4q6iF, 0.5100, 3.90, 0.113, 218, 106, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
2191, 4q6iD, 0.5100, 3.90, 0.113, 218, 106, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
2192, 4aehH, 0.5100, 4.02, 0.099, 219, 111, CRYSTAL STRUCTURE OF THE ANTI-AAHI FAB9C2 ANTIBODY
2193, 3utsJ, 0.5100, 3.79, 0.102, 246, 108, 1E6-A*0201-ALWGPDPAAA COMPLEX MONOCLINIC
2194, 3u9pM, 0.5100, 3.90, 0.094, 211, 106, CRYSTAL STRUCTURE OF MURINE SIDEROCALIN IN COMPLEX WITH AN FAB FRAGMENT
2195, 3hmxH, 0.5100, 3.79, 0.064, 217, 109, CRYSTAL STRUCTURE OF USTEKINUMAB FAB/IL-12 COMPLEX
2196, 3gsnB, 0.5100, 3.69, 0.075, 243, 106, CRYSTAL STRUCTURE OF THE PUBLIC RA14 TCR IN COMPLEX WITH THE HCMV DOMINANT NLV/HLA-A2 EPITOPE
2197, 2gcyA, 0.5100, 4.06, 0.074, 216, 108, HUMANIZED ANTIBODY C25 FAB FRAGMENT
2198, 2cdgB, 0.5100, 3.61, 0.085, 244, 106, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE-SPECIFIC T CELL RECEPTORS (TCR 5B)
2199, 1uweL, 0.5100, 3.91, 0.112, 213, 107, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
2200, 1oazJ, 0.5100, 4.02, 0.081, 122, 111, IGE FV SPE7 COMPLEXED WITH A RECOMBINANT THIOREDOXIN
2201, 1kj2B, 0.5100, 3.51, 0.069, 117, 102, MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
2202, 1fgnH, 0.5100, 4.02, 0.081, 214, 111, MONOCLONAL MURINE ANTIBODY 5G9-ANTI-HUMAN TISSUE FACTOR
2203, 1cz8X, 0.5100, 3.95, 0.075, 213, 107, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY
2204, 6eh8A, 0.5099, 3.83, 0.120, 201, 108, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
2205, 6dg2C, 0.5099, 3.90, 0.109, 211, 110, ANTIGEN BINDING FRAGMENT OF THE PAN-EBOLAVIRUS MONOCLONAL ANTIBODY 6D6 
2206, 5w23J, 0.5099, 3.98, 0.073, 219, 110, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
2207, 5usiH, 0.5099, 3.87, 0.056, 212, 108, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV138
2208, 5i71C, 0.5099, 3.92, 0.113, 214, 106, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE
2209, 5dgyD, 0.5099, 3.65, 0.020, 833, 100, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
2210, 5brzD, 0.5099, 3.88, 0.139, 197, 108, MAGE-A3 REACTIVE TCR IN COMPLEX WITH MAGE-A3 IN HLA-A1
2211, 4zwjD, 0.5099, 3.65, 0.020, 833, 100, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
2212, 4p1yA, 0.5099, 4.17, 0.107, 267, 112, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
2213, 4nobA, 0.5099, 3.60, 0.077, 112, 104, CRYSTAL STRUCTURE OF THE 1ST IG DOMAIN FROM MOUSE POLYMERIC IMMUNOGLOBULIN RECEPTOR [PSI-NYSGRC-006220]
2214, 4lcuA, 0.5099, 4.21, 0.071, 219, 113, STRUCTURE OF KCSA WITH E118A MUTATION
2215, 3pqyO, 0.5099, 3.64, 0.105, 240, 105, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
2216, 3l5wA, 0.5099, 3.88, 0.085, 213, 106, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB
2217, 2q8bL, 0.5099, 3.95, 0.112, 213, 107, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
2218, 1ze3C, 0.5099, 2.86, 0.096, 205, 94, CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF FIMD (N- TERMINAL DOMAIN) WITH FIMC AND THE PILIN DOMAIN OF FIMH
2219, 6funA, 0.5098, 3.87, 0.156, 202, 109, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2220, 6ddvB, 0.5098, 3.93, 0.073, 222, 110, CRYSTAL STRUCTURE ANALYSIS OF THE EPITOPE OF AN ANTI-MICA ANTIBODY 
2221, 5x2nL, 0.5098, 3.98, 0.103, 216, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
2222, 5x2nK, 0.5098, 3.98, 0.103, 216, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
2223, 5x2mL, 0.5098, 3.98, 0.103, 217, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMINE
2224, 5wk3U, 0.5098, 4.00, 0.081, 221, 111, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
2225, 5vk6A, 0.5098, 4.19, 0.080, 219, 113, OPEN CONFORMATION OF KCSA NON-INACTIVATING E71A MUTANT
2226, 5ur8B, 0.5098, 3.87, 0.075, 215, 106, HUMAN ANTIBODY FRAGMENT (FAB) TO MENINGOCOCCAL FACTOR H BINDING PROTEIN
2227, 5uddN, 0.5098, 3.87, 0.064, 221, 109, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2228, 5i73C, 0.5098, 4.00, 0.113, 214, 106, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL AND ALLOSTERIC SITES
2229, 5i1lB, 0.5098, 3.80, 0.065, 213, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV4-1
2230, 5gzoL, 0.5098, 3.99, 0.075, 213, 107, STRUCTURE OF NEUTRALIZING ANTIBODY BOUND TO ZIKA ENVELOPE PROTEIN
2231, 5ec1A, 0.5098, 4.19, 0.080, 219, 113, KCSA WITH V76ESTER MUTATION
2232, 4tnvJ, 0.5098, 3.85, 0.073, 223, 109, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2233, 4lkcA, 0.5098, 3.87, 0.095, 213, 105, AN ANTIBODY AGAINST THE C-TERMINAL DOMAIN OF PCSK9 LOWERS LDL CHOLESTEROL LEVELS IN VIVO
2234, 4d9qL, 0.5098, 3.88, 0.075, 213, 106, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
2235, 4am0B, 0.5098, 3.98, 0.104, 212, 106, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
2236, 3sqoL, 0.5098, 3.95, 0.093, 213, 107, PCSK9 J16 FAB COMPLEX
2237, 3njhA, 0.5098, 3.37, 0.124, 121, 97, D37A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS.
2238, 3idxL, 0.5098, 4.07, 0.065, 214, 108, CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13 SPACE GROUP C222
2239, 3fo2A, 0.5098, 3.81, 0.105, 216, 105, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT)
2240, 3dxaJ, 0.5098, 3.69, 0.094, 244, 106, CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN
2241, 3dxaE, 0.5098, 3.69, 0.094, 244, 106, CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN
2242, 3cviH, 0.5098, 3.96, 0.064, 213, 110, HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
2243, 2uy7G, 0.5098, 3.45, 0.141, 216, 99, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
2244, 2uy7C, 0.5098, 3.47, 0.141, 216, 99, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
2245, 1ypzH, 0.5098, 4.09, 0.073, 230, 109, IMMUNE RECEPTOR
2246, 1q72L, 0.5098, 3.83, 0.113, 218, 106, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH COCAINE
2247, 1gpoM, 0.5098, 3.91, 0.123, 218, 106, CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT
2248, 6mtoH, 0.5097, 3.99, 0.063, 219, 111, CRYSTAL STRUCTURE OF VRC42.01 FAB IN COMPLEX WITH T117-F MPER SCAFFOLD 
2249, 5mo9H, 0.5097, 3.80, 0.093, 212, 107, STRUCTURE OF HUMAN TRKB RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH THE FAB FRGMENT OF ANTIBODY AB20
2250, 5ivxE, 0.5097, 3.77, 0.085, 194, 106, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR AND H2-DD P18-I10 COMPLEX
2251, 4r7dD, 0.5097, 4.05, 0.084, 211, 107, FAB HU 15C1
2252, 4am0D, 0.5097, 4.00, 0.112, 212, 107, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
2253, 3vxrE, 0.5097, 3.79, 0.093, 242, 107, THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(WT) PEPTIDE
2254, 3to4C, 0.5097, 3.85, 0.159, 190, 107, STRUCTURE OF MOUSE VALPHA14VBETA2-MOUSECD1D-ALPHA-GALACTOSYLCERAMIDE
2255, 3tf7C, 0.5097, 3.76, 0.103, 232, 107, 42F3 QL9/H2-LD COMPLEX
2256, 3gi8H, 0.5097, 4.11, 0.089, 220, 112, CRYSTAL STRUCTURE OF APCT K158A TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
2257, 3fo1L, 0.5097, 3.95, 0.104, 216, 106, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT)
2258, 2xknC, 0.5097, 3.91, 0.065, 213, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-EGFR ANTIBODY 7A7
2259, 2nljB, 0.5097, 4.19, 0.080, 218, 113, POTASSIUM CHANNEL KCSA(M96V)-FAB COMPLEX IN KCL
2260, 1ypzF, 0.5097, 4.25, 0.072, 230, 111, IMMUNE RECEPTOR
2261, 1kiuC, 0.5097, 2.92, 0.074, 205, 95, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
2262, 1fl6A, 0.5097, 3.75, 0.105, 217, 105, THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4
2263, 1faiH, 0.5097, 3.89, 0.073, 221, 109, THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9 FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY
2264, 1b6dA, 0.5097, 3.94, 0.065, 212, 107, BENCE JONES PROTEIN DEL: AN ENTIRE IMMUNOGLOBULIN KAPPA LIGHT-CHAIN DIMER
2265, 6didH, 0.5096, 3.85, 0.094, 217, 106, HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT  3417 POST-BOOST 1 
2266, 6didE, 0.5096, 3.85, 0.094, 217, 106, HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT  3417 POST-BOOST 1 
2267, 6didC, 0.5096, 3.85, 0.094, 217, 106, HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT  3417 POST-BOOST 1 
2268, 5yfiH, 0.5096, 4.04, 0.080, 221, 112, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY 
2269, 5x2qL, 0.5096, 3.97, 0.103, 217, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH GLYCINE
2270, 5tezI, 0.5096, 3.72, 0.086, 202, 105, TCR F50 RECGONIZING M1-HLA-A2
2271, 5otjB, 0.5096, 3.95, 0.074, 222, 108, MONOMERIC POLCALCIN (PHL P 7) IN COMPLEX WITH TWO IDENTICAL ALLERGEN- SPECIFIC ANTIBODIES 
2272, 5i66B, 0.5096, 3.98, 0.131, 213, 107, X-RAY STRUCTURE OF THE FAB FRAGMENT OF 8B6 A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE HUMAN SEROTONIN TRANSPORTER
2273, 5eu6E, 0.5096, 3.81, 0.130, 244, 108, HLA CLASS I ANTIGEN
2274, 4tnwH, 0.5096, 3.99, 0.072, 223, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2275, 4rgnC, 0.5096, 3.88, 0.104, 213, 106, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
2276, 4p3dB, 0.5096, 4.00, 0.121, 218, 107, MT1-MMP:FAB COMPLEX (FORM II)
2277, 4p2qJ, 0.5096, 4.10, 0.054, 245, 111, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK
2278, 3p0vM, 0.5096, 3.86, 0.075, 212, 106, ANTI-EGFR/HER3 FAB DL11 ALONE
2279, 3f7vA, 0.5096, 4.18, 0.071, 219, 113, KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 23 A OPENING AT T112
2280, 2uylB, 0.5096, 4.08, 0.071, 213, 112, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2281, 1r3lB, 0.5096, 4.19, 0.071, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN CS+
2282, 1nccL, 0.5096, 4.00, 0.131, 214, 107, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
2283, 1kiuE, 0.5096, 2.92, 0.074, 205, 95, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
2284, 1kiuA, 0.5096, 2.92, 0.074, 205, 95, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
2285, 1fl6L, 0.5096, 3.76, 0.105, 217, 105, THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4
2286, 8pazA, 0.5095, 2.46, 0.141, 123, 85, OXIDIZED NATIVE PSEUDOAZURIN FROM A. FAECALIS
2287, 6fy1H, 0.5095, 3.74, 0.065, 226, 107, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A SCAFFOLDED AUTOLOGOUS V1V2 
2288, 5ye3A, 0.5095, 4.04, 0.084, 213, 107, CRYSTAL STRUCTURE OF THE COMPLEX OF DI-ACETYLATED HISTONE H4 AND 2A7D9 FAB FRAGMENT 
2289, 5xajF, 0.5095, 3.79, 0.065, 213, 107, STRUCTURAL MIMICRY OF THE DENGUE VIRUS ENVELOPE GLYCOPROTEIN REVEALED BY THE CRYSTALLOGRAPHIC STUDY OF AN IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX.
2290, 5x2pK, 0.5095, 3.99, 0.103, 216, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMATE
2291, 5x2mK, 0.5095, 3.99, 0.103, 216, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMINE
2292, 5l0qE, 0.5095, 3.92, 0.113, 212, 106, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ADAM10 D+C DOMAIN AND A CONFORMATION SPECIFIC MAB 8C7.
2293, 5d6cA, 0.5095, 3.94, 0.112, 219, 107, STRUCTURE OF 4497 FAB BOUND TO SYNTHETIC WALL TEICHOIC ACID FRAGMENT
2294, 5c09J, 0.5095, 3.88, 0.092, 246, 109, HLA CLASS I HISTOCOMPATIBILITY ANTIGEN
2295, 5b4mL, 0.5095, 3.97, 0.104, 218, 106, CRYSTAL STRUCTURE OF AN FAB AGAINST HUMAN INFLUENZA A
2296, 4y1aD, 0.5095, 3.81, 0.093, 205, 107, IMMUNE COMPLEX
2297, 4p1xG, 0.5095, 4.17, 0.107, 266, 112, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
2298, 4jhaH, 0.5095, 3.89, 0.064, 226, 109, CRYSTAL STRUCTURE OF RSV-NEUTRALIZING HUMAN ANTIBODY D25
2299, 4hwbH, 0.5095, 3.76, 0.056, 216, 107, CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA 1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT
2300, 4grmB, 0.5095, 3.51, 0.077, 240, 104, THE CRYSTAL STRUCTURE OF THE HIGH AFFINITY TCR A6
2301, 3pqyJ, 0.5095, 3.63, 0.105, 240, 105, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
2302, 3ogcA, 0.5095, 4.21, 0.088, 219, 113, KCSA E71A VARIANT IN PRESENCE OF NA+
2303, 3mv8E, 0.5095, 3.65, 0.076, 242, 105, CRYSTAL STRUCTURE OF THE TK3-GLN55HIS TCR IN COMPLEX WITH HLA- B*3501/HPVG
2304, 3l7eA, 0.5095, 3.85, 0.086, 213, 105, CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836
2305, 3fo0L, 0.5095, 3.96, 0.104, 216, 106, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (WILD-TYPE)
2306, 2wmpA, 0.5095, 3.44, 0.141, 215, 99, STRUCTURE OF THE E. COLI CHAPERONE PAPD IN COMPLEX WITH THE PILIN DOMAIN OF THE PAPGII ADHESIN
2307, 1r3jB, 0.5095, 4.09, 0.080, 219, 112, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF TL+
2308, 1lo4L, 0.5095, 3.86, 0.104, 217, 106, RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY 9D9
2309, 1kiuG, 0.5095, 2.92, 0.074, 205, 95, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
2310, 6fxnQ, 0.5094, 3.82, 0.056, 215, 107, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
2311, 6furA, 0.5094, 3.83, 0.156, 202, 109, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2312, 6bftB, 0.5094, 3.95, 0.075, 214, 107, STRUCTURE OF BEVACIZUMAB FAB MUTANT IN COMPLEX WITH VEGF 
2313, 5ywfD, 0.5094, 4.09, 0.045, 218, 111, CRYSTAL STRUCTURE OF 2H4 FAB
2314, 5tzuL, 0.5094, 3.91, 0.103, 213, 107, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF B6H12.2
2315, 5opyL, 0.5094, 3.92, 0.113, 212, 106, CRYSTAL STRUCTURE OF ANTI-ALPHAVBETA3 INTEGRIN FAB LM609
2316, 5mvjD, 0.5094, 3.79, 0.133, 218, 105, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
2317, 5lxgH, 0.5094, 3.68, 0.057, 119, 105, REVISED CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 1 IN AN OPEN CONFORMATION
2318, 5j9pA, 0.5094, 4.19, 0.088, 219, 113, KCSA IN VITRO
2319, 4zykL, 0.5094, 3.89, 0.085, 213, 106, CRYSTAL STRUCTURE OF QUATERNARY-SPECIFIC RSV-NEUTRALIZING HUMAN ANTIBODY AM14
2320, 4xhjG, 0.5094, 3.86, 0.067, 196, 105, GHGL OF VARICELLA-ZOSTER VIRUS IN COMPLEX WITH HUMAN NEUTRALIZING ANTIBODIES.
2321, 4onhA, 0.5094, 3.81, 0.120, 201, 108, CRYSTAL STRUCTURE OF DN6 TCR
2322, 4jfdE, 0.5094, 3.83, 0.093, 245, 107, PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR
2323, 4etqA, 0.5094, 4.02, 0.080, 217, 112, VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
2324, 3riaJ, 0.5094, 3.93, 0.073, 215, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2325, 3rhwJ, 0.5094, 3.93, 0.073, 215, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2326, 3igaA, 0.5094, 4.15, 0.063, 219, 111, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+ AND K+
2327, 3he6C, 0.5094, 3.95, 0.148, 203, 108, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA8.2 NKT TCR
2328, 3h9sE, 0.5094, 3.68, 0.067, 245, 105, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TEL1P PEPTIDE
2329, 2vweE, 0.5094, 4.01, 0.099, 219, 111, CRYSTAL STRUCTURE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-B IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB FRAGMENT
2330, 2ok0H, 0.5094, 3.94, 0.091, 216, 110, FAB ED10-DNA COMPLEX
2331, 2nr6F, 0.5094, 3.98, 0.064, 213, 110, CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
2332, 2ih1A, 0.5094, 4.19, 0.080, 219, 113, ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
2333, 2fjfW, 0.5094, 3.99, 0.093, 211, 107, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
2334, 1xgyH, 0.5094, 3.98, 0.055, 216, 109, CRYSTAL STRUCTURE OF ANTI-META I RHODOPSIN FAB FRAGMENT K42- 41L
2335, 1pazA, 0.5094, 2.47, 0.141, 120, 85, REFINEMENT OF THE STRUCTURE OF PSEUDOAZURIN FROM ALCALIGENES FAECALIS S-6 AT 1.55 ANGSTROMS RESOLUTION
2336, 6frcA, 0.5093, 3.84, 0.138, 202, 109, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2337, 6erxQ, 0.5093, 3.83, 0.056, 215, 107, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
2338, 5vh4B, 0.5093, 3.94, 0.094, 213, 106, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-TNFA ANTIBODY INFLIXIMAB IN AN I-CENTERED ORTHORHOMBIC CRYSTAL FORM
2339, 5uddK, 0.5093, 4.04, 0.063, 220, 111, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2340, 5sx5L, 0.5093, 3.93, 0.075, 212, 107, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3 MUTANT S468R.
2341, 5e2wL, 0.5093, 3.93, 0.085, 216, 106, ANTI-TAU AT8 FAB WITH TRIPLY PHOSPHORYLATED TAU PEPTIDE
2342, 4z7uE, 0.5093, 3.70, 0.135, 198, 104, S13 COMPLEX
2343, 4yk4Y, 0.5093, 3.90, 0.085, 211, 106, HUMAN ANTIBODY 641 I-9 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006
2344, 4tnvW, 0.5093, 4.02, 0.072, 224, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2345, 4rgnL, 0.5093, 3.88, 0.104, 213, 106, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
2346, 4p2rJ, 0.5093, 4.11, 0.054, 245, 111, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK
2347, 4nrzA, 0.5093, 3.78, 0.075, 225, 107, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66.6
2348, 4hjjH, 0.5093, 4.27, 0.070, 341, 114, STRUCTURE REVEALS FUNCTION OF THE DUAL VARIABLE DOMAIN IMMUNOGLOBULIN (DVD-IG) MOLECULE
2349, 4g3yL, 0.5093, 3.94, 0.094, 214, 106, CRYSTAL STRUCTURE OF TNF-ALPHA IN COMPLEX WITH INFLIXIMAB FAB FRAGMENT
2350, 4d9rL, 0.5093, 3.76, 0.076, 214, 105, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
2351, 3riaG, 0.5093, 3.93, 0.073, 200, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2352, 3ri5H, 0.5093, 4.05, 0.081, 221, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
2353, 3rhwG, 0.5093, 3.93, 0.073, 200, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2354, 3gsnA, 0.5093, 3.87, 0.094, 199, 106, CRYSTAL STRUCTURE OF THE PUBLIC RA14 TCR IN COMPLEX WITH THE HCMV DOMINANT NLV/HLA-A2 EPITOPE
2355, 3fb8A, 0.5093, 4.09, 0.071, 219, 112, KCSA POTASSIUM CHANNEL IN THE OPEN-CONDUCTIVE STATE WITH 20 A OPENING AT T112 IN THE PRESENCE OF RB+ ION
2356, 3fb6A, 0.5093, 4.09, 0.071, 219, 112, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 16 A OPENING AT T112
2357, 3f7yA, 0.5093, 4.09, 0.071, 219, 112, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 17 A OPENING AT T112
2358, 3f5wA, 0.5093, 4.09, 0.071, 219, 112, KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 32 A OPENING AT T112
2359, 3eo1H, 0.5093, 3.95, 0.055, 216, 109, STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
2360, 3eo1B, 0.5093, 3.95, 0.055, 216, 109, STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
2361, 3bkyH, 0.5093, 3.92, 0.073, 226, 109, CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY C2H7 FAB IN COMPLEX WITH A CD20 PEPTIDE
2362, 1seqL, 0.5093, 3.76, 0.124, 208, 105, FAB MNAC13
2363, 1r3kB, 0.5093, 4.18, 0.088, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF TL+
2364, 1qblH, 0.5093, 3.92, 0.082, 219, 110, FAB E8 (FABE8A) X-RAY STRUCTURE AT 2.26 ANGSTROM RESOLUTION
2365, 1k4cA, 0.5093, 4.09, 0.071, 219, 112, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF K+
2366, 1cz8L, 0.5093, 3.95, 0.075, 213, 107, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY
2367, 1afvM, 0.5093, 4.01, 0.084, 217, 107, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
2368, 1afvL, 0.5093, 4.01, 0.084, 217, 107, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
2369, 6higH, 0.5092, 4.01, 0.063, 209, 111, HPD-1/NBO1A FAB COMPLEX 
2370, 6c6qD, 0.5092, 3.73, 0.086, 109, 105, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR 
2371, 5w1vN, 0.5092, 3.82, 0.124, 202, 105, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
2372, 5vh4L, 0.5092, 3.94, 0.094, 213, 106, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-TNFA ANTIBODY INFLIXIMAB IN AN I-CENTERED ORTHORHOMBIC CRYSTAL FORM
2373, 5u72G, 0.5092, 3.72, 0.065, 243, 107, STRUCTURE OF HUMAN MR1-5OH-DCF IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2374, 5mu0J, 0.5092, 3.95, 0.113, 217, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
2375, 5hyjJ, 0.5092, 3.78, 0.074, 246, 108, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA
2376, 5hj3F, 0.5092, 4.06, 0.084, 189, 107, CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP GPCL.
2377, 5eblA, 0.5092, 4.16, 0.088, 219, 113, KCSA T75G IN THE CONDUCTIVE STATE
2378, 5c0aE, 0.5092, 3.89, 0.092, 246, 109, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING MVW PEPTIDE
2379, 5c08J, 0.5092, 3.90, 0.073, 245, 109, 1E6 TCR IN COMPLEX WITH HLA-A0E CARRYING RQWGPDPAAV
2380, 4yk4B, 0.5092, 3.90, 0.085, 211, 106, HUMAN ANTIBODY 641 I-9 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006
2381, 4tnvU, 0.5092, 3.94, 0.073, 221, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2382, 4nnpY, 0.5092, 3.96, 0.084, 213, 107, CRYSTAL STRUCTURE OF APO MANGANESE ABC TRANSPORTER MNTC FROM STAPHYLOCOCCUS AUREUS BOUND TO AN ANTAGONISTIC FAB FRAGMENT
2383, 4mswA, 0.5092, 4.08, 0.089, 219, 112, Y78 ESTER MUTANT OF KCSA IN HIGH K+
2384, 4jffE, 0.5092, 3.84, 0.120, 245, 108, PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR
2385, 4hfuH, 0.5092, 3.99, 0.064, 224, 110, CRYSTAL STRUCTURE OF FAB 8M2 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
2386, 3wihI, 0.5092, 3.95, 0.073, 219, 110, CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.
2387, 3wihH, 0.5092, 3.95, 0.073, 219, 110, CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.
2388, 3sobL, 0.5092, 3.87, 0.094, 213, 106, THE STRUCTURE OF THE FIRST YWTD BETA PROPELLER DOMAIN OF LRP6 IN COMPLEX WITH A FAB
2389, 3p0vL, 0.5092, 3.87, 0.075, 212, 106, ANTI-EGFR/HER3 FAB DL11 ALONE
2390, 3mv7E, 0.5092, 3.83, 0.075, 241, 107, CRYSTAL STRUCTURE OF THE TK3 TCR IN COMPLEX WITH HLA-B*3501/HPVG
2391, 3dggA, 0.5092, 4.00, 0.084, 217, 107, CRYSTAL STRUCTURE OF FABOX108
2392, 3argC, 0.5092, 3.96, 0.148, 202, 108, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-ALPHA- GLUCOSYLCERAMIDE(C20:2)
2393, 2oslB, 0.5092, 3.70, 0.125, 213, 104, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
2394, 2nmsA, 0.5092, 3.95, 0.103, 112, 107, THE CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE INHIBITOR RECEPTOR EXPRESSED ON MYELOID CELLS IREM-1
2395, 2bocA, 0.5092, 4.18, 0.071, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRAETHYLARSONIUM (TEAS)
2396, 1riuL, 0.5092, 3.92, 0.112, 218, 107, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH NORBENZOYLECGONINE
2397, 1pzaA, 0.5092, 2.47, 0.141, 120, 85, THE CRYSTAL STRUCTURES OF REDUCED PSEUDOAZURIN FROM ALCALIGENES FAECALIS S-6 AT TWO PH VALUES
2398, 1nfdD, 0.5092, 3.89, 0.111, 239, 108, AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY
2399, 1mfdH, 0.5092, 3.86, 0.083, 211, 109, THE SOLUTION STRUCTURE OF A TRISACCHARIDE-ANTIBODY COMPLEX: COMPARISON OF NMR MEASUREMENTS WITH A CRYSTAL STRUCTURE
2400, 6qeeC, 0.5091, 4.06, 0.081, 225, 111, NANODISC RECONSTITUTED HUMAN-MOUSE CHIMERIC ABCB1 (ABCB1HM)-EQ MUTANT IN COMPLEX WITH UIC2 FAB AND ZOSUQUIDAR. 
2401, 6pazA, 0.5091, 2.47, 0.129, 123, 85, OXIDIZED MUTANT P80I PSEUDOAZURIN FROM A. FAECALIS
2402, 6eh7A, 0.5091, 3.84, 0.147, 202, 109, F11 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS HAAEMAGGLUTININ EPITOPE PKYVKQNTLKLAT CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
2403, 5tilG, 0.5091, 3.78, 0.104, 114, 106, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2 DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE V3P AND T-CELL RECEPTOR P14
2404, 5do2D, 0.5091, 4.04, 0.084, 214, 107, COMPLEX STRUCTURE OF MERS-RBD BOUND WITH 4C2 ANTIBODY
2405, 4tnvV, 0.5091, 4.02, 0.072, 224, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2406, 4tnvI, 0.5091, 4.02, 0.072, 222, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2407, 4r7dH, 0.5091, 4.04, 0.075, 212, 107, FAB HU 15C1
2408, 4qxtA, 0.5091, 3.72, 0.057, 114, 105, CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8)IN COMPLEX WITH FC27-MSP2 14-30
2409, 4prpE, 0.5091, 3.77, 0.075, 241, 106, CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:01-HPVG-Q5 COMPLEX
2410, 4p1yE, 0.5091, 4.17, 0.107, 265, 112, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
2411, 4p1xA, 0.5091, 4.18, 0.107, 265, 112, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
2412, 4nylB, 0.5091, 3.99, 0.075, 117, 107, CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT
2413, 4m6mH, 0.5091, 4.01, 0.072, 215, 111, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 9.5
2414, 3qh3D, 0.5091, 3.65, 0.075, 241, 106, THE CRYSTAL STRUCTURE OF TCR A6
2415, 3iu4L, 0.5091, 3.93, 0.112, 213, 107, ANTI NEUGCGM3 GANGLIOSIDE CHIMERIC ANTIBODY CHP3
2416, 3hplA, 0.5091, 4.20, 0.071, 219, 113, KCSA E71H-F103A MUTANT IN THE CLOSED STATE
2417, 1xedF, 0.5091, 3.78, 0.075, 111, 107, CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR PIGR
2418, 1tefB, 0.5091, 2.73, 0.146, 99, 89, CRYSTAL STRUCTURE OF THE SPINACH PLASTOCYANIN MUTANTS G8D/K30C/T69C AND K30C/T69C- A STUDY OF THE EFFECT ON CRYSTAL PACKING AND THERMOSTABILITY FROM THE INTRODUCTION OF A NOVEL DISULFIDE BOND
2419, 1q9oC, 0.5091, 3.87, 0.113, 219, 106, S45-18 FAB UNLIGANDED
2420, 6r2sA, 0.5090, 3.90, 0.084, 213, 107, THE STRUCTURE OF PLASMODIUM VIVAX DUFFY BINDING PROTEIN (PVDBP) BOUND TO HUMAN ANTIBODY DB9 
2421, 6flbL, 0.5090, 3.99, 0.103, 216, 107, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 2 
2422, 6cjkC, 0.5090, 3.73, 0.095, 217, 105, ANTI HIV FAB 10A 
2423, 6bckH, 0.5090, 3.95, 0.064, 222, 109, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY N49P7 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120 CORE. 
2424, 5x2oL, 0.5090, 3.98, 0.103, 216, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ARGININE
2425, 5k59L, 0.5090, 3.98, 0.084, 212, 107, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
2426, 5i1dA, 0.5090, 4.00, 0.093, 218, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV4-1
2427, 5f3bF, 0.5090, 3.92, 0.113, 213, 106, STRUCTURE OF MYOSTATIN IN COMPLEX WITH CHIMERIC RK35 ANTIBODY
2428, 5e94C, 0.5090, 3.99, 0.075, 214, 107, ANTIBODY-BOUND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR EXTRACELLULAR DOMAIN
2429, 5bk5G, 0.5090, 3.93, 0.094, 217, 106, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 663 GERMLINE ANTIBODY
2430, 4tnwY, 0.5090, 4.00, 0.072, 221, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2431, 4tnwW, 0.5090, 4.01, 0.072, 224, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2432, 4tnvH, 0.5090, 4.01, 0.072, 223, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2433, 4tnvF, 0.5090, 4.02, 0.072, 222, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2434, 4qrpL, 0.5090, 3.90, 0.140, 243, 107, CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL AND DD31 TCR
2435, 4p1yG, 0.5090, 4.18, 0.107, 266, 112, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
2436, 4k3jL, 0.5090, 4.01, 0.075, 217, 107, CRYSTAL STRUCTURE OF ONARTUZUMAB FAB IN COMPLEX WITH MET AND HGF-BETA
2437, 4i2xC, 0.5090, 3.98, 0.121, 214, 107, CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
2438, 4g6kL, 0.5090, 3.74, 0.077, 212, 104, CRYSTAL STRUCTURE OF THE THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB IN ITS UNBOUND STATE
2439, 3rifG, 0.5090, 3.90, 0.073, 214, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2440, 3ra7L, 0.5090, 3.93, 0.085, 211, 106, BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY
2441, 3q5tA, 0.5090, 3.77, 0.103, 238, 107, V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES
2442, 3nykA, 0.5090, 2.47, 0.141, 120, 85, THE STRUCTURE OF COBALT-SUBSTITUTED PSEUDOAZURIN FROM ALCALIGENES FAECALIS
2443, 3k2uL, 0.5090, 3.89, 0.085, 208, 106, CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC INHIBITORY ANTIBODY FAB40
2444, 3eobL, 0.5090, 3.90, 0.085, 214, 106, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM II
2445, 3arbC, 0.5090, 3.92, 0.148, 203, 108, TERNARY CRYSTAL STRUCTURE OF THE NKT TCR-CD1D-ALPHA-GALACTOSYLCERAMIDE ANALOGUE-OCH
2446, 2xraL, 0.5090, 3.89, 0.094, 215, 106, CRYSTAL STRUCTURE OF THE HK20 FAB IN COMPLEX WITH A GP41 MIMETIC 5-HELIX
2447, 2xa8L, 0.5090, 3.95, 0.075, 218, 107, CRYSTAL STRUCTURE OF THE FAB DOMAIN OF OMALIZUMAB AT 2.41A
2448, 2vweL, 0.5090, 4.00, 0.099, 219, 111, CRYSTAL STRUCTURE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-B IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB FRAGMENT
2449, 2atkA, 0.5090, 4.23, 0.080, 219, 113, STRUCTURE OF A MUTANT KCSA K+ CHANNEL
2450, 1ahwD, 0.5090, 3.86, 0.104, 214, 106, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
2451, 6bzyL, 0.5089, 3.87, 0.094, 215, 106, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE 22D11 BROADLY NEUTRALIZING ANTIBODY 
2452, 6bliB, 0.5089, 3.98, 0.084, 214, 107, RSV G PEPTIDE BOUND TO FAB CB002.5
2453, 5y9jH, 0.5089, 3.81, 0.047, 218, 107, BAFF IN COMPLEX WITH BELIMUMAB
2454, 5w0pB, 0.5089, 3.66, 0.029, 802, 102, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
2455, 5o1rL, 0.5089, 3.82, 0.075, 211, 106, HUMAN FAB 5H2 BOUND TO NHBA-C3 FROM NEISSERIA MENINGITIDIS SEROGROUP B 
2456, 5o14D, 0.5089, 3.95, 0.075, 215, 107, CO-CRYSTAL STRUCTURE OF A CROSS-REACTIVE BACTERICIDAL HUMAN ANTIBODY TARGETING MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN
2457, 5mu0H, 0.5089, 3.94, 0.113, 217, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
2458, 5ihbA, 0.5089, 3.99, 0.110, 213, 109, STRUCTURE OF THE IMMUNE RECEPTOR CD33
2459, 5d2lI, 0.5089, 3.89, 0.113, 185, 106, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
2460, 5c0cJ, 0.5089, 3.88, 0.073, 247, 109, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDWIVA
2461, 5c07E, 0.5089, 3.86, 0.093, 246, 108, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING YQFGPDFPIA
2462, 4p3cL, 0.5089, 4.00, 0.121, 218, 107, MT1-MMP:FAB COMPLEX (FORM I)
2463, 4jo3L, 0.5089, 3.97, 0.065, 214, 107, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB IN COMPLEX WITH V3 C-TERMINUS OF HIV-1 CONSENSUS B GP120
2464, 4am0A, 0.5089, 3.90, 0.082, 211, 110, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
2465, 3vxmE, 0.5089, 3.78, 0.075, 243, 107, THE COMPLEX BETWEEN C1-28 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE
2466, 3tn0C, 0.5089, 3.95, 0.148, 203, 108, STRUCTURE OF MOUSE VA14VB8.2NKT TCR-MOUSE CD1D-A-C-GALACTOSYLCERAMIDE COMPLEX
2467, 3nifE, 0.5089, 3.99, 0.064, 216, 110, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
2468, 3areC, 0.5089, 3.90, 0.148, 203, 108, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-4 DEOXY-ALPHA- GALACTOSYLCERAMIDE
2469, 2z4qB, 0.5089, 4.20, 0.080, 218, 113, CRYSTAL STRUCTURE OF A MURINE ANTIBODY FAB 528
2470, 2w0fA, 0.5089, 4.20, 0.088, 218, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRAOCTYLAMMONIUM
2471, 2po6C, 0.5089, 3.78, 0.103, 203, 107, CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
2472, 2p80D, 0.5089, 2.48, 0.141, 123, 85, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN NITRITE REDUCTASE AND PSEUDOAZURIN FROM A. FAECALIS
2473, 2itdA, 0.5089, 4.18, 0.088, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN BARIUM CHLORIDE
2474, 1rzfH, 0.5089, 3.79, 0.075, 218, 107, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY E51
2475, 1qygL, 0.5089, 3.94, 0.112, 218, 107, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH BENZOYLECGONINE
2476, 1nj9H, 0.5089, 3.98, 0.064, 215, 109, COCAINE HYDROLYTIC ANTIBODY 15A10
2477, 5w23I, 0.5088, 3.89, 0.073, 219, 109, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
2478, 5v52D, 0.5088, 4.09, 0.155, 127, 110, STRUCTURE OF TIGIT BOUND TO NECTIN-2 (CD112)
2479, 5mu0N, 0.5088, 3.94, 0.113, 215, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
2480, 5mp5D, 0.5088, 3.79, 0.133, 218, 105, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
2481, 5l0qB, 0.5088, 3.92, 0.113, 212, 106, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ADAM10 D+C DOMAIN AND A CONFORMATION SPECIFIC MAB 8C7.
2482, 5ks9G, 0.5088, 3.79, 0.067, 192, 105, BEL502-DQ8-GLIA-ALPHA1 COMPLEX
2483, 5k59F, 0.5088, 3.96, 0.084, 212, 107, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
2484, 5fk9B, 0.5088, 3.94, 0.092, 241, 109, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN A F47A MUTANT IN COMPLEX WITH A T CELL RECEPTOR
2485, 5f3bB, 0.5088, 3.93, 0.113, 213, 106, STRUCTURE OF MYOSTATIN IN COMPLEX WITH CHIMERIC RK35 ANTIBODY
2486, 5d4kB, 0.5088, 3.73, 0.074, 536, 108, CRYSTAL STRUCTURE OF THE HUMAN POLYMERIC IG RECEPTOR (PIGR) ECTODOMAIN
2487, 4p1yC, 0.5088, 4.18, 0.107, 266, 112, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
2488, 4njaL, 0.5088, 3.97, 0.103, 217, 107, CRYSTAL STRUCTURE OF FAB 6C8 IN COMPLEX WITH MPTS
2489, 4mwfL, 0.5088, 3.95, 0.075, 212, 106, STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C
2490, 3v0wL, 0.5088, 3.95, 0.093, 211, 107, CRYSTAL STRUCTURE OF FAB WN1 222-5 IN COMPLEX WITH LPS
2491, 3se9H, 0.5088, 4.12, 0.063, 225, 111, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC- PG04 IN COMPLEX WITH HIV-1 GP120
2492, 3pazA, 0.5088, 2.48, 0.141, 123, 85, REDUCED NATIVE PSEUDOAZURIN FROM A. FAECALIS
2493, 3o41B, 0.5088, 4.01, 0.103, 217, 107, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 15-MER PEPTIDE EPITOPE
2494, 3mv9E, 0.5088, 3.84, 0.075, 241, 107, CRYSTAL STRUCTURE OF THE TK3-GLN55ALA TCR IN COMPLEX WITH HLA- B*3501/HPVG
2495, 3dpbA, 0.5088, 3.15, 0.095, 196, 95, CRYSTAL STRUCTURE OF THE COMPLEX OF THE CAF1M CHAPERONE WITH THE MINI-FIBER OF TWO CAF1 SUBUNITS (CAF1:CAF1) CARRYING THE ALA9VAL ALA11VAL AND LEU13VAL MUTATIONS IN THE GD DONOR STRAND
2496, 3difA, 0.5088, 4.01, 0.131, 213, 107, CRYSTAL STRUCTURE OF FABOX117
2497, 2p5wE, 0.5088, 3.57, 0.076, 242, 105, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
2498, 2jixL, 0.5088, 3.84, 0.075, 214, 106, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
2499, 2gsiC, 0.5088, 3.88, 0.094, 215, 106, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
2500, 2dwdA, 0.5088, 4.18, 0.088, 219, 113, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN TL+
2501, 1rfdL, 0.5088, 3.94, 0.112, 218, 107, ANTI-COCAINE ANTIBODY M82G2
2502, 1k4dA, 0.5088, 4.08, 0.089, 219, 112, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF K+
2503, 7pazA, 0.5087, 2.49, 0.141, 123, 85, REDUCED MUTANT P80I PSEUDOAZURIN FROM A. FAECALIS
2504, 6h3uL, 0.5087, 4.04, 0.075, 113, 107, SCHMALLENBERG VIRUS GLYCOPROTEIN GC HEAD DOMAIN IN COMPLEX WITH SCFV 4B6 
2505, 6frbA, 0.5087, 3.84, 0.147, 202, 109, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2506, 6dcvB, 0.5087, 3.79, 0.065, 226, 108, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 
2507, 6by2B, 0.5087, 3.96, 0.113, 212, 106, CLOSED AND DEEP-INACTIVATED CONFORMATION OF KCSA-T75A MUTANT 
2508, 5x2oK, 0.5087, 3.98, 0.103, 216, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ARGININE
2509, 5w1wO, 0.5087, 3.71, 0.076, 243, 105, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
2510, 5uweH, 0.5087, 3.67, 0.057, 224, 106, CRYSTAL STRUCTURE OF THE ADCC-POTENT; WEAKLY NEUTRALIZING HIV ENV CO- RECEPTOR BINDING SITE ANTIBODY N12-I2 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48U1 
2511, 5udcB, 0.5087, 3.90, 0.055, 218, 109, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
2512, 5k9jL, 0.5087, 3.77, 0.095, 212, 105, CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 ISOLATED FOLLOWING H5 IMMUNIZATION.
2513, 5j0bD, 0.5087, 3.93, 0.094, 209, 106, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 6 -SIALYLLACTOSE
2514, 4tnvX, 0.5087, 4.02, 0.072, 224, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2515, 4risH, 0.5087, 3.96, 0.082, 228, 110, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
2516, 4p1xC, 0.5087, 4.18, 0.107, 267, 112, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
2517, 4ki5D, 0.5087, 3.83, 0.114, 211, 105, CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99
2518, 4k2uM, 0.5087, 4.04, 0.075, 200, 107, CRYSTAL STRUCTURE OF PFEBA-175 F1 IN COMPLEX WITH R218 ANTIBODY FAB FRAGMENT
2519, 4jo4M, 0.5087, 3.98, 0.075, 214, 107, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB
2520, 3t77A, 0.5087, 3.88, 0.113, 219, 106, S25-2- A(2-4)KDO DISACCHARIDE COMPLEX
2521, 2vl5D, 0.5087, 4.02, 0.112, 216, 107, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
2522, 2qscL, 0.5087, 4.00, 0.075, 215, 107, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3-FAB F425-B4E8 IN COMPLEX WITH A V3-PEPTIDE
2523, 2hvkA, 0.5087, 4.09, 0.080, 219, 112, CRYSTAL STRUCTURE OF THE KCSA-FAB-TBA COMPLEX IN HIGH K+
2524, 2f53D, 0.5087, 3.75, 0.131, 193, 107, DIRECTED EVOLUTION OF HUMAN T-CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT APPARENT CROSS-REACTIVITY
2525, 2axjA, 0.5087, 3.74, 0.084, 242, 107, CRYSTAL STRUCTURES OF T CELL RECEPTOR BETA CHAINS RELATED TO RHEUMATOID ARTHRITIS
2526, 2adgA, 0.5087, 4.00, 0.112, 211, 107, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425
2527, 1uweX, 0.5087, 3.93, 0.112, 213, 107, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
2528, 1tegB, 0.5087, 2.73, 0.146, 99, 89, CRYSTAL STRUCTURE OF THE SPINACH PLASTOCYANIN MUTANTS G8D/K30C/T69C AND K30C/T69C- A STUDY OF THE EFFECT ON CRYSTAL PACKING AND THERMOSTABILITY FROM THE INTRODUCTION OF A NOVEL DISULFIDE BOND
2529, 1ncdL, 0.5087, 3.91, 0.140, 214, 107, REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
2530, 1mamL, 0.5087, 3.75, 0.087, 214, 104, CRYSTAL STRUCTURE TO 2.45 A RESOLUTION OF A MONOCLONAL FAB SPECIFIC FOR THE BRUCELLA A CELL WALL POLYSACCHARIDE ANTIGEN
2531, 6fr8A, 0.5086, 3.88, 0.138, 202, 109, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
2532, 6e4xY, 0.5086, 3.71, 0.096, 208, 104, HUMAN ANTIBODY S5V2-29 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ A/TEXAS/50/2012 (H3N2) 
2533, 6azkA, 0.5086, 3.93, 0.094, 212, 106, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- HYDROXYPROPYL)-L-ARGININE MEDITOPE VARIANT
2534, 6attL, 0.5086, 3.97, 0.094, 220, 106, 39S FAB BOUND TO HER2 ECD 
2535, 5xctA, 0.5086, 4.06, 0.055, 167, 110, CRYSTAL STRUCTURE OF P20.1 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
2536, 5wkhD, 0.5086, 3.60, 0.115, 198, 104, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS3
2537, 5w23L, 0.5086, 3.97, 0.103, 216, 107, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
2538, 5pazA, 0.5086, 2.47, 0.129, 123, 85, REDUCED MUTANT P80A PSEUDOAZURIN FROM A. FAECALIS
2539, 5mu0F, 0.5086, 3.95, 0.113, 216, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
2540, 5lwyH, 0.5086, 3.68, 0.067, 119, 105, REVISED CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 2 IN COMPLEX WITH A C18 FREE FATTY ACID
2541, 5lfvB, 0.5086, 4.05, 0.119, 311, 109, CRYSTAL STRUCTURE OF GLYCOSYLATED MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) IG1-3 WITH SOAKED TRISACCHARIDE LIGAND
2542, 5j06A, 0.5086, 3.99, 0.110, 213, 109, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 3 -SIALYLLACTOSE
2543, 5ibuG, 0.5086, 3.92, 0.046, 225, 109, FAB (UNBOUND)
2544, 5i1eL, 0.5086, 3.98, 0.084, 211, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV1-39
2545, 5gzoD, 0.5086, 4.01, 0.075, 213, 107, STRUCTURE OF NEUTRALIZING ANTIBODY BOUND TO ZIKA ENVELOPE PROTEIN
2546, 5ezjB, 0.5086, 3.86, 0.104, 213, 106, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - ORTHORHOMBIC FORM
2547, 5d96I, 0.5086, 4.04, 0.112, 214, 107, OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTIBODY TARGETING MOUSE AND HUMAN QSOX1
2548, 4qyoA, 0.5086, 3.83, 0.057, 114, 106, CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8)IN COMPLEX WITH MSP2 14-22
2549, 4lbeA, 0.5086, 4.18, 0.071, 219, 112, STRUCTURE OF KCSA WITH R122A MUTATION
2550, 4l8sB, 0.5086, 3.72, 0.084, 242, 107, CRYSTAL STRUCTURE OF A HUMAN VALPHA7.2/VBETA13.3 MAIT TCR IN COMPLEX WITH BOVINE MR1
2551, 4g6mL, 0.5086, 3.87, 0.076, 213, 105, CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB
2552, 4d9qD, 0.5086, 3.90, 0.075, 213, 106, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
2553, 3riaH, 0.5086, 4.06, 0.081, 221, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2554, 3rhwH, 0.5086, 4.06, 0.081, 221, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2555, 3p0yL, 0.5086, 4.02, 0.075, 213, 107, ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAIN III OF EGFR EXTRACELLULAR REGION
2556, 3oz9L, 0.5086, 3.66, 0.135, 211, 104, CRYSTAL STRUCTURE OF ANTI-GP41 FAB NC-1
2557, 3fo2L, 0.5086, 3.83, 0.105, 216, 105, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT)
2558, 1pzbA, 0.5086, 2.48, 0.141, 120, 85, THE CRYSTAL STRUCTURES OF REDUCED PSEUDOAZURIN FROM ALCALIGENES FAECALIS S-6 AT TWO PH VALUES
2559, 1j8hD, 0.5086, 3.91, 0.127, 198, 110, CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR INFLUENZA HA ANTIGEN PEPTIDE AND MHC CLASS II MOLECULE HLA-DR4
2560, 6ncpD, 0.5085, 3.88, 0.085, 212, 106, CRYSTAL STRUCTURE OF HIV-1 BROADLY NEUTRALIZING ANTIBODY ACS202 
2561, 6fxnF, 0.5085, 3.84, 0.047, 220, 107, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
2562, 6c09D, 0.5085, 3.73, 0.103, 244, 107, TERNARY CRYSTAL STRUCTURE OF THE 3C8 TCR-CD1C-MONOACYLGLYCEROL COMPLEX
2563, 6bzuF, 0.5085, 4.01, 0.112, 214, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
2564, 6awqC, 0.5085, 4.01, 0.121, 214, 107, ANOMALOUS CHLORIDE SIGNAL REVEALS THE POSITION OF SERTRALINE COMPLEXED WITH THE SEROTONIN TRANSPORTER AT THE CENTRAL SITE
2565, 6awoC, 0.5085, 4.01, 0.121, 214, 107, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH SERTRALINE AT THE CENTRAL SITE
2566, 5yxuG, 0.5085, 3.74, 0.075, 239, 106, AN AFFINITY ENHANCED T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HCV NS3 PEPTIDE KLVALGINAV 
2567, 5vxrL, 0.5085, 4.01, 0.103, 217, 107, THE ANTIGEN-BINDING FRAGMENT OF MAB24 IN COMPLEX WITH A PEPTIDE FROM HEPATITIS C VIRUS E2 EPITOPE I (412-423)
2568, 5u6qE, 0.5085, 3.72, 0.065, 244, 107, STRUCTURE OF HUMAN MR1-3-F-SA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2569, 5nivA, 0.5085, 3.81, 0.114, 212, 105, CRYSTAL STRUCTURE OF 5D3 FAB
2570, 5k9kB, 0.5085, 3.78, 0.095, 215, 105, CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.
2571, 5i75C, 0.5085, 4.01, 0.121, 214, 107, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE AND BR-CITALOPRAM AT THE ALLOSTERIC SITE
2572, 5ebmB, 0.5085, 3.96, 0.113, 212, 106, KCSA T75G MUTANT IN THE NONCONDUCTIVE STATE
2573, 5d96B, 0.5085, 4.04, 0.112, 214, 107, OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTIBODY TARGETING MOUSE AND HUMAN QSOX1
2574, 5c09E, 0.5085, 3.83, 0.103, 244, 107, HLA CLASS I HISTOCOMPATIBILITY ANTIGEN
2575, 4zykB, 0.5085, 3.89, 0.085, 214, 106, CRYSTAL STRUCTURE OF QUATERNARY-SPECIFIC RSV-NEUTRALIZING HUMAN ANTIBODY AM14
2576, 4xzuB, 0.5085, 3.82, 0.114, 213, 105, CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY
2577, 4wuuE, 0.5085, 4.05, 0.064, 223, 110, STRUCTURE OF ESK1 IN COMPLEX WITH HLA-A*0201/WT1
2578, 4qy8A, 0.5085, 3.72, 0.057, 114, 105, CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8) IN COMPLEX WITH 3D7-MSP2 14-30
2579, 4pazA, 0.5085, 2.47, 0.141, 123, 85, OXIDIZED MUTANT P80A PSEUDOAZURIN FROM A. FAECALIS
2580, 4oduL, 0.5085, 3.95, 0.084, 212, 107, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15
2581, 4krpC, 0.5085, 3.89, 0.094, 211, 106, NANOBODY/VHH DOMAIN 9G8 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR
2582, 4jo4L, 0.5085, 4.03, 0.065, 214, 107, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB
2583, 4g9fE, 0.5085, 3.58, 0.067, 250, 105, CRYSTAL STRUCTURE OF C12C TCR-HLAB2705-KK10-L6M
2584, 4d3cL, 0.5085, 4.04, 0.075, 209, 107, CRYSTAL STRUCTURE OF THE NK1 DOMAIN OF HGF IN COMPLEX WITH ANTI-HGF MONOCLONAL ANTIBODY SFN68.
2585, 4am0L, 0.5085, 4.03, 0.112, 212, 107, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
2586, 3v4vM, 0.5085, 4.00, 0.081, 213, 111, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
2587, 3uzeA, 0.5085, 3.84, 0.066, 229, 106, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 3 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
2588, 3t4yA, 0.5085, 3.89, 0.113, 219, 106, S25-2- KDO MONOSACCHARIDE COMPLEX
2589, 3or6A, 0.5085, 4.07, 0.089, 219, 112, ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71Q
2590, 3lh2H, 0.5085, 3.69, 0.067, 127, 105, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_1VI7A_S0_002_N 4E10 FV COMPLEX
2591, 3fb5A, 0.5085, 4.10, 0.071, 219, 112, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 14.5 A OPENING AT T112
2592, 3bj91, 0.5085, 3.87, 0.139, 116, 108, CRYSTAL STRUCTURE OF THE SURROGATE LIGHT CHAIN VARIABLE DOMAIN VPREBJ
2593, 2r0kL, 0.5085, 3.90, 0.094, 214, 106, PROTEASE DOMAIN OF HGFA WITH INHIBITOR FAB58
2594, 2ih3A, 0.5085, 4.08, 0.089, 219, 112, ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
2595, 2iamD, 0.5085, 3.62, 0.067, 239, 105, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
2596, 2hvjB, 0.5085, 3.95, 0.113, 212, 106, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN LOW K+
2597, 2hg5A, 0.5085, 4.21, 0.071, 219, 113, CS+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
2598, 2fjfE, 0.5085, 3.99, 0.093, 211, 107, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
2599, 2fjfC, 0.5085, 3.99, 0.093, 211, 107, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
2600, 2dwdB, 0.5085, 3.96, 0.113, 212, 106, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN TL+
2601, 1xgyI, 0.5085, 3.98, 0.064, 215, 109, CRYSTAL STRUCTURE OF ANTI-META I RHODOPSIN FAB FRAGMENT K42- 41L
2602, 1x9uA, 0.5085, 2.97, 0.151, 105, 93, UMECYANIN FROM HORSE RADDISH- CRYSTAL STRUCTURE OF THE REDUCED FORM
2603, 1uwgL, 0.5085, 3.96, 0.121, 213, 107, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
2604, 1beyL, 0.5085, 3.94, 0.075, 214, 107, ANTIBODY TO CAMPATH-1H HUMANIZED FAB
2605, 6d78E, 0.5084, 3.59, 0.086, 240, 105, THE COMPLEX BETWEEN HIGH-AFFINITY TCR DMF5(ALPHA-D26Y;BETA-L98W) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35)PEPTIDE 
2606, 6b9jH, 0.5084, 3.88, 0.056, 212, 108, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV138
2607, 5w1wT, 0.5084, 3.62, 0.077, 243, 104, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
2608, 5w1wJ, 0.5084, 3.83, 0.084, 243, 107, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
2609, 5th2C, 0.5084, 3.93, 0.094, 213, 106, CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT
2610, 5mv3D, 0.5084, 4.05, 0.112, 217, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2611, 5lx9H, 0.5084, 3.78, 0.065, 228, 108, CRYSTAL STRUCTURE OF HUMAN ADIPONECTIN RECEPTOR 2 IN COMPLEX WITH A C18 FREE FATTY ACID AT 2.4 ANGSTROM RESOLUTION
2612, 5ebwA, 0.5084, 4.11, 0.089, 218, 112, KCSA WITH G77ESTER MUTATION
2613, 4yxlH, 0.5084, 4.07, 0.080, 218, 112, CRYSTAL STRUCTURE OF SYRIAN HAMSTER PRION PROTEIN COMPLEXED WITH POM1 FAB
2614, 4x6cF, 0.5084, 3.81, 0.074, 243, 108, CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR
2615, 4oziH, 0.5084, 3.85, 0.102, 243, 108, S2 PROTEIN COMPLEX
2616, 4gajL, 0.5084, 4.04, 0.103, 215, 107, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33 IN COMPLEX WITH ITS HCV EPITOPE (E2 RESIDUES 411-424)
2617, 4apqC, 0.5084, 3.95, 0.148, 196, 108, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-SULFATIDE
2618, 3tzvA, 0.5084, 3.79, 0.103, 196, 107, CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE
2619, 3t65A, 0.5084, 3.88, 0.113, 219, 106, S25-2- A(2-8)KDO DISACCHARIDE COMPLEX
2620, 3rifH, 0.5084, 3.91, 0.073, 221, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2621, 3mugH, 0.5084, 4.02, 0.064, 237, 110, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
2622, 3kj6H, 0.5084, 4.04, 0.108, 217, 111, CRYSTAL STRUCTURE OF A METHYLATED BETA2 ADRENERGIC RECEPTOR- FAB COMPLEX
2623, 3j6lB, 0.5084, 3.90, 0.064, 121, 109, KINETIC AND STRUCTURAL ANALYSIS OF COXSACKIEVIRUS B3 RECEPTOR INTERACTIONS AND FORMATION OF THE A-PARTICLE
2624, 3i9gH, 0.5084, 3.86, 0.064, 222, 109, CRYSTAL STRUCTURE OF THE LT1009 (SONEPCIZUMAB) ANTIBODY FAB FRAGMENT IN COMPLEX WITH SPHINGOSINE-1-PHOSPHATE
2625, 3he7C, 0.5084, 3.88, 0.150, 197, 107, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA7 NKT TCR
2626, 3fb7A, 0.5084, 4.10, 0.071, 219, 112, OPEN KCSA POTASSIUM CHANNEL IN THE PRESENCE OF RB+ ION
2627, 2f54K, 0.5084, 3.77, 0.131, 206, 107, DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY
2628, 2bobA, 0.5084, 4.21, 0.071, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRABUTYLAMMONIUM (TBA)
2629, 1yuhB, 0.5084, 4.00, 0.098, 218, 112, FAB FRAGMENT
2630, 1x9rA, 0.5084, 2.96, 0.140, 105, 93, UMECYANIN FROM HORSE RADDISH- CRYSTAL STRUCTURE OF THE OXIDISED FORM
2631, 1ws8C, 0.5084, 2.94, 0.129, 103, 93, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
2632, 1iaiL, 0.5084, 4.05, 0.112, 214, 107, IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX
2633, 1f5wB, 0.5084, 3.90, 0.064, 121, 109, DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN
2634, 1ct8C, 0.5084, 3.96, 0.093, 214, 107, CATALYTIC ANTIBODY 7C8 COMPLEX
2635, 6eqbE, 0.5083, 3.84, 0.120, 244, 108, HLA CLASS I HISTOCOMPATIBILITY ANTIGEN 
2636, 6eluC, 0.5083, 4.02, 0.103, 217, 107, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
2637, 6dfiL, 0.5083, 3.76, 0.095, 215, 105, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z021 BOUND TO ZIKA VIRUS ENVELOPE PROTEIN DIII 
2638, 5xj4L, 0.5083, 4.03, 0.075, 113, 106, COMPLEX STRUCTURE OF DURVALUMAB-SCFV/PD-L1 
2639, 5vqmD, 0.5083, 3.94, 0.064, 216, 110, CLOSTRIDIUM DIFFICILE TCDB-GTD BOUND TO PA41 FAB
2640, 5uddT, 0.5083, 4.02, 0.075, 211, 107, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2641, 5u17E, 0.5083, 3.71, 0.065, 244, 107, STRUCTURE OF HUMAN MR1-DA-6-FP IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2642, 5sx4I, 0.5083, 3.92, 0.075, 213, 107, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3.
2643, 5mu2N, 0.5083, 4.02, 0.112, 218, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2644, 5i74C, 0.5083, 4.12, 0.112, 214, 107, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH BR-CITALOPRAM AT THE CENTRAL SITE
2645, 5eukA, 0.5083, 4.02, 0.084, 212, 107, CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT
2646, 5dr5L, 0.5083, 4.10, 0.074, 215, 108, CRYSTAL STRUCTURE OF THE SCLEROSTIN-NEUTRALIZING FAB ABD09097
2647, 4zs6D, 0.5083, 4.01, 0.084, 210, 107, RECEPTOR BINDING DOMAIN AND FAB COMPLEX
2648, 4tnwJ, 0.5083, 3.86, 0.073, 222, 109, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2649, 4tnvY, 0.5083, 4.02, 0.072, 221, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2650, 4tnvG, 0.5083, 4.01, 0.072, 224, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2651, 4ma3A, 0.5083, 3.84, 0.075, 218, 106, CRYSTAL STRUCTURE OF ANTI-HINGE RABBIT ANTIBODY C2095
2652, 4alaH, 0.5083, 3.85, 0.082, 208, 110, STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
2653, 3ze1E, 0.5083, 3.98, 0.064, 216, 110, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2654, 3uttE, 0.5083, 3.87, 0.093, 244, 108, 1E6-A*0201-ALWGPDPAAA COMPLEX TRICLINIC
2655, 3tzvG, 0.5083, 3.79, 0.103, 201, 107, CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE
2656, 3stlA, 0.5083, 4.15, 0.071, 219, 112, KCSA POTASSIUM CHANNEL MUTANT Y82C WITH CADMIUM BOUND
2657, 2jk5A, 0.5083, 4.12, 0.071, 219, 112, POTASSIUM CHANNEL KCSA IN COMPLEX WITH TETRABUTYLAMMONIUM IN HIGH K
2658, 2eytB, 0.5083, 3.71, 0.085, 243, 106, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2659, 1xf5C, 0.5083, 3.92, 0.113, 220, 106, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C Y64W)IN SPACE GROUP P21212
2660, 1s3kL, 0.5083, 4.06, 0.102, 216, 108, CRYSTAL STRUCTURE OF A HUMANIZED FAB (HU3S193) IN COMPLEX WITH THE LEWIS Y TETRASACCHARIDE
2661, 1rz8A, 0.5083, 3.98, 0.084, 214, 107, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 17B
2662, 1qfuH, 0.5083, 4.08, 0.098, 223, 112, INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
2663, 6obzL, 0.5082, 3.97, 0.084, 213, 107, CRYSTAL STRUCTURE OF FLUA-20 FAB 
2664, 6fuoA, 0.5082, 3.89, 0.156, 202, 109, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2665, 6fg1L, 0.5082, 3.87, 0.066, 211, 106, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA32. 
2666, 6eynC, 0.5082, 4.04, 0.093, 207, 107, STRUCTURE OF THE 8D6 (ANTI-IGE) FAB 
2667, 6cmgC, 0.5082, 3.73, 0.066, 226, 106, CRYSTAL STRUCTURE OF THE HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN BOUND TO A POTENT CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODY M102.3 
2668, 6aq7L, 0.5082, 3.98, 0.103, 216, 107, STRUCTURE OF POM6 FAB FRAGMENT COMPLEXED WITH MOUSE PRPC
2669, 5ywoR, 0.5082, 4.06, 0.054, 218, 112, STRUCTURE OF JEV-2F2 FAB COMPLEX
2670, 5ywoN, 0.5082, 4.06, 0.054, 218, 112, STRUCTURE OF JEV-2F2 FAB COMPLEX
2671, 5xhvQ, 0.5082, 4.02, 0.075, 214, 107, CRYSTAL STRUCTURE OF FAB S40 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ HA1 SUBUNIT.
2672, 5wuxD, 0.5082, 3.99, 0.075, 201, 107, TNFALPHA-CERTOLIZUMAB FAB
2673, 5vkeB, 0.5082, 3.96, 0.113, 212, 106, OPEN CONFORMATION OF KCSA DEEP-INACTIVATED
2674, 5sx5K, 0.5082, 3.94, 0.075, 213, 107, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3 MUTANT S468R.
2675, 5icxA, 0.5082, 3.91, 0.094, 212, 106, CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE
2676, 5ezoL, 0.5082, 3.88, 0.094, 213, 106, CRYSTAL STRUCTURE OF PFCYRPA IN COMPLEX WITH AN INVASION-INHIBITORY ANTIBODY FAB.
2677, 5e1aB, 0.5082, 4.03, 0.103, 212, 107, STRUCTURE OF KCSA WITH L24C/R117C MUTATIONS
2678, 5bzdA, 0.5082, 3.79, 0.086, 213, 105, CRYSTAL STRUCTURE OF PCDN-27A AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
2679, 5bmfL, 0.5082, 4.11, 0.102, 216, 108, CRYSTAL STRUCTURE OF A THEOPHYLLINE BINDING ANTIBODY FAB FRAGMENT
2680, 4zypG, 0.5082, 3.89, 0.085, 213, 106, CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN
2681, 4z7oH, 0.5082, 3.98, 0.064, 216, 110, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
2682, 4udtB, 0.5082, 3.87, 0.093, 241, 107, T CELL RECEPTOR (TRAV22TRBV7-9) STRUCTURE
2683, 4nryL, 0.5082, 3.85, 0.095, 207, 105, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66
2684, 4mxvL, 0.5082, 4.00, 0.103, 211, 107, STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB
2685, 4jryE, 0.5082, 3.82, 0.075, 242, 106, CRYSTAL STRUCTURE OF SB47 TCR-HLA B*3505-LPEP COMPLEX
2686, 4hs6L, 0.5082, 4.03, 0.084, 218, 107, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY MRCT10.V362
2687, 3zkmD, 0.5082, 3.97, 0.112, 217, 107, BACE2 FAB COMPLEX
2688, 3zdzE, 0.5082, 3.98, 0.064, 216, 110, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2689, 3zdxH, 0.5082, 3.98, 0.064, 216, 110, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2690, 3v4vH, 0.5082, 4.00, 0.081, 211, 111, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
2691, 3tt1M, 0.5082, 4.04, 0.103, 215, 107, CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
2692, 3scmC, 0.5082, 3.94, 0.148, 191, 108, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-ISOGLOBOTRIHEXOSYLCERAMIDE
2693, 3rvtC, 0.5082, 3.92, 0.094, 213, 106, STRUCTURE OF 4C1 FAB IN P212121 SPACE GROUP
2694, 3qi9C, 0.5082, 4.09, 0.156, 196, 109, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-PHOSPHOTIDYLINOSITOL WITH MOUSE VALPHA14-VBETA6 2A3-D NKT TCR
2695, 3l7fA, 0.5082, 4.04, 0.084, 213, 107, STRUCTURE OF IL-13 ANTIBODY H2L6 A HUMANIZED VARIANT OF C836
2696, 2itcB, 0.5082, 3.97, 0.113, 212, 106, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN SODIUM CHLORIDE
2697, 2dblH, 0.5082, 3.91, 0.064, 219, 110, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
2698, 2axjB, 0.5082, 3.75, 0.084, 242, 107, CRYSTAL STRUCTURES OF T CELL RECEPTOR BETA CHAINS RELATED TO RHEUMATOID ARTHRITIS
2699, 1xcqA, 0.5082, 4.00, 0.093, 220, 107, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
2700, 1rivL, 0.5082, 3.92, 0.112, 218, 107, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH META- OXYBENZOYLECGONINE
2701, 1q9wA, 0.5082, 3.86, 0.113, 219, 106, S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
2702, 6foeL, 0.5081, 3.92, 0.075, 214, 106, BAXB01 FAB FRAGMENT
2703, 6foeB, 0.5081, 3.92, 0.085, 214, 106, BAXB01 FAB FRAGMENT
2704, 6flaB, 0.5081, 4.01, 0.103, 216, 107, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 1 
2705, 6erxF, 0.5081, 3.83, 0.047, 220, 107, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
2706, 6eleL, 0.5081, 3.96, 0.085, 211, 106, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
2707, 5xkuB, 0.5081, 3.91, 0.075, 211, 106, CRYSTAL STRUCTURE OF HEMAGGLUTININ GLOBULAR HEAD FROM AN H7N9 INFLUENZA VIRUS IN COMPLEX WITH A NEUTRALIZING ANTIBODY HNIGGA6
2708, 5mv3B, 0.5081, 3.98, 0.113, 218, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2709, 5iszD, 0.5081, 3.83, 0.112, 200, 107, CRYSTAL STRUCTURE OF LS01-TCR/M1-HLA-A*02 COMPLEX
2710, 5ihbD, 0.5081, 3.84, 0.095, 209, 105, STRUCTURE OF THE IMMUNE RECEPTOR CD33
2711, 5i6xC, 0.5081, 3.94, 0.121, 214, 107, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH PAROXETINE AT THE CENTRAL SITE
2712, 5i1dL, 0.5081, 4.03, 0.093, 220, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV4-1
2713, 5ff6A, 0.5081, 4.01, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT
2714, 5etuA, 0.5081, 4.01, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH L5E MEDITOPE VARIANT
2715, 5d2nE, 0.5081, 3.86, 0.102, 245, 108, CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX
2716, 4y19D, 0.5081, 3.77, 0.093, 205, 107, IMMUNE COMPLEX
2717, 4ma8H, 0.5081, 4.01, 0.081, 218, 111, CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH CHLORPROMAZINE
2718, 4m6oL, 0.5081, 4.01, 0.084, 214, 107, CRYSTAL STRUCTURE OF ANTI-NGF ANTIBODY CNTO7309
2719, 4lbeB, 0.5081, 3.96, 0.113, 212, 106, STRUCTURE OF KCSA WITH R122A MUTATION
2720, 4gkzA, 0.5081, 3.91, 0.128, 202, 109, HA1.7 A MHC CLASS II RESTRICTED TCR SPECIFIC FOR HAEMAGGLUTININ
2721, 4ffzL, 0.5081, 4.06, 0.103, 216, 107, CRYSTAL STRUCTURE OF DENV1-E111 FAB FRAGMENT BOUND TO DENV-1 DIII (WESTERN PACIFIC-74 STRAIN).
2722, 3zkmL, 0.5081, 3.96, 0.112, 217, 107, BACE2 FAB COMPLEX
2723, 3ze1H, 0.5081, 3.98, 0.064, 216, 110, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2724, 3vg9C, 0.5081, 4.00, 0.073, 224, 110, CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 2.7 A RESOLUTION
2725, 3tt1L, 0.5081, 4.04, 0.103, 215, 107, CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
2726, 3t3mH, 0.5081, 3.97, 0.064, 216, 110, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
2727, 3sy0A, 0.5081, 3.88, 0.113, 219, 106, S25-2- A(2-8)-A(2-4)KDO TRISACCHARIDE COMPLEX
2728, 3ri5J, 0.5081, 3.91, 0.073, 215, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
2729, 3qeqE, 0.5081, 3.77, 0.103, 243, 107, THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
2730, 3nidH, 0.5081, 3.98, 0.064, 216, 110, THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
2731, 3hmwL, 0.5081, 3.90, 0.085, 214, 106, CRYSTAL STRUCTURE OF USTEKINUMAB FAB
2732, 3difC, 0.5081, 3.91, 0.142, 214, 106, CRYSTAL STRUCTURE OF FABOX117
2733, 2vxqL, 0.5081, 3.94, 0.075, 213, 107, CRYSTAL STRUCTURE OF THE MAJOR GRASS POLLEN ALLERGEN PHL P 2 IN COMPLEX WITH ITS SPECIFIC IGE-FAB
2734, 2v7hA, 0.5081, 3.84, 0.086, 214, 105, CRYSTAL STRUCTURE OF AN IMMUNOGEN SPECIFIC ANTI- MANNOPYRANOSIDE MONOCLONAL ANTIBODY FAB FRAGMENT
2735, 2po6G, 0.5081, 3.80, 0.103, 204, 107, CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
2736, 2h8pA, 0.5081, 4.09, 0.089, 219, 112, STRUCTURE OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
2737, 1zoxA, 0.5081, 3.77, 0.085, 110, 106, CLM-1 MOUSE MYELOID RECEPTOR EXTRACELLULAR DOMAIN
2738, 1zglS, 0.5081, 3.79, 0.131, 176, 107, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
2739, 1yjdL, 0.5081, 3.93, 0.094, 212, 106, CRYSTAL STRUCTURE OF HUMAN CD28 IN COMPLEX WITH THE FAB FRAGMENT OF A MITOGENIC ANTIBODY (5.11A1)
2740, 1uwgX, 0.5081, 3.94, 0.121, 213, 107, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
2741, 1uweY, 0.5081, 3.79, 0.066, 218, 106, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
2742, 1q9wC, 0.5081, 3.88, 0.113, 219, 106, S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
2743, 1ncbH, 0.5081, 3.78, 0.065, 221, 108, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
2744, 1k4dB, 0.5081, 3.97, 0.113, 212, 106, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF K+
2745, 1dbjH, 0.5081, 4.02, 0.071, 219, 112, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
2746, 1bj1L, 0.5081, 3.98, 0.075, 213, 107, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY
2747, 1ahwA, 0.5081, 3.88, 0.104, 214, 106, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
2748, 6mftB, 0.5080, 3.81, 0.086, 209, 105, CRYSTAL STRUCTURE OF GLYCOSYLATED 426C HIV-1 GP120 CORE G459C IN COMPLEX WITH GLVRC01 A60C HEAVY CHAIN 
2749, 6eynL, 0.5080, 4.02, 0.093, 217, 107, STRUCTURE OF THE 8D6 (ANTI-IGE) FAB 
2750, 6dcvH, 0.5080, 3.97, 0.064, 226, 110, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 
2751, 6bjzL, 0.5080, 4.01, 0.093, 214, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY CONTAINING THE FLUORESCENT NON-CANONICAL AMINO ACID L-(7- HYDROXYCOUMARIN-4-YL)ETHYLGLYCINE AT PH 5.5 
2752, 6b9jA, 0.5080, 3.88, 0.056, 212, 108, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV138
2753, 5wk3W, 0.5080, 4.04, 0.081, 221, 111, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
2754, 5w24L, 0.5080, 4.03, 0.103, 215, 107, CRYSTAL STRUCTURE OF 5C4 FAB
2755, 5u72E, 0.5080, 3.72, 0.075, 243, 107, STRUCTURE OF HUMAN MR1-5OH-DCF IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2756, 5tkkL, 0.5080, 4.04, 0.084, 213, 107, STRUCTURE OF MOUSE VACCINATION-ELICITED HIV NEUTRALIZING ANTIBODY VFP5.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
2757, 5tezJ, 0.5080, 3.70, 0.075, 240, 106, TCR F50 RECGONIZING M1-HLA-A2
2758, 5n2kM, 0.5080, 3.69, 0.096, 212, 104, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
2759, 5mv3G, 0.5080, 3.95, 0.113, 217, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2760, 5mhrK, 0.5080, 3.88, 0.073, 122, 109, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
2761, 5hpmA, 0.5080, 3.90, 0.094, 213, 106, CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE
2762, 5ec1B, 0.5080, 3.96, 0.113, 209, 106, KCSA WITH V76ESTER MUTATION
2763, 5bzwA, 0.5080, 3.76, 0.086, 213, 105, CRYSTAL STRUCTURE OF PCDN-27B AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
2764, 5bk3B, 0.5080, 4.01, 0.093, 217, 107, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
2765, 4z7qH, 0.5080, 3.98, 0.064, 216, 110, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
2766, 4l4vE, 0.5080, 3.72, 0.065, 243, 107, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH
2767, 4g6jL, 0.5080, 4.05, 0.093, 212, 107, CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH THE THERAPEUTIC ANTIBODY BINDING FRAGMENT OF CANAKINUMAB
2768, 4g6aL, 0.5080, 4.05, 0.103, 218, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY AP33
2769, 3zknD, 0.5080, 3.96, 0.112, 217, 107, BACE2 FAB INHIBITOR COMPLEX
2770, 3ze0H, 0.5080, 3.98, 0.064, 216, 110, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2771, 3uzeB, 0.5080, 3.83, 0.057, 226, 106, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 3 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
2772, 3ulvH, 0.5080, 3.90, 0.064, 225, 109, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)
2773, 3uluF, 0.5080, 4.21, 0.097, 217, 113, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1)
2774, 3qumC, 0.5080, 3.97, 0.103, 218, 107, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY
2775, 3qpqF, 0.5080, 3.95, 0.091, 220, 110, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
2776, 3fzuL, 0.5080, 3.93, 0.075, 213, 107, IGG1 FAB CHARACTERIZED BY H/D EXCHANGE
2777, 2zahB, 0.5080, 4.11, 0.038, 296, 104, X-RAY STRUCTURE OF MELON NECROTIC SPOT VIRUS
2778, 2y5tB, 0.5080, 3.98, 0.112, 218, 107, CRYSTAL STRUCTURE OF THE PATHOGENIC AUTOANTIBODY CIIC1 IN COMPLEX WITH THE TRIPLE-HELICAL C1 PEPTIDE
2779, 2uylW, 0.5080, 4.04, 0.089, 213, 112, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2780, 2uweL, 0.5080, 3.86, 0.094, 194, 106, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION
2781, 2o5yH, 0.5080, 4.06, 0.064, 219, 110, CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB PROGESTERONE COMPLEX
2782, 2ih1B, 0.5080, 3.97, 0.113, 212, 106, ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
2783, 2hfeA, 0.5080, 4.09, 0.089, 219, 112, RB+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
2784, 1tetH, 0.5080, 4.02, 0.072, 209, 111, CRYSTAL STRUCTURE OF AN ANTICHOLERA TOXIN PEPTIDE COMPLEX AT 2.3 ANGSTROMS
2785, 1r3lA, 0.5080, 3.96, 0.113, 212, 106, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN CS+
2786, 1r3iL, 0.5080, 3.96, 0.113, 212, 106, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN RB+
2787, 1qunM, 0.5080, 2.94, 0.095, 198, 95, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
2788, 1qunI, 0.5080, 2.94, 0.095, 198, 95, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
2789, 1igjD, 0.5080, 3.76, 0.074, 217, 108, 26-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY
2790, 1bj1J, 0.5080, 3.98, 0.075, 213, 107, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY
2791, 6oc3D, 0.5079, 3.81, 0.094, 213, 106, CRYSTAL STRUCTURE OF FLUA-20 FAB IN COMPLEX WITH THE HEAD DOMAIN OF H1 (A/SOLOMON ISLANDS/3/2006) 
2792, 6emjL, 0.5079, 3.96, 0.085, 211, 106, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
2793, 5zmjH, 0.5079, 4.01, 0.045, 227, 110, CRYSTAL STRUCTURE OF THE FAB REGION OF A NEUTRALIZING FULLY HUMAN ANTIBODY AGAINST GM-CSF 
2794, 5xqwH, 0.5079, 3.86, 0.074, 210, 108, CATALYTIC ANTIBODY 7B9 
2795, 5vshF, 0.5079, 3.99, 0.093, 211, 107, CH1/CLAMBDA FAB BASED ON PERTUZUMAB
2796, 5vplC, 0.5079, 3.90, 0.094, 211, 106, CRYSTAL STRUCTURE OF DER F 1 COMPLEXED WITH FAB 4C1
2797, 5vcoC, 0.5079, 4.01, 0.084, 211, 107, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
2798, 5t1kA, 0.5079, 3.90, 0.094, 213, 106, CETUXIMAB FAB IN COMPLEX WITH CQFDA(PH)2STRRLKC
2799, 5nb5M, 0.5079, 4.00, 0.112, 218, 107, PRINCIPLES FOR COMPUTATIONAL DESIGN OF ANTIBODIES
2800, 5mv4G, 0.5079, 3.97, 0.113, 218, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
2801, 5mu2J, 0.5079, 4.03, 0.112, 218, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2802, 5mu0P, 0.5079, 4.14, 0.111, 216, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
2803, 5mp1L, 0.5079, 3.91, 0.123, 218, 106, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
2804, 5mp1D, 0.5079, 3.93, 0.113, 218, 106, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
2805, 5eblB, 0.5079, 3.97, 0.113, 212, 106, KCSA T75G IN THE CONDUCTIVE STATE
2806, 5d7iF, 0.5079, 3.74, 0.084, 243, 107, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT M33.64 TCR
2807, 5cbeA, 0.5079, 3.60, 0.058, 125, 103, E10 IN COMPLEX WITH CXCL13
2808, 4x7tL, 0.5079, 3.97, 0.084, 218, 107, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 2
2809, 4x6cE, 0.5079, 3.67, 0.095, 198, 105, CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR
2810, 4rgoL, 0.5079, 3.95, 0.112, 212, 107, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 14G8
2811, 4r0lB, 0.5079, 3.80, 0.087, 114, 104, ANTI-CANINE CD28 ANTIBODY 1C6 BOUND CANINE CD28
2812, 4q0xH, 0.5079, 3.97, 0.064, 216, 110, CRYSTAL STRUCTURE OF NON-NEUTRALIZING ANTIBODY IN COMPLEX WITH EPITOPE II OF HCV E2
2813, 4pp2C, 0.5079, 4.01, 0.084, 211, 107, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
2814, 4mauL, 0.5079, 4.01, 0.093, 216, 107, CRYSTAL STRUCTURE OF ANTI-ST2L ANTIBODY C2244
2815, 4ma7H, 0.5079, 3.99, 0.081, 218, 111, CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH PROMAZINE
2816, 4jfeE, 0.5079, 3.85, 0.120, 245, 108, PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR
2817, 4edwL, 0.5079, 3.81, 0.085, 214, 106, NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM HUMANIZED VERSION OF MOUSE MAB 911 (TANEZUMAB)
2818, 4dkeM, 0.5079, 4.03, 0.084, 212, 107, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB1.1
2819, 3zknL, 0.5079, 3.96, 0.112, 217, 107, BACE2 FAB INHIBITOR COMPLEX
2820, 3ze0E, 0.5079, 3.99, 0.064, 216, 110, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2821, 3pqyE, 0.5079, 3.65, 0.105, 240, 105, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
2822, 3oklA, 0.5079, 3.88, 0.113, 219, 106, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO
2823, 3l7fD, 0.5079, 3.95, 0.085, 213, 106, STRUCTURE OF IL-13 ANTIBODY H2L6 A HUMANIZED VARIANT OF C836
2824, 3gb7B, 0.5079, 4.06, 0.103, 212, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+
2825, 2r1xA, 0.5079, 3.88, 0.113, 219, 106, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2826, 2bnrD, 0.5079, 3.77, 0.131, 203, 107, STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
2827, 2bdnH, 0.5079, 4.11, 0.080, 217, 112, CRYSTAL STRUCTURE OF HUMAN MCP-1 BOUND TO A BLOCKING ANTIBODY 11K2
2828, 1zwiA, 0.5079, 4.21, 0.071, 219, 113, STRUCTURE OF MUTANT KCSA POTASSIUM CHANNEL
2829, 1ahwB, 0.5079, 4.03, 0.081, 214, 111, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
2830, 6qexC, 0.5078, 4.15, 0.098, 225, 112, NANODISC RECONSTITUTED HUMAN ABCB1 IN COMPLEX WITH UIC2 FAB AND TAXOL 
2831, 6okqB, 0.5078, 3.84, 0.086, 210, 105, CRYSTAL STRUCTURE OF THE SF12 FAB 
2832, 6ocbL, 0.5078, 3.76, 0.095, 213, 105, CRYSTAL STRUCTURE OF FLUA-20 FAB IN COMPLEX WITH THE HEAD DOMAIN OF H3 (A/HONG KONG/1/1968) 
2833, 6eh6A, 0.5078, 3.95, 0.136, 202, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2834, 5xrqB, 0.5078, 3.78, 0.095, 212, 105, CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 
2835, 5xotE, 0.5078, 3.58, 0.077, 242, 104, CRYSTAL STRUCTURE OF PHLA-B35 IN COMPLEX WITH TU55 T CELL RECEPTOR
2836, 5vshL, 0.5078, 3.88, 0.094, 213, 106, CH1/CLAMBDA FAB BASED ON PERTUZUMAB
2837, 5vkhB, 0.5078, 3.96, 0.113, 212, 106, CLOSED CONFORMATION OF KCSA Y82A-F103A MUTANT
2838, 5tl5L, 0.5078, 3.99, 0.093, 217, 107, COMPLEX BETWEEN HUMAN CD27 AND ANTIBODY M2177
2839, 5o1rM, 0.5078, 3.83, 0.075, 212, 106, HUMAN FAB 5H2 BOUND TO NHBA-C3 FROM NEISSERIA MENINGITIDIS SEROGROUP B 
2840, 5nb5L, 0.5078, 4.00, 0.121, 218, 107, PRINCIPLES FOR COMPUTATIONAL DESIGN OF ANTIBODIES
2841, 5ksaC, 0.5078, 3.89, 0.085, 195, 106, BEL602-DQ8.5-GLIA-GAMMA1 COMPLEX
2842, 5j9pB, 0.5078, 3.97, 0.113, 212, 106, KCSA IN VITRO
2843, 5id0A, 0.5078, 3.94, 0.094, 212, 106, CETUXIMAB FAB IN COMPLEX WITH AMINOHEPTANOIC ACID-LINKED MEDITOPE
2844, 5d2nD, 0.5078, 3.83, 0.132, 198, 106, CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX
2845, 5cp3A, 0.5078, 3.88, 0.132, 218, 106, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES IN COMPLEX WITH SULFATHIAZOLE
2846, 4x6dG, 0.5078, 3.72, 0.105, 200, 105, CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR
2847, 4nylF, 0.5078, 3.92, 0.076, 124, 105, CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT
2848, 4nrxL, 0.5078, 3.91, 0.094, 213, 106, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
2849, 4mhhL, 0.5078, 4.01, 0.121, 217, 107, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)
2850, 4g6aD, 0.5078, 4.06, 0.103, 218, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY AP33
2851, 4d9rD, 0.5078, 3.92, 0.075, 213, 107, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
2852, 3utpL, 0.5078, 3.73, 0.093, 246, 107, 1E6 TCR SPECIFIC FOR HLA-A*0201-ALWGPDPAAA
2853, 3sdcC, 0.5078, 3.94, 0.148, 191, 108, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-GLOBOTRIHEXOSYLCERAMIDE
2854, 3rvvC, 0.5078, 3.90, 0.094, 211, 106, CRYSTAL STRUCTURE OF DER F 1 COMPLEXED WITH FAB 4C1
2855, 3rifF, 0.5078, 3.91, 0.073, 171, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2856, 3qfjE, 0.5078, 3.67, 0.067, 245, 105, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED TAX (Y5F) PEPTIDE
2857, 3or7A, 0.5078, 4.11, 0.080, 219, 112, ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71I
2858, 3o2dL, 0.5078, 3.93, 0.123, 216, 106, CRYSTAL STRUCTURE OF HIV-1 PRIMARY RECEPTOR CD4 IN COMPLEX WITH A POTENT ANTIVIRAL ANTIBODY
2859, 3bpcA, 0.5078, 3.89, 0.113, 216, 106, CO-CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH 5-DEOXY-4- EPI-23-DEHYDRO KDO (4.8) KDO
2860, 2ygtA, 0.5078, 4.25, 0.100, 282, 110, CLOSTRIDIUM PERFRINGENS DELTA-TOXIN
2861, 2r4sH, 0.5078, 4.03, 0.117, 217, 111, CRYSTAL STRUCTURE OF THE HUMAN BETA2 ADRENOCEPTOR
2862, 2oslL, 0.5078, 3.74, 0.115, 213, 104, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
2863, 2o5zH, 0.5078, 3.89, 0.056, 219, 108, CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB 5-BETA- ANDROSTANE-317-DIONE COMPLEX
2864, 2hvjA, 0.5078, 4.15, 0.080, 218, 112, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN LOW K+
2865, 2hfgL, 0.5078, 4.02, 0.084, 213, 107, CRYSTAL STRUCTURE OF HBR3 BOUND TO CB3S-FAB
2866, 1s5hA, 0.5078, 3.98, 0.113, 211, 106, POTASSIUM CHANNEL KCSA-FAB COMPLEX T75C MUTANT IN K+
2867, 1igfL, 0.5078, 3.94, 0.112, 219, 107, CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS
2868, 1f11C, 0.5078, 3.99, 0.103, 216, 107, F124 FAB FRAGMENT FROM A MONOCLONAL ANTI-PRES2 ANTIBODY
2869, 6jmqD, 0.5077, 3.92, 0.103, 219, 107, LAT1-CD98HC COMPLEX BOUND TO MEM-108 FAB 
2870, 6dc8L, 0.5077, 3.98, 0.113, 218, 106, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 8B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
2871, 6awnC, 0.5077, 4.05, 0.121, 214, 107, X-RAY STRUCTURE OF THE S439T HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH PAROXETINE AT THE CENTRAL SITE
2872, 6at6A, 0.5077, 3.74, 0.133, 190, 105, CRYSTAL STRUCTURE OF THE KFJ5 TCR
2873, 6a0xG, 0.5077, 3.78, 0.056, 223, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 
2874, 5yfiL, 0.5077, 3.98, 0.103, 214, 107, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY 
2875, 5vk6B, 0.5077, 3.97, 0.113, 212, 106, OPEN CONFORMATION OF KCSA NON-INACTIVATING E71A MUTANT
2876, 5tlkA, 0.5077, 4.04, 0.093, 215, 107, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND H2191
2877, 5mv4S, 0.5077, 3.94, 0.113, 218, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
2878, 5mv4M, 0.5077, 4.04, 0.112, 217, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
2879, 5mv4D, 0.5077, 3.94, 0.113, 217, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
2880, 5mu2P, 0.5077, 4.02, 0.112, 217, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2881, 5mu2L, 0.5077, 4.02, 0.112, 218, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2882, 5mu2H, 0.5077, 4.03, 0.112, 217, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2883, 5mu0D, 0.5077, 4.14, 0.111, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
2884, 5mp1K, 0.5077, 3.94, 0.113, 218, 106, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
2885, 5hyqA, 0.5077, 4.01, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE
2886, 5d2lK, 0.5077, 3.92, 0.103, 192, 107, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
2887, 5c0bJ, 0.5077, 3.81, 0.093, 244, 107, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDFPTI
2888, 5bk5C, 0.5077, 3.95, 0.094, 217, 106, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 663 GERMLINE ANTIBODY
2889, 4ww1B, 0.5077, 4.02, 0.092, 241, 109, CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV21-TRAJ8 AND BETA CHAIN-TRBV7-8
2890, 4nnpL, 0.5077, 3.92, 0.084, 213, 107, CRYSTAL STRUCTURE OF APO MANGANESE ABC TRANSPORTER MNTC FROM STAPHYLOCOCCUS AUREUS BOUND TO AN ANTAGONISTIC FAB FRAGMENT
2891, 4lmqL, 0.5077, 4.01, 0.093, 214, 107, DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF A HUMANIZED ANTIBODY TARGETING CXCL12
2892, 4jhwH, 0.5077, 4.01, 0.073, 226, 110, CRYSTAL STRUCTURE OF RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN STABILIZED IN THE PREFUSION CONFORMATION BY HUMAN ANTIBODY D25
2893, 4gq9H, 0.5077, 3.81, 0.083, 218, 109, CHIKUNGUNYA VIRUS NEUTRALIZING ANTIBODY 9.8B FAB FRAGMENT
2894, 3v6oE, 0.5077, 4.07, 0.121, 213, 107, LEPTIN RECEPTOR-ANTIBODY COMPLEX
2895, 3t3pH, 0.5077, 3.97, 0.064, 216, 110, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
2896, 3t3mE, 0.5077, 3.99, 0.064, 214, 110, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
2897, 3or7B, 0.5077, 3.97, 0.113, 212, 106, ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71I
2898, 3nigH, 0.5077, 3.98, 0.064, 216, 110, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
2899, 3j2zH, 0.5077, 3.82, 0.083, 218, 109, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
2900, 3j2yD, 0.5077, 3.82, 0.083, 218, 109, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
2901, 3j2yB, 0.5077, 3.82, 0.083, 218, 109, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
2902, 3igaB, 0.5077, 3.96, 0.113, 212, 106, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+ AND K+
2903, 3eoaL, 0.5077, 3.91, 0.075, 214, 106, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM I
2904, 3cfdA, 0.5077, 4.05, 0.084, 213, 107, PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN
2905, 2jk5B, 0.5077, 3.97, 0.113, 212, 106, POTASSIUM CHANNEL KCSA IN COMPLEX WITH TETRABUTYLAMMONIUM IN HIGH K
2906, 2hffL, 0.5077, 4.01, 0.093, 211, 107, CRYSTAL STRUCTURE OF CB2 FAB
2907, 2gkiB, 0.5077, 3.95, 0.112, 238, 107, HEAVY AND LIGHT CHAIN VARIABLE SINGLE DOMAINS OF AN ANTI-DNA BINDING ANTIBODY HYDROLYZE BOTH DOUBLE- AND SINGLE-STRANDED DNAS WITHOUT SEQUENCE SPECIFICITY
2908, 2eytD, 0.5077, 3.78, 0.084, 243, 107, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2909, 1ymhB, 0.5077, 4.02, 0.089, 218, 112, ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W
2910, 1uwxM, 0.5077, 4.04, 0.064, 218, 110, P1.2 SEROSUBTYPE ANTIGEN DERIVED FROM N. MENINGITIDIS PORA IN COMPLEX WITH FAB FRAGMENT
2911, 1iqwH, 0.5077, 4.00, 0.090, 221, 111, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MOUSE ANTI- HUMAN FAS ANTIBODY HFE7A
2912, 1igyA, 0.5077, 3.96, 0.104, 213, 106, STRUCTURE OF IMMUNOGLOBULIN
2913, 6obzB, 0.5076, 3.97, 0.084, 213, 107, CRYSTAL STRUCTURE OF FLUA-20 FAB 
2914, 6fr4B, 0.5076, 3.71, 0.086, 243, 105, 003 TCR STUDY OF CDR LOOP FLEXIBILITY 
2915, 6eluF, 0.5076, 4.06, 0.103, 217, 107, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
2916, 6dcvA, 0.5076, 3.91, 0.104, 220, 106, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 
2917, 6cphD, 0.5076, 3.87, 0.093, 200, 107, CRYSTAL STRUCTURE OF A TCR 
2918, 6c09C, 0.5076, 3.90, 0.102, 192, 108, TERNARY CRYSTAL STRUCTURE OF THE 3C8 TCR-CD1C-MONOACYLGLYCEROL COMPLEX
2919, 6bliK, 0.5076, 3.99, 0.084, 214, 107, RSV G PEPTIDE BOUND TO FAB CB002.5
2920, 6a3wD, 0.5076, 3.72, 0.048, 116, 105, COMPLEX STRUCTURE OF 4-1BB AND UTOMILUMAB 
2921, 5x4gB, 0.5076, 4.03, 0.112, 213, 107, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CD147 MONOCLONAL ANTIBODY 6H8
2922, 5wk3S, 0.5076, 4.06, 0.081, 221, 111, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
2923, 5w1vI, 0.5076, 3.86, 0.152, 202, 105, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
2924, 5vshD, 0.5076, 3.99, 0.093, 211, 107, CH1/CLAMBDA FAB BASED ON PERTUZUMAB
2925, 5vjqD, 0.5076, 3.98, 0.112, 213, 107, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
2926, 5vjoD, 0.5076, 4.04, 0.103, 211, 107, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT I29F AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
2927, 5u1rE, 0.5076, 3.73, 0.065, 243, 107, STRUCTURE OF HUMAN MR1-DICLOFENAC IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2928, 5mv4V, 0.5076, 3.94, 0.113, 218, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
2929, 5mu2D, 0.5076, 4.03, 0.112, 218, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2930, 5mu0B, 0.5076, 4.04, 0.112, 217, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
2931, 5j74B, 0.5076, 3.84, 0.125, 233, 104, FLUOROGEN ACTIVATING PROTEIN AM2.2 IN COMPLEX WITH TO1-2P
2932, 5ir1A, 0.5076, 3.93, 0.094, 213, 106, CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT
2933, 5icyA, 0.5076, 3.91, 0.094, 212, 106, CETUXIMAB FAB IN COMPLEX WITH LINEAR MEDITOPE
2934, 5hj3N, 0.5076, 4.08, 0.084, 203, 107, CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP GPCL.
2935, 5gz0C, 0.5076, 3.94, 0.094, 213, 106, CRYSTAL STRUCTURE OF FM329 A RECOMBINANT FAB ADOPTED FROM CETUXIMAB
2936, 4zptL, 0.5076, 4.02, 0.084, 212, 107, STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 1)
2937, 4z7oE, 0.5076, 3.99, 0.064, 216, 110, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
2938, 4z7nH, 0.5076, 3.99, 0.064, 216, 110, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
2939, 4yzfH, 0.5076, 3.91, 0.085, 218, 106, CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3
2940, 4priE, 0.5076, 3.89, 0.074, 240, 108, CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:08-HPVG COMPLEX
2941, 4n20A, 0.5076, 3.97, 0.067, 639, 105, CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (0 MM CA2+)
2942, 4jlrL, 0.5076, 3.80, 0.095, 210, 105, CRYSTAL STRUCTURE OF A DESIGNED RESPIRATORY SYNCYTIAL VIRUS IMMUNOGEN IN COMPLEX WITH MOTAVIZUMAB
2943, 4hxaL, 0.5076, 3.78, 0.124, 213, 105, CRYSTAL STRUCTURE OF 13D9 FAB
2944, 4h88H, 0.5076, 4.02, 0.072, 218, 111, STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH MOUSE PRPC FRAGMENT 120- 230
2945, 4g8gE, 0.5076, 3.64, 0.067, 248, 105, CRYSTAL STRUCTURE OF C12C TCR-HA B2705-KK10
2946, 4bz1H, 0.5076, 3.89, 0.082, 212, 110, STRUCTURE OF DENGUE VIRUS EDIII IN COMPLEX WITH FAB 3E31
2947, 3vfgL, 0.5076, 3.90, 0.113, 211, 106, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 3F8 FAB FRAGMENT THAT BINDS TO GD2 GANGLIOSIDE
2948, 3v4pM, 0.5076, 4.05, 0.080, 211, 112, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
2949, 3v4pH, 0.5076, 4.06, 0.080, 211, 112, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
2950, 3l7eL, 0.5076, 3.88, 0.086, 213, 105, CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836
2951, 3jbc7, 0.5076, 3.78, 0.075, 129, 107, COMPLEX OF POLIOVIRUS WITH VHH PVSP29F
2952, 3j2zF, 0.5076, 3.82, 0.083, 218, 109, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
2953, 3j2zD, 0.5076, 3.82, 0.083, 218, 109, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
2954, 3j2zB, 0.5076, 3.82, 0.083, 218, 109, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
2955, 3j2yH, 0.5076, 3.82, 0.083, 218, 109, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
2956, 3j2yF, 0.5076, 3.82, 0.083, 218, 109, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
2957, 3i75A, 0.5076, 3.90, 0.085, 212, 106, ANTIBODY STRUCTURE
2958, 3hujE, 0.5076, 3.82, 0.112, 199, 107, CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
2959, 2jixG, 0.5076, 3.81, 0.076, 214, 105, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
2960, 2ianJ, 0.5076, 3.65, 0.057, 239, 105, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
2961, 2fjfA, 0.5076, 4.01, 0.093, 211, 107, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
2962, 2eytC, 0.5076, 3.83, 0.103, 202, 107, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2963, 2eyrB, 0.5076, 3.72, 0.085, 241, 106, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2964, 1za6F, 0.5076, 3.84, 0.074, 324, 108, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
2965, 1ob1E, 0.5076, 4.02, 0.081, 219, 111, CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19
2966, 6okqE, 0.5075, 3.97, 0.085, 210, 106, CRYSTAL STRUCTURE OF THE SF12 FAB 
2967, 6k7oL, 0.5075, 4.01, 0.075, 218, 107, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
2968, 5yxnA, 0.5075, 3.95, 0.128, 192, 109, A T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HEPATITIS C VIRUS NS3 PEPTIDE (KLVALGINAV) 
2969, 5wkfI, 0.5075, 3.53, 0.115, 198, 104, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS1
2970, 5vphC, 0.5075, 3.90, 0.094, 211, 106, CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1
2971, 5uddM, 0.5075, 4.07, 0.072, 221, 111, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2972, 5u16H, 0.5075, 3.72, 0.065, 243, 107, STRUCTURE OF HUMAN MR1-2-OH-1-NA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2973, 5mv4P, 0.5075, 3.94, 0.113, 218, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
2974, 5mv3J, 0.5075, 3.94, 0.113, 218, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2975, 5mu0L, 0.5075, 4.01, 0.112, 217, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
2976, 5jueH, 0.5075, 4.03, 0.081, 225, 111, CRYSTAL STRUCTURE OF UIC2 FAB
2977, 5ggqL, 0.5075, 3.97, 0.075, 211, 107, CRYSTAL STRUCTURE OF NIVOLUMAB FAB FRAGMENT
2978, 5eziL, 0.5075, 3.88, 0.104, 214, 106, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - HEXAGONAL FORM
2979, 5ec2B, 0.5075, 3.97, 0.113, 212, 106, KCSA WITH V76ESTER+G77DA MUTATIONS
2980, 5c0aJ, 0.5075, 3.84, 0.103, 244, 107, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING MVW PEPTIDE
2981, 5bk5A, 0.5075, 3.91, 0.094, 219, 106, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 663 GERMLINE ANTIBODY
2982, 5bk3F, 0.5075, 3.97, 0.103, 217, 107, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
2983, 4pozC, 0.5075, 3.96, 0.075, 211, 107, FAB FRAGMENT OF DER P 1 SPECIFIC ANTIBODY 10B9
2984, 4lcuB, 0.5075, 3.97, 0.113, 212, 106, STRUCTURE OF KCSA WITH E118A MUTATION
2985, 4jreH, 0.5075, 4.04, 0.063, 213, 111, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND
2986, 3zdzH, 0.5075, 3.99, 0.064, 216, 110, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2987, 3ulvL, 0.5075, 3.97, 0.075, 214, 107, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)
2988, 3stzB, 0.5075, 3.96, 0.113, 212, 106, KCSA POTASSIUM CHANNEL MUTANT Y82C WITH NITROXIDE SPIN LABEL
2989, 3rvxC, 0.5075, 3.90, 0.094, 211, 106, CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1
2990, 3naaH, 0.5075, 4.07, 0.090, 225, 111, CRYSTAL STRUCTURE OF FAB15 MUT5
2991, 3l7fL, 0.5075, 4.02, 0.084, 213, 107, STRUCTURE OF IL-13 ANTIBODY H2L6 A HUMANIZED VARIANT OF C836
2992, 3d85A, 0.5075, 4.03, 0.093, 213, 107, CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH NEUTRALIZING FAB
2993, 2or9M, 0.5075, 3.81, 0.095, 218, 105, THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT/EPITOPE PEPTIDE COMPLEX REVEALS A NOVEL BINDING MODE DOMINATED BY THE HEAVY CHAIN HYPERVARIABLE LOOPS
2994, 2ih3B, 0.5075, 3.97, 0.113, 212, 106, ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
2995, 2hrpL, 0.5075, 3.83, 0.095, 215, 105, ANTIGEN-ANTIBODY COMPLEX
2996, 2gsiA, 0.5075, 3.77, 0.095, 215, 105, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
2997, 2af2A, 0.5075, 4.63, 0.061, 153, 115, SOLUTION STRUCTURE OF DISULFIDE REDUCED AND COPPER DEPLETED HUMAN SUPEROXIDE DISMUTASE
2998, 1za6D, 0.5075, 3.89, 0.074, 324, 108, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
2999, 1mlbA, 0.5075, 3.96, 0.103, 214, 107, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME
3000, 1jpsL, 0.5075, 3.98, 0.084, 213, 107, CRYSTAL STRUCTURE OF TISSUE FACTOR IN COMPLEX WITH HUMANIZED FAB D3H44
3001, 1jnnL, 0.5075, 4.00, 0.112, 211, 107, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
3002, 1il1B, 0.5075, 3.88, 0.113, 219, 106, CRYSTAL STRUCTURE OF G3-519 AN ANTI-HIV MONOCLONAL ANTIBODY
3003, 1f11A, 0.5075, 3.99, 0.103, 216, 107, F124 FAB FRAGMENT FROM A MONOCLONAL ANTI-PRES2 ANTIBODY
3004, 1e4xH, 0.5075, 4.06, 0.089, 216, 112, CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
3005, 1aj7H, 0.5075, 4.05, 0.089, 217, 112, IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID. AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY
3006, 6ogxD, 0.5074, 3.90, 0.075, 213, 106, TERNARY COMPLEX OF OX40R (TNFRSF4) BOUND TO FAB1 AND FAB2 
3007, 6dcwL, 0.5074, 3.92, 0.104, 219, 106, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 FAB IN COMPLEX WITH A HUMAN TAU PEPTIDE 
3008, 6bfqL, 0.5074, 3.99, 0.084, 212, 107, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
3009, 5yupL, 0.5074, 3.88, 0.123, 215, 106, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF FVIIA ANTIBODY MAB4F5 
3010, 5wuvL, 0.5074, 4.02, 0.075, 213, 107, CRYSTAL STRUCTURE OF CERTOLIZUMAB FAB
3011, 5wkfJ, 0.5074, 3.91, 0.111, 244, 108, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS1
3012, 5mvjF, 0.5074, 3.90, 0.123, 218, 106, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
3013, 5mhrI, 0.5074, 4.08, 0.062, 213, 112, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
3014, 5i2iA, 0.5074, 4.03, 0.084, 213, 107, STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE
3015, 5hdbH, 0.5074, 3.99, 0.064, 216, 110, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
3016, 5dmiL, 0.5074, 3.88, 0.094, 213, 106, STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH CHI220 FAB
3017, 5bo1L, 0.5074, 4.00, 0.093, 214, 107, CRYSTAL STRUCTURE OF A HUMAN JAG1 FRAGMENT IN COMPLEX WITH AN ANTI- JAG1 FAB
3018, 5bk3L, 0.5074, 3.97, 0.094, 217, 106, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
3019, 4z7uG, 0.5074, 3.71, 0.135, 198, 104, S13 COMPLEX
3020, 4rh4A, 0.5074, 2.51, 0.141, 123, 85, ZINC-SUBSTITUTED PSEUDOAZURIN SOLVED BY S/ZN-SAD PHASING
3021, 4rgnD, 0.5074, 4.00, 0.090, 210, 111, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
3022, 4pljC, 0.5074, 4.05, 0.112, 201, 107, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE IV) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
3023, 4nkoA, 0.5074, 3.99, 0.094, 115, 106, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
3024, 4j1uA, 0.5074, 3.95, 0.103, 210, 107, CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
3025, 4hgwA, 0.5074, 3.89, 0.113, 217, 106, CRYSTAL STRUCTURE OF S25-2 IN COMPLEX WITH A 56-DEHYDRO-KDO DISACCHARIDE
3026, 4fqrj, 0.5074, 4.03, 0.075, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3027, 4fqrd, 0.5074, 4.03, 0.084, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3028, 4fnlM, 0.5074, 4.03, 0.075, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05
3029, 3nifH, 0.5074, 3.99, 0.064, 219, 110, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
3030, 3ijyC, 0.5074, 3.91, 0.104, 217, 106, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO
3031, 3aazL, 0.5074, 4.13, 0.102, 228, 108, CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY
3032, 2xknA, 0.5074, 3.96, 0.065, 213, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-EGFR ANTIBODY 7A7
3033, 2wucL, 0.5074, 3.81, 0.086, 214, 105, CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC NON- INHIBITORY ANTIBODY FAB40.DELTATRP AND AC-KQLR-CHLOROMETHYLKETONE
3034, 2w60A, 0.5074, 4.05, 0.072, 217, 111, ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4
3035, 2r2bA, 0.5074, 3.88, 0.113, 217, 106, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
3036, 2nx5I, 0.5074, 3.71, 0.133, 188, 105, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
3037, 2hjfB, 0.5074, 4.02, 0.103, 212, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRABUTYLAMMONIUM (TBA)
3038, 2fjgL, 0.5074, 4.02, 0.084, 211, 107, STRUCTURE OF THE G6 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
3039, 2fjgA, 0.5074, 4.04, 0.084, 211, 107, STRUCTURE OF THE G6 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
3040, 1uywN, 0.5074, 3.90, 0.113, 211, 106, CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
3041, 1pzcA, 0.5074, 2.48, 0.141, 122, 85, APO-PSEUDOAZURIN (METAL FREE PROTEIN)
3042, 1nsnL, 0.5074, 3.98, 0.104, 217, 106, THE CRYSTAL STRUCTURE OF ANTIBODY N10-STAPHYLOCOCCAL NUCLEASE COMPLEX AT 2.9 ANGSTROMS RESOLUTION
3043, 1ncaL, 0.5074, 3.94, 0.140, 214, 107, REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
3044, 1h3pL, 0.5074, 3.96, 0.121, 219, 107, STRUCTURAL CHARACTERISATION OF A MONOCLONAL ANTIBODY SPECIFIC FOR THE PRES1 REGION OF THE HEPATITIS B VIRUS
3045, 1e4wH, 0.5074, 3.95, 0.090, 213, 111, CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
3046, 1ap2D, 0.5074, 3.77, 0.057, 123, 105, SINGLE CHAIN FV OF C219
3047, 6k7oC, 0.5073, 4.01, 0.075, 218, 107, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
3048, 6gk7L, 0.5073, 4.03, 0.093, 216, 107, CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY DMCBTAU-27.1; DOUBLE MUTANT (S31Y; T100I) OF CBTAU-27.1; IN COMPLEX WITH TAU PEPTIDE A8119B (RESIDUES 299-318) 
3049, 6fraA, 0.5073, 3.88, 0.147, 201, 109, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
3050, 6eluI, 0.5073, 4.06, 0.103, 217, 107, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
3051, 6eljB, 0.5073, 3.78, 0.086, 213, 105, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
3052, 6cdoA, 0.5073, 4.13, 0.107, 230, 112, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP16.02 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
3053, 6aynC, 0.5073, 3.99, 0.084, 212, 107, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- AMINOPROPYL)-L-ARGININE MEDITOPE VARIANT
3054, 6a3wA, 0.5073, 3.73, 0.048, 116, 105, COMPLEX STRUCTURE OF 4-1BB AND UTOMILUMAB 
3055, 5u2vH, 0.5073, 3.68, 0.066, 242, 106, STRUCTURE OF HUMAN MR1-HMB IN COMPLEX WITH HUMAN MAIT A-F7 TCR
3056, 5tjeE, 0.5073, 3.97, 0.110, 116, 109, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 AND T CELL RECEPTOR P14
3057, 5t1mA, 0.5073, 3.90, 0.094, 213, 106, CETUXIMAB FAB IN COMPLEX WITH CQYDLSTRRLKC
3058, 5t0yI, 0.5073, 3.96, 0.064, 217, 110, 2A10 ANTIBODY FAB FRAGMENT
3059, 5j06C, 0.5073, 4.09, 0.102, 211, 108, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 3 -SIALYLLACTOSE
3060, 5iopA, 0.5073, 3.94, 0.094, 213, 106, CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT
3061, 5id1A, 0.5073, 4.01, 0.084, 212, 107, CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE
3062, 5e2tL, 0.5073, 4.04, 0.093, 216, 107, CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY AT8 FAB
3063, 5d2nF, 0.5073, 3.96, 0.101, 246, 109, CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX
3064, 4yzfL, 0.5073, 3.99, 0.084, 218, 107, CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3
3065, 4webL, 0.5073, 3.88, 0.104, 217, 106, STRUCTURE OF THE CORE ECTODOMAIN OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN 2
3066, 4r97B, 0.5073, 3.97, 0.121, 214, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF KKO
3067, 4r7nR, 0.5073, 4.07, 0.075, 213, 107, FAB C2E3
3068, 4r7dL, 0.5073, 4.05, 0.084, 211, 107, FAB HU 15C1
3069, 4en3B, 0.5073, 3.80, 0.084, 240, 107, CRYSTAL STRUCTURE OF A HUMAN VALPHA24(-) NKT TCR IN COMPLEX WITH CD1D/ALPHA-GALACTOSYLCERAMIDE
3070, 4bz1L, 0.5073, 3.95, 0.104, 218, 106, STRUCTURE OF DENGUE VIRUS EDIII IN COMPLEX WITH FAB 3E31
3071, 3sdaC, 0.5073, 3.93, 0.148, 196, 108, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
3072, 3or6B, 0.5073, 4.05, 0.103, 212, 107, ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71Q
3073, 3oknA, 0.5073, 3.89, 0.113, 218, 106, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO(2.4)KDO
3074, 3nidE, 0.5073, 3.99, 0.064, 214, 110, THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
3075, 3nacH, 0.5073, 3.97, 0.091, 225, 110, CRYSTAL STRUCTURE OF FAB15 MUT7
3076, 3mbeG, 0.5073, 3.65, 0.105, 192, 105, TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27)
3077, 3mbeC, 0.5073, 3.65, 0.105, 192, 105, TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27)
3078, 3j8f7, 0.5073, 4.03, 0.101, 306, 109, CRYO-EM RECONSTRUCTION OF POLIOVIRUS-RECEPTOR COMPLEX
3079, 3ijhC, 0.5073, 3.91, 0.104, 217, 106, STRUCTURE OF S67-27 IN COMPLEX WITH KO
3080, 2vc2H, 0.5073, 4.00, 0.064, 219, 110, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758
3081, 2q8aH, 0.5073, 3.98, 0.093, 199, 108, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
3082, 2pyeD, 0.5073, 3.79, 0.104, 195, 106, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY TCR CLONE C5C1 COMPLEXED WITH MHC
3083, 2p7tB, 0.5073, 3.97, 0.113, 212, 106, CRYSTAL STRUCTURE OF KCSA MUTANT
3084, 2nz9E, 0.5073, 3.99, 0.084, 216, 107, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
3085, 2nljA, 0.5073, 3.94, 0.113, 212, 106, POTASSIUM CHANNEL KCSA(M96V)-FAB COMPLEX IN KCL
3086, 2jixA, 0.5073, 3.93, 0.065, 214, 107, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
3087, 2g5bC, 0.5073, 3.92, 0.121, 217, 107, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
3088, 2g5bA, 0.5073, 3.92, 0.121, 217, 107, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
3089, 1t4kC, 0.5073, 3.91, 0.094, 217, 106, CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB
3090, 1rsfA, 0.5073, 4.15, 0.073, 126, 110, NMR STRUCTURE OF MONOMERIC CAR D1 DOMAIN
3091, 1qunO, 0.5073, 3.07, 0.094, 198, 96, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
3092, 1qunK, 0.5073, 3.07, 0.094, 198, 96, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
3093, 1ct8A, 0.5073, 3.98, 0.093, 214, 107, CATALYTIC ANTIBODY 7C8 COMPLEX
3094, 1cicA, 0.5073, 3.95, 0.140, 214, 107, IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
3095, 1c5dA, 0.5073, 4.00, 0.093, 213, 107, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR
3096, 6oc3B, 0.5072, 3.83, 0.094, 213, 106, CRYSTAL STRUCTURE OF FLUA-20 FAB IN COMPLEX WITH THE HEAD DOMAIN OF H1 (A/SOLOMON ISLANDS/3/2006) 
3097, 6mqrL, 0.5072, 3.98, 0.084, 213, 107, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY 0PV-A.01 IN COMPLEX WITH FP (RESIDUE 512-519) 
3098, 6jmrC, 0.5072, 3.99, 0.063, 214, 111, CD98HC EXTRACELLULAR DOMAIN BOUND TO HBJ127 FAB AND MEM-108 FAB 
3099, 6fg2M, 0.5072, 3.88, 0.075, 211, 106, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA84. 
3100, 6bzwB, 0.5072, 4.07, 0.103, 217, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY AP33 
3101, 6bftL, 0.5072, 3.97, 0.075, 213, 107, STRUCTURE OF BEVACIZUMAB FAB MUTANT IN COMPLEX WITH VEGF 
3102, 6azlA, 0.5072, 3.90, 0.094, 212, 106, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N- CARBOXYETHYLARGININE MEDITOPE VARIANT
3103, 5vshB, 0.5072, 3.89, 0.094, 213, 106, CH1/CLAMBDA FAB BASED ON PERTUZUMAB
3104, 5mvzH, 0.5072, 4.13, 0.080, 221, 112, FAB 4AB007 BOUND TO INTERLEUKIN-1-BETA
3105, 5mubM, 0.5072, 3.97, 0.113, 217, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
3106, 5mu2F, 0.5072, 4.04, 0.112, 217, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3107, 5mp1G, 0.5072, 3.93, 0.123, 218, 106, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
3108, 5lfrB, 0.5072, 4.17, 0.117, 312, 111, CRYSTAL STRUCTURE OF GLYCOSYLATED MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) IG1-3
3109, 5j0bC, 0.5072, 4.10, 0.091, 212, 110, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 6 -SIALYLLACTOSE
3110, 5i76C, 0.5072, 4.05, 0.084, 213, 107, CRYSTAL STRUCTURE OF FM318 A RECOMBINANT FAB ADOPTED FROM CETUXIMAB
3111, 5i0zA, 0.5072, 3.67, 0.067, 120, 104, CRYSTAL STRUCTURE OF THE SINGLE DOMAIN CATALYTIC ANTIBODY 3D8-VH
3112, 5fb8A, 0.5072, 4.04, 0.093, 218, 107, STRUCTURE OF INTERLEUKIN-16 BOUND TO THE 14.1 ANTIBODY
3113, 5f88A, 0.5072, 4.03, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT
3114, 5esqA, 0.5072, 4.04, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH CYCLIC BETA-ALANINE-LINKED MEDITOPE
3115, 5e6iA, 0.5072, 3.84, 0.143, 196, 105, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
3116, 4xhjC, 0.5072, 3.93, 0.066, 207, 106, GHGL OF VARICELLA-ZOSTER VIRUS IN COMPLEX WITH HUMAN NEUTRALIZING ANTIBODIES.
3117, 4wfeF, 0.5072, 3.80, 0.105, 211, 105, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND CONDUCTIVE CONFORMATION
3118, 4wcyL, 0.5072, 4.01, 0.093, 217, 107, FAB FRAGMENT OF MOUSE AZ130 MONOCLONAL ANTIBODY
3119, 4rgnF, 0.5072, 4.00, 0.090, 210, 111, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
3120, 4r97C, 0.5072, 4.02, 0.081, 218, 111, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF KKO
3121, 4p46A, 0.5072, 3.88, 0.131, 199, 107, J809.B5 Y31A TCR BOUND TO IAB3K
3122, 4nrxB, 0.5072, 3.91, 0.094, 207, 106, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
3123, 4nqdE, 0.5072, 3.72, 0.065, 243, 107, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND NON-COVALENTLY BOUND 5-(2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
3124, 4i9wF, 0.5072, 3.80, 0.105, 211, 105, HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE
3125, 4g8eA, 0.5072, 3.80, 0.121, 201, 107, CRYSTAL STRUCTURE OF CLONE18 TCR
3126, 3ze2H, 0.5072, 3.99, 0.064, 216, 110, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
3127, 3zdyH, 0.5072, 3.99, 0.064, 216, 110, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
3128, 3us0D, 0.5072, 3.62, 0.108, 192, 102, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING A TWO BASE PAIR AT SPACER BETWEEN HALF SITES
3129, 3tyfC, 0.5072, 3.80, 0.103, 197, 107, CRYSTAL STRUCTURE OF A CD1D-LYSOPHOSPHATIDYLCHOLINE REACTIVE INKT TCR
3130, 3t3pE, 0.5072, 3.99, 0.064, 214, 110, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
3131, 3o6fD, 0.5072, 3.89, 0.093, 245, 108, CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4
3132, 3ncjH, 0.5072, 4.07, 0.090, 225, 111, CRYSTAL STRUCTURE OF FAB15 MUT8
3133, 3lhpL, 0.5072, 3.93, 0.057, 111, 106, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_D0_1ISEA_004_N 4E10 FV COMPLEX
3134, 3kpsE, 0.5072, 3.72, 0.104, 241, 106, CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
3135, 3i9gL, 0.5072, 3.99, 0.103, 213, 107, CRYSTAL STRUCTURE OF THE LT1009 (SONEPCIZUMAB) ANTIBODY FAB FRAGMENT IN COMPLEX WITH SPHINGOSINE-1-PHOSPHATE
3136, 3gkwL, 0.5072, 4.13, 0.111, 199, 108, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NIMOTUZUMAB. AN ANTI- EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY
3137, 3fzuD, 0.5072, 3.96, 0.084, 213, 107, IGG1 FAB CHARACTERIZED BY H/D EXCHANGE
3138, 3fctC, 0.5072, 3.91, 0.094, 213, 106, MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN
3139, 3cfeA, 0.5072, 4.01, 0.084, 213, 107, CRYSTAL STRUCTURE OF PURPLE-FLUORESCENT ANTIBODY EP2-25C10
3140, 2zjsH, 0.5072, 3.90, 0.064, 220, 109, CRYSTAL STRUCTURE OF SECYE TRANSLOCON FROM THERMUS THERMOPHILUS WITH A FAB FRAGMENT
3141, 2r4rH, 0.5072, 4.05, 0.108, 217, 111, CRYSTAL STRUCTURE OF THE HUMAN BETA2 ADRENOCEPTOR
3142, 2q76A, 0.5072, 4.02, 0.112, 212, 107, MOUSE ANTI-HEN EGG WHITE LYSOZYME ANTIBODY F10.6.6 FAB FRAGMENT
3143, 2nyyC, 0.5072, 3.96, 0.084, 216, 107, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1
3144, 2nx5T, 0.5072, 3.65, 0.133, 188, 105, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
3145, 2fatL, 0.5072, 3.75, 0.114, 212, 105, AN ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) ANTIBODY: CRYSTAL STRUCTURE AND BINDING EPITOPE
3146, 2f58L, 0.5072, 3.92, 0.094, 216, 106, IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 12-RESIDUE CYCLIC PEPTIDE (INCLUDING RESIDUES 315-324 OF HIV-1 GP120) (MN ISOLATE)
3147, 2f54D, 0.5072, 3.76, 0.131, 205, 107, DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY
3148, 2atkB, 0.5072, 4.05, 0.103, 212, 107, STRUCTURE OF A MUTANT KCSA K+ CHANNEL
3149, 1mjuL, 0.5072, 4.09, 0.084, 219, 107, 1.22 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12
3150, 6mxsL, 0.5071, 3.94, 0.083, 218, 108, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M] 
3151, 6eljL, 0.5071, 3.97, 0.085, 212, 106, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
3152, 6ehwB, 0.5071, 4.09, 0.093, 237, 107, SCFV ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN DRUG DISCOVERY
3153, 6eh7B, 0.5071, 3.68, 0.085, 240, 106, F11 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS HAAEMAGGLUTININ EPITOPE PKYVKQNTLKLAT CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
3154, 6bfqF, 0.5071, 4.00, 0.084, 213, 107, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
3155, 6azkC, 0.5071, 4.00, 0.084, 212, 107, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- HYDROXYPROPYL)-L-ARGININE MEDITOPE VARIANT
3156, 6aynA, 0.5071, 3.90, 0.094, 212, 106, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- AMINOPROPYL)-L-ARGININE MEDITOPE VARIANT
3157, 5w23N, 0.5071, 4.06, 0.103, 215, 107, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
3158, 5w1wE, 0.5071, 3.75, 0.075, 243, 107, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
3159, 5nmeD, 0.5071, 3.84, 0.121, 201, 107, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTVATL
3160, 5mv3M, 0.5071, 4.04, 0.112, 218, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3161, 5mubV, 0.5071, 3.97, 0.113, 217, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
3162, 5mubS, 0.5071, 3.97, 0.113, 217, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
3163, 5mubJ, 0.5071, 3.97, 0.113, 217, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
3164, 5immA, 0.5071, 4.13, 0.072, 120, 111, NANOBODY TARGETING MOUSE VSIG4 IN SPACEGROUP P212121
3165, 5d06A, 0.5071, 3.29, 0.050, 1526, 100, CRYSTAL STRUCTURE OF THE CANDIDA GLABRATA GLYCOGEN DEBRANCHING ENZYME
3166, 5c08E, 0.5071, 3.86, 0.093, 244, 108, 1E6 TCR IN COMPLEX WITH HLA-A0E CARRYING RQWGPDPAAV
3167, 5bq7A, 0.5071, 4.08, 0.054, 220, 111, CRYSTAL STRUCTURE OF CHIKUNGUNYA VIRUS-HUMAN FAB 5F-10 FRAGMENT
3168, 4zpvB, 0.5071, 4.00, 0.084, 212, 107, STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 2)
3169, 4wfhF, 0.5071, 3.81, 0.105, 211, 105, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND NONCONDUCTIVE CONFORMATION
3170, 4wffF, 0.5071, 3.80, 0.105, 211, 105, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND NONCONDUCTIVE CONFORMATION
3171, 4oqtL, 0.5071, 4.01, 0.084, 214, 107, LINGO-1/LI81 FAB COMPLEX
3172, 4o5iQ, 0.5071, 3.91, 0.056, 226, 108, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ
3173, 4mwfB, 0.5071, 3.96, 0.075, 211, 106, STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C
3174, 4k7pX, 0.5071, 3.71, 0.087, 213, 104, GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
3175, 4gw1A, 0.5071, 4.04, 0.084, 212, 107, CQFD MEDITOPE
3176, 4ffwH, 0.5071, 3.90, 0.093, 208, 108, CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4 DPP-IV CD26) IN COMPLEX WITH FAB + SITAGLIPTIN
3177, 4etqH, 0.5071, 4.07, 0.080, 215, 112, VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
3178, 3ze2E, 0.5071, 4.00, 0.064, 216, 110, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
3179, 3uypA, 0.5071, 3.83, 0.057, 226, 106, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 4 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
3180, 3ubxH, 0.5071, 4.09, 0.063, 221, 111, CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX
3181, 3ri5F, 0.5071, 3.92, 0.073, 188, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
3182, 3nigE, 0.5071, 4.00, 0.064, 214, 110, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
3183, 3fb8B, 0.5071, 3.97, 0.113, 212, 106, KCSA POTASSIUM CHANNEL IN THE OPEN-CONDUCTIVE STATE WITH 20 A OPENING AT T112 IN THE PRESENCE OF RB+ ION
3184, 3fb6B, 0.5071, 3.97, 0.113, 212, 106, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 16 A OPENING AT T112
3185, 3f7yB, 0.5071, 3.97, 0.113, 212, 106, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 17 A OPENING AT T112
3186, 3f7vB, 0.5071, 4.06, 0.103, 212, 107, KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 23 A OPENING AT T112
3187, 3f5wB, 0.5071, 3.97, 0.113, 212, 106, KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 32 A OPENING AT T112
3188, 3chnS, 0.5071, 3.85, 0.073, 585, 109, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
3189, 3cfeL, 0.5071, 4.01, 0.084, 213, 107, CRYSTAL STRUCTURE OF PURPLE-FLUORESCENT ANTIBODY EP2-25C10
3190, 2uylY, 0.5071, 4.05, 0.089, 213, 112, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
3191, 2r2hA, 0.5071, 3.89, 0.113, 219, 106, STRUCTURE OF S25-2 IN COMPLEX WITH KO
3192, 2pyfA, 0.5071, 3.87, 0.112, 205, 107, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY UNBOUND TCR CLONE 5-1
3193, 2pcpD, 0.5071, 3.89, 0.073, 215, 109, ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
3194, 2ocwA, 0.5071, 4.24, 0.091, 585, 110, SOLUTION STRUCTURE OF HUMAN SECRETORY COMPONENT
3195, 2itdB, 0.5071, 4.04, 0.103, 212, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN BARIUM CHLORIDE
3196, 2hvkB, 0.5071, 3.96, 0.113, 212, 106, CRYSTAL STRUCTURE OF THE KCSA-FAB-TBA COMPLEX IN HIGH K+
3197, 2hg5B, 0.5071, 3.96, 0.113, 212, 106, CS+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
3198, 2gsiG, 0.5071, 3.76, 0.095, 215, 105, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
3199, 2bobB, 0.5071, 4.05, 0.103, 212, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRABUTYLAMMONIUM (TBA)
3200, 1z3gI, 0.5071, 3.98, 0.073, 214, 110, CRYSTAL STRUCTURE OF COMPLEX BETWEEN PVS25 AND FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8
3201, 1ymhA, 0.5071, 4.01, 0.103, 220, 107, ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W
3202, 1rhhD, 0.5071, 3.69, 0.057, 232, 105, CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION
3203, 1r3jA, 0.5071, 3.98, 0.113, 212, 106, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF TL+
3204, 1ncdH, 0.5071, 3.80, 0.065, 221, 108, REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
3205, 1mj8L, 0.5071, 3.85, 0.095, 214, 105, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-126
3206, 1mf2M, 0.5071, 3.80, 0.095, 215, 105, ANTI HIV1 PROTEASE FAB COMPLEX
3207, 1mexL, 0.5071, 4.05, 0.112, 213, 107, ANTIBODY CATALYSIS OF A BIMOLECULAR CYCLOADDITION REACTION
3208, 1lcsB, 0.5071, 4.74, 0.058, 205, 121, RECEPTOR-BINDING DOMAIN FROM SUBGROUP B FELINE LEUKEMIA VIRUS
3209, 1k4cB, 0.5071, 3.97, 0.113, 212, 106, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF K+
3210, 1fl5A, 0.5071, 3.84, 0.113, 217, 106, THE UNLIGANDED GERMLINE PRECURSOR TO THE SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4.
3211, 1eajB, 0.5071, 3.82, 0.065, 120, 108, DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN AT 1.35 ANGSTROM RESOLUTION
3212, 6oe5C, 0.5070, 3.80, 0.095, 211, 105, SPLAYED OPEN PREFUSION RSV F CAPTURED BY CR9501 AND MOTAVIZUMAB FABS 
3213, 6iuvL, 0.5070, 3.95, 0.103, 215, 107, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 3C11 
3214, 6fr9B, 0.5070, 3.66, 0.085, 240, 106, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
3215, 6fg2L, 0.5070, 3.89, 0.085, 211, 106, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA84. 
3216, 6dcaK, 0.5070, 3.99, 0.064, 213, 110, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 6B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
3217, 6bzwF, 0.5070, 4.07, 0.103, 217, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY AP33 
3218, 6axpA, 0.5070, 4.04, 0.084, 212, 107, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-OCTYLARGININE MEDITOPE VARIANT
3219, 6au5C, 0.5070, 4.03, 0.084, 213, 107, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-BUTYLARGININE MEDITOPE VARIANT
3220, 5x2nH, 0.5070, 4.07, 0.063, 223, 111, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
3221, 5w23M, 0.5070, 4.12, 0.102, 215, 108, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
3222, 5t1mC, 0.5070, 3.90, 0.094, 213, 106, CETUXIMAB FAB IN COMPLEX WITH CQYDLSTRRLKC
3223, 5swzN, 0.5070, 3.97, 0.102, 201, 108, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
3224, 5mv4B, 0.5070, 4.12, 0.111, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
3225, 5mubG, 0.5070, 3.97, 0.113, 217, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
3226, 5mubD, 0.5070, 3.98, 0.113, 217, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
3227, 5i1hL, 0.5070, 3.85, 0.086, 214, 105, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV3-20
3228, 5hdbE, 0.5070, 3.99, 0.064, 214, 110, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
3229, 5gjtL, 0.5070, 4.00, 0.075, 211, 107, CRYSTAL STRUCTURE OF H1 HEMAGGLUTININ FROM A/WASHINGTON/05/2011 IN COMPLEX WITH A NEUTRALIZING ANTIBODY 3E1
3230, 5e6iL, 0.5070, 3.76, 0.093, 242, 107, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
3231, 5d2nC, 0.5070, 3.94, 0.131, 198, 107, CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX
3232, 4zptB, 0.5070, 4.03, 0.084, 212, 107, STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 1)
3233, 4zfgL, 0.5070, 4.04, 0.075, 213, 107, DUAL-SPECIFICITY FAB 5A12 IN COMPLEX WITH ANGIOPOIETIN 2
3234, 4z7nE, 0.5070, 4.00, 0.064, 216, 110, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
3235, 4uimF, 0.5070, 4.01, 0.084, 214, 107, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.3
3236, 4mxwV, 0.5070, 4.03, 0.103, 211, 107, STRUCTURE OF HETEROTRIMERIC LYMPHOTOXIN LTA1B2 BOUND TO LYMPHOTOXIN BETA RECEPTOR LTBR AND ANTI-LTA FAB
3237, 4jlrB, 0.5070, 3.79, 0.095, 210, 105, CRYSTAL STRUCTURE OF A DESIGNED RESPIRATORY SYNCYTIAL VIRUS IMMUNOGEN IN COMPLEX WITH MOTAVIZUMAB
3238, 4g8fA, 0.5070, 3.70, 0.125, 184, 104, CRYSTAL STRUCTURE OF CLONE42 TCR
3239, 3ubxG, 0.5070, 4.09, 0.063, 221, 111, CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX
3240, 3stlB, 0.5070, 3.94, 0.113, 212, 106, KCSA POTASSIUM CHANNEL MUTANT Y82C WITH CADMIUM BOUND
3241, 3rdtA, 0.5070, 3.72, 0.124, 199, 105, CRYSTAL STRUCTURE OF 809.B5 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE
3242, 3okdA, 0.5070, 3.88, 0.113, 219, 106, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO
3243, 3j42L, 0.5070, 3.89, 0.123, 212, 106, OBSTRUCTION OF DENGUE VIRUS MATURATION BY FAB FRAGMENTS OF THE 2H2 ANTIBODY
3244, 3j42J, 0.5070, 3.89, 0.123, 212, 106, OBSTRUCTION OF DENGUE VIRUS MATURATION BY FAB FRAGMENTS OF THE 2H2 ANTIBODY
3245, 3j42H, 0.5070, 3.89, 0.123, 212, 106, OBSTRUCTION OF DENGUE VIRUS MATURATION BY FAB FRAGMENTS OF THE 2H2 ANTIBODY
3246, 3i75B, 0.5070, 4.01, 0.073, 223, 109, ANTIBODY STRUCTURE
3247, 3hzyA, 0.5070, 3.89, 0.104, 215, 106, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
3248, 3fb7B, 0.5070, 4.06, 0.103, 212, 107, OPEN KCSA POTASSIUM CHANNEL IN THE PRESENCE OF RB+ ION
3249, 3fb5B, 0.5070, 4.06, 0.103, 212, 107, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 14.5 A OPENING AT T112
3250, 3cfdL, 0.5070, 4.04, 0.084, 213, 107, PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN
3251, 2ztnA, 0.5070, 4.08, 0.067, 472, 105, HEPATITIS E VIRUS ORF2 (GENOTYPE 3)
3252, 2arjA, 0.5070, 4.06, 0.093, 211, 107, CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB
3253, 1zwiB, 0.5070, 3.96, 0.113, 212, 106, STRUCTURE OF MUTANT KCSA POTASSIUM CHANNEL
3254, 1rhhA, 0.5070, 4.11, 0.083, 215, 108, CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION
3255, 1q9oA, 0.5070, 3.88, 0.113, 219, 106, S45-18 FAB UNLIGANDED
3256, 1pmyA, 0.5070, 2.69, 0.105, 123, 86, REFINED CRYSTAL STRUCTURE OF PSEUDOAZURIN FROM METHYLOBACTERIUM EXTORQUENS AM1 AT 1.5 ANGSTROMS RESOLUTION
3257, 1ngwL, 0.5070, 4.02, 0.084, 213, 107, CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
3258, 1ngwA, 0.5070, 4.02, 0.084, 213, 107, CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
3259, 1lp9L, 0.5070, 3.85, 0.094, 194, 106, XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1
3260, 1i9jL, 0.5070, 3.79, 0.124, 219, 105, TESTOSTERONE COMPLEX STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT
3261, 1fskL, 0.5070, 4.03, 0.108, 220, 111, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
3262, 1fskF, 0.5070, 4.03, 0.108, 220, 111, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
3263, 1fskC, 0.5070, 4.03, 0.108, 220, 111, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
3264, 6n81D, 0.5069, 4.05, 0.075, 211, 107, CRYSTAL STRUCTURE OF GII.4 2002 NOROVIRUS P DOMAIN IN COMPLEX WITH CROSS-REACTIVE HUMAN ANTIBODY A1227 
3265, 6mkrA, 0.5069, 3.98, 0.120, 195, 108, 5287 TCR BOUND TO IAB PADI4 
3266, 6frbB, 0.5069, 3.68, 0.085, 240, 106, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
3267, 6bfqD, 0.5069, 3.97, 0.084, 213, 107, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
3268, 6au5A, 0.5069, 3.91, 0.094, 212, 106, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-BUTYLARGININE MEDITOPE VARIANT
3269, 6anaL, 0.5069, 3.95, 0.112, 217, 107, LL2 FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
3270, 5wuxL, 0.5069, 4.01, 0.075, 213, 107, TNFALPHA-CERTOLIZUMAB FAB
3271, 5w24H, 0.5069, 4.01, 0.073, 216, 110, CRYSTAL STRUCTURE OF 5C4 FAB
3272, 5vkeA, 0.5069, 3.96, 0.073, 219, 110, OPEN CONFORMATION OF KCSA DEEP-INACTIVATED
3273, 5vebL, 0.5069, 3.78, 0.086, 215, 105, CRYSTAL STRUCTURE OF A FAB BINDING TO EXTRACELLULAR DOMAIN 5 OF CADHERIN-6
3274, 5vebB, 0.5069, 3.76, 0.086, 215, 105, CRYSTAL STRUCTURE OF A FAB BINDING TO EXTRACELLULAR DOMAIN 5 OF CADHERIN-6
3275, 5uddS, 0.5069, 4.04, 0.075, 211, 107, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
3276, 5t1lA, 0.5069, 4.02, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH CQA(PH)2DLSTRRLKC PEPTIDE
3277, 5mp5L, 0.5069, 3.83, 0.132, 218, 106, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
3278, 5mhrN, 0.5069, 4.09, 0.062, 214, 112, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
3279, 5lf5A, 0.5069, 4.15, 0.127, 484, 110, MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) DEGLYCOSYLATED FULL EXTRACELLULAR DOMAIN WITH CO-PURIFIED LIGAND
3280, 5k8aL, 0.5069, 3.72, 0.096, 213, 104, NIST FAB
3281, 5ihbC, 0.5069, 3.93, 0.102, 212, 108, STRUCTURE OF THE IMMUNE RECEPTOR CD33
3282, 5i1aA, 0.5069, 4.01, 0.075, 211, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-11
3283, 5eocL, 0.5069, 4.05, 0.103, 216, 107, CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I
3284, 5ebwB, 0.5069, 3.99, 0.113, 210, 106, KCSA WITH G77ESTER MUTATION
3285, 4yo0A, 0.5069, 4.03, 0.081, 209, 111, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1 WITH BOUND PA PEPTIDE
3286, 4wffG, 0.5069, 4.09, 0.081, 210, 111, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND NONCONDUCTIVE CONFORMATION
3287, 4qexM, 0.5069, 4.05, 0.093, 213, 107, CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217
3288, 4qexL, 0.5069, 4.05, 0.093, 212, 107, CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217
3289, 4ozgH, 0.5069, 3.69, 0.114, 240, 105, D2 PROTEIN COMPLEX
3290, 4gw5C, 0.5069, 4.03, 0.084, 213, 107, CQYN MEDITOPE - CETUXIMAB FAB
3291, 4g8eB, 0.5069, 3.55, 0.067, 241, 104, CRYSTAL STRUCTURE OF CLONE18 TCR
3292, 3w13D, 0.5069, 3.86, 0.096, 114, 104, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1-CR IN COMPLEX WITH HIGH-AFFINITY INSULIN ANALOGUE [D-PRO-B26]-DTI-NH2 ALPHACT PEPTIDE(693-719) AND FAB 83-7
3293, 3us0B, 0.5069, 3.70, 0.097, 193, 103, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING A TWO BASE PAIR AT SPACER BETWEEN HALF SITES
3294, 3tt3L, 0.5069, 4.13, 0.093, 216, 108, CRYSTAL STRUCTURE OF LEUT IN THE INWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
3295, 3qumK, 0.5069, 3.99, 0.091, 219, 110, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY
3296, 3okkA, 0.5069, 3.89, 0.113, 220, 106, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO
3297, 3okeA, 0.5069, 3.91, 0.113, 217, 106, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KO
3298, 3o45B, 0.5069, 3.98, 0.103, 217, 107, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 17-MER PEPTIDE EPITOPE
3299, 3eobA, 0.5069, 3.96, 0.075, 214, 106, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM II
3300, 3c60E, 0.5069, 3.93, 0.131, 199, 107, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR YAE62
3301, 3bszL, 0.5069, 4.16, 0.102, 215, 108, CRYSTAL STRUCTURE OF THE TRANSTHYRETIN-RETINOL BINDING PROTEIN-FAB COMPLEX
3302, 3b07C, 0.5069, 4.19, 0.107, 284, 112, CRYSTAL STRUCTURE OF OCTAMERIC PORE FORM OF GAMMA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
3303, 2r0lL, 0.5069, 3.99, 0.093, 214, 107, SHORT FORM HGFA WITH INHIBITORY FAB75
3304, 2jccL, 0.5069, 3.80, 0.094, 194, 106, AH3 RECOGNITION OF MUTANT HLA-A2 W167A
3305, 2hffA, 0.5069, 4.03, 0.093, 213, 107, CRYSTAL STRUCTURE OF CB2 FAB
3306, 2fjhL, 0.5069, 4.00, 0.075, 214, 107, STRUCTURE OF THE B20-4 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
3307, 2bnqD, 0.5069, 3.78, 0.131, 203, 107, STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
3308, 2ap2B, 0.5069, 3.71, 0.057, 122, 105, SINGLE CHAIN FV OF C219 IN COMPLEX WITH SYNTHETIC EPITOPE PEPTIDE
3309, 1yy9C, 0.5069, 4.03, 0.084, 211, 107, STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF CETUXIMAB/ERBITUX/IMC- C225
3310, 1nmbH, 0.5069, 3.94, 0.083, 122, 108, THE STRUCTURE OF A COMPLEX BETWEEN THE NC10 ANTIBODY AND INFLUENZA VIRUS NEURAMINIDASE AND COMPARISON WITH THE OVERLAPPING BINDING SITE OF THE NC41 ANTIBODY
3311, 1mlcA, 0.5069, 3.98, 0.103, 214, 107, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG- WHITE LYSOZYME COMPLEXED WITH LYSOZYME
3312, 1i9rH, 0.5069, 3.99, 0.064, 219, 110, STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY
3313, 1i9iL, 0.5069, 3.93, 0.113, 219, 106, NATIVE CRYSTAL STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT
3314, 1fskI, 0.5069, 4.03, 0.108, 220, 111, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
3315, 1bqhH, 0.5069, 4.04, 0.054, 125, 111, MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8
3316, 6iuvD, 0.5068, 3.99, 0.093, 215, 107, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 3C11 
3317, 6furB, 0.5068, 3.73, 0.084, 240, 107, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
3318, 6ddvA, 0.5068, 3.94, 0.104, 217, 106, CRYSTAL STRUCTURE ANALYSIS OF THE EPITOPE OF AN ANTI-MICA ANTIBODY 
3319, 6dcvL, 0.5068, 3.90, 0.094, 220, 106, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 
3320, 6cdpA, 0.5068, 4.02, 0.099, 221, 111, VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP20.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
3321, 6apdL, 0.5068, 3.72, 0.095, 213, 105, CRYSTAL STRUCTURE OF RSV F BOUND BY AM22 AND THE INFANT ANTIBODY ADI- 19425
3322, 5uixL, 0.5068, 3.95, 0.085, 213, 106, CRYSTAL STRUCTURE OF THE DH576 CD4BS FAB (UNLIGANDED) FROM THE RV305 HIV VACCINE TRIAL
3323, 5udcL, 0.5068, 3.99, 0.075, 211, 107, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
3324, 5tz2H, 0.5068, 4.05, 0.081, 213, 111, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B222
3325, 5tlkE, 0.5068, 4.05, 0.093, 215, 107, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND H2191
3326, 5mv3S, 0.5068, 4.03, 0.112, 218, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3327, 5mubB, 0.5068, 3.98, 0.113, 217, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
3328, 5kqvP, 0.5068, 3.98, 0.073, 220, 109, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14 (REVISED STRUCTURE)
3329, 5kanL, 0.5068, 3.95, 0.066, 214, 106, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.G.07 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
3330, 5bs0D, 0.5068, 3.90, 0.148, 197, 108, MAGE-A3 REACTIVE TCR IN COMPLEX WITH TITIN EPITOPE IN HLA-A1
3331, 5bo1M, 0.5068, 3.99, 0.093, 214, 107, CRYSTAL STRUCTURE OF A HUMAN JAG1 FRAGMENT IN COMPLEX WITH AN ANTI- JAG1 FAB
3332, 4ww2B, 0.5068, 3.83, 0.112, 243, 107, CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV21-TRAJ8 BETA CHAIN- TRBV7-8 ANTIGEN-PRESENTING GLYCOPROTEIN CD1D AND BETA-2- MICROGLOBULIN
3333, 4plkL, 0.5068, 4.07, 0.084, 208, 107, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
3334, 4pj5E, 0.5068, 3.73, 0.065, 243, 107, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT TRBV6-1 TCR
3335, 4nwtH, 0.5068, 3.94, 0.045, 232, 110, CRYSTAL STRUCTURE OF THE ANTI-HUMAN NGF FAB APE1531
3336, 4nryB, 0.5068, 3.89, 0.085, 205, 106, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66
3337, 4jo3M, 0.5068, 4.03, 0.065, 214, 107, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB IN COMPLEX WITH V3 C-TERMINUS OF HIV-1 CONSENSUS B GP120
3338, 4jhaL, 0.5068, 3.99, 0.075, 211, 107, CRYSTAL STRUCTURE OF RSV-NEUTRALIZING HUMAN ANTIBODY D25
3339, 4gw5A, 0.5068, 4.04, 0.084, 212, 107, CQYN MEDITOPE - CETUXIMAB FAB
3340, 3wiiI, 0.5068, 4.07, 0.081, 220, 111, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1.
3341, 3vxtB, 0.5068, 3.69, 0.085, 241, 106, T36-5 TCR SPECIFIC FOR HLA-A24-NEF134-10
3342, 3qq9L, 0.5068, 4.05, 0.093, 217, 107, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-HUMAN RSV (RESPIRATORY SYNCYTIAL VIRUS) F PROTEIN MAB 101F
3343, 3mffB, 0.5068, 3.63, 0.095, 242, 105, 1F1E8HU TCR
3344, 3lizL, 0.5068, 3.94, 0.104, 211, 106, CRYSTAL STRUCTURE OF BLA G 2 COMPLEXED WITH FAB 4C3
3345, 3ikcC, 0.5068, 3.97, 0.112, 217, 107, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO
3346, 3gnmH, 0.5068, 4.06, 0.081, 218, 111, THE CRYSTAL STRUCTURE OF THE JAA-F11 MONOCLONAL ANTIBODY FAB FRAGMENT
3347, 3fctD, 0.5068, 4.05, 0.072, 216, 111, MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN
3348, 2vdkH, 0.5068, 4.00, 0.064, 219, 110, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
3349, 2q8bH, 0.5068, 3.98, 0.093, 199, 108, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
3350, 2pcpA, 0.5068, 4.01, 0.131, 216, 107, ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
3351, 2hfeB, 0.5068, 3.98, 0.113, 211, 106, RB+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
3352, 2eytA, 0.5068, 3.89, 0.102, 202, 108, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
3353, 2eysB, 0.5068, 3.80, 0.084, 243, 107, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
3354, 2esvE, 0.5068, 3.71, 0.085, 240, 106, STRUCTURE OF THE HLA-E-VMAPRTLIL/KK50.4 TCR COMPLEX
3355, 2dweB, 0.5068, 4.06, 0.103, 212, 107, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN RB+
3356, 1za6H, 0.5068, 3.88, 0.074, 324, 108, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
3357, 1uywL, 0.5068, 3.96, 0.112, 212, 107, CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
3358, 1jptL, 0.5068, 4.05, 0.075, 213, 107, CRYSTAL STRUCTURE OF FAB D3H44
3359, 6mwxO, 0.5067, 4.12, 0.080, 218, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
3360, 6mwxK, 0.5067, 4.12, 0.080, 218, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
3361, 6mwxG, 0.5067, 4.12, 0.080, 218, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
3362, 6mwxC, 0.5067, 4.12, 0.080, 218, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
3363, 6mwvO, 0.5067, 4.12, 0.080, 218, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
3364, 6mwvK, 0.5067, 4.12, 0.080, 218, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
3365, 6mwvG, 0.5067, 4.12, 0.080, 218, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
3366, 6mwvC, 0.5067, 4.12, 0.080, 218, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
3367, 6mwcO, 0.5067, 4.12, 0.080, 218, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
3368, 6mwcK, 0.5067, 4.12, 0.080, 218, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
3369, 6mwcG, 0.5067, 4.12, 0.080, 218, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
3370, 6mwcC, 0.5067, 4.12, 0.080, 218, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
3371, 6mw9O, 0.5067, 4.12, 0.080, 218, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
3372, 6mw9K, 0.5067, 4.12, 0.080, 218, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
3373, 6mw9G, 0.5067, 4.12, 0.080, 218, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
3374, 6mw9C, 0.5067, 4.12, 0.080, 218, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
3375, 6muiO, 0.5067, 4.12, 0.080, 218, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
3376, 6muiK, 0.5067, 4.12, 0.080, 218, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
3377, 6muiG, 0.5067, 4.12, 0.080, 218, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
3378, 6muiC, 0.5067, 4.12, 0.080, 218, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
3379, 6mqmE, 0.5067, 3.90, 0.094, 217, 106, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY DF1W-A.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
3380, 6jmqC, 0.5067, 4.00, 0.054, 214, 111, LAT1-CD98HC COMPLEX BOUND TO MEM-108 FAB 
3381, 5viyJ, 0.5067, 4.05, 0.089, 223, 112, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
3382, 5viyH, 0.5067, 4.05, 0.089, 223, 112, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
3383, 5mubP, 0.5067, 3.97, 0.113, 217, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
3384, 5mu2B, 0.5067, 3.99, 0.112, 218, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3385, 5k9kL, 0.5067, 4.07, 0.084, 215, 107, CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.
3386, 5jhdI, 0.5067, 3.89, 0.093, 203, 107, CRYSTAL STRUCTURE OF LS10-TCR/M1-HLA-A*02 COMPLEX
3387, 5g64M, 0.5067, 3.89, 0.075, 214, 106, THE COMPLEX BETWEEN HUMAN IGE-FC AND TWO ANTI-IGE FAB FRAGMENTS
3388, 5dqjB, 0.5067, 4.03, 0.112, 217, 107, STRUCTURE OF UNLIGANDED S55-5 FAB
3389, 5dq9L, 0.5067, 4.01, 0.103, 212, 107, STRUCTURE OF S55-3 FAB IN COMPLEX WITH LIPID A
3390, 5d06B, 0.5067, 3.22, 0.051, 1506, 99, CRYSTAL STRUCTURE OF THE CANDIDA GLABRATA GLYCOGEN DEBRANCHING ENZYME
3391, 5cgyC, 0.5067, 3.99, 0.055, 222, 109, FAB FRAGMENT OF CHIKUNGUNYA VIRUS NEUTRALIZING HUMAN MONOCLONAL ANTIBODY 4J21
3392, 5bk5E, 0.5067, 3.94, 0.104, 217, 106, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 663 GERMLINE ANTIBODY
3393, 5anyL, 0.5067, 4.12, 0.080, 218, 112, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
3394, 5anyK, 0.5067, 4.12, 0.080, 218, 112, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
3395, 5anyJ, 0.5067, 4.12, 0.080, 218, 112, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
3396, 5anyI, 0.5067, 4.12, 0.080, 218, 112, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
3397, 5a16F, 0.5067, 3.93, 0.085, 218, 106, CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1
3398, 4xzuE, 0.5067, 3.96, 0.064, 208, 110, CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY
3399, 4x6dF, 0.5067, 3.72, 0.066, 241, 106, CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR
3400, 4uujB, 0.5067, 4.04, 0.103, 212, 107, POTASSIUM CHANNEL KCSA-FAB WITH TETRAHEXYLAMMONIUM
3401, 4tw1A, 0.5067, 4.26, 0.080, 281, 113, CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH
3402, 4oziF, 0.5067, 4.06, 0.081, 243, 111, S2 PROTEIN COMPLEX
3403, 4nwvA, 0.5067, 4.08, 0.037, 355, 107, CRYSTAL STRUCTURE OF ORSAY VIRUS-LIKE PARTICLE
3404, 4nj9L, 0.5067, 4.02, 0.103, 212, 107, CRYSTAL STRUCTURE OF FAB 8B10 IN COMPLEX WITH MPTS
3405, 4kxzH, 0.5067, 3.93, 0.055, 223, 109, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
3406, 4kaqH, 0.5067, 3.99, 0.100, 220, 110, STRUCTURE OF RITUXIMAB FAB
3407, 4j1uE, 0.5067, 3.84, 0.104, 214, 106, CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
3408, 4dkfL, 0.5067, 3.95, 0.075, 212, 106, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2
3409, 4buhB, 0.5067, 3.78, 0.066, 231, 106, HUMAN IGE AGAINST THE MAJOR ALLERGEN BET V 1 - CRYSTAL STRUCTURE OF CLONE M0418 SCFV
3410, 3qynD, 0.5067, 3.63, 0.098, 190, 102, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING 2 BASE PAIR SPACER BETWEEN HALF SITES
3411, 3qa3B, 0.5067, 4.01, 0.064, 224, 110, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3412, 3mltH, 0.5067, 4.09, 0.062, 215, 112, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
3413, 3hujG, 0.5067, 3.90, 0.111, 202, 108, CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
3414, 2vdoH, 0.5067, 4.00, 0.064, 219, 110, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE HHLGGAKQAGDV
3415, 2vdmH, 0.5067, 4.01, 0.064, 219, 110, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN
3416, 2rcsH, 0.5067, 4.03, 0.082, 217, 110, IMMUNOGLOBULIN 48G7 GERMLINE FAB-AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY
3417, 1yylH, 0.5067, 3.83, 0.074, 229, 108, CRYSTAL STRUCTURE OF CD4M33 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
3418, 1xctC, 0.5067, 4.03, 0.103, 220, 107, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55A L57H Y64W) IN SPACE GROUP P21212
3419, 1nqbC, 0.5067, 3.81, 0.065, 232, 107, TRIVALENT ANTIBODY FRAGMENT
3420, 1jnlL, 0.5067, 4.00, 0.103, 211, 107, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
3421, 1i9rX, 0.5067, 4.00, 0.064, 219, 110, STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY
3422, 1i9eA, 0.5067, 3.90, 0.093, 115, 107, TCR DOMAIN
3423, 1figL, 0.5067, 3.98, 0.112, 215, 107, ROUTES TO CATALYSIS: STRUCTURE OF A CATALYTIC ANTIBODY AND COMPARISON WITH ITS NATURAL COUNTERPART
3424, 6fumB, 0.5066, 3.68, 0.085, 240, 106, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
3425, 6faxL, 0.5066, 3.85, 0.075, 211, 106, COMPLEX OF HUMAN CD40 ECTODOMAIN WITH LOB 7.4 FAB
3426, 6cdoB, 0.5066, 4.05, 0.112, 219, 107, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP16.02 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
3427, 6bpaF, 0.5066, 3.94, 0.103, 211, 107, PLASMODIUM VIVAX RETICULOCYTE BINDING PROTEIN 2B (PVRBP2B) BOUND TO MONOCLONAL ANTIBODY 3E9 
3428, 5ysgA, 0.5066, 2.60, 0.116, 120, 86, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN MET16GLY VARIANT; REDUCED FORM. 
3429, 5w1wS, 0.5066, 3.83, 0.124, 202, 105, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
3430, 5w06H, 0.5066, 4.09, 0.072, 216, 111, HUMAN TISSUE FACTOR IN COMPLEX WITH ANTIBODY M1587
3431, 5vicL, 0.5066, 3.94, 0.085, 211, 106, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z004 BOUND TO DENV-1 ENVELOPE PROTEIN DIII
3432, 5udcG, 0.5066, 4.01, 0.075, 213, 107, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
3433, 5nphH, 0.5066, 4.06, 0.072, 214, 111, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN J4 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE FAB FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
3434, 5nmeI, 0.5066, 3.83, 0.121, 200, 107, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTVATL
3435, 5ks9E, 0.5066, 3.82, 0.067, 193, 105, BEL502-DQ8-GLIA-ALPHA1 COMPLEX
3436, 5fuzL, 0.5066, 3.88, 0.075, 216, 106, EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION OF A HUMANISED ANTI-HUMAN SERUM ALBUMIN (HSA) FV DOMAIN: AN INVESTIGATION INTO THE CORRELATION BETWEEN AFFINITY AND SERUM HALF-LIFE
3437, 5drzL, 0.5066, 3.92, 0.095, 216, 105, CRYSTAL STRUCTURE OF ANTI-HIV-1 ANTIBODY F240 FAB IN COMPLEX WITH GP41 PEPTIDE
3438, 5dq9D, 0.5066, 4.01, 0.103, 211, 107, STRUCTURE OF S55-3 FAB IN COMPLEX WITH LIPID A
3439, 5dlmL, 0.5066, 3.94, 0.113, 217, 106, COMPLEX OF INFLUENZA M2E AND ANTIBODY
3440, 4zpvL, 0.5066, 4.01, 0.084, 212, 107, STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 2)
3441, 4zdhB, 0.5066, 3.74, 0.066, 241, 106, CRYSTAL STRUCTURE OF JKA6 TCR
3442, 4z5rR, 0.5066, 4.04, 0.075, 217, 107, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
3443, 4rirA, 0.5066, 4.12, 0.080, 219, 112, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
3444, 4n24A, 0.5066, 3.98, 0.067, 645, 105, CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (100 UM CA2+)
3445, 4ffzY, 0.5066, 4.07, 0.103, 216, 107, CRYSTAL STRUCTURE OF DENV1-E111 FAB FRAGMENT BOUND TO DENV-1 DIII (WESTERN PACIFIC-74 STRAIN).
3446, 4cadB, 0.5066, 3.87, 0.073, 221, 109, MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1
3447, 3zdxE, 0.5066, 4.00, 0.064, 216, 110, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
3448, 3qpqE, 0.5066, 4.08, 0.093, 215, 107, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
3449, 3ojdA, 0.5066, 4.00, 0.112, 214, 107, ANTI-INDOLICIDIN MONOCLONAL ANTIBODY V2D2 (FAB FRAGMENT)
3450, 3lmjH, 0.5066, 4.08, 0.054, 225, 111, STRUCTURE OF HUMAN ANTI HIV 21C FAB
3451, 3cxdL, 0.5066, 3.94, 0.104, 213, 106, CRYSTAL STRUCTURE OF ANTI-OSTEOPONTIN ANTIBODY 23C3 IN COMPLEX WITH ITS EPITOPE PEPTIDE
3452, 2vdqH, 0.5066, 4.00, 0.064, 219, 110, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE HHLGGAKQRGDV
3453, 2vdlH, 0.5066, 4.00, 0.064, 219, 110, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
3454, 2jxmA, 0.5066, 2.58, 0.112, 97, 89, ENSEMBLE OF TWENTY STRUCTURES OF THE PROCHLOROTHRIX HOLLANDICA PLASTOCYANIN- CYTOCHROME F COMPLEX
3455, 2axhA, 0.5066, 3.74, 0.085, 240, 106, CRYSTAL STRUCTURES OF T CELL RECEPTOR BETA CHAINS RELATED TO RHEUMATOID ARTHRITIS
3456, 2arjL, 0.5066, 3.98, 0.093, 211, 107, CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB
3457, 1ob1B, 0.5066, 4.04, 0.081, 219, 111, CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19
3458, 1mf2L, 0.5066, 3.81, 0.095, 215, 105, ANTI HIV1 PROTEASE FAB COMPLEX
3459, 1ejoL, 0.5066, 3.98, 0.093, 216, 107, FAB FRAGMENT OF NEUTRALISING MONOCLONAL ANTIBODY 4C4 COMPLEXED WITH G-H LOOP FROM FMDV.
3460, 1b3iA, 0.5066, 2.58, 0.112, 97, 89, NMR SOLUTION STRUCTURE OF PLASTOCYANIN FROM THE PHOTOSYNTHETIC PROKARYOTE PROCHLOROTHRIX HOLLANDICA (MINIMIZED AVERAGE STRUCTURE)
3461, 6fr3B, 0.5065, 3.72, 0.086, 243, 105, 003 TCR STUDY OF CDR LOOP FLEXIBILITY 
3462, 6eleB, 0.5065, 3.95, 0.085, 213, 106, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
3463, 6cmiD, 0.5065, 3.96, 0.055, 228, 110, CRYSTAL STRUCTURE OF THE HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN BOUND TO A POTENT CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODY M102.3 
3464, 6bzwD, 0.5065, 4.08, 0.103, 216, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY AP33 
3465, 6azlC, 0.5065, 4.03, 0.084, 212, 107, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N- CARBOXYETHYLARGININE MEDITOPE VARIANT
3466, 6a3wG, 0.5065, 3.75, 0.048, 116, 105, COMPLEX STRUCTURE OF 4-1BB AND UTOMILUMAB 
3467, 5vjoB, 0.5065, 3.93, 0.113, 211, 106, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT I29F AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
3468, 5v7rL, 0.5065, 3.94, 0.093, 215, 107, CYRSTAL STRUCTURE OF ANTI-TAU ANTIBODY CBTAU-7.1 FAB
3469, 5u16F, 0.5065, 3.69, 0.066, 240, 106, STRUCTURE OF HUMAN MR1-2-OH-1-NA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
3470, 5tq0H, 0.5065, 4.05, 0.072, 212, 111, CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2A IN THE PRESENCE OF EDTA
3471, 5th2A, 0.5065, 4.04, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT
3472, 5mvjB, 0.5065, 3.85, 0.132, 218, 106, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
3473, 5mv4J, 0.5065, 4.05, 0.112, 218, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
3474, 5mhsG, 0.5065, 3.99, 0.084, 205, 107, T1L REOVIRUS SIGMA1 COMPLEXED WITH 5C6 FAB FRAGMENTS
3475, 5jziI, 0.5065, 4.02, 0.118, 207, 110, CRYSTAL STRUCTURE OF 1406 TCR BOUND TO HLA-A2 WITH HCV 1406-1415 ANTIGEN PEPTIDE
3476, 5itfA, 0.5065, 3.94, 0.094, 213, 106, CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT
3477, 5iczA, 0.5065, 4.03, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH GQFDLSTRRLKG PEPTIDE
3478, 5i76A, 0.5065, 3.96, 0.094, 213, 106, CRYSTAL STRUCTURE OF FM318 A RECOMBINANT FAB ADOPTED FROM CETUXIMAB
3479, 5gjsL, 0.5065, 4.01, 0.075, 207, 107, CRYSTAL STRUCTURE OF H1 HEMAGGLUTININ FROM A/CALIFORNIA/04/2009 IN COMPLEX WITH A NEUTRALIZING ANTIBODY 3E1
3480, 4zypE, 0.5065, 3.91, 0.094, 213, 106, CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN
3481, 4z7qE, 0.5065, 4.00, 0.064, 214, 110, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
3482, 4z5rT, 0.5065, 4.04, 0.075, 217, 107, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
3483, 4rqqL, 0.5065, 3.91, 0.095, 215, 105, CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3484, 4nryH, 0.5065, 3.99, 0.091, 214, 110, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66
3485, 4iiqB, 0.5065, 3.79, 0.084, 243, 107, CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH BOVINE MR1
3486, 4i2xD, 0.5065, 4.03, 0.064, 219, 110, CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
3487, 4i2xB, 0.5065, 4.03, 0.064, 229, 110, CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
3488, 4gayB, 0.5065, 4.05, 0.103, 216, 107, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33
3489, 4fqrp, 0.5065, 4.05, 0.084, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3490, 4fnlL, 0.5065, 4.03, 0.075, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05
3491, 3vi3F, 0.5065, 3.92, 0.055, 218, 109, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
3492, 3t0eD, 0.5065, 3.89, 0.092, 245, 109, CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX OF T CELL RECEPTOR PEPTIDE-MHC AND CD4
3493, 3rgvA, 0.5065, 3.86, 0.112, 200, 107, A SINGLE TCR BOUND TO MHCI AND MHC II REVEALS SWITCHABLE TCR CONFORMERS
3494, 3qa3H, 0.5065, 4.01, 0.064, 224, 110, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3495, 3okoA, 0.5065, 3.91, 0.113, 217, 106, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO
3496, 3mxvH, 0.5065, 4.02, 0.073, 220, 110, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-SHH 5E1 CHIMERA
3497, 3bszM, 0.5065, 4.16, 0.102, 215, 108, CRYSTAL STRUCTURE OF THE TRANSTHYRETIN-RETINOL BINDING PROTEIN-FAB COMPLEX
3498, 2zzqA, 0.5065, 4.10, 0.056, 483, 108, CRYSTAL STRUCTURE ANALYSIS OF THE HEV CAPSID PROTEIN PORF2
3499, 2w0fB, 0.5065, 3.98, 0.113, 212, 106, POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRAOCTYLAMMONIUM
3500, 2vdrH, 0.5065, 4.00, 0.064, 219, 110, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE LGGAKQRGDV
3501, 2vdpH, 0.5065, 4.01, 0.064, 219, 110, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDELGGAKQAGDV
3502, 2orbL, 0.5065, 3.96, 0.113, 212, 106, THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT
3503, 2i9lE, 0.5065, 3.90, 0.113, 219, 106, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
3504, 2cdeC, 0.5065, 3.77, 0.124, 192, 105, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
3505, 2aepL, 0.5065, 4.08, 0.093, 129, 107, AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX.
3506, 1v7nN, 0.5065, 3.72, 0.125, 212, 104, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
3507, 1mlbB, 0.5065, 3.97, 0.064, 218, 109, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME
3508, 1m7dA, 0.5065, 3.84, 0.114, 215, 105, CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A TRISACCHARIDE
3509, 1cgsH, 0.5065, 3.88, 0.056, 214, 108, LOCAL AND TRANSMITTED CONFORMATIONAL CHANGES ON COMPLEXATION OF AN ANTI-SWEETENER FAB
3510, 6my4B, 0.5064, 3.95, 0.112, 217, 107, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M;LC-S30BR] 
3511, 6fr5A, 0.5064, 3.87, 0.130, 202, 108, HA1.7 TCR STUDY OF CDR LOOP FLEXIBILITY 
3512, 6dw2A, 0.5064, 4.02, 0.075, 213, 107, STRUCTURE OF THE 6078 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
3513, 6d0uD, 0.5064, 4.07, 0.075, 213, 107, CRYSTAL STRUCTURE OF C05 V110P/A117E MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ; HA1 SUBUNIT 
3514, 6cdmA, 0.5064, 4.00, 0.091, 218, 110, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
3515, 5ysgD, 0.5064, 2.60, 0.116, 120, 86, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN MET16GLY VARIANT; REDUCED FORM. 
3516, 5x2qH, 0.5064, 4.02, 0.064, 219, 110, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH GLYCINE
3517, 5vzxL, 0.5064, 3.83, 0.094, 218, 106, CRYSTAL STRUCTURE OF CRENEZUMAB FAB
3518, 5tudE, 0.5064, 3.85, 0.105, 211, 105, STRUCTURAL INSIGHTS INTO THE EXTRACELLULAR RECOGNITION OF THE HUMAN SEROTONIN 2B RECEPTOR BY AN ANTIBODY
3519, 5trpL, 0.5064, 3.94, 0.113, 217, 106, CRYSTAL STRUCTURE OF THE UNLIGANDED DH270 COOPERATING LINEAGE MEMBER DH272
3520, 5tljC, 0.5064, 4.05, 0.093, 215, 107, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND M2191
3521, 5mvjL, 0.5064, 3.83, 0.132, 219, 106, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
3522, 5mp5F, 0.5064, 3.84, 0.132, 216, 106, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
3523, 5kmvL, 0.5064, 3.83, 0.094, 218, 106, CRYSTAL STRUCTURE OF CRENEZUMAB FAB
3524, 5kbdA, 0.5064, 3.54, 0.089, 201, 101, STRUCTURAL STUDIES OF TRANSCRIPTION FACTOR P73 DNA BINDING DOMAIN BOUND TO PA26 20-MER RESPONSE ELEMENT
3525, 5ik3D, 0.5064, 3.98, 0.103, 218, 107, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E03 FAB FRAGMENT
3526, 5dqdL, 0.5064, 3.93, 0.113, 217, 106, STRUCTURE OF S55-5 FAB IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE
3527, 4z5rA, 0.5064, 4.04, 0.075, 217, 107, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
3528, 4pljL, 0.5064, 4.07, 0.112, 212, 107, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE IV) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
3529, 4onfL, 0.5064, 3.90, 0.113, 218, 106, FAB FRAGMENT OF 3D6 IN COMPLEX WITH AMYLOID BETA 1-7
3530, 4nwwA, 0.5064, 4.13, 0.037, 341, 107, CRYSTAL STRUCTURE OF AN N-TERMINALLY TRUNCATED CAPSID PROTEIN MUTANT OF ORSAY VIRUS
3531, 4hs8L, 0.5064, 3.88, 0.075, 218, 106, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY HU5B3.V3
3532, 4fqrt, 0.5064, 4.05, 0.075, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3533, 4fqrn, 0.5064, 4.05, 0.084, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3534, 3vgaC, 0.5064, 4.08, 0.072, 220, 111, CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 3.1 A RESOLUTION
3535, 3ujtH, 0.5064, 3.97, 0.091, 207, 110, STRUCTURE OF THE FAB FRAGMENT OF AB-52 AN ANTIBODY THAT BINDS THE O- ANTIGEN OF FRANCISELLA TULARENSIS
3536, 3sdxG, 0.5064, 3.80, 0.103, 196, 107, CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
3537, 3q3gK, 0.5064, 4.02, 0.064, 224, 110, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3538, 3opzH, 0.5064, 3.88, 0.055, 220, 109, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
3539, 3gnmL, 0.5064, 4.01, 0.121, 217, 107, THE CRYSTAL STRUCTURE OF THE JAA-F11 MONOCLONAL ANTIBODY FAB FRAGMENT
3540, 3d39E, 0.5064, 3.63, 0.076, 245, 105, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(4-FLUOROPHENYLALANINE)) PEPTIDE
3541, 2xqyJ, 0.5064, 4.12, 0.098, 216, 112, CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
3542, 2uylM, 0.5064, 3.96, 0.113, 216, 106, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
3543, 2r6pD, 0.5064, 4.10, 0.062, 216, 112, FIT OF E PROTEIN AND FAB 1A1D-2 INTO 24 ANGSTROM RESOLUTION CRYOEM MAP OF FAB COMPLEXED WITH DENGUE 2 VIRUS.
3544, 2r29H, 0.5064, 4.10, 0.062, 216, 112, NEUTRALIZATION OF DENGUE VIRUS BY A SEROTYPE CROSS-REACTIVE ANTIBODY ELUCIDATED BY CRYOELECTRON MICROSCOPY AND X-RAY CRYSTALLOGRAPHY
3545, 2jkwA, 0.5064, 2.70, 0.140, 124, 86, PSEUDOAZURIN M16F
3546, 2i9lC, 0.5064, 3.90, 0.113, 219, 106, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
3547, 2cdeE, 0.5064, 3.80, 0.124, 192, 105, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
3548, 1za6B, 0.5064, 3.86, 0.074, 324, 108, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
3549, 1yntD, 0.5064, 4.07, 0.089, 218, 112, STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY
3550, 1xf4A, 0.5064, 3.94, 0.104, 213, 106, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING
3551, 1tupC, 0.5064, 3.80, 0.068, 195, 103, TUMOR SUPPRESSOR P53 COMPLEXED WITH DNA
3552, 1tsrC, 0.5064, 3.80, 0.068, 195, 103, P53 CORE DOMAIN IN COMPLEX WITH DNA
3553, 1mlcC, 0.5064, 3.97, 0.103, 214, 107, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG- WHITE LYSOZYME COMPLEXED WITH LYSOZYME
3554, 1igyC, 0.5064, 4.01, 0.112, 213, 107, STRUCTURE OF IMMUNOGLOBULIN
3555, 6i9iB, 0.5063, 4.05, 0.074, 216, 108, RIFT VALLEY FEVER VIRUS GN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FRAGMENT 
3556, 6fraB, 0.5063, 3.67, 0.085, 240, 106, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
3557, 6eh6B, 0.5063, 3.68, 0.085, 240, 106, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
3558, 6e15C, 0.5063, 2.99, 0.084, 199, 95, HANDOVER MECHANISM OF THE GROWING PILUS BY THE BACTERIAL OUTER MEMBRANE USHER FIMD 
3559, 6dwaL, 0.5063, 4.00, 0.103, 219, 107, STRUCTURE OF THE 4497 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
3560, 6c68C, 0.5063, 3.90, 0.113, 205, 106, MHC-INDEPENDENT T CELL RECEPTOR A11 
3561, 5ywyL, 0.5063, 3.99, 0.103, 214, 107, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY. 
3562, 5whzL, 0.5063, 3.96, 0.104, 336, 106, PGDM1400-10E8V4 CODV FAB
3563, 5w42L, 0.5063, 3.79, 0.086, 212, 105, CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/MINNESOTA/11/2010 (H3N2) 
3564, 5w0kH, 0.5063, 4.22, 0.080, 213, 113, CRYSTAL STRUCTURE OF EBV GHGL/CL40/GP42 N-DOMAIN
3565, 5t78C, 0.5063, 3.84, 0.114, 216, 105, CRYSTAL STRUCTURE OF THERAPEUTIC MAB AR20.5 IN COMPLEX WITH MUC1 PEPTIDE
3566, 5muqH, 0.5063, 4.00, 0.064, 219, 110, CRYSTAL STRUCTURE OF DC8E8 FAB AT PH 7.0 CONTAINING A ZN ATOM 
3567, 5mhrG, 0.5063, 3.84, 0.123, 211, 106, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
3568, 5ivzA, 0.5063, 4.01, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH ARG8CIR MEDITOPE VARIANT
3569, 5i8oL, 0.5063, 4.09, 0.083, 217, 108, HMM5 FAB IN COMPLEX WITH DISACCHARIDE
3570, 5gz0A, 0.5063, 3.93, 0.094, 213, 106, CRYSTAL STRUCTURE OF FM329 A RECOMBINANT FAB ADOPTED FROM CETUXIMAB
3571, 5f88C, 0.5063, 4.04, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT
3572, 5bk3D, 0.5063, 4.01, 0.093, 217, 107, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
3573, 4z5rJ, 0.5063, 4.04, 0.075, 217, 107, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
3574, 4yxhH, 0.5063, 4.09, 0.080, 218, 112, CRYSTAL STRUCTURE OF DEER PRION PROTEIN COMPLEXED WITH POM1 FAB
3575, 4wfgF, 0.5063, 3.81, 0.105, 211, 105, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND CONDUCTIVE CONFORMATION
3576, 4wffE, 0.5063, 4.02, 0.082, 211, 110, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND NONCONDUCTIVE CONFORMATION
3577, 4rgmH, 0.5063, 4.03, 0.081, 216, 111, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 20B1
3578, 4pj9D, 0.5063, 3.70, 0.085, 230, 106, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRAJ20 TCR
3579, 4otxM, 0.5063, 4.01, 0.103, 213, 107, STRUCTURE OF THE ANTI-FRANCISELLA TULARENSIS O-ANTIGEN ANTIBODY N203 FAB FRAGMENT
3580, 4nrzH, 0.5063, 3.95, 0.082, 226, 110, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66.6
3581, 4lriB, 0.5063, 3.85, 0.094, 217, 106, ANTI CMV FAB FRAGMENT
3582, 4i9wG, 0.5063, 4.10, 0.081, 210, 111, HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE
3583, 4fqrh, 0.5063, 4.04, 0.084, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3584, 4fqrf, 0.5063, 4.05, 0.084, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3585, 4ffvH, 0.5063, 3.99, 0.082, 209, 110, CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4 DPP-IV CD26) IN COMPLEX WITH 11A19 FAB
3586, 3tyfA, 0.5063, 3.80, 0.103, 199, 107, CRYSTAL STRUCTURE OF A CD1D-LYSOPHOSPHATIDYLCHOLINE REACTIVE INKT TCR
3587, 3sdxE, 0.5063, 3.80, 0.103, 196, 107, CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
3588, 3o41L, 0.5063, 4.04, 0.103, 218, 107, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 15-MER PEPTIDE EPITOPE
3589, 3mlwH, 0.5063, 4.06, 0.055, 228, 110, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE
3590, 3dx9B, 0.5063, 3.98, 0.102, 244, 108, CRYSTAL STRUCTURE OF THE DM1 TCR AT 2.75A
3591, 3bt2L, 0.5063, 3.74, 0.114, 211, 105, STRUCTURE OF UROKINASE RECEPTOR UROKINASE AND VITRONECTIN COMPLEX
3592, 3b2vL, 0.5063, 3.95, 0.085, 213, 106, CRYSTAL STRUCTURE OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
3593, 2r6pF, 0.5063, 4.10, 0.062, 216, 112, FIT OF E PROTEIN AND FAB 1A1D-2 INTO 24 ANGSTROM RESOLUTION CRYOEM MAP OF FAB COMPLEXED WITH DENGUE 2 VIRUS.
3594, 2o5yL, 0.5063, 4.13, 0.111, 218, 108, CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB PROGESTERONE COMPLEX
3595, 2i9lG, 0.5063, 3.90, 0.113, 219, 106, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
3596, 2i9lA, 0.5063, 3.90, 0.113, 219, 106, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
3597, 2h8pB, 0.5063, 3.97, 0.113, 212, 106, STRUCTURE OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
3598, 1yntB, 0.5063, 4.07, 0.089, 218, 112, STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY
3599, 1qunE, 0.5063, 2.95, 0.074, 200, 95, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
3600, 1qunC, 0.5063, 2.95, 0.074, 200, 95, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
3601, 1pkqE, 0.5063, 4.05, 0.110, 121, 109, MYELIN OLIGODENDROCYTE GLYCOPROTEIN-(8-18C5) FAB-COMPLEX
3602, 1mjjL, 0.5063, 4.09, 0.084, 216, 107, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG
3603, 1igtC, 0.5063, 3.98, 0.084, 214, 107, STRUCTURE OF IMMUNOGLOBULIN
3604, 1e6jL, 0.5063, 3.75, 0.105, 210, 105, CRYSTAL STRUCTURE OF HIV-1 CAPSID PROTEIN (P24) IN COMPLEX WITH FAB13B5
3605, 1dbbH, 0.5063, 3.98, 0.054, 219, 112, THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB  AND PROGESTERONE-FAB  COMPLEX
3606, 6okqC, 0.5062, 3.83, 0.086, 210, 105, CRYSTAL STRUCTURE OF THE SF12 FAB 
3607, 6d0uL, 0.5062, 4.06, 0.084, 213, 107, CRYSTAL STRUCTURE OF C05 V110P/A117E MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ; HA1 SUBUNIT 
3608, 6bfqB, 0.5062, 3.96, 0.084, 212, 107, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
3609, 6a3wJ, 0.5062, 3.73, 0.048, 116, 105, COMPLEX STRUCTURE OF 4-1BB AND UTOMILUMAB 
3610, 5ysgB, 0.5062, 2.60, 0.116, 120, 86, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN MET16GLY VARIANT; REDUCED FORM. 
3611, 5y9cL, 0.5062, 3.98, 0.093, 203, 107, CRYSTAL STRUCTURE OF HPV58 PENTAMER IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY A12A3
3612, 5wawL, 0.5062, 3.92, 0.085, 218, 106, FCABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY
3613, 5vjqH, 0.5062, 3.99, 0.112, 212, 107, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
3614, 5tljG, 0.5062, 3.81, 0.095, 215, 105, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND M2191
3615, 5lspT, 0.5062, 4.05, 0.084, 212, 107, 107_A07 FAB IN COMPLEX WITH FRAGMENT OF THE MET RECEPTOR
3616, 5iv2A, 0.5062, 3.92, 0.094, 213, 106, CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT
3617, 5i1gL, 0.5062, 4.02, 0.075, 211, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV3-11
3618, 5i1aL, 0.5062, 4.00, 0.075, 212, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-11
3619, 5hcgH, 0.5062, 3.97, 0.074, 332, 108, CRYSTAL STRUCTURE OF FREE-CODV.
3620, 5fb8B, 0.5062, 4.00, 0.073, 223, 110, STRUCTURE OF INTERLEUKIN-16 BOUND TO THE 14.1 ANTIBODY
3621, 5e8dH, 0.5062, 4.08, 0.064, 216, 110, CRYSTAL STRUCTURE OF HUMAN EPIREGULIN IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY 9E5
3622, 5dfvF, 0.5062, 4.08, 0.103, 217, 107, CRYSTAL STRUCTURE OF HUMAN CD81 LARGE EXTRACELLULAR LOOP IN COMPLEX WITH MURINE FAB FRAGMENT K04
3623, 5a16B, 0.5062, 3.93, 0.085, 218, 106, CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1
3624, 4x6cH, 0.5062, 3.69, 0.066, 243, 106, CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR
3625, 4x6bC, 0.5062, 3.76, 0.095, 186, 105, BK6 TCR APO STRUCTURE
3626, 4rgnG, 0.5062, 4.01, 0.112, 220, 107, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
3627, 4nqeH, 0.5062, 3.72, 0.075, 231, 106, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX BOUND TO 5-(2- OXOETHYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
3628, 4nkoC, 0.5062, 4.01, 0.094, 115, 106, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
3629, 4n2kA, 0.5062, 4.00, 0.067, 637, 105, CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (Q350A 0 MM CA2+)
3630, 4n22A, 0.5062, 3.98, 0.067, 642, 105, CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (50 UM CA2+)
3631, 4ma3L, 0.5062, 3.91, 0.085, 218, 106, CRYSTAL STRUCTURE OF ANTI-HINGE RABBIT ANTIBODY C2095
3632, 4m61C, 0.5062, 3.94, 0.121, 219, 107, CRYSTAL STRUCTURE OF UNLIGANDED ANTI-DNA FAB A52
3633, 4kphM, 0.5062, 3.85, 0.124, 195, 105, STRUCTURE OF THE FAB FRAGMENT OF N62 A PROTECTIVE MONOCLONAL ANTIBODY TO THE NONREDUCING END OF FRANCISELLA TULARENSIS O-ANTIGEN
3634, 4jhwL, 0.5062, 4.03, 0.075, 211, 107, CRYSTAL STRUCTURE OF RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN STABILIZED IN THE PREFUSION CONFORMATION BY HUMAN ANTIBODY D25
3635, 4fqrl, 0.5062, 4.04, 0.075, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3636, 4dcqB, 0.5062, 4.06, 0.063, 218, 111, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 3B5H10 AN ANTIBODY-SPECIFIC FOR EXTENDED POLYGLUTAMINE REPEATS (ORTHORHOMBIC FORM)
3637, 3uzvB, 0.5062, 3.96, 0.056, 229, 108, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 2 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
3638, 3q3gH, 0.5062, 4.03, 0.064, 224, 110, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3639, 3mxwH, 0.5062, 3.91, 0.064, 220, 109, CRYSTAL STRUCTURE SONIC HEDGEHOG BOUND TO THE 5E1 FAB FRAGMENT
3640, 3mffD, 0.5062, 3.72, 0.094, 242, 106, 1F1E8HU TCR
3641, 3kprE, 0.5062, 3.75, 0.104, 241, 106, CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLKAWTF A MIMOTOPE
3642, 3hplB, 0.5062, 3.97, 0.113, 212, 106, KCSA E71H-F103A MUTANT IN THE CLOSED STATE
3643, 3eoaA, 0.5062, 3.98, 0.075, 214, 106, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM I
3644, 2xqyK, 0.5062, 4.05, 0.103, 218, 107, CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
3645, 2uylA, 0.5062, 3.98, 0.113, 218, 106, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
3646, 2q8aL, 0.5062, 3.94, 0.121, 214, 107, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
3647, 2pcpB, 0.5062, 3.81, 0.074, 215, 108, ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
3648, 2j8uE, 0.5062, 3.73, 0.105, 194, 105, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION.
3649, 2g60H, 0.5062, 4.11, 0.089, 208, 112, STRUCTURE OF ANTI-FLAG M2 FAB DOMAIN
3650, 2g5bE, 0.5062, 3.91, 0.121, 217, 107, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
3651, 1t4kA, 0.5062, 3.91, 0.094, 217, 106, CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB
3652, 1qsfD, 0.5062, 3.87, 0.112, 200, 107, STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A
3653, 1dbaH, 0.5062, 3.87, 0.054, 219, 111, THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB  AND PROGESTERONE-FAB  COMPLEX
3654, 6idhL, 0.5061, 4.00, 0.121, 217, 107, ANTIBODY 64M-5 FAB IN LIGAND-FREE FORM 
3655, 6hf1F, 0.5061, 3.89, 0.065, 210, 108, MUTANT OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH AN ANTIBODY FAB 
3656, 6fuqB, 0.5061, 3.60, 0.086, 240, 105, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
3657, 6fuoB, 0.5061, 3.69, 0.085, 240, 106, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
3658, 6faxH, 0.5061, 4.01, 0.072, 216, 111, COMPLEX OF HUMAN CD40 ECTODOMAIN WITH LOB 7.4 FAB
3659, 6eynA, 0.5061, 4.01, 0.093, 214, 107, STRUCTURE OF THE 8D6 (ANTI-IGE) FAB 
3660, 6ellB, 0.5061, 4.02, 0.084, 213, 107, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
3661, 6d9gC, 0.5061, 4.01, 0.082, 221, 110, X-RAY STRUCTURE OF THE FAB FRAGMENT OF 15B8; A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE HUMAN SEROTONIN TRANSPORTER 
3662, 6by3B, 0.5061, 3.98, 0.113, 212, 106, OPEN AND CONDUCTIVE CONFORMATION OF KCSA-T75A MUTANT 
3663, 5wkhJ, 0.5061, 3.92, 0.111, 244, 108, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS3
3664, 5vjqF, 0.5061, 3.94, 0.112, 212, 107, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
3665, 5u17G, 0.5061, 3.70, 0.075, 241, 106, STRUCTURE OF HUMAN MR1-DA-6-FP IN COMPLEX WITH HUMAN MAIT A-F7 TCR
3666, 5mv3V, 0.5061, 4.02, 0.112, 218, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3667, 5muqA, 0.5061, 4.00, 0.064, 219, 110, CRYSTAL STRUCTURE OF DC8E8 FAB AT PH 7.0 CONTAINING A ZN ATOM 
3668, 5iw1C, 0.5061, 3.92, 0.102, 189, 108, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR
3669, 5hyjI, 0.5061, 3.67, 0.095, 193, 105, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA
3670, 5girH, 0.5061, 3.97, 0.118, 208, 110, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE
3671, 5dq9B, 0.5061, 4.01, 0.103, 212, 107, STRUCTURE OF S55-3 FAB IN COMPLEX WITH LIPID A
3672, 4zffB, 0.5061, 4.06, 0.075, 210, 107, DUAL-ACTING FAB 5A12 IN COMPLEX WITH VEGF
3673, 4z5rV, 0.5061, 4.04, 0.075, 217, 107, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
3674, 4wfhE, 0.5061, 4.01, 0.082, 211, 110, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND NONCONDUCTIVE CONFORMATION
3675, 4rgnE, 0.5061, 4.01, 0.112, 220, 107, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
3676, 4p2qO, 0.5061, 4.02, 0.055, 242, 109, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK
3677, 4oz4L, 0.5061, 3.93, 0.132, 218, 106, X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.
3678, 4nylD, 0.5061, 3.92, 0.075, 211, 106, CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT
3679, 4kxzL, 0.5061, 4.09, 0.084, 213, 107, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
3680, 4kuzL, 0.5061, 3.95, 0.103, 216, 107, CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 4A5 FAB IN TRIGONAL FORM
3681, 4guqA, 0.5061, 3.61, 0.099, 200, 101, STRUCTURE OF MUTS139F P73 DNA BINDING DOMAIN COMPLEXED WITH 20BP DNA RESPONSE ELEMENT
3682, 4ffwD, 0.5061, 3.90, 0.093, 209, 108, CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4 DPP-IV CD26) IN COMPLEX WITH FAB + SITAGLIPTIN
3683, 4ffvC, 0.5061, 3.69, 0.117, 207, 103, CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4 DPP-IV CD26) IN COMPLEX WITH 11A19 FAB
3684, 4dkeL, 0.5061, 4.03, 0.084, 214, 107, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB1.1
3685, 3tyfD, 0.5061, 3.72, 0.094, 242, 106, CRYSTAL STRUCTURE OF A CD1D-LYSOPHOSPHATIDYLCHOLINE REACTIVE INKT TCR
3686, 3d3vE, 0.5061, 3.68, 0.066, 245, 106, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(34-DIFLUOROPHENYLALANINE)) PEPTIDE
3687, 2uylX, 0.5061, 3.99, 0.113, 216, 106, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
3688, 2h32H, 0.5061, 4.07, 0.072, 211, 111, CRYSTAL STRUCTURE OF THE PRE-B CELL RECEPTOR
3689, 1x9rB, 0.5061, 2.90, 0.130, 104, 92, UMECYANIN FROM HORSE RADDISH- CRYSTAL STRUCTURE OF THE OXIDISED FORM
3690, 1r3kA, 0.5061, 4.07, 0.103, 212, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF TL+
3691, 6mxrL, 0.5060, 3.97, 0.083, 218, 108, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M] 
3692, 6mkdA, 0.5060, 3.96, 0.130, 193, 108, 4699 TCR BOUND TO I-AB PADI4 
3693, 6fr6A, 0.5060, 3.85, 0.130, 202, 108, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
3694, 6crqJ, 0.5060, 3.98, 0.056, 125, 108, GLUTARALDEHYDE-TREATED BG505 SOSIP.664 ENV IN COMPLEX WITH PGV04 FAB 
3695, 6cnvH, 0.5060, 3.90, 0.055, 214, 109, INFLUENZA B/BRISBANE HEMAGGLUTININ FAB CR9115 SD84H COMPLEX 
3696, 5yhlL, 0.5060, 3.99, 0.103, 214, 107, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY. 
3697, 5y11A, 0.5060, 4.15, 0.071, 219, 112, SFTSV GN WITH NEUTRALIZING ANTIBODY MAB4-5
3698, 5w1vE, 0.5060, 3.75, 0.076, 243, 105, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
3699, 5vjqB, 0.5060, 3.96, 0.104, 212, 106, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
3700, 5tihH, 0.5060, 3.81, 0.065, 212, 107, STRUCTURAL BASIS FOR INHIBITION OF ERYTHROCYTE INVASION BY ANTIBODIES TO PLASMODIUM FALCIPARUM PROTEIN CYRPA
3701, 5kvfL, 0.5060, 3.96, 0.131, 220, 107, ZIKA SPECIFIC ANTIBODY ZV-64 BOUND TO ZIKA ENVELOPE DIII
3702, 5id1C, 0.5060, 4.04, 0.084, 212, 107, CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE
3703, 5i19L, 0.5060, 4.03, 0.084, 213, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV1-39
3704, 5dqjL, 0.5060, 4.03, 0.112, 217, 107, STRUCTURE OF UNLIGANDED S55-5 FAB
3705, 4z5rL, 0.5060, 4.05, 0.075, 217, 107, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
3706, 4wfeG, 0.5060, 4.10, 0.081, 210, 111, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND CONDUCTIVE CONFORMATION
3707, 4uimD, 0.5060, 4.05, 0.084, 214, 107, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.3
3708, 4rirH, 0.5060, 4.08, 0.081, 219, 111, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
3709, 4qthA, 0.5060, 3.91, 0.064, 215, 109, CRYSTAL STRUCTURE OF ANTI-UPAR FAB 8B12
3710, 4plkK, 0.5060, 4.06, 0.093, 208, 107, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
3711, 4p2rE, 0.5060, 4.09, 0.055, 245, 110, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK
3712, 4odsL, 0.5060, 4.00, 0.103, 218, 107, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S55-3
3713, 4jr9L, 0.5060, 4.00, 0.093, 211, 107, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK
3714, 4ffwC, 0.5060, 3.85, 0.124, 207, 105, CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4 DPP-IV CD26) IN COMPLEX WITH FAB + SITAGLIPTIN
3715, 4e41E, 0.5060, 3.76, 0.095, 236, 105, STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
3716, 3w11D, 0.5060, 3.86, 0.096, 114, 104, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1-CR IN COMPLEX WITH HUMAN INSULIN ALPHA-CT PEPTIDE(704-719) AND FAB 83-7
3717, 3rhwF, 0.5060, 3.93, 0.073, 191, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
3718, 3qynC, 0.5060, 3.81, 0.097, 196, 103, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING 2 BASE PAIR SPACER BETWEEN HALF SITES
3719, 3qa3K, 0.5060, 4.02, 0.064, 224, 110, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3720, 3okmA, 0.5060, 3.97, 0.121, 215, 107, CRYSTAL STRUCTURE OF UNLIGANDED S25-39
3721, 3bszH, 0.5060, 3.82, 0.083, 215, 108, CRYSTAL STRUCTURE OF THE TRANSTHYRETIN-RETINOL BINDING PROTEIN-FAB COMPLEX
3722, 2o5zL, 0.5060, 3.83, 0.114, 218, 105, CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB 5-BETA- ANDROSTANE-317-DIONE COMPLEX
3723, 2nw2A, 0.5060, 3.79, 0.143, 196, 105, CRYSTAL STRUCTURE OF ELS4 TCR AT 1.4A
3724, 2n7aA, 0.5060, 4.00, 0.102, 145, 108, SOLUTION STRUCTURE OF THE HUMAN SIGLEC-8 LECTIN DOMAIN
3725, 1xcqB, 0.5060, 3.97, 0.091, 218, 110, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
3726, 1tcrA, 0.5060, 3.99, 0.101, 202, 109, MURINE T-CELL ANTIGEN RECEPTOR 2C CLONE
3727, 1p5uA, 0.5060, 3.12, 0.096, 206, 94, X-RAY STRUCTURE OF THE TERNARY CAF1M:CAF1:CAF1 CHAPERONE:SUBUNIT:SUBUNIT COMPLEX
3728, 1kcrL, 0.5060, 3.97, 0.112, 213, 107, CRYSTAL STRUCTURE OF ANTIBODY PC283 IN COMPLEX WITH PS1 PEPTIDE
3729, 1k6qH, 0.5060, 4.07, 0.081, 213, 111, CRYSTAL STRUCTURE OF ANTIBODY FAB FRAGMENT D3
3730, 1egjL, 0.5060, 3.81, 0.086, 215, 105, DOMAIN 4 OF THE BETA COMMON CHAIN IN COMPLEX WITH AN ANTIBODY
3731, 1ck0L, 0.5060, 3.91, 0.123, 216, 106, ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II UNLIGANDED FORM
3732, 6nb8L, 0.5059, 4.01, 0.093, 219, 107, CRYSTAL STRUCTURE OF ANTI- SARS-COV HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT 
3733, 6flaL, 0.5059, 4.05, 0.103, 216, 107, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 1 
3734, 6fg2H, 0.5059, 4.00, 0.055, 212, 110, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA84. 
3735, 6fbjL, 0.5059, 4.05, 0.103, 213, 107, MONOCLONAL ANTIBODY TARGETING MATRIX METALLOPROTEINASE 7 
3736, 6crqD, 0.5059, 3.96, 0.065, 125, 108, GLUTARALDEHYDE-TREATED BG505 SOSIP.664 ENV IN COMPLEX WITH PGV04 FAB 
3737, 6at6B, 0.5059, 3.62, 0.076, 240, 105, CRYSTAL STRUCTURE OF THE KFJ5 TCR
3738, 5y9kH, 0.5059, 3.77, 0.057, 216, 106, STRUCTURE OF THE BELIMUMAB FAB FRAGMENT
3739, 5x8lO, 0.5059, 3.91, 0.104, 213, 106, PD-L1 IN COMPLEX WITH ATEZOLIZUMAB
3740, 5wkhI, 0.5059, 3.64, 0.124, 198, 105, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS3
3741, 5vkkB, 0.5059, 3.97, 0.093, 219, 107, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CD22 EPRATUZUMAB
3742, 5nhtB, 0.5059, 3.66, 0.086, 242, 105, HUMAN 199.54-16 TCR IN COMPLEX WITH MELAN-A/MART-1 (26-35) PEPTIDE AND HLA-A2 
3743, 5mx3L, 0.5059, 3.92, 0.132, 218, 106, STRUCTURE OF DC8E8 FAB CRYSTALLIZED AT PH 8.5
3744, 5mv3P, 0.5059, 3.97, 0.113, 215, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3745, 5mhrP, 0.5059, 4.09, 0.062, 213, 112, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
3746, 5kqvC, 0.5059, 4.05, 0.073, 211, 110, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14 (REVISED STRUCTURE)
3747, 5k8aE, 0.5059, 3.82, 0.095, 213, 105, NIST FAB
3748, 5j3dL, 0.5059, 4.03, 0.093, 215, 107, CRYSTAL STRUCTURE OF HUMAN FAB 14N4 IN COMPLEX WITH POST-FUSION RSV F
3749, 5ivxF, 0.5059, 3.67, 0.095, 234, 105, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR AND H2-DD P18-I10 COMPLEX
3750, 5hpmC, 0.5059, 4.01, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE
3751, 5ff6C, 0.5059, 4.02, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT
3752, 5drnB, 0.5059, 4.12, 0.074, 215, 108, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24 IN COMPLEX WITH HYPUSINE
3753, 5dmgD, 0.5059, 3.98, 0.075, 217, 107, X-RAY STRUCTURE OF THE FAB FRAGMENT OF THE ANTI TAU ANTIBODY RB86 IN COMPLEX WITH THE PHOSPHORYLATED TAU PEPTIDE (416-430)
3754, 5d7lE, 0.5059, 3.82, 0.065, 241, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAV36 TCR
3755, 5a3iC, 0.5059, 3.90, 0.073, 226, 110, CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN FLD194 FAB AND TRANSMISSIBLE MUTANT H5 HAEMAGGLUTININ
3756, 4z5rP, 0.5059, 4.05, 0.075, 217, 107, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
3757, 4wnqD, 0.5059, 3.94, 0.093, 242, 108, THE MOLECULAR BASES OF DELTA/ALPHA-BETA T-CELL MEDIATED ANTIGEN RECOGNITION
3758, 4wfgG, 0.5059, 4.10, 0.081, 210, 111, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND CONDUCTIVE CONFORMATION
3759, 4rgmC, 0.5059, 4.02, 0.081, 217, 111, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 20B1
3760, 4qxuL, 0.5059, 4.00, 0.121, 219, 107, NOVEL INHIBITION MECHANISM OF MEMBRANE METALLOPROTEASE BY AN EXOSITE- SWIVELING CONFORMATIONAL ANTIBODY
3761, 4mswB, 0.5059, 3.94, 0.113, 212, 106, Y78 ESTER MUTANT OF KCSA IN HIGH K+
3762, 4kvcL, 0.5059, 3.84, 0.132, 212, 106, 2H2 FAB FRAGMENT OF IMMATURE DENGUE VIRUS
3763, 4fqrx, 0.5059, 4.05, 0.084, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3764, 4fqrv, 0.5059, 4.05, 0.084, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3765, 4dvbL, 0.5059, 3.81, 0.125, 215, 104, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF PRO-UPA ANTIBODY MAB-112
3766, 4dn3L, 0.5059, 4.00, 0.075, 214, 107, CRYSTAL STRUCTURE OF ANTI-MCP-1 ANTIBODY CNTO888
3767, 4cadK, 0.5059, 3.89, 0.064, 221, 109, MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1
3768, 3w12D, 0.5059, 3.87, 0.096, 114, 104, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1-CR IN COMPLEX WITH HIGH-AFFINITY INSULIN ANALOGUE [D-PRO-B26]-DTI-NH2 ALPHA-CT PEPTIDE(704-719) AND FAB 83-7
3769, 3v6zD, 0.5059, 3.97, 0.121, 219, 107, CRYSTAL STRUCTURE OF HEPATITIS B VIRUS E-ANTIGEN
3770, 3sknF, 0.5059, 3.79, 0.075, 241, 107, CRYSTAL STRUCTURE OF THE RL42 TCR UNLIGANDED
3771, 3riaF, 0.5059, 3.93, 0.073, 191, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
3772, 3r1gL, 0.5059, 3.85, 0.086, 214, 105, STRUCTURE BASIS OF ALLOSTERIC INHIBITION OF BACE1 BY AN EXOSITE- BINDING ANTIBODY
3773, 3qdmE, 0.5059, 3.67, 0.113, 242, 106, THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) DECAMERIC PEPTIDE
3774, 3q3gB, 0.5059, 4.03, 0.064, 224, 110, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3775, 3ogcB, 0.5059, 4.08, 0.103, 212, 107, KCSA E71A VARIANT IN PRESENCE OF NA+
3776, 3o6fH, 0.5059, 3.90, 0.093, 243, 108, CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4
3777, 3h3pI, 0.5059, 3.67, 0.067, 126, 104, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10 FV COMPLEX
3778, 3fctA, 0.5059, 3.95, 0.094, 213, 106, MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN
3779, 3dx9D, 0.5059, 3.98, 0.102, 244, 108, CRYSTAL STRUCTURE OF THE DM1 TCR AT 2.75A
3780, 2xtlB, 0.5059, 3.75, 0.077, 452, 104, STRUCTURE OF THE MAJOR PILUS BACKBONE PROTEIN FROM STREPTOCOCCUS AGALACTIAE
3781, 2vdnH, 0.5059, 4.02, 0.064, 219, 110, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST EPTIFIBATIDE
3782, 2uweE, 0.5059, 3.88, 0.094, 194, 106, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION
3783, 2r23A, 0.5059, 3.90, 0.113, 217, 106, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
3784, 2eyrA, 0.5059, 3.89, 0.102, 202, 108, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
3785, 1yy8C, 0.5059, 4.04, 0.084, 213, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE MONOCLONAL ANTIBODY CETUXIMAB/ERBITUX/IMC-C225
3786, 1nmaH, 0.5059, 3.71, 0.094, 122, 106, N9 NEURAMINIDASE COMPLEXES WITH ANTIBODIES NC41 AND NC10: EMPIRICAL FREE-ENERGY CALCULATIONS CAPTURE SPECIFICITY TRENDS OBSERVED WITH MUTANT BINDING DATA
3787, 1nd0C, 0.5059, 4.00, 0.123, 219, 106, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
3788, 1mieL, 0.5059, 4.11, 0.083, 218, 108, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS5-393
3789, 1mh5B, 0.5059, 3.83, 0.092, 172, 109, THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE ANALOG
3790, 1fgnL, 0.5059, 3.90, 0.094, 214, 106, MONOCLONAL MURINE ANTIBODY 5G9-ANTI-HUMAN TISSUE FACTOR
3791, 6fupB, 0.5058, 3.69, 0.085, 240, 106, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
3792, 6f2sJ, 0.5058, 4.67, 0.062, 195, 113, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
3793, 6cugE, 0.5058, 3.68, 0.066, 244, 106, CRYSTAL STRUCTURE OF BC8B TCR-CD1B-PC COMPLEX 
3794, 6be4L, 0.5058, 4.05, 0.130, 213, 108, CRYSTAL STRUCTURE OF A POLYSACCHARIDE-BINDING HUMAN FAB (F598) IN COMPLEX WITH NONA-N-ACETYL-D-GLUCOSAMINE (9NAC)
3795, 6b73C, 0.5058, 3.91, 0.073, 126, 109, CRYSTAL STRUCTURE OF A NANOBODY-STABILIZED ACTIVE STATE OF THE KAPPA- OPIOID RECEPTOR
3796, 5w0kE, 0.5058, 4.15, 0.088, 214, 113, CRYSTAL STRUCTURE OF EBV GHGL/CL40/GP42 N-DOMAIN
3797, 5vpgC, 0.5058, 3.91, 0.094, 211, 106, CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1
3798, 5tbdA, 0.5058, 3.69, 0.058, 114, 104, CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB4D11) IN COMPLEX WITH 3D7-MSP2 215-222
3799, 5mvzA, 0.5058, 4.14, 0.080, 221, 112, FAB 4AB007 BOUND TO INTERLEUKIN-1-BETA
3800, 5mp5B, 0.5058, 3.84, 0.132, 217, 106, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
3801, 5iopC, 0.5058, 4.04, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT
3802, 5i1kH, 0.5058, 4.00, 0.082, 211, 110, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV3-20
3803, 5dlmM, 0.5058, 4.01, 0.113, 217, 106, COMPLEX OF INFLUENZA M2E AND ANTIBODY
3804, 5bzdC, 0.5058, 4.02, 0.075, 214, 107, CRYSTAL STRUCTURE OF PCDN-27A AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
3805, 5a16D, 0.5058, 3.95, 0.085, 218, 106, CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1
3806, 4zs6L, 0.5058, 4.02, 0.093, 210, 107, RECEPTOR BINDING DOMAIN AND FAB COMPLEX
3807, 4pjaF, 0.5058, 3.69, 0.094, 235, 106, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-B10 TCR
3808, 4p2rO, 0.5058, 4.02, 0.055, 242, 109, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK
3809, 4n3tA, 0.5058, 4.69, 0.068, 153, 118, CANDIDA ALBICANS SUPEROXIDE DISMUTASE 5 (SOD5) CU(I)
3810, 4mjiJ, 0.5058, 3.72, 0.132, 241, 106, T CELL RESPONSE TO A HIV REVERSE TRANSCRIPTASE EPITOPE PRESENTED BY THE PROTECTIVE ALLELE HLA-B*51:01
3811, 4jreL, 0.5058, 3.99, 0.084, 211, 107, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND
3812, 4fqrb, 0.5058, 4.05, 0.075, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3813, 3v6zB, 0.5058, 3.97, 0.121, 219, 107, CRYSTAL STRUCTURE OF HEPATITIS B VIRUS E-ANTIGEN
3814, 3rvwC, 0.5058, 3.91, 0.094, 211, 106, CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1
3815, 3qynB, 0.5058, 3.69, 0.087, 193, 103, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING 2 BASE PAIR SPACER BETWEEN HALF SITES
3816, 3qwoL, 0.5058, 3.77, 0.095, 210, 105, CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB
3817, 3qumH, 0.5058, 4.02, 0.091, 217, 110, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY
3818, 3mugJ, 0.5058, 3.96, 0.064, 237, 110, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3819, 3kykL, 0.5058, 4.02, 0.075, 211, 107, CRYSTAL STRUCTURE OF LI33 IGG1 FAB
3820, 3i02A, 0.5058, 3.88, 0.113, 219, 106, CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
3821, 3gb7A, 0.5058, 4.24, 0.080, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+
3822, 3bszN, 0.5058, 3.82, 0.083, 215, 108, CRYSTAL STRUCTURE OF THE TRANSTHYRETIN-RETINOL BINDING PROTEIN-FAB COMPLEX
3823, 2w9eL, 0.5058, 3.76, 0.135, 212, 104, STRUCTURE OF ICSM 18 (ANTI-PRP THERAPEUTIC ANTIBODY) FAB FRAGMENT COMPLEXED WITH HUMAN PRP FRAGMENT 119-231
3824, 2dtmL, 0.5058, 3.91, 0.123, 218, 106, THERMODYNAMIC AND STRUCTURAL ANALYSES OF HYDROLYTIC MECHANISM BY CATALYTIC ANTIBODIES
3825, 2axhB, 0.5058, 3.75, 0.085, 240, 106, CRYSTAL STRUCTURES OF T CELL RECEPTOR BETA CHAINS RELATED TO RHEUMATOID ARTHRITIS
3826, 1z3gH, 0.5058, 3.97, 0.073, 214, 110, CRYSTAL STRUCTURE OF COMPLEX BETWEEN PVS25 AND FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8
3827, 1xcqD, 0.5058, 3.94, 0.063, 218, 111, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
3828, 1kcvL, 0.5058, 3.96, 0.112, 214, 107, CRYSTAL STRUCTURE OF ANTIBODY PC282
3829, 1h0dA, 0.5058, 3.85, 0.085, 216, 106, CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN IN COMPLEX WITH FAB FRAGMENT OF ITS MONOCLONAL ANTIBODY MAB 26-2F
3830, 6n81L, 0.5057, 4.04, 0.075, 211, 107, CRYSTAL STRUCTURE OF GII.4 2002 NOROVIRUS P DOMAIN IN COMPLEX WITH CROSS-REACTIVE HUMAN ANTIBODY A1227 
3831, 6mxrB, 0.5057, 3.95, 0.112, 217, 107, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M] 
3832, 6mqmB, 0.5057, 4.06, 0.093, 217, 107, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY DF1W-A.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
3833, 6mlkL, 0.5057, 3.85, 0.094, 217, 106, STRUCTURE OF THIOESTERASE FROM DEBS WITH A THIOESTERASE-SPECIFIC ANTIBODY 
3834, 6mamF, 0.5057, 4.09, 0.065, 216, 108, CLEAVED EBOLA GP IN COMPLEX WITH A BROADLY NEUTRALIZING HUMAN ANTIBODY; ADI-15946 
3835, 6ddrB, 0.5057, 4.02, 0.091, 221, 110, CRYSTAL STRUCTURE ANALYSIS OF THE EPITOPE OF AN ANTI-MICA ANTIBODY 
3836, 5wkiE, 0.5057, 3.82, 0.103, 248, 107, CRYSTAL STRUCTURE OF PG90 TCR-CD1B-PG COMPLEX
3837, 5vzxI, 0.5057, 3.85, 0.094, 219, 106, CRYSTAL STRUCTURE OF CRENEZUMAB FAB
3838, 5vr9L, 0.5057, 3.77, 0.076, 212, 105, CH1/CKAPPA FAB BASED ON MATUZUMAB
3839, 5uddR, 0.5057, 3.99, 0.075, 211, 107, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
3840, 5uddL, 0.5057, 3.96, 0.055, 221, 110, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
3841, 5tudB, 0.5057, 3.75, 0.115, 211, 104, STRUCTURAL INSIGHTS INTO THE EXTRACELLULAR RECOGNITION OF THE HUMAN SEROTONIN 2B RECEPTOR BY AN ANTIBODY
3842, 5nmfD, 0.5057, 3.86, 0.121, 200, 107, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTIATL
3843, 5iv2C, 0.5057, 4.05, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT
3844, 5hysL, 0.5057, 3.92, 0.075, 217, 106, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
3845, 5e6iH, 0.5057, 3.63, 0.095, 239, 105, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
3846, 4yxkH, 0.5057, 4.11, 0.071, 218, 112, CRYSTAL STRUCTURE OF ELK PRION PROTEIN COMPLEXED WITH POM1 FAB
3847, 4xccH, 0.5057, 3.89, 0.064, 226, 109, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); I422 SPACE GROUP
3848, 4p2qT, 0.5057, 4.02, 0.055, 242, 109, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK
3849, 4n2hA, 0.5057, 4.01, 0.067, 639, 105, CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (D177A 0 MM CA2+)
3850, 4kxzM, 0.5057, 4.09, 0.084, 213, 107, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
3851, 4i9wE, 0.5057, 4.09, 0.081, 211, 111, HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE
3852, 4g7yL, 0.5057, 3.97, 0.084, 211, 107, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E 2.8 A)
3853, 4fqrr, 0.5057, 4.05, 0.075, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3854, 4etqB, 0.5057, 3.88, 0.133, 212, 105, VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
3855, 4cadH, 0.5057, 3.90, 0.064, 221, 109, MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1
3856, 3o45L, 0.5057, 4.05, 0.103, 218, 107, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 17-MER PEPTIDE EPITOPE
3857, 3ixyI, 0.5057, 4.28, 0.080, 221, 113, THE PSEUDO-ATOMIC STRUCTURE OF DENGUE IMMATURE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF THE ANTI-FUSION LOOP ANTIBODY E53
3858, 3ijsC, 0.5057, 3.98, 0.112, 216, 107, STRUCTURE OF S67-27 IN COMPLEX WITH TSBP
3859, 3ietA, 0.5057, 3.95, 0.121, 215, 107, CRYSTAL STRUCTURE OF 237MAB WITH ANTIGEN
3860, 3e8uH, 0.5057, 4.10, 0.081, 213, 111, CRYSTAL STRUCTURE AND THERMODYNAMIC ANALYSIS OF DIAGNOSTIC FAB 106.3 COMPLEXED WITH BNP 5-13 (C10A) REVEAL BASIS OF SELECTIVE MOLECULAR RECOGNITION
3861, 3c60A, 0.5057, 3.93, 0.140, 199, 107, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR YAE62
3862, 3aazB, 0.5057, 4.11, 0.102, 229, 108, CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY
3863, 2z91B, 0.5057, 3.70, 0.115, 211, 104, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9
3864, 2r56L, 0.5057, 4.04, 0.093, 211, 107, CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN
3865, 2g60L, 0.5057, 3.94, 0.131, 213, 107, STRUCTURE OF ANTI-FLAG M2 FAB DOMAIN
3866, 2bnuA, 0.5057, 3.86, 0.130, 203, 108, STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
3867, 1uweH, 0.5057, 3.83, 0.065, 218, 107, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
3868, 1lk3H, 0.5057, 4.07, 0.081, 219, 111, ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT
3869, 1cf8L, 0.5057, 3.84, 0.114, 215, 105, CONVERGENCE OF CATALYTIC ANTIBODY AND TERPENE CYCLASE MECHANISMS: POLYENE CYCLIZATION DIRECTED BY CARBOCATION-PI INTERACTIONS
3870, 6rcoC, 0.5056, 3.88, 0.055, 222, 109, PFRH5-BINDING MONOCLONAL ANTIBODY R5.004 
3871, 6my4L, 0.5056, 3.95, 0.112, 218, 107, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M;LC-S30BR] 
3872, 6mxsB, 0.5056, 3.85, 0.085, 217, 106, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M] 
3873, 6ml8L, 0.5056, 4.08, 0.075, 212, 107, CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM H1N1 INFLUENZA A VIRUS A/DENVER/57 BOUND TO THE C05 ANTIBODY 
3874, 6funB, 0.5056, 3.69, 0.085, 240, 106, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
3875, 6fg2I, 0.5056, 4.00, 0.055, 218, 110, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA84. 
3876, 6d9gB, 0.5056, 3.84, 0.086, 216, 105, X-RAY STRUCTURE OF THE FAB FRAGMENT OF 15B8; A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE HUMAN SEROTONIN TRANSPORTER 
3877, 6b73D, 0.5056, 3.92, 0.073, 122, 109, CRYSTAL STRUCTURE OF A NANOBODY-STABILIZED ACTIVE STATE OF THE KAPPA- OPIOID RECEPTOR
3878, 5wjoB, 0.5056, 3.82, 0.103, 248, 107, CRYSTAL STRUCTURE OF THE UNLIGANDED PG90 TCR
3879, 5t78A, 0.5056, 3.85, 0.114, 216, 105, CRYSTAL STRUCTURE OF THERAPEUTIC MAB AR20.5 IN COMPLEX WITH MUC1 PEPTIDE
3880, 5kmvI, 0.5056, 3.85, 0.094, 219, 106, CRYSTAL STRUCTURE OF CRENEZUMAB FAB
3881, 5eu6D, 0.5056, 3.95, 0.128, 204, 109, HLA CLASS I ANTIGEN
3882, 5c7kE, 0.5056, 3.96, 0.064, 224, 110, CRYSTAL STRUCTURE BG505 SOSIP GP140 HIV-1 ENV TRIMER BOUND TO BROADLY NEUTRALIZING ANTIBODIES PGT128 AND 8ANC195
3883, 5c08I, 0.5056, 3.83, 0.112, 191, 107, 1E6 TCR IN COMPLEX WITH HLA-A0E CARRYING RQWGPDPAAV
3884, 4pjbH, 0.5056, 3.71, 0.066, 238, 106, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
3885, 4ojfL, 0.5056, 3.79, 0.095, 219, 105, HUMANISED 3D6 FAB COMPLEXED TO AMYLOID BETA 1-8
3886, 4m61A, 0.5056, 3.93, 0.121, 219, 107, CRYSTAL STRUCTURE OF UNLIGANDED ANTI-DNA FAB A52
3887, 4i2xA, 0.5056, 3.96, 0.140, 214, 107, CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
3888, 4fp8L, 0.5056, 4.03, 0.075, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
3889, 4dkfM, 0.5056, 3.95, 0.075, 207, 107, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2
3890, 4cniB, 0.5056, 4.05, 0.103, 214, 107, CRYSTAL STRUCTURE OF THE FAB PORTION OF OLOKIZUMAB IN COMPLEX WITH IL-6
3891, 3w0wE, 0.5056, 3.64, 0.095, 241, 105, THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE IN SPACE GROUP P212121
3892, 3sgeI, 0.5056, 3.99, 0.104, 219, 106, CRYSTAL STRUCTURE OF MAB 17.2 IN COMPLEX WITH R13 PEPTIDE
3893, 3qwoB, 0.5056, 3.83, 0.095, 210, 105, CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB
3894, 3g04B, 0.5056, 3.88, 0.073, 215, 109, CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A THYROID- STIMULATING AUTOANTIBODY
3895, 2vlmE, 0.5056, 3.72, 0.085, 240, 106, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
3896, 2nx5U, 0.5056, 3.75, 0.104, 243, 106, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
3897, 2nx5P, 0.5056, 3.73, 0.104, 243, 106, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
3898, 2f53E, 0.5056, 3.62, 0.076, 243, 105, DIRECTED EVOLUTION OF HUMAN T-CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT APPARENT CROSS-REACTIVITY
3899, 2bocB, 0.5056, 4.00, 0.113, 212, 106, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRAETHYLARSONIUM (TEAS)
3900, 1ynkH, 0.5056, 3.93, 0.055, 219, 110, IDENTIFICATION OF KEY RESIDUES OF THE NC6.8 FAB ANTIBODY FRAGMENT BINDING TO SYNTHETIC SWEETENERS: CRYSTAL STRUCTURE OF NC6.8 CO-CRYSTALIZED WITH HIGH POTENCY SWEETENER COMPOUND SC45647
3901, 1xf3H, 0.5056, 3.91, 0.074, 216, 108, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P65
3902, 1rhhC, 0.5056, 3.96, 0.084, 215, 107, CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION
3903, 1q0xH, 0.5056, 3.96, 0.064, 215, 110, ANTI-MORPHINE ANTIBODY 9B1 UNLIGANDED FORM
3904, 1nlbL, 0.5056, 4.04, 0.103, 220, 107, CRYSTAL STRUCTURE OF ANTI-HCV MONOCLONAL ANTIBODY 19D9D6
3905, 1lk3M, 0.5056, 3.88, 0.105, 210, 105, ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT
3906, 1ktkE, 0.5056, 3.98, 0.099, 247, 111, COMPLEX OF STREPTOCOCCAL PYROGENIC ENTEROTOXIN C (SPEC) WITH A HUMAN T CELL RECEPTOR BETA CHAIN (VBETA2.1)
3907, 1iqwL, 0.5056, 4.03, 0.103, 215, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MOUSE ANTI- HUMAN FAS ANTIBODY HFE7A
3908, 1iaiH, 0.5056, 4.08, 0.080, 219, 112, IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX
3909, 6otcL, 0.5055, 3.86, 0.085, 215, 106, SYNTHETIC FAB BOUND TO MARBURG VIRUS VP35 INTERFERON INHIBITORY DOMAIN 
3910, 6medB, 0.5055, 3.97, 0.075, 213, 106, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
3911, 6dcaI, 0.5055, 3.99, 0.064, 213, 110, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 6B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
3912, 6bzuD, 0.5055, 3.99, 0.113, 214, 106, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
3913, 6b5mL, 0.5055, 4.00, 0.103, 217, 107, STRUCTURE OF PFCSP PEPTIDE 21 WITH HUMAN PROTECTIVE ANTIBODY CIS43
3914, 5u2vF, 0.5055, 3.71, 0.066, 242, 106, STRUCTURE OF HUMAN MR1-HMB IN COMPLEX WITH HUMAN MAIT A-F7 TCR
3915, 5th9M, 0.5055, 4.04, 0.084, 214, 107, STRUCTURE DETERMINATION OF A POTENT SELECTIVE ANTIBODY INHIBITOR OF HUMAN MMP9 (GS-5745 BOUND TO MMP-9)
3916, 5kzpG, 0.5055, 4.04, 0.090, 226, 111, STRUCTURE OF THE HCV1-C1 ANTIBODY-ANTIGEN COMPLEX
3917, 5itfC, 0.5055, 4.04, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT
3918, 5hhoE, 0.5055, 3.79, 0.085, 240, 106, CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-G4E
3919, 5d93B, 0.5055, 3.82, 0.105, 212, 105, OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM A MOUSE QSOX1-SPECIFIC ANTIBODY
3920, 5aumB, 0.5055, 4.02, 0.093, 216, 107, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH THE LIGAND PEPTIDE
3921, 5a16H, 0.5055, 3.95, 0.085, 218, 106, CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1
3922, 4xxdD, 0.5055, 3.80, 0.104, 217, 106, CRYSTAL STRUCTURE OF MID-REGION AMYLOID BETA CAPTURE BY SOLANEZUMAB
3923, 4tw1M, 0.5055, 4.28, 0.080, 287, 113, CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH
3924, 4k7pL, 0.5055, 4.06, 0.103, 214, 107, GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
3925, 4irzL, 0.5055, 3.83, 0.067, 208, 105, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB NATALIZUMAB
3926, 3vxuE, 0.5055, 3.68, 0.085, 241, 106, THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE
3927, 3qiuD, 0.5055, 4.07, 0.055, 238, 109, CRYSTAL STRUCTURE OF THE 226 TCR IN COMPLEX WITH MCC/I-EK
3928, 3mbxL, 0.5055, 3.92, 0.113, 220, 106, CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY X836
3929, 3hr5Q, 0.5055, 3.98, 0.084, 219, 107, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
3930, 3hr5L, 0.5055, 3.79, 0.086, 219, 105, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
3931, 3cm9O, 0.5055, 4.06, 0.075, 214, 107, SOLUTION STRUCTURE OF HUMAN SIGA2
3932, 3cm9N, 0.5055, 4.06, 0.075, 214, 107, SOLUTION STRUCTURE OF HUMAN SIGA2
3933, 3cm9M, 0.5055, 4.06, 0.075, 214, 107, SOLUTION STRUCTURE OF HUMAN SIGA2
3934, 3cm9L, 0.5055, 4.06, 0.075, 214, 107, SOLUTION STRUCTURE OF HUMAN SIGA2
3935, 2z91D, 0.5055, 3.70, 0.115, 208, 104, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9
3936, 2xqyL, 0.5055, 4.05, 0.103, 218, 107, CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
3937, 2r1wA, 0.5055, 3.96, 0.121, 216, 107, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
3938, 2ianO, 0.5055, 3.69, 0.057, 238, 105, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
3939, 2g5bG, 0.5055, 3.94, 0.121, 217, 107, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
3940, 1qunG, 0.5055, 3.08, 0.073, 200, 96, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
3941, 1qunA, 0.5055, 3.08, 0.073, 200, 96, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
3942, 1opgL, 0.5055, 4.01, 0.104, 214, 106, OPG2 FAB FRAGMENT
3943, 1nd0A, 0.5055, 4.00, 0.123, 219, 106, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
3944, 1axsA, 0.5055, 3.94, 0.094, 211, 106, MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN
3945, 6o3aA, 0.5054, 3.97, 0.093, 212, 107, CRYSTAL STRUCTURE OF FRIZZLED 7 CRD IN COMPLEX WITH F7.B FAB 
3946, 6njmJ, 0.5054, 3.94, 0.000, 213, 106, STRUCTURE OF A COMPLEX 
3947, 6medD, 0.5054, 4.01, 0.075, 212, 107, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
3948, 6mamD, 0.5054, 4.13, 0.065, 215, 108, CLEAVED EBOLA GP IN COMPLEX WITH A BROADLY NEUTRALIZING HUMAN ANTIBODY; ADI-15946 
3949, 6i04D, 0.5054, 4.04, 0.075, 212, 107, CRYSTAL STRUCTURE OF SEMA DOMAIN OF THE MET RECEPTOR IN COMPLEX WITH FAB 
3950, 6fr3A, 0.5054, 3.88, 0.130, 202, 108, 003 TCR STUDY OF CDR LOOP FLEXIBILITY 
3951, 6eyoI, 0.5054, 3.82, 0.083, 208, 109, STRUCTURE OF EXTENDED IGE-FC IN COMPLEX WITH TWO ANTI-IGE FABS 
3952, 6eh9B, 0.5054, 3.88, 0.065, 241, 107, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
3953, 6eh9A, 0.5054, 3.90, 0.147, 202, 109, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
3954, 6e0pM, 0.5054, 3.99, 0.083, 229, 109, CRYO-EM STRUCTURE OF THE CENTROMERIC NUCLEOSOME (NATIVE ALPHA SATELLITE DNA) IN COMPLEX WITH A SINGLE CHAIN ANTIBODY FRAGMENT 
3955, 5t6pC, 0.5054, 3.85, 0.114, 216, 105, CRYSTAL STRUCTURE OF THERAPEUTIC MAB AR20.5 IN COMPLEX WITH MUC1 PEPTIDE
3956, 5otjH, 0.5054, 4.11, 0.063, 222, 111, MONOMERIC POLCALCIN (PHL P 7) IN COMPLEX WITH TWO IDENTICAL ALLERGEN- SPECIFIC ANTIBODIES 
3957, 5e6iP, 0.5054, 3.84, 0.143, 191, 105, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
3958, 5d2lP, 0.5054, 3.82, 0.112, 235, 107, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
3959, 4xxdA, 0.5054, 3.78, 0.105, 218, 105, CRYSTAL STRUCTURE OF MID-REGION AMYLOID BETA CAPTURE BY SOLANEZUMAB
3960, 4wfeE, 0.5054, 4.10, 0.081, 211, 111, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND CONDUCTIVE CONFORMATION
3961, 4tw1I, 0.5054, 4.27, 0.080, 290, 113, CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH
3962, 4pjiH, 0.5054, 3.71, 0.085, 238, 106, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-C10 TCR
3963, 4n2mA, 0.5054, 4.00, 0.067, 643, 105, CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (E354A 0 MM CA2+)
3964, 4mhhI, 0.5054, 3.99, 0.121, 217, 107, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)
3965, 4m7lH, 0.5054, 3.91, 0.055, 222, 109, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN TISSUE FACTOR EXTRACELLULAR DOMAIN AND ANTIBODY 10H10 FAB FRAGMENT
3966, 4lu5M, 0.5054, 3.81, 0.114, 219, 105, STRUCTURE OF MURINE IGG2A A20G2-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.9 ANGSTROMS
3967, 4jreC, 0.5054, 4.01, 0.093, 211, 107, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND
3968, 4janH, 0.5054, 4.17, 0.063, 218, 111, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH103 IN COMPLEX WITH HIV-1 GP120
3969, 4f3fB, 0.5054, 4.02, 0.064, 219, 110, CRYSTAL STRUCTURE OF MSLN7-64 MORAB-009 FAB COMPLEX
3970, 4ebqL, 0.5054, 3.75, 0.124, 211, 105, FAB STRUCTURE OF ANTI-VACCINIA VIRUS D8L ANTIGEN MOUSE IGG2A LA5
3971, 4djmH, 0.5054, 2.92, 0.097, 201, 93, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
3972, 3w0wD, 0.5054, 3.87, 0.104, 204, 106, THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE IN SPACE GROUP P212121
3973, 3us0C, 0.5054, 3.82, 0.097, 196, 103, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING A TWO BASE PAIR AT SPACER BETWEEN HALF SITES
3974, 3tu6A, 0.5054, 2.75, 0.115, 127, 87, THE STRUCTURE OF A PSEUDOAZURIN FROM SINORHIZOBIUM MELILTOI
3975, 3qjfD, 0.5054, 3.89, 0.074, 239, 108, CRYSTAL STRUCTURE OF THE 2B4 TCR
3976, 3nz8B, 0.5054, 4.00, 0.121, 217, 107, CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8
3977, 3mj8B, 0.5054, 3.87, 0.074, 211, 108, CRYSTAL STRUCTURE OF HL4E10 FAB A HAMSTER AB STIMULATORY FOR GAMMADELTA T CELLS
3978, 3eyvA, 0.5054, 4.02, 0.103, 219, 107, ANTI-LEWIS Y FAB FRAGMENT WITH LEWIS Y ANTIGEN IN THE PRESENCE OF ZINC IONS
3979, 2z4qA, 0.5054, 3.91, 0.123, 219, 106, CRYSTAL STRUCTURE OF A MURINE ANTIBODY FAB 528
3980, 2xraH, 0.5054, 3.69, 0.067, 223, 105, CRYSTAL STRUCTURE OF THE HK20 FAB IN COMPLEX WITH A GP41 MIMETIC 5-HELIX
3981, 2vq1A, 0.5054, 4.02, 0.121, 216, 107, ANTI TRIMERIC LEWIS X FAB54-5C10-A
3982, 2qr0S, 0.5054, 3.89, 0.085, 213, 106, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
3983, 2qqkL, 0.5054, 3.81, 0.095, 211, 105, NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB
3984, 2fd6L, 0.5054, 3.74, 0.114, 214, 105, STRUCTURE OF HUMAN UROKINASE PLASMINOGEN ACTIVATOR IN COMPLEX WITH UROKINASE RECEPTOR AND AN ANTI-UPAR ANTIBODY AT 1.9 A
3985, 1r24B, 0.5054, 3.85, 0.083, 217, 108, FAB FROM MURINE IGG3 KAPPA
3986, 1moeA, 0.5054, 4.06, 0.093, 240, 107, THE THREE-DIMENSIONAL STRUCTURE OF AN ENGINEERED SCFV T84.66 DIMER OR DIABODY IN VL TO VH LINKAGE.
3987, 1gpoL, 0.5054, 3.93, 0.123, 216, 106, CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT
3988, 1fptL, 0.5054, 3.93, 0.113, 219, 106, THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX BETWEEN THE FAB FRAGMENT OF AN NEUTRALIZING ANTIBODY FOR TYPE 1 POLIOVIRUS AND ITS VIRAL EPITOPE
3989, 1c1eH, 0.5054, 3.92, 0.073, 219, 110, CRYSTAL STRUCTURE OF A DIELS-ALDERASE CATALYTIC ANTIBODY 1E9 IN COMPLEX WITH ITS HAPTEN
3990, 1bd2D, 0.5054, 3.96, 0.093, 190, 108, COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7 VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201
3991, 6njmN, 0.5053, 3.94, 0.000, 213, 106, STRUCTURE OF A COMPLEX 
3992, 6j5fH, 0.5053, 3.68, 0.058, 120, 104, COMPLEX STRUCTURE OF MAB 4.2-SCFV WITH TICK-BORNE ENCEPHALITIS VIRUS ENVELOPE PROTEIN DOMAIN III 
3993, 6h3hC, 0.5053, 3.99, 0.064, 214, 110, FAB FRAGMENT OF ANTIBODY AGAINST FULLERENE C60 
3994, 6frcB, 0.5053, 3.70, 0.085, 240, 106, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
3995, 6fj5D, 0.5053, 3.70, 0.069, 199, 102, P53-DNA COMPLEX 5 
3996, 6bzwH, 0.5053, 4.10, 0.103, 218, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY AP33 
3997, 6bzvD, 0.5053, 4.07, 0.103, 215, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY 19B3 
3998, 6bzvB, 0.5053, 4.08, 0.103, 213, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY 19B3 
3999, 6axpC, 0.5053, 3.91, 0.094, 212, 106, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-OCTYLARGININE MEDITOPE VARIANT
4000, 5yd5C, 0.5053, 3.94, 0.055, 240, 109, CRYSTAL STRUCTURE OF THE SCFV ANTIBODY 4B08 WITH EPITOPE PEPTIDE (MUTATION N3A) 
4001, 5wuxB, 0.5053, 4.00, 0.075, 212, 107, TNFALPHA-CERTOLIZUMAB FAB
4002, 5t6pA, 0.5053, 3.85, 0.114, 216, 105, CRYSTAL STRUCTURE OF THERAPEUTIC MAB AR20.5 IN COMPLEX WITH MUC1 PEPTIDE
4003, 5swzS, 0.5053, 3.97, 0.102, 203, 108, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
4004, 5mthB, 0.5053, 4.01, 0.121, 218, 107, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACEGROUP P21 
4005, 5iczC, 0.5053, 4.06, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH GQFDLSTRRLKG PEPTIDE
4006, 5icyC, 0.5053, 4.03, 0.084, 212, 107, CETUXIMAB FAB IN COMPLEX WITH LINEAR MEDITOPE
4007, 5dtfL, 0.5053, 4.09, 0.075, 211, 107, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98.61 IN COMPLEX WITH HYPUSINE
4008, 5d7kE, 0.5053, 3.72, 0.066, 241, 106, STRUCTURE OF MR1-REACTIVE MAV36 TCR
4009, 5cp7G, 0.5053, 3.92, 0.132, 218, 106, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES
4010, 4x7tH, 0.5053, 4.04, 0.072, 222, 111, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 2
4011, 4uokL, 0.5053, 4.05, 0.112, 215, 107, ELECTRON CRYO-MICROSCOPY OF VENEZUELAN EQUINE ENCEPHALITIS VIRUS TC-83 IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 3B4C-4
4012, 4p2rT, 0.5053, 4.02, 0.055, 242, 109, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK
4013, 4n2dA, 0.5053, 3.99, 0.067, 636, 105, CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (D123N 0 MM CA2+)
4014, 4k55A, 0.5053, 4.05, 0.093, 118, 108, STRUCTURE OF THE EXTRACELLULAR DOMAIN OF BUTYROPHILIN BTN3A1 IN COMPLEX WITH (E)-4-HYDROXY-3-METHYL-BUT-2-ENYL PYROPHOSPHATE (HMBPP)
4015, 4hkbJ, 0.5053, 3.90, 0.046, 218, 108, CH67 FAB (UNBOUND) FROM THE CH65-67 LINEAGE
4016, 4hc1N, 0.5053, 3.95, 0.113, 213, 106, CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB 10G3
4017, 4gmsL, 0.5053, 4.09, 0.112, 211, 107, CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ
4018, 4cniL, 0.5053, 4.05, 0.093, 214, 107, CRYSTAL STRUCTURE OF THE FAB PORTION OF OLOKIZUMAB IN COMPLEX WITH IL-6
4019, 3vxtD, 0.5053, 3.75, 0.094, 241, 106, T36-5 TCR SPECIFIC FOR HLA-A24-NEF134-10
4020, 3vi4F, 0.5053, 3.92, 0.055, 218, 109, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
4021, 3uluH, 0.5053, 4.07, 0.081, 225, 111, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1)
4022, 3opzL, 0.5053, 3.95, 0.123, 212, 106, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
4023, 3nzhL, 0.5053, 4.03, 0.103, 214, 107, CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 5F6 FAB
4024, 3ixxG, 0.5053, 4.28, 0.080, 221, 113, THE PSEUDO-ATOMIC STRUCTURE OF WEST NILE IMMATURE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF THE ANTI-FUSION LOOP ANTIBODY E53
4025, 3hzkA, 0.5053, 3.95, 0.112, 218, 107, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO
4026, 2or9L, 0.5053, 3.82, 0.105, 216, 105, THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT/EPITOPE PEPTIDE COMPLEX REVEALS A NOVEL BINDING MODE DOMINATED BY THE HEAVY CHAIN HYPERVARIABLE LOOPS
4027, 2ianT, 0.5053, 3.69, 0.067, 238, 105, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
4028, 2ialB, 0.5053, 3.72, 0.066, 239, 106, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
4029, 2gk0L, 0.5053, 3.89, 0.114, 217, 105, STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A TWINNED CRYSTAL IN SPACE GROUP C2
4030, 1ibgL, 0.5053, 3.97, 0.093, 217, 107, STRUCTURE AND SPECIFICITY OF THE ANTI-DIGOXIN ANTIBODY 40-50
4031, 1i8mB, 0.5053, 4.00, 0.082, 213, 110, CRYSTAL STRUCTURE OF A RECOMBINANT ANTI-SINGLE-STRANDED DNA ANTIBODY FRAGMENT COMPLEXED WITH DT5
4032, 1acyL, 0.5053, 4.00, 0.093, 215, 107, CRYSTAL STRUCTURE OF THE PRINCIPAL NEUTRALIZING SITE OF HIV- 2 1
4033, 6my5L, 0.5052, 4.10, 0.110, 218, 109, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M;LC-S30BR] 
4034, 6jmrD, 0.5052, 3.98, 0.103, 219, 107, CD98HC EXTRACELLULAR DOMAIN BOUND TO HBJ127 FAB AND MEM-108 FAB 
4035, 5yxuA, 0.5052, 4.08, 0.109, 191, 110, AN AFFINITY ENHANCED T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HCV NS3 PEPTIDE KLVALGINAV 
4036, 5uddJ, 0.5052, 3.96, 0.064, 224, 110, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
4037, 5k8aA, 0.5052, 3.82, 0.095, 213, 105, NIST FAB
4038, 5j0bA, 0.5052, 4.03, 0.093, 213, 108, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 6 -SIALYLLACTOSE
4039, 5i6zC, 0.5052, 4.05, 0.121, 214, 107, X-RAY STRUCTURE OF THE TS2 HUMAN SEROTONIN TRANSPORTER
4040, 5girL, 0.5052, 4.05, 0.093, 212, 107, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE
4041, 5fhcL, 0.5052, 3.84, 0.105, 211, 105, CRYSTAL STRUCTURE OF PROTECTIVE HUMAN ANTIBODIES 100 AND 114 IN COMPLEX WITH EBOLA VIRUS FUSION GLYCOPROTEIN (GP)
4042, 5ewiL, 0.5052, 3.94, 0.112, 217, 107, CRYSTAL STRUCTURE OF THE HUMAN FAB VRC38.01 AN HIV-1 V1V2-DIRECTED NEUTRALIZING ANTIBODY ISOLATED FROM DONOR N90
4043, 5esqC, 0.5052, 4.03, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH CYCLIC BETA-ALANINE-LINKED MEDITOPE
4044, 5epmF, 0.5052, 4.14, 0.111, 218, 108, CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT
4045, 5e94A, 0.5052, 4.03, 0.075, 214, 107, ANTIBODY-BOUND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR EXTRACELLULAR DOMAIN
4046, 5e1aA, 0.5052, 4.02, 0.073, 219, 110, STRUCTURE OF KCSA WITH L24C/R117C MUTATIONS
4047, 5b3jF, 0.5052, 4.00, 0.084, 211, 107, ACTIVATION OF NMDA RECEPTORS AND THE MECHANISM OF INHIBITION BY IFENPRODIL
4048, 4x80L, 0.5052, 3.85, 0.114, 213, 105, CRYSTAL STRUCTURE OF MURINE 7B4 FAB MONOCLONAL ANTIBODY AGAINST ADAMTS5
4049, 4wv1A, 0.5052, 4.03, 0.093, 214, 107, CRYSTAL STRUCTURE OF THE FGFR2 D2 DOMAIN IN COMPLEX WITH FAB 2B.1.3
4050, 4whyL, 0.5052, 3.98, 0.104, 218, 106, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P21 CRYSTAL FORM
4051, 4u1gF, 0.5052, 4.03, 0.103, 215, 107, PLASMODIUM FALCIPARUM RETICULOCYTE-BINDING PROTEIN HOMOLOGUE 5 (PFRH5) BOUND TO MONOCLONAL ANTIBODY QA1
4052, 4q7gA, 0.5052, 4.06, 0.091, 300, 110, 1.7 ANGSTROM CRYSTAL STRUCTURE OF LEUKOTOXIN LUKD FROM STAPHYLOCOCCUS AUREUS.
4053, 4prhE, 0.5052, 3.81, 0.075, 240, 107, CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:08-HPVG-D5 COMPLEX
4054, 4np4I, 0.5052, 4.00, 0.073, 221, 110, CLOSTRIDIUM DIFFICILE TOXIN B CROP DOMAIN IN COMPLEX WITH FAB DOMAINS OF NEUTRALIZING ANTIBODY BEZLOTOXUMAB
4055, 4lexL, 0.5052, 3.87, 0.094, 217, 106, UNLIGANDED CRYSTAL STRUCTURE OF MAB7
4056, 4fp8O, 0.5052, 4.06, 0.075, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
4057, 4ei6A, 0.5052, 3.72, 0.095, 201, 105, STRUCTURE OF XV19 VALPHA1-VBETA16 TYPE-II NATURAL KILLER T CELL RECEPTOR
4058, 4dgiH, 0.5052, 4.08, 0.080, 218, 112, STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH HUMAN PRPC FRAGMENT 120- 230
4059, 3us2J, 0.5052, 3.69, 0.098, 182, 102, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 19 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING TWO HALF SITES WITH A SINGLE BASE PAIR OVERLAP
4060, 3us2B, 0.5052, 3.69, 0.098, 182, 102, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 19 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING TWO HALF SITES WITH A SINGLE BASE PAIR OVERLAP
4061, 3qnyC, 0.5052, 3.80, 0.096, 219, 104, MONOCLINIC FORM OF HUMAN IGA1 FAB FRAGMENT SHARING SAME FV AS IGG
4062, 3q3gD, 0.5052, 4.04, 0.064, 224, 110, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
4063, 3nabH, 0.5052, 3.97, 0.064, 217, 110, CRYSTAL STRUCTURE OF FAB15 MUT6
4064, 3lh2I, 0.5052, 3.85, 0.056, 127, 107, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_1VI7A_S0_002_N 4E10 FV COMPLEX
4065, 3kj4B, 0.5052, 3.92, 0.113, 219, 106, STRUCTURE OF RAT NOGO RECEPTOR BOUND TO 1D9 ANTAGONIST ANTIBODY
4066, 3jbaL, 0.5052, 3.85, 0.096, 115, 104, THE U4 ANTIBODY EPITOPE ON HUMAN PAPILLOMAVIRUS 16 IDENTIFIED BY CRYO- EM
4067, 3i02C, 0.5052, 3.95, 0.121, 196, 107, CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
4068, 2uylV, 0.5052, 4.17, 0.111, 216, 108, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
4069, 2qtjN, 0.5052, 4.03, 0.084, 214, 107, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
4070, 2qqlL, 0.5052, 3.82, 0.086, 214, 105, NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB
4071, 2fbjL, 0.5052, 3.78, 0.105, 213, 105, REFINED CRYSTAL STRUCTURE OF THE GALACTAN-BINDING IMMUNOGLOBULIN FAB J539 AT 1.95-ANGSTROMS RESOLUTION
4072, 1nj9B, 0.5052, 3.81, 0.075, 215, 107, COCAINE HYDROLYTIC ANTIBODY 15A10
4073, 1mwaC, 0.5052, 3.94, 0.102, 202, 108, 2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX
4074, 1lmkC, 0.5052, 3.82, 0.057, 238, 106, THE STRUCTURE OF A BIVALENT DIABODY
4075, 1fbiH, 0.5052, 4.11, 0.098, 221, 112, CRYSTAL STRUCTURE OF A CROSS-REACTION COMPLEX BETWEEN FAB F9.13.7 AND GUINEA-FOWL LYSOZYME
4076, 1cloL, 0.5052, 3.71, 0.125, 213, 104, ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY A5B7
4077, 1a3rL, 0.5052, 3.94, 0.121, 220, 107, FAB FRAGMENT (ANTIBODY 8F5) COMPLEXED WITH PEPTIDE FROM HUMAN RHINOVIRUS (SEROTYPE 2) VIRAL CAPSID PROTEIN VP2 (RESIDUES 156-170)
4078, 6oknD, 0.5051, 3.95, 0.075, 213, 106, OX40R (TNFRSF4) BOUND TO FAB 1A7 
4079, 6gv4A, 0.5051, 3.90, 0.049, 256, 103, HIGH-RESOLUTION CRYO-EM OF FAB-LABELED HUMAN PARECHOVIRUS 3 
4080, 5x2pH, 0.5051, 4.15, 0.062, 219, 112, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMATE
4081, 5tjeG, 0.5051, 3.81, 0.112, 112, 107, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 AND T CELL RECEPTOR P14
4082, 5th9L, 0.5051, 4.07, 0.084, 214, 107, STRUCTURE DETERMINATION OF A POTENT SELECTIVE ANTIBODY INHIBITOR OF HUMAN MMP9 (GS-5745 BOUND TO MMP-9)
4083, 5otjL, 0.5051, 3.85, 0.094, 213, 106, MONOMERIC POLCALCIN (PHL P 7) IN COMPLEX WITH TWO IDENTICAL ALLERGEN- SPECIFIC ANTIBODIES 
4084, 5mhrH, 0.5051, 3.86, 0.123, 205, 106, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
4085, 5lfuA, 0.5051, 4.32, 0.116, 487, 112, MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) GLYCOSYLATED AND LYSINE- METHYLATED FULL EXTRACELLULAR DOMAIN
4086, 5it2H, 0.5051, 4.08, 0.081, 218, 111, STRUCTURE OF A TRANSGLUTAMINASE 2-SPECIFIC AUTOANTIBODY 693-10-B06 FAB FRAGMENT
4087, 5icxC, 0.5051, 4.06, 0.084, 212, 107, CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE
4088, 5hyqC, 0.5051, 4.02, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE
4089, 5etuC, 0.5051, 4.02, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH L5E MEDITOPE VARIANT
4090, 5d2lF, 0.5051, 3.78, 0.112, 238, 107, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
4091, 5d2lE, 0.5051, 3.79, 0.104, 187, 106, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
4092, 4wfgE, 0.5051, 4.10, 0.081, 211, 111, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND CONDUCTIVE CONFORMATION
4093, 4ogaD, 0.5051, 3.93, 0.095, 114, 105, INSULIN IN COMPLEX WITH SITE 1 OF THE HUMAN INSULIN RECEPTOR
4094, 4mjiE, 0.5051, 3.80, 0.131, 240, 107, T CELL RESPONSE TO A HIV REVERSE TRANSCRIPTASE EPITOPE PRESENTED BY THE PROTECTIVE ALLELE HLA-B*51:01
4095, 4kmtH, 0.5051, 4.02, 0.082, 218, 110, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY 5-51/O12
4096, 4imlL, 0.5051, 3.73, 0.087, 210, 103, CROSSFAB BINDING TO HUMAN ANGIOPOIETIN 2
4097, 4i3sH, 0.5051, 4.23, 0.071, 222, 113, CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P21
4098, 3vxuJ, 0.5051, 3.68, 0.085, 241, 106, THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE
4099, 3vg0L, 0.5051, 4.02, 0.113, 213, 106, ANTIBODY FAB FRAGMENT
4100, 3utpD, 0.5051, 3.87, 0.103, 199, 107, 1E6 TCR SPECIFIC FOR HLA-A*0201-ALWGPDPAAA
4101, 3us2D, 0.5051, 3.69, 0.098, 182, 102, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 19 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING TWO HALF SITES WITH A SINGLE BASE PAIR OVERLAP
4102, 3u0tA, 0.5051, 3.95, 0.113, 218, 106, FAB-ANTIBODY COMPLEX
4103, 3qa3D, 0.5051, 4.02, 0.064, 224, 110, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
4104, 3j3oL, 0.5051, 4.00, 0.112, 219, 107, CONFORMATIONAL SHIFT OF A MAJOR POLIOVIRUS ANTIGEN CONFIRMED BY IMMUNO-CRYOGENIC ELECTRON MICROSCOPY: 160S POLIOVIRUS AND C3-FAB COMPLEX
4105, 3ixtL, 0.5051, 3.83, 0.105, 211, 105, CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE
4106, 3hzmA, 0.5051, 3.96, 0.112, 218, 107, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO
4107, 3hfmL, 0.5051, 3.95, 0.112, 214, 107, STRUCTURE OF AN ANTIBODY-ANTIGEN COMPLEX. CRYSTAL STRUCTURE OF THE HY/HEL-10 FAB-LYSOZYME COMPLEX
4108, 3e8uL, 0.5051, 4.07, 0.103, 216, 107, CRYSTAL STRUCTURE AND THERMODYNAMIC ANALYSIS OF DIAGNOSTIC FAB 106.3 COMPLEXED WITH BNP 5-13 (C10A) REVEAL BASIS OF SELECTIVE MOLECULAR RECOGNITION
4109, 3cleH, 0.5051, 4.06, 0.071, 218, 112, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23
4110, 3chnO, 0.5051, 4.03, 0.084, 214, 107, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
4111, 3chnN, 0.5051, 4.03, 0.084, 214, 107, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
4112, 3chnM, 0.5051, 4.03, 0.084, 214, 107, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
4113, 3chnL, 0.5051, 4.03, 0.084, 214, 107, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
4114, 2y5tA, 0.5051, 4.18, 0.107, 222, 112, CRYSTAL STRUCTURE OF THE PATHOGENIC AUTOANTIBODY CIIC1 IN COMPLEX WITH THE TRIPLE-HELICAL C1 PEPTIDE
4115, 2r1yA, 0.5051, 3.95, 0.121, 217, 107, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
4116, 2qtjO, 0.5051, 4.03, 0.084, 214, 107, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
4117, 2qtjM, 0.5051, 4.03, 0.084, 214, 107, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
4118, 2qtjL, 0.5051, 4.03, 0.084, 214, 107, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
4119, 2qr0K, 0.5051, 4.00, 0.084, 213, 107, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
4120, 2nz9C, 0.5051, 3.97, 0.084, 216, 107, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
4121, 2nx5E, 0.5051, 3.83, 0.112, 243, 107, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
4122, 2esgM, 0.5051, 4.03, 0.084, 214, 107, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULIN IGA1 AND HUMAN SERUM ALBUMIN
4123, 2esgL, 0.5051, 4.03, 0.084, 214, 107, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULIN IGA1 AND HUMAN SERUM ALBUMIN
4124, 2e7lB, 0.5051, 3.78, 0.105, 110, 105, STRUCTURE OF A HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
4125, 2cgrL, 0.5051, 3.82, 0.113, 219, 106, LOCAL AND TRANSMITTED CONFORMATIONAL CHANGES ON COMPLEXATION OF AN ANTI-SWEETENER FAB
4126, 1za6G, 0.5051, 4.04, 0.103, 220, 107, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
4127, 1za6A, 0.5051, 4.03, 0.103, 220, 107, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
4128, 1yy8A, 0.5051, 4.04, 0.084, 213, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE MONOCLONAL ANTIBODY CETUXIMAB/ERBITUX/IMC-C225
4129, 1vgeL, 0.5051, 4.03, 0.084, 214, 107, TR1.9 FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY
4130, 1uwxH, 0.5051, 4.08, 0.072, 218, 111, P1.2 SEROSUBTYPE ANTIGEN DERIVED FROM N. MENINGITIDIS PORA IN COMPLEX WITH FAB FRAGMENT
4131, 1ngyA, 0.5051, 3.99, 0.084, 213, 107, CHIMERIC MATURE FAB 7G12-APO
4132, 1ngwH, 0.5051, 4.13, 0.062, 216, 112, CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
4133, 1n64L, 0.5051, 3.93, 0.113, 220, 106, CRYSTAL STRUCTURE ANALYSIS OF THE IMMUNODOMINANT ANTIGENIC SITE ON HEPATITIS C VIRUS PROTEIN BOUND TO MAB 19D9D6
4134, 1mj7L, 0.5051, 4.08, 0.084, 218, 107, CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS5-393 AND A TRANSITION-STATE ANALOG
4135, 1igaD, 0.5051, 4.03, 0.084, 214, 107, MODEL OF HUMAN IGA1 DETERMINED BY SOLUTION SCATTERING CURVE- FITTING AND HOMOLOGY MODELLING
4136, 1igaC, 0.5051, 4.03, 0.084, 214, 107, MODEL OF HUMAN IGA1 DETERMINED BY SOLUTION SCATTERING CURVE- FITTING AND HOMOLOGY MODELLING
4137, 1a4kH, 0.5051, 4.12, 0.053, 217, 113, DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE
4138, 6rcoA, 0.5050, 3.89, 0.055, 221, 109, PFRH5-BINDING MONOCLONAL ANTIBODY R5.004 
4139, 6k7oE, 0.5050, 3.94, 0.075, 218, 106, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
4140, 6fr7B, 0.5050, 3.90, 0.065, 241, 107, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
4141, 6emjB, 0.5050, 4.03, 0.084, 213, 107, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4142, 6ellL, 0.5050, 3.96, 0.085, 213, 106, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4143, 6c61B, 0.5050, 3.96, 0.064, 243, 109, MHC-INDEPENDENT T-CELL RECEPTOR B12A 
4144, 6c08D, 0.5050, 3.94, 0.055, 214, 110, ZEBRAFISH SLC38A9 WITH ARGININE BOUND IN THE CYTOSOL OPEN STATE 
4145, 6bitI, 0.5050, 4.03, 0.073, 213, 109, SIRPALPHA ANTIBODY COMPLEX
4146, 6avgC, 0.5050, 3.69, 0.144, 196, 104, CRYSTAL STRUCTURE OF THE KFJ37 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
4147, 5umnD, 0.5050, 4.08, 0.075, 213, 107, CRYSTAL STRUCTURE OF C05 VPGSGW MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
4148, 5uhyI, 0.5050, 4.06, 0.103, 214, 107, A HUMAN ANTIBODY AGAINST ZIKA VIRUS CROSSLINKS THE E PROTEIN TO PREVENT INFECTION
4149, 5uhyG, 0.5050, 4.06, 0.103, 214, 107, A HUMAN ANTIBODY AGAINST ZIKA VIRUS CROSSLINKS THE E PROTEIN TO PREVENT INFECTION
4150, 5tztL, 0.5050, 3.85, 0.095, 219, 105, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B161
4151, 5tq2H, 0.5050, 4.05, 0.080, 205, 112, CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2A IN COMPLEX WITH ZINC AT GLUN1 AND GLUN2A
4152, 5o4yB, 0.5050, 3.83, 0.096, 118, 104, STRUCTURE OF HUMAN PD-L1 IN COMPLEX WITH INHIBITOR
4153, 5nmdC, 0.5050, 3.85, 0.121, 200, 107, TCR SPECIFIC FOR HLA A02 PRESENTING HIV EPITOPE SLYNTVATL
4154, 5mp3L, 0.5050, 3.97, 0.131, 218, 107, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 30-MER TAU PEPTIDE AT PH 6.5 
4155, 5mp3B, 0.5050, 3.95, 0.131, 218, 107, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 30-MER TAU PEPTIDE AT PH 6.5 
4156, 5l2kD, 0.5050, 3.75, 0.123, 185, 106, CRYSTAL STRUCTURE OF GEM42 TCR-CD1B-GMM COMPLEX
4157, 5kvgL, 0.5050, 4.06, 0.103, 214, 107, ZIKA SPECIFIC ANTIBODY ZV-67 BOUND TO ZIKA ENVELOPE DIII
4158, 5id0C, 0.5050, 4.03, 0.084, 212, 107, CETUXIMAB FAB IN COMPLEX WITH AMINOHEPTANOIC ACID-LINKED MEDITOPE
4159, 5i6xB, 0.5050, 4.00, 0.073, 218, 110, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH PAROXETINE AT THE CENTRAL SITE
4160, 5hhmJ, 0.5050, 3.78, 0.085, 240, 106, CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-F5L
4161, 5hhmE, 0.5050, 3.78, 0.085, 240, 106, CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-F5L
4162, 5hhmD, 0.5050, 3.85, 0.105, 194, 105, CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-F5L
4163, 5h35I, 0.5050, 4.00, 0.121, 217, 107, CRYSTAL STRUCTURES OF THE TRIC TRIMERIC INTRACELLULAR CATION CHANNEL ORTHOLOGUE FROM SULFOLOBUS SOLFATARICUS
4164, 5eukC, 0.5050, 4.02, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT
4165, 5cp7E, 0.5050, 3.98, 0.132, 218, 106, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES
4166, 5a1zI, 0.5050, 3.77, 0.056, 120, 107, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 STRAIN PVP94- 07 COMPLEXED WITH HUMAN ANTIBODY 2D22 FAB AT 37 DEGREES C
4167, 4x6dH, 0.5050, 3.68, 0.067, 242, 105, CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR
4168, 4qrpE, 0.5050, 3.82, 0.121, 243, 107, CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL AND DD31 TCR
4169, 4onhB, 0.5050, 3.54, 0.077, 233, 104, CRYSTAL STRUCTURE OF DN6 TCR
4170, 4jrxD, 0.5050, 3.97, 0.111, 204, 108, CRYSTAL STRUCTURE OF CA5 TCR-HLA B*3505-LPEP COMPLEX
4171, 4grmC, 0.5050, 3.85, 0.086, 187, 105, THE CRYSTAL STRUCTURE OF THE HIGH AFFINITY TCR A6
4172, 3us1D, 0.5050, 3.70, 0.098, 182, 102, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR RESPONSE ELEMENT CONTAINING A TWO BASE PAIR GC SPACER BETWEEN HALF SITES
4173, 3u0tC, 0.5050, 3.95, 0.113, 219, 106, FAB-ANTIBODY COMPLEX
4174, 3fctB, 0.5050, 4.00, 0.063, 216, 111, MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN
4175, 2eysA, 0.5050, 3.86, 0.102, 202, 108, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
4176, 2ataB, 0.5050, 3.70, 0.069, 198, 102, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX II)
4177, 1xedB, 0.5050, 3.45, 0.089, 109, 101, CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR PIGR
4178, 1fe8M, 0.5050, 3.97, 0.075, 211, 107, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
4179, 1emtL, 0.5050, 4.06, 0.084, 214, 107, FAB ANTIBODY FRAGMENT OF AN C60 ANTIFULLERENE ANTIBODY
4180, 6medI, 0.5049, 4.02, 0.075, 213, 107, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
4181, 6j5gH, 0.5049, 3.68, 0.058, 120, 104, COMPLEX STRUCTURE OF MAB 4.2-SCFV WITH TICK-BORNE ENCEPHALITIS VIRUS ENVELOPE PROTEIN 
4182, 6j5dH, 0.5049, 3.67, 0.067, 120, 104, COMPLEX STRUCTURE OF MAB 4.2-SCFV WITH LOUPING ILL VIRUS ENVELOPE PROTEIN DOMAIN III 
4183, 6fr7A, 0.5049, 3.93, 0.136, 203, 110, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
4184, 6flaH, 0.5049, 3.95, 0.083, 217, 109, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 1 
4185, 6eh5A, 0.5049, 3.88, 0.130, 202, 108, 003 HUMAN T-CELL RECEPTOR SPECIFIC FOR HIV GAG EPITOPE SLYNTVATL CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-A*0201 
4186, 6cxyL, 0.5049, 3.81, 0.105, 217, 105, CRYSTAL STRUCTURE OF HUMAN E-CADHERIN BOUND BY MOUSE MONOCLONAL ANTIBODY FAB MAB-1_19A11 
4187, 6b5lL, 0.5049, 4.02, 0.103, 218, 107, STRUCTURE OF PFCSP PEPTIDE 20 WITH HUMAN PROTECTIVE ANTIBODY CIS43
4188, 6azxB, 0.5049, 4.08, 0.093, 211, 107, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 663 ANTIBODY
4189, 6axkB, 0.5049, 3.89, 0.103, 214, 107, CRYSTAL STRUCTURE OF FAB311 COMPLEX
4190, 6arpC, 0.5049, 3.93, 0.094, 213, 106, STRUCTURE OF A MUTANT CETUXIMAB FAB FRAGMENT 
4191, 5yl1A, 0.5049, 4.50, 0.055, 185, 110, T=1 SUBVIRAL PARTICLE OF PENAEUS VANNAMEI NODAVIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-37  and 251-368) 
4192, 5wkzH, 0.5049, 4.06, 0.063, 221, 111, VH1-69 GERMLINE ANTIBODY PREDICTED FROM CR6261 
4193, 5udcC, 0.5049, 4.02, 0.075, 211, 107, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
4194, 5myxA, 0.5049, 3.86, 0.114, 219, 105, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 24 IN COMPLEX WITH HUMAN ABETA-PE3-18
4195, 5mthL, 0.5049, 4.00, 0.121, 219, 107, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACEGROUP P21 
4196, 5i15L, 0.5049, 3.98, 0.085, 214, 106, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV1-39
4197, 5hyjD, 0.5049, 3.81, 0.104, 193, 106, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA
4198, 5gisH, 0.5049, 4.00, 0.118, 210, 110, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE
4199, 5drzA, 0.5049, 3.96, 0.113, 218, 106, CRYSTAL STRUCTURE OF ANTI-HIV-1 ANTIBODY F240 FAB IN COMPLEX WITH GP41 PEPTIDE
4200, 5dk3A, 0.5049, 4.00, 0.075, 218, 107, CRYSTAL STRUCTURE OF PEMBROLIZUMAB A FULL LENGTH IGG4 ANTIBODY
4201, 5d6cL, 0.5049, 4.12, 0.102, 219, 108, STRUCTURE OF 4497 FAB BOUND TO SYNTHETIC WALL TEICHOIC ACID FRAGMENT
4202, 5c08D, 0.5049, 3.61, 0.086, 189, 105, 1E6 TCR IN COMPLEX WITH HLA-A0E CARRYING RQWGPDPAAV
4203, 4yx2H, 0.5049, 4.07, 0.080, 214, 112, CRYSTAL STRUCTURE OF BOVINE PRION PROTEIN COMPLEXED WITH POM1 FAB
4204, 4pjaH, 0.5049, 3.71, 0.085, 238, 106, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-B10 TCR
4205, 4odvL, 0.5049, 4.05, 0.093, 214, 107, FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY A6 IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE
4206, 4laqL, 0.5049, 3.91, 0.133, 118, 105, CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN THE FREE FORM AND IN COMPLEX WITH AMPHETAMINE AND 4-HYDROXYMETHAMPHETAMINE
4207, 4gw1C, 0.5049, 4.05, 0.084, 213, 107, CQFD MEDITOPE
4208, 4gg6G, 0.5049, 3.73, 0.144, 177, 104, PROTEIN COMPLEX
4209, 4g80F, 0.5049, 3.98, 0.084, 211, 107, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT 3.8 A)
4210, 4elmE, 0.5049, 3.83, 0.094, 179, 106, CRYSTAL STRUCTURE OF THE MOUSE CD1D-LYSOSULFATIDE-HY19.3 TCR COMPLEX
4211, 3wiiH, 0.5049, 4.05, 0.081, 220, 111, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1.
4212, 3us2H, 0.5049, 3.79, 0.097, 182, 103, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 19 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING TWO HALF SITES WITH A SINGLE BASE PAIR OVERLAP
4213, 3umtA, 0.5049, 3.91, 0.056, 227, 107, SCFV12 ANTI-BCLA ANTIBODY SINGLE CHAIN VARIABLE FRAGMENT
4214, 3t0vA, 0.5049, 3.82, 0.096, 112, 104, UNLIGANDED FLUOROGEN ACTIVATING PROTEIN M8VL
4215, 3sjvO, 0.5049, 3.64, 0.076, 241, 105, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
4216, 3opzM, 0.5049, 3.96, 0.123, 212, 106, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
4217, 3mmeC, 0.5049, 4.09, 0.081, 222, 111, STRUCTURE AND FUNCTIONAL DISSECTION OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
4218, 3ixtB, 0.5049, 3.83, 0.105, 210, 105, CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE
4219, 2r8sL, 0.5049, 3.81, 0.086, 214, 105, HIGH RESOLUTION STRUCTURE OF A SPECIFIC SYNTHETIC FAB BOUND TO P4-P6 RNA RIBOZYME DOMAIN
4220, 2qr0Q, 0.5049, 3.98, 0.084, 213, 107, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
4221, 2f54E, 0.5049, 3.65, 0.076, 241, 105, DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY
4222, 1uwgH, 0.5049, 3.89, 0.064, 208, 109, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
4223, 1t66C, 0.5049, 4.00, 0.112, 219, 107, THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN.
4224, 1nd0G, 0.5049, 4.01, 0.123, 219, 106, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
4225, 1mfcH, 0.5049, 3.88, 0.083, 211, 109, HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA
4226, 1lk3L, 0.5049, 3.94, 0.104, 210, 106, ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT
4227, 1l3nB, 0.5049, 4.59, 0.078, 153, 115, THE SOLUTION STRUCTURE OF REDUCED DIMERIC COPPER ZINC SOD: THE STRUCTURAL EFFECTS OF DIMERIZATION
4228, 6my5B, 0.5048, 4.09, 0.110, 218, 109, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M;LC-S30BR] 
4229, 6mnnA, 0.5048, 3.95, 0.130, 196, 108, 6236 TCR BOUND TO I-AB PADI4 
4230, 6gfeL, 0.5048, 3.90, 0.085, 215, 106, HIGH-RESOLUTION STRUCTURE OF A THERAPEUTIC FULL-LENGTH ANTI-NPRA ANTIBODY WITH EXCEPTIONAL CONFORMATIONAL DIVERSITY 
4231, 6eyoM, 0.5048, 4.07, 0.093, 201, 107, STRUCTURE OF EXTENDED IGE-FC IN COMPLEX WITH TWO ANTI-IGE FABS 
4232, 6dcaO, 0.5048, 4.01, 0.104, 215, 106, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 6B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
4233, 6be2L, 0.5048, 4.07, 0.130, 213, 108, CRYSTAL STRUCTURE OF A POLYSACCHARIDE-BINDING HUMAN FAB (F598)
4234, 6b5oL, 0.5048, 4.04, 0.093, 219, 107, STRUCTURE OF PFCSP PEPTIDE 29 WITH HUMAN PROTECTIVE ANTIBODY CIS43
4235, 6apdO, 0.5048, 3.81, 0.094, 213, 106, CRYSTAL STRUCTURE OF RSV F BOUND BY AM22 AND THE INFANT ANTIBODY ADI- 19425
4236, 5vcoA, 0.5048, 4.00, 0.084, 211, 107, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
4237, 5tlkG, 0.5048, 3.95, 0.075, 215, 107, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND H2191
4238, 5o14C, 0.5048, 4.10, 0.072, 223, 111, CO-CRYSTAL STRUCTURE OF A CROSS-REACTIVE BACTERICIDAL HUMAN ANTIBODY TARGETING MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN
4239, 5jziE, 0.5048, 3.85, 0.084, 240, 107, CRYSTAL STRUCTURE OF 1406 TCR BOUND TO HLA-A2 WITH HCV 1406-1415 ANTIGEN PEPTIDE
4240, 5ibtH, 0.5048, 4.11, 0.081, 218, 111, UCA FAB (UNBOUND) FROM 6515 LINEAGE
4241, 5i66A, 0.5048, 4.04, 0.072, 218, 111, X-RAY STRUCTURE OF THE FAB FRAGMENT OF 8B6 A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE HUMAN SEROTONIN TRANSPORTER
4242, 5i1iL, 0.5048, 4.05, 0.103, 219, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV4-1
4243, 5hysB, 0.5048, 3.95, 0.075, 217, 107, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
4244, 5drnL, 0.5048, 4.12, 0.065, 213, 108, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24 IN COMPLEX WITH HYPUSINE
4245, 5d7jB, 0.5048, 3.72, 0.085, 240, 106, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64(Y95ALPHAF) TCR
4246, 5d5mH, 0.5048, 3.72, 0.085, 241, 106, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64 TCR
4247, 5b3jL, 0.5048, 3.99, 0.084, 212, 107, ACTIVATION OF NMDA RECEPTORS AND THE MECHANISM OF INHIBITION BY IFENPRODIL
4248, 4zezG, 0.5048, 4.06, 0.109, 207, 110, CRYSTAL STRUCTURE OF HCV 1406 TCR/HCV NS3: 1406-1415/HLA-A2 COMPLEX
4249, 4wnqB, 0.5048, 3.86, 0.093, 241, 107, THE MOLECULAR BASES OF DELTA/ALPHA-BETA T-CELL MEDIATED ANTIGEN RECOGNITION
4250, 4wffD, 0.5048, 3.83, 0.105, 211, 105, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND NONCONDUCTIVE CONFORMATION
4251, 4qxgH, 0.5048, 3.97, 0.082, 218, 110, ANTIGEN BINDING FRAGMENT OF AN ANTI IFNAR1 ANTIBODY
4252, 4pp2A, 0.5048, 4.00, 0.084, 211, 107, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
4253, 4p5tA, 0.5048, 3.89, 0.120, 197, 108, 14.C6 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE
4254, 4n2fA, 0.5048, 4.01, 0.067, 633, 105, CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (D169A 0 MM CA2+)
4255, 4mhhK, 0.5048, 4.03, 0.121, 217, 107, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)
4256, 4jryD, 0.5048, 3.93, 0.121, 201, 107, CRYSTAL STRUCTURE OF SB47 TCR-HLA B*3505-LPEP COMPLEX
4257, 4hs6A, 0.5048, 4.06, 0.093, 218, 107, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY MRCT10.V362
4258, 4fp8N, 0.5048, 4.10, 0.084, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
4259, 4e41J, 0.5048, 3.81, 0.094, 238, 106, STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
4260, 3v6fB, 0.5048, 3.98, 0.121, 219, 107, CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6) UNBOUND
4261, 3opzN, 0.5048, 3.95, 0.123, 212, 106, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
4262, 3o4lE, 0.5048, 3.97, 0.083, 245, 109, GENETIC AND STRUCTURAL BASIS FOR SELECTION OF A UBIQUITOUS T CELL RECEPTOR DEPLOYED IN EPSTEIN-BARR VIRUS
4263, 3mo1A, 0.5048, 3.95, 0.112, 218, 107, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT
4264, 3inuL, 0.5048, 4.04, 0.084, 217, 107, CRYSTAL STRUCTURE OF AN UNBOUND KZ52 NEUTRALIZING ANTI-EBOLAVIRUS ANTIBODY.
4265, 3f58L, 0.5048, 4.03, 0.093, 215, 107, IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 12-RESIDUE CYCLIC PEPTIDE (INCLUDING RESIDUES 315-324 OF HIV-1 GP120 (MN ISOLATE); H315S MUTATION
4266, 3ck0L, 0.5048, 3.96, 0.131, 216, 107, ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II COMPLEX WITH HUMAN ANGIOTENSIN II
4267, 3c5zE, 0.5048, 3.93, 0.150, 201, 107, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
4268, 3baeH, 0.5048, 3.79, 0.093, 219, 108, CRYSTAL STRUCTURE OF FAB WO2 BOUND TO THE N TERMINAL DOMAIN OF AMYLOID BETA PEPTIDE (1-28)
4269, 2r56M, 0.5048, 4.04, 0.093, 211, 107, CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN
4270, 2qr0W, 0.5048, 4.01, 0.084, 213, 107, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
4271, 2qr0M, 0.5048, 3.98, 0.084, 213, 107, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
4272, 2p5eD, 0.5048, 3.77, 0.114, 194, 105, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
4273, 2o5xL, 0.5048, 4.04, 0.121, 218, 107, CRYSTAL STRUCTURE OF 1E9 LEUH47TRP/ARGH100TRP AN ENGINEERED DIELS- ALDERASE FAB WITH NM STEROID-BINDING AFFINITY
4274, 2ialD, 0.5048, 3.80, 0.065, 239, 107, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
4275, 2fatH, 0.5048, 4.06, 0.064, 214, 110, AN ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) ANTIBODY: CRYSTAL STRUCTURE AND BINDING EPITOPE
4276, 1za6E, 0.5048, 4.04, 0.103, 220, 107, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
4277, 1v7nL, 0.5048, 3.76, 0.125, 213, 104, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
4278, 1uywM, 0.5048, 4.01, 0.064, 218, 110, CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
4279, 1t04D, 0.5048, 4.04, 0.073, 218, 110, THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB IN C2 SPACE GROUP
4280, 1q0yH, 0.5048, 3.96, 0.064, 215, 110, ANTI-MORPHINE ANTIBODY 9B1 COMPLEXED WITH MORPHINE
4281, 1pg7Z, 0.5048, 4.03, 0.073, 220, 110, MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB
4282, 1ngwB, 0.5048, 4.20, 0.080, 216, 113, CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
4283, 1mh5H, 0.5048, 3.86, 0.092, 190, 109, THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE ANALOG
4284, 6fn4C, 0.5047, 4.08, 0.100, 225, 110, APO FORM OF UIC2 FAB COMPLEX OF HUMAN-MOUSE CHIMERIC ABCB1 (ABCB1HM)
4285, 6cuhB, 0.5047, 3.75, 0.066, 240, 106, CRYSTAL STRUCTURE OF THE UNLIGANDED BC8B TCR 
4286, 6cbvL, 0.5047, 4.00, 0.084, 213, 107, CRYSTAL STRUCTURE OF BRIL BOUND TO AN AFFINITY MATURED SYNTHETIC ANTIBODY. 
4287, 6bb4H, 0.5047, 4.00, 0.082, 216, 110, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY C5.2 TARGETING A PHOSPHO-TAU EPITOPE. 
4288, 6azxD, 0.5047, 4.08, 0.084, 215, 107, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 663 ANTIBODY
4289, 5yxuF, 0.5047, 4.03, 0.109, 190, 110, AN AFFINITY ENHANCED T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HCV NS3 PEPTIDE KLVALGINAV 
4290, 5x2nJ, 0.5047, 4.16, 0.062, 219, 112, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
4291, 5vigL, 0.5047, 4.05, 0.084, 212, 107, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z006 BOUND TO ZIKA VIRUS ENVELOPE PROTEIN DIII
4292, 5u8qH, 0.5047, 3.66, 0.067, 118, 104, STRUCTURE OF THE ECTODOMAIN OF THE HUMAN TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR IN COMPLEX WITH IGF-I
4293, 5t1lC, 0.5047, 4.03, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH CQA(PH)2DLSTRRLKC PEPTIDE
4294, 5szfL, 0.5047, 4.07, 0.084, 212, 107, 2A10 FAB FRAGMENT 2.54 ANGSTOMS
4295, 5o4yC, 0.5047, 3.89, 0.095, 118, 105, STRUCTURE OF HUMAN PD-L1 IN COMPLEX WITH INHIBITOR
4296, 5nmgD, 0.5047, 3.83, 0.131, 200, 107, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYFNTIAVL
4297, 5mx3H, 0.5047, 3.92, 0.073, 219, 110, STRUCTURE OF DC8E8 FAB CRYSTALLIZED AT PH 8.5
4298, 5kvgH, 0.5047, 3.81, 0.083, 218, 108, ZIKA SPECIFIC ANTIBODY ZV-67 BOUND TO ZIKA ENVELOPE DIII
4299, 5hj3B, 0.5047, 3.96, 0.094, 203, 106, CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP GPCL.
4300, 5dtfB, 0.5047, 3.96, 0.094, 214, 106, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98.61 IN COMPLEX WITH HYPUSINE
4301, 5cu9A, 0.5047, 4.63, 0.068, 153, 117, CANDIDA ALBICANS SUPEROXIDE DISMUTASE 5 (SOD5) APO
4302, 4xmlL, 0.5047, 3.84, 0.094, 215, 106, CRYSTAL STRUCTURE OF FAB OF HIV-1 GP120 V3-SPECIFIC HUMAN MONOCLONAL ANTIBODY 2424
4303, 4x6bA, 0.5047, 3.77, 0.095, 196, 105, BK6 TCR APO STRUCTURE
4304, 4uv4L, 0.5047, 3.86, 0.094, 217, 106, CRYSTAL STRUCTURE OF ANTI-FPR FPRO0165 FAB FRAGMENT
4305, 4otxL, 0.5047, 3.98, 0.112, 211, 107, STRUCTURE OF THE ANTI-FRANCISELLA TULARENSIS O-ANTIGEN ANTIBODY N203 FAB FRAGMENT
4306, 4o5iO, 0.5047, 3.94, 0.056, 226, 108, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ
4307, 4k23L, 0.5047, 3.78, 0.114, 218, 105, STRUCTURE OF ANTI-UPAR FAB ATN-658
4308, 4hc1L, 0.5047, 3.95, 0.113, 213, 106, CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB 10G3
4309, 4g80B, 0.5047, 3.89, 0.085, 211, 106, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT 3.8 A)
4310, 4cmhB, 0.5047, 3.97, 0.083, 216, 109, CRYSTAL STRUCTURE OF CD38 WITH A NOVEL CD38-TARGETING ANTIBODY SAR650984
4311, 3w9dC, 0.5047, 3.70, 0.057, 211, 105, STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB
4312, 3vw3L, 0.5047, 4.03, 0.120, 215, 108, ANTIBODY 64M-5 FAB IN COMPLEX WITH A DOUBLE-STRANDED DNA (6-4) PHOTOPRODUCT
4313, 3qiwD, 0.5047, 3.99, 0.056, 238, 108, CRYSTAL STRUCTURE OF THE 226 TCR IN COMPLEX WITH MCC-P5E/I-EK
4314, 3ld8B, 0.5047, 4.07, 0.103, 217, 107, STRUCTURE OF JMJD6 AND FAB FRAGMENTS
4315, 3jb4B, 0.5047, 3.80, 0.029, 222, 102, STRUCTURE OF LJUNGAN VIRUS: INSIGHT INTO PICORNAVIRUS PACKAGING
4316, 3j7eL, 0.5047, 3.88, 0.086, 115, 105, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
4317, 3j7eE, 0.5047, 3.88, 0.086, 115, 105, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
4318, 3j7eC, 0.5047, 3.88, 0.086, 115, 105, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
4319, 3j7eA, 0.5047, 3.88, 0.086, 115, 105, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
4320, 3if1A, 0.5047, 3.96, 0.121, 215, 107, CRYSTAL STRUCTURE OF 237MAB IN COMPLEX WITH A GALNAC
4321, 3hr5P, 0.5047, 3.98, 0.084, 219, 107, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
4322, 3hmwH, 0.5047, 3.85, 0.073, 218, 110, CRYSTAL STRUCTURE OF USTEKINUMAB FAB
4323, 3c5zA, 0.5047, 3.93, 0.150, 202, 107, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
4324, 3bkjH, 0.5047, 3.79, 0.093, 224, 108, CRYSTAL STRUCTURE OF FAB WO2 BOUND TO THE N TERMINAL DOMAIN OF AMYLOID BETA PEPTIDE (1-16)
4325, 2qr0G, 0.5047, 4.01, 0.084, 213, 107, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
4326, 1xf4L, 0.5047, 3.91, 0.104, 213, 106, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING
4327, 1xcqG, 0.5047, 3.98, 0.093, 219, 107, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
4328, 1nd0E, 0.5047, 4.01, 0.123, 219, 106, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
4329, 1mhhC, 0.5047, 4.04, 0.103, 219, 107, ANTIBODY-ANTIGEN COMPLEX
4330, 1ai1L, 0.5047, 4.00, 0.093, 215, 107, HIV-1 V3 LOOP MIMIC
4331, 6o3bA, 0.5046, 4.02, 0.075, 213, 107, CRYSTAL STRUCTURE OF FRIZZLED 7 CRD IN COMPLEX WITH F6 FAB 
4332, 6mnoA, 0.5046, 3.96, 0.130, 196, 108, 6235 TCR BOUND TO I-AB PADI4 
4333, 6meiL, 0.5046, 4.01, 0.075, 214, 107, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
4334, 6jbtH, 0.5046, 4.00, 0.055, 217, 110, COMPLEX STRUCTURE OF TORIPALIMAB-FAB AND PD-1 
4335, 6f2sB, 0.5046, 4.66, 0.071, 195, 112, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
4336, 6eluL, 0.5046, 4.02, 0.103, 217, 107, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
4337, 6ejgD, 0.5046, 4.00, 0.074, 231, 108, CRYSTAL STRUCTURE OF HUMAN CD81 LARGE EXTRACELLULAR LOOP IN COMPLEX WITH SINGLE CHAIN FV FRAGMENT 4 
4338, 6e0cM, 0.5046, 3.92, 0.083, 229, 108, CRYO-EM STRUCTURE OF THE CENP-A NUCLEOSOME (W601) IN COMPLEX WITH A SINGLE CHAIN ANTIBODY FRAGMENT 
4339, 6dc7L, 0.5046, 4.08, 0.111, 218, 108, APO FAB STRUCTURE OF MOUSE MONOCLONAL ANTIBODY 8B2 
4340, 6d0uI, 0.5046, 4.08, 0.075, 213, 107, CRYSTAL STRUCTURE OF C05 V110P/A117E MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ; HA1 SUBUNIT 
4341, 6awpC, 0.5046, 4.09, 0.121, 214, 107, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH FLUVOXAMINE AT THE CENTRAL SITE
4342, 5w1vT, 0.5046, 3.74, 0.066, 243, 106, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
4343, 5umnF, 0.5046, 4.06, 0.075, 213, 107, CRYSTAL STRUCTURE OF C05 VPGSGW MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
4344, 5t1kC, 0.5046, 3.95, 0.112, 213, 107, CETUXIMAB FAB IN COMPLEX WITH CQFDA(PH)2STRRLKC
4345, 5nmgI, 0.5046, 3.88, 0.121, 200, 107, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYFNTIAVL
4346, 5mjvC, 0.5046, 3.87, 0.039, 257, 103, REBUILD AND RE-REFINED MODEL FOR HUMAN PARECHOVIRUS 1
4347, 5iw1E, 0.5046, 3.94, 0.102, 189, 108, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR
4348, 5ezlL, 0.5046, 3.95, 0.103, 213, 107, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - MONOCLINIC FORM
4349, 5e6iQ, 0.5046, 3.70, 0.094, 238, 106, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
4350, 5a3iG, 0.5046, 3.91, 0.073, 226, 110, CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN FLD194 FAB AND TRANSMISSIBLE MUTANT H5 HAEMAGGLUTININ
4351, 4wfhD, 0.5046, 3.83, 0.105, 211, 105, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND NONCONDUCTIVE CONFORMATION
4352, 4oz4B, 0.5046, 3.97, 0.131, 218, 107, X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.
4353, 4nrxE, 0.5046, 3.94, 0.094, 211, 106, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
4354, 4lriA, 0.5046, 4.07, 0.084, 217, 107, ANTI CMV FAB FRAGMENT
4355, 4jr9H, 0.5046, 4.03, 0.054, 213, 112, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK
4356, 4hixL, 0.5046, 3.80, 0.095, 219, 105, CRYSTAL STRUCTURE OF A HUMANISED 3D6 FAB BOUND TO AMYLOID BETA PEPTIDE
4357, 4ftvE, 0.5046, 3.83, 0.075, 245, 107, THE COMPLEX BETWEEN THE HIGH AFFINITY VERSION OF A6 TCR (A6C134) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TAX NONAMERIC PEPTIDE
4358, 4ag4H, 0.5046, 4.03, 0.108, 209, 111, CRYSTAL STRUCTURE OF A DDR1-FAB COMPLEX
4359, 3x2dO, 0.5046, 3.90, 0.086, 211, 105, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
4360, 3wlwH, 0.5046, 3.93, 0.056, 217, 108, MOLECULAR ARCHITECTURE OF THE ERBB2 EXTRACELLULAR DOMAIN HOMODIMER
4361, 3sknA, 0.5046, 3.86, 0.104, 197, 106, CRYSTAL STRUCTURE OF THE RL42 TCR UNLIGANDED
4362, 3sgdI, 0.5046, 3.85, 0.105, 218, 105, CRYSTAL STRUCTURE OF THE MOUSE MAB 17.2
4363, 3ncyW, 0.5046, 3.84, 0.114, 211, 105, X-RAY CRYSTAL STRUCTURE OF AN ARGININE AGMATINE ANTIPORTER (ADIC) IN COMPLEX WITH A FAB FRAGMENT
4364, 3ncyS, 0.5046, 3.84, 0.114, 211, 105, X-RAY CRYSTAL STRUCTURE OF AN ARGININE AGMATINE ANTIPORTER (ADIC) IN COMPLEX WITH A FAB FRAGMENT
4365, 2vq1E, 0.5046, 4.02, 0.104, 216, 106, ANTI TRIMERIC LEWIS X FAB54-5C10-A
4366, 2qr0A, 0.5046, 4.01, 0.084, 213, 107, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
4367, 2p5eE, 0.5046, 3.66, 0.076, 241, 105, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
4368, 1zanL, 0.5046, 4.00, 0.112, 213, 107, CRYSTAL STRUCTURE OF ANTI-NGF AD11 FAB
4369, 1xf4H, 0.5046, 4.09, 0.072, 213, 111, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING
4370, 1r70A, 0.5046, 4.06, 0.084, 214, 107, MODEL OF HUMAN IGA2 DETERMINED BY SOLUTION SCATTERING CURVE FITTING AND HOMOLOGY MODELLING
4371, 1p7kH, 0.5046, 3.92, 0.082, 220, 110, CRYSTAL STRUCTURE OF AN ANTI-SSDNA ANTIGEN-BINDING FRAGMENT (FAB) BOUND TO 4-(2-HYDROXYETHYL)PIPERAZINE-1-ETHANESULFONIC ACID (HEPES)
4372, 1nqbA, 0.5046, 3.84, 0.065, 232, 107, TRIVALENT ANTIBODY FRAGMENT
4373, 1lmkE, 0.5046, 3.93, 0.056, 238, 108, THE STRUCTURE OF A BIVALENT DIABODY
4374, 1fbiQ, 0.5046, 4.13, 0.081, 221, 111, CRYSTAL STRUCTURE OF A CROSS-REACTION COMPLEX BETWEEN FAB F9.13.7 AND GUINEA-FOWL LYSOZYME
4375, 1dqdL, 0.5046, 3.77, 0.124, 214, 105, CRYSTAL STRUCTURE OF FAB HGR-2 F6 A COMPETITIVE ANTAGONIST OF THE GLUCAGON RECEPTOR
4376, 1ce1L, 0.5046, 3.95, 0.075, 211, 106, 1.9A STRUCTURE OF THE THERAPEUTIC ANTIBODY CAMPATH-1H FAB IN COMPLEX WITH A SYNTHETIC PEPTIDE ANTIGEN
4377, 6o39A, 0.5045, 3.85, 0.085, 212, 106, CRYSTAL STRUCTURE OF FRIZZLED 5 CRD IN COMPLEX WITH F2.I FAB 
4378, 6furD, 0.5045, 3.63, 0.086, 240, 105, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
4379, 6eh4D, 0.5045, 3.88, 0.130, 204, 108, 003 HUMAN T-CELL RECEPTOR SPECIFIC FOR HIV GAG EPITOPE SLYNTVATL CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-A*0201 
4380, 6c68A, 0.5045, 3.95, 0.121, 205, 107, MHC-INDEPENDENT T CELL RECEPTOR A11 
4381, 6b0hC, 0.5045, 4.10, 0.084, 213, 107, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1262
4382, 5ywpN, 0.5045, 4.13, 0.054, 218, 111, JEV-2H4 FAB COMPLEX 
4383, 5wkfD, 0.5045, 3.57, 0.115, 198, 104, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS1
4384, 5tljF, 0.5045, 3.95, 0.092, 219, 109, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND M2191
4385, 5tljE, 0.5045, 4.03, 0.093, 215, 107, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND M2191
4386, 5tbdE, 0.5045, 3.63, 0.058, 113, 103, CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB4D11) IN COMPLEX WITH 3D7-MSP2 215-222
4387, 5k8aM, 0.5045, 3.94, 0.094, 213, 106, NIST FAB
4388, 5iw1A, 0.5045, 3.93, 0.102, 189, 108, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR
4389, 5dwuL, 0.5045, 4.15, 0.084, 207, 107, BETA COMMON RECEPTOR IN COMPLEX WITH A FAB
4390, 5d4kA, 0.5045, 3.77, 0.074, 539, 108, CRYSTAL STRUCTURE OF THE HUMAN POLYMERIC IG RECEPTOR (PIGR) ECTODOMAIN
4391, 4zffL, 0.5045, 4.03, 0.075, 213, 107, DUAL-ACTING FAB 5A12 IN COMPLEX WITH VEGF
4392, 4z7wG, 0.5045, 3.96, 0.130, 191, 108, T316 COMPLEX
4393, 4wfhG, 0.5045, 4.14, 0.071, 210, 112, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND NONCONDUCTIVE CONFORMATION
4394, 4uihF, 0.5045, 3.75, 0.047, 120, 107, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 STRAIN NEW GUINEA-C COMPLEXED WITH HUMAN ANTIBODY 2D22 FAB AT 37 DEGREE C. THE FAB MOLECULES WERE ADDED TO THE VIRUS BEFORE 37 DEGREE C INCUBATION.
4395, 4uifI, 0.5045, 3.75, 0.047, 120, 107, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 IN COMPLEX WITH ANTIGEN-BINDING FRAGMENTS OF HUMAN ANTIBODY 2D22
4396, 4pb0L, 0.5045, 3.81, 0.114, 216, 105, STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-FRANCISELLA TULARENSIS GROEL ANTIBODY AB53
4397, 4jm0A, 0.5045, 4.02, 0.098, 175, 112, STRUCTURE OF HUMAN CYTOMEGALOVIRUS IMMUNE MODULATOR UL141
4398, 4ffyH, 0.5045, 4.01, 0.073, 119, 110, CRYSTAL STRUCTURE OF DENV1-E111 SINGLE CHAIN VARIABLE FRAGMENT BOUND TO DENV-1 DIII STRAIN 16007.
4399, 4f33B, 0.5045, 4.04, 0.064, 219, 110, CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009
4400, 4djmA, 0.5045, 3.15, 0.106, 196, 94, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
4401, 3wd5L, 0.5045, 4.01, 0.084, 213, 107, CRYSTAL STRUCTURE OF TNFALPHA IN COMPLEX WITH ADALIMUMAB FAB FRAGMENT
4402, 3vi3L, 0.5045, 4.06, 0.103, 219, 107, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
4403, 3v6fL, 0.5045, 3.98, 0.121, 219, 107, CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6) UNBOUND
4404, 3us0A, 0.5045, 4.10, 0.095, 195, 105, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING A TWO BASE PAIR AT SPACER BETWEEN HALF SITES
4405, 3u30E, 0.5045, 3.99, 0.084, 211, 107, CRYSTAL STRUCTURE OF A LINEAR-SPECIFIC UBIQUITIN FAB BOUND TO LINEAR UBIQUITIN
4406, 3mugB, 0.5045, 4.01, 0.072, 237, 111, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4407, 3lrgA, 0.5045, 3.60, 0.118, 114, 102, STRUCTURE OF ANTI-HUNTINGTIN VL DOMAIN
4408, 3ietC, 0.5045, 3.95, 0.121, 217, 107, CRYSTAL STRUCTURE OF 237MAB WITH ANTIGEN
4409, 3hi1L, 0.5045, 4.01, 0.093, 215, 107, STRUCTURE OF HIV-1 GP120 (CORE WITH V3) IN COMPLEX WITH CD4-BINDING- SITE ANTIBODY F105
4410, 3bgfH, 0.5045, 4.14, 0.081, 216, 111, X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB
4411, 2w65C, 0.5045, 4.12, 0.081, 211, 111, ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 IN COMPLEX WITH A CITRULLINATED PEPTIDE
4412, 2r2eA, 0.5045, 3.98, 0.121, 219, 107, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
4413, 2nr6D, 0.5045, 4.05, 0.072, 213, 111, CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
4414, 2j21A, 0.5045, 3.69, 0.059, 188, 102, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-N268D-R282W
4415, 2hrpM, 0.5045, 3.82, 0.095, 218, 105, ANTIGEN-ANTIBODY COMPLEX
4416, 1xedE, 0.5045, 3.80, 0.075, 111, 106, CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR PIGR
4417, 1mhhD, 0.5045, 4.10, 0.098, 214, 112, ANTIBODY-ANTIGEN COMPLEX
4418, 1kb5L, 0.5045, 4.02, 0.151, 214, 106, MURINE T-CELL RECEPTOR VARIABLE DOMAIN/FAB COMPLEX
4419, 1f3dH, 0.5045, 4.03, 0.073, 217, 109, CATALYTIC ANTIBODY 4B2 IN COMPLEX WITH ITS AMIDINIUM HAPTEN.
4420, 1ehlH, 0.5045, 4.04, 0.064, 217, 110, 64M-2 ANTIBODY FAB COMPLEXED WITH D(5HT)(6-4)T
4421, 1a0qL, 0.5045, 3.90, 0.086, 211, 105, 29G11 COMPLEXED WITH PHENYL [1-(1-N-SUCCINYLAMINO)PENTYL] PHOSPHONATE
4422, 6oe5L, 0.5044, 4.10, 0.065, 212, 107, SPLAYED OPEN PREFUSION RSV F CAPTURED BY CR9501 AND MOTAVIZUMAB FABS 
4423, 6fr4A, 0.5044, 3.88, 0.130, 202, 108, 003 TCR STUDY OF CDR LOOP FLEXIBILITY 
4424, 6d0uF, 0.5044, 4.00, 0.075, 213, 107, CRYSTAL STRUCTURE OF C05 V110P/A117E MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ; HA1 SUBUNIT 
4425, 6crqI, 0.5044, 4.25, 0.064, 125, 110, GLUTARALDEHYDE-TREATED BG505 SOSIP.664 ENV IN COMPLEX WITH PGV04 FAB 
4426, 6bgtA, 0.5044, 4.04, 0.093, 211, 107, STRUCTURE OF TRASTUZUMAB FAB MUTANT IN COMPLEX WITH HER2 EXTRACELLULAR DOMAIN 
4427, 6b5nL, 0.5044, 4.02, 0.093, 219, 107, STRUCTURE OF PFCSP PEPTIDE 25 WITH HUMAN PROTECTIVE ANTIBODY CIS43
4428, 6awnB, 0.5044, 4.07, 0.080, 218, 112, X-RAY STRUCTURE OF THE S439T HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH PAROXETINE AT THE CENTRAL SITE
4429, 6a0xE, 0.5044, 3.89, 0.064, 223, 109, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 
4430, 5wkfE, 0.5044, 3.88, 0.102, 244, 108, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS1
4431, 5w1vJ, 0.5044, 3.86, 0.084, 243, 107, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
4432, 5ur8A, 0.5044, 4.20, 0.071, 229, 112, HUMAN ANTIBODY FRAGMENT (FAB) TO MENINGOCOCCAL FACTOR H BINDING PROTEIN
4433, 5nbwL, 0.5044, 3.90, 0.095, 214, 105, CRYSTAL STRUCTURE OF THE FAB FRAGMENT 22F12 IN COMPLEX WITH 3- HYDROXYBENZO[A]PYRENE
4434, 5mo3L, 0.5044, 3.94, 0.121, 218, 107, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 8.5 
4435, 5mcwB, 0.5044, 3.90, 0.058, 199, 103, P53-DNA COMPLEX 4 
4436, 5kw9H, 0.5044, 3.62, 0.067, 215, 105, STRUCTURAL BASIS FOR NOROVIRUS NEUTRALIZATION BY A HBGA BLOCKING HUMAN IGA ANTIBODY
4437, 5j3dD, 0.5044, 4.04, 0.084, 215, 107, CRYSTAL STRUCTURE OF HUMAN FAB 14N4 IN COMPLEX WITH POST-FUSION RSV F
4438, 5iw1D, 0.5044, 3.65, 0.096, 233, 104, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR
4439, 5i73B, 0.5044, 4.08, 0.072, 218, 111, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL AND ALLOSTERIC SITES
4440, 5i71B, 0.5044, 4.09, 0.081, 218, 111, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE
4441, 5i1lL, 0.5044, 4.05, 0.093, 220, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV4-1
4442, 5hysD, 0.5044, 3.96, 0.075, 217, 107, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
4443, 5hj3J, 0.5044, 4.06, 0.093, 209, 107, CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP GPCL.
4444, 5fhaL, 0.5044, 3.91, 0.094, 212, 106, CRYSTAL STRUCTURE OF PROTECTIVE EBOLA VIRUS ANTIBODY 114
4445, 5dubB, 0.5044, 4.08, 0.075, 214, 107, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98 IN COMPLEX WITH DEOXYHYPUSINE
4446, 5dfvD, 0.5044, 4.06, 0.103, 217, 107, CRYSTAL STRUCTURE OF HUMAN CD81 LARGE EXTRACELLULAR LOOP IN COMPLEX WITH MURINE FAB FRAGMENT K04
4447, 5c0cD, 0.5044, 3.81, 0.075, 200, 106, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDWIVA
4448, 4wv1D, 0.5044, 4.01, 0.093, 214, 107, CRYSTAL STRUCTURE OF THE FGFR2 D2 DOMAIN IN COMPLEX WITH FAB 2B.1.3
4449, 4s1dF, 0.5044, 4.10, 0.103, 213, 107, STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE
4450, 4pjiF, 0.5044, 3.78, 0.103, 240, 107, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-C10 TCR
4451, 4nrxA, 0.5044, 4.09, 0.089, 229, 112, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
4452, 4gg6E, 0.5044, 3.73, 0.144, 187, 104, PROTEIN COMPLEX
4453, 3tzvH, 0.5044, 3.82, 0.093, 244, 107, CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE
4454, 3sjvT, 0.5044, 3.72, 0.075, 241, 106, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
4455, 3o2vL, 0.5044, 4.03, 0.104, 218, 106, CRYSTAL STRUCTURE OF 1E9 PHEL89SER/LEUH47TRP/METH100BPHE AN ENGINEERED DIELS-ALDERASE FAB WITH MODIFIED SPECIFICITY AND CATALYTIC ACTIVITY
4456, 3mlwI, 0.5044, 4.01, 0.055, 228, 109, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE
4457, 3kprJ, 0.5044, 3.76, 0.104, 241, 106, CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLKAWTF A MIMOTOPE
4458, 3i50L, 0.5044, 3.73, 0.106, 207, 104, CRYSTAL STRUCTURE OF THE WEST NILE VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE E53 ANTIBODY FAB
4459, 3clfH, 0.5044, 4.00, 0.081, 220, 111, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23
4460, 2zckL, 0.5044, 3.90, 0.104, 218, 106, CRYSTAL STRUCTURE OF A TERNARY COMPLEX BETWEEN PSA A SUBSTRAT-ACYL INTERMEDIATE AND AN ACTIVATING ANTIBODY
4461, 2yplE, 0.5044, 3.61, 0.087, 238, 104, STRUCTURAL FEATURES UNDERLYING T-CELL RECEPTOR SENSITIVITY TO CONCEALED MHC CLASS I MICROPOLYMORPHISMS
4462, 2q76C, 0.5044, 4.03, 0.112, 212, 107, MOUSE ANTI-HEN EGG WHITE LYSOZYME ANTIBODY F10.6.6 FAB FRAGMENT
4463, 2nx5N, 0.5044, 3.68, 0.133, 188, 105, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
4464, 1sbsL, 0.5044, 3.82, 0.114, 220, 105, CRYSTAL STRUCTURE OF AN ANTI-HCG FAB
4465, 1q9wD, 0.5044, 4.06, 0.081, 226, 111, S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
4466, 1nmaL, 0.5044, 4.03, 0.075, 109, 106, N9 NEURAMINIDASE COMPLEXES WITH ANTIBODIES NC41 AND NC10: EMPIRICAL FREE-ENERGY CALCULATIONS CAPTURE SPECIFICITY TRENDS OBSERVED WITH MUTANT BINDING DATA
4467, 1n64H, 0.5044, 4.13, 0.089, 218, 112, CRYSTAL STRUCTURE ANALYSIS OF THE IMMUNODOMINANT ANTIGENIC SITE ON HEPATITIS C VIRUS PROTEIN BOUND TO MAB 19D9D6
4468, 1ikfL, 0.5044, 4.03, 0.093, 214, 107, A CONFORMATION OF CYCLOSPORIN A IN AQUEOUS ENVIRONMENT REVEALED BY THE X-RAY STRUCTURE OF A CYCLOSPORIN-FAB COMPLEX
4469, 1ae6H, 0.5044, 4.13, 0.062, 218, 112, IGG-FAB FRAGMENT OF MOUSE MONOCLONAL ANTIBODY CTM01
4470, 6k2iA, 0.5043, 4.10, 0.083, 131, 109, SOLUTION STRUCTURE OF CAMELID NANOBODY NB11 AGAINST AFLATOXIN B1 
4471, 6c68D, 0.5043, 3.80, 0.057, 238, 106, MHC-INDEPENDENT T CELL RECEPTOR A11 
4472, 6arpA, 0.5043, 3.92, 0.094, 213, 106, STRUCTURE OF A MUTANT CETUXIMAB FAB FRAGMENT 
4473, 5x2qJ, 0.5043, 4.13, 0.063, 218, 111, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH GLYCINE
4474, 5vgjL, 0.5043, 3.99, 0.112, 217, 107, CRYSTAL STRUCTURE OF THE HUMAN FAB VRC38.01 AN HIV-1 V1V2-DIRECTED NEUTRALIZING ANTIBODY ISOLATED FROM DONOR N90 BOUND TO A SCAFFOLDED WITO V1V2 DOMAIN
4475, 5tztB, 0.5043, 3.99, 0.094, 218, 106, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B161
4476, 5tlkC, 0.5043, 4.02, 0.075, 215, 107, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND H2191
4477, 5mx3B, 0.5043, 3.98, 0.131, 218, 107, STRUCTURE OF DC8E8 FAB CRYSTALLIZED AT PH 8.5
4478, 5mp1F, 0.5043, 4.02, 0.064, 215, 110, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
4479, 5mhrR, 0.5043, 4.11, 0.071, 213, 112, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
4480, 5mcwA, 0.5043, 3.90, 0.068, 199, 103, P53-DNA COMPLEX 4 
4481, 5kbkA, 0.5043, 4.61, 0.068, 157, 117, CANDIDA ALBICANS SUPEROXIDE DISMUTASE 5 (SOD5) E110A MUTANT
4482, 5jhdJ, 0.5043, 3.85, 0.084, 239, 107, CRYSTAL STRUCTURE OF LS10-TCR/M1-HLA-A*02 COMPLEX
4483, 5fhbH, 0.5043, 3.99, 0.063, 228, 111, CRYSTAL STRUCTURE OF PROTECTIVE EBOLA VIRUS ANTIBODY 100
4484, 5eocJ, 0.5043, 4.07, 0.117, 214, 111, CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I
4485, 5d1zC, 0.5043, 3.95, 0.075, 208, 107, ISDB NEAT1 BOUND BY CLONE D4-10
4486, 4whtT, 0.5043, 3.94, 0.104, 215, 106, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P1 CRYSTAL FORM
4487, 4wfeD, 0.5043, 3.83, 0.105, 211, 105, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND CONDUCTIVE CONFORMATION
4488, 4qwwC, 0.5043, 3.74, 0.135, 212, 104, CRYSTAL STRUCTURE OF THE FAB410-BFACHE COMPLEX
4489, 4p4kG, 0.5043, 3.86, 0.132, 203, 106, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTO IMMUNITY
4490, 4oz4H, 0.5043, 3.94, 0.073, 219, 110, X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.
4491, 4nwtL, 0.5043, 4.02, 0.093, 220, 107, CRYSTAL STRUCTURE OF THE ANTI-HUMAN NGF FAB APE1531
4492, 4jo2L, 0.5043, 4.05, 0.084, 216, 107, CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 CONSENSUS A GP120
4493, 4g7vL, 0.5043, 4.00, 0.084, 211, 107, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E 2.5 A)
4494, 3vi4H, 0.5043, 3.97, 0.055, 218, 110, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
4495, 3v6fD, 0.5043, 4.01, 0.112, 219, 107, CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6) UNBOUND
4496, 3o6lL, 0.5043, 3.94, 0.113, 217, 106, ANTI-TAT HIV 11H6H1 FAB  COMPLEXED WITH A 15-MER TAT PEPTIDE
4497, 3njhC, 0.5043, 3.37, 0.115, 120, 96, D37A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS.
4498, 3lh9A, 0.5043, 3.86, 0.099, 286, 101, CRYSTAL STRUCTURE OF MOUSE VPS26B(L197S/R199E) IN SPACEGROUP P41 21 2
4499, 3ldbB, 0.5043, 4.06, 0.103, 217, 107, STRUCTURE OF JMJD6 COMPLEXD WITH ALPHA-KETOGLUTARATE AND FAB FRAGMENT.
4500, 3l5wL, 0.5043, 4.09, 0.084, 213, 107, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB
4501, 3j3pL, 0.5043, 4.00, 0.112, 219, 107, CONFORMATIONAL SHIFT OF A MAJOR POLIOVIRUS ANTIGEN CONFIRMED BY IMMUNO-CRYOGENIC ELECTRON MICROSCOPY: 135S POLIOVIRUS AND C3-FAB COMPLEX
4502, 3iu3L, 0.5043, 3.73, 0.125, 208, 104, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY BASILIXIMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN
4503, 3if1C, 0.5043, 3.97, 0.121, 215, 107, CRYSTAL STRUCTURE OF 237MAB IN COMPLEX WITH A GALNAC
4504, 32c2A, 0.5043, 4.06, 0.093, 217, 107, STRUCTURE OF AN ACTIVITY SUPPRESSING FAB FRAGMENT TO CYTOCHROME P450 AROMATASE
4505, 2xqyG, 0.5043, 4.13, 0.098, 216, 112, CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
4506, 2iffL, 0.5043, 3.81, 0.114, 212, 105, STRUCTURE OF AN ANTIBODY-LYSOZYME COMPLEX: EFFECT OF A CONSERVATIVE MUTATION
4507, 2gsiE, 0.5043, 3.96, 0.094, 215, 106, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
4508, 2bnrE, 0.5043, 3.59, 0.077, 241, 104, STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
4509, 2b2xM, 0.5043, 3.73, 0.096, 210, 104, VLA1 RDELTAH I-DOMAIN COMPLEXED WITH A QUADRUPLE MUTANT OF THE AQC2 FAB
4510, 1xf3A, 0.5043, 3.85, 0.105, 213, 105, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P65
4511, 1nakL, 0.5043, 4.00, 0.131, 217, 107, IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE))
4512, 1mfeH, 0.5043, 3.92, 0.083, 210, 109, RECOGNITION OF A CELL-SURFACE OLIGO-SACCHARIDE OF PATHOGENIC SALMONELLA BY AN ANTIBODY FAB FRAGMENT
4513, 1a6wH, 0.5043, 3.97, 0.073, 120, 109, B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-5-IODO-3- NITROPHENYL) ACETATE COMPOUND
4514, 6mqmK, 0.5042, 4.02, 0.093, 217, 107, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY DF1W-A.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
4515, 6f2sE, 0.5042, 4.78, 0.070, 195, 114, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
4516, 6e63C, 0.5042, 3.97, 0.103, 212, 107, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY TB31F 
4517, 6be3L, 0.5042, 4.07, 0.130, 213, 108, CRYSTAL STRUCTURE OF A POLYSACCHARIDE-BINDING HUMAN FAB (F598) IN COMPLEX WITH N-ACETYL-D-GLUCOSAMINE (GLCNAC)
4518, 6b5sH, 0.5042, 3.98, 0.045, 215, 111, STRUCTURE OF PFCSP PEPTIDE 25 WITH HUMAN ANTIBODY CIS42
4519, 5lspH, 0.5042, 4.03, 0.055, 216, 110, 107_A07 FAB IN COMPLEX WITH FRAGMENT OF THE MET RECEPTOR
4520, 5lgyD, 0.5042, 3.71, 0.069, 196, 102, LYSINE 120-ACETYLATED P53 DNA BINDING DOMAIN IN A COMPLEX WITH THE BAX RESPONSE ELEMENT.
4521, 5lgyB, 0.5042, 3.70, 0.059, 197, 102, LYSINE 120-ACETYLATED P53 DNA BINDING DOMAIN IN A COMPLEX WITH THE BAX RESPONSE ELEMENT.
4522, 5jhdE, 0.5042, 3.86, 0.084, 239, 107, CRYSTAL STRUCTURE OF LS10-TCR/M1-HLA-A*02 COMPLEX
4523, 5ir1C, 0.5042, 3.93, 0.094, 213, 106, CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT
4524, 5epmB, 0.5042, 4.17, 0.111, 218, 108, CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT
4525, 5e6iB, 0.5042, 3.70, 0.085, 241, 106, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
4526, 4y1aE, 0.5042, 3.81, 0.074, 240, 108, IMMUNE COMPLEX
4527, 4u1gC, 0.5042, 4.00, 0.103, 215, 107, PLASMODIUM FALCIPARUM RETICULOCYTE-BINDING PROTEIN HOMOLOGUE 5 (PFRH5) BOUND TO MONOCLONAL ANTIBODY QA1
4528, 4ps4L, 0.5042, 4.03, 0.084, 213, 107, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND M1295 FAB
4529, 4plkC, 0.5042, 4.08, 0.112, 198, 107, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
4530, 4o5iW, 0.5042, 3.96, 0.056, 226, 108, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ
4531, 4j8rC, 0.5042, 4.01, 0.113, 210, 106, STRUCTURE OF AN OCTAPEPTIDE REPEAT OF THE PRION PROTEIN BOUND TO THE POM2 FAB ANTIBODY FRAGMENT
4532, 4i9wD, 0.5042, 3.83, 0.105, 211, 105, HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE
4533, 4gkzB, 0.5042, 3.88, 0.065, 241, 107, HA1.7 A MHC CLASS II RESTRICTED TCR SPECIFIC FOR HAEMAGGLUTININ
4534, 3vi4L, 0.5042, 3.94, 0.094, 219, 106, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
4535, 3qnxA, 0.5042, 3.87, 0.113, 219, 106, ORTHORHOMBIC FORM OF HUMAN IGA1 FAB FRAGMENT SHARING SAME FV AS IGG
4536, 3mugD, 0.5042, 3.98, 0.064, 237, 110, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4537, 3mlrH, 0.5042, 4.04, 0.063, 226, 111, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A NY5 V3 PEPTIDE
4538, 3hnsL, 0.5042, 3.89, 0.086, 214, 105, CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL HEXASACCHARIDE
4539, 3gi9L, 0.5042, 3.94, 0.113, 219, 106, CRYSTAL STRUCTURE OF APCT TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
4540, 3dsfL, 0.5042, 4.02, 0.112, 213, 107, CRYSTAL STRUCTURE OF ANTI-OSTEOPONTIN ANTIBODY 23C3 IN COMPLEX WITH W43A MUTATED EPITOPE PEPTIDE
4541, 2zclL, 0.5042, 4.04, 0.103, 218, 107, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN COMPLEXED WITH AN ACTIVATING ANTIBODY
4542, 2vlkD, 0.5042, 3.95, 0.104, 199, 106, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
4543, 2pcpC, 0.5042, 4.04, 0.131, 216, 107, ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
4544, 2ianE, 0.5042, 3.61, 0.067, 238, 104, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
4545, 1xcqF, 0.5042, 4.00, 0.090, 218, 111, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
4546, 1mhpL, 0.5042, 3.76, 0.087, 212, 104, CRYSTAL STRUCTURE OF A CHIMERIC ALPHA1 INTEGRIN I-DOMAIN IN COMPLEX WITH THE FAB FRAGMENT OF A HUMANIZED NEUTRALIZING ANTIBODY
4547, 1kgcE, 0.5042, 3.77, 0.104, 241, 106, IMMUNE RECEPTOR
4548, 1hq4C, 0.5042, 3.86, 0.114, 215, 105, STRUCTURE OF NATIVE CATALYTIC ANTIBODY HA5-19A4
4549, 1hq4A, 0.5042, 3.86, 0.114, 215, 105, STRUCTURE OF NATIVE CATALYTIC ANTIBODY HA5-19A4
4550, 1fskK, 0.5042, 3.91, 0.142, 214, 106, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
4551, 1fskH, 0.5042, 3.91, 0.142, 214, 106, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
4552, 1fskE, 0.5042, 3.91, 0.142, 214, 106, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
4553, 1fskB, 0.5042, 3.91, 0.142, 214, 106, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
4554, 1axsL, 0.5042, 3.94, 0.094, 211, 106, MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN
4555, 6i8sH, 0.5041, 4.03, 0.073, 214, 110, DISCOVERY AND CHARACTERISATION OF AN ANTIBODY THAT SELECTIVELY MODULATES THE INHIBITORY ACTIVITY OF PLASMINOGEN ACTIVATOR INHIBITOR- 1 
4556, 6fgbL, 0.5041, 3.83, 0.095, 219, 105, HUMAN FCRN EXTRA-CELLULAR DOMAIN COMPLEXED WITH FAB FRAGMENT OF ROZANOLIXIZUMAB 
4557, 6f2sK, 0.5041, 4.81, 0.070, 195, 114, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
4558, 6erxM, 0.5041, 3.95, 0.064, 215, 109, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
4559, 6dcaJ, 0.5041, 4.02, 0.064, 213, 110, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 6B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
4560, 5ywfB, 0.5041, 4.04, 0.054, 218, 111, CRYSTAL STRUCTURE OF 2H4 FAB
4561, 5xotD, 0.5041, 3.89, 0.121, 203, 107, CRYSTAL STRUCTURE OF PHLA-B35 IN COMPLEX WITH TU55 T CELL RECEPTOR
4562, 5x2mH, 0.5041, 4.16, 0.062, 219, 112, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMINE
4563, 5w1vD, 0.5041, 3.80, 0.144, 201, 104, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
4564, 5uddP, 0.5041, 4.07, 0.075, 212, 107, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
4565, 5nqkB, 0.5041, 3.64, 0.076, 242, 105, HUMAN 199.16 TCR IN COMPLEX WITH MELAN-A/MART-1 (26-35) PEPTIDE AND HLA-A2 
4566, 5nmfI, 0.5041, 3.89, 0.121, 201, 107, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTIATL
4567, 5kzpE, 0.5041, 4.06, 0.090, 226, 111, STRUCTURE OF THE HCV1-C1 ANTIBODY-ANTIGEN COMPLEX
4568, 5jziJ, 0.5041, 3.86, 0.084, 241, 107, CRYSTAL STRUCTURE OF 1406 TCR BOUND TO HLA-A2 WITH HCV 1406-1415 ANTIGEN PEPTIDE
4569, 5hcgL, 0.5041, 4.05, 0.093, 327, 107, CRYSTAL STRUCTURE OF FREE-CODV.
4570, 5h2bB, 0.5041, 3.94, 0.113, 211, 106, STRUCTURE OF A NOVEL ANTIBODY G196
4571, 5ezlB, 0.5041, 3.91, 0.104, 213, 106, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - MONOCLINIC FORM
4572, 5ea0L, 0.5041, 3.98, 0.093, 219, 107, STRUCTURE OF THE ANTIBODY 7968 WITH HUMAN COMPLEMENT FACTOR H-DERIVED PEPTIDE
4573, 4ztoL, 0.5041, 4.00, 0.094, 216, 106, FAB/EPITOPE COMPLEX STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION
4574, 4yhkL, 0.5041, 4.16, 0.102, 218, 108, REVERSAL AGENT FOR DABIGATRAN
4575, 4xr8C, 0.5041, 3.59, 0.069, 199, 101, CRYSTAL STRUCTURE OF THE HPV16 E6/E6AP/P53 TERNARY COMPLEX AT 2.25 A RESOLUTION
4576, 4p23A, 0.5041, 3.85, 0.140, 199, 107, J809.B5 TCR BOUND TO IAB/3K
4577, 4nryA, 0.5041, 4.11, 0.090, 218, 111, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66
4578, 4nkoE, 0.5041, 4.01, 0.094, 115, 106, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
4579, 4lu5L, 0.5041, 3.91, 0.113, 219, 106, STRUCTURE OF MURINE IGG2A A20G2-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.9 ANGSTROMS
4580, 4hxbL, 0.5041, 4.00, 0.121, 219, 107, CRYSTAL STRUCTURE OF 6B9 FAB
4581, 4fp8M, 0.5041, 4.05, 0.075, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
4582, 4f33D, 0.5041, 4.05, 0.064, 219, 110, CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009
4583, 4etqL, 0.5041, 3.75, 0.125, 212, 104, VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
4584, 3zdyE, 0.5041, 4.09, 0.063, 216, 111, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
4585, 3wsqL, 0.5041, 3.74, 0.068, 215, 103, STRUCTURE OF HER2 WITH AN FAB
4586, 3sknC, 0.5041, 3.88, 0.104, 197, 106, CRYSTAL STRUCTURE OF THE RL42 TCR UNLIGANDED
4587, 3qnyA, 0.5041, 3.81, 0.096, 218, 104, MONOCLINIC FORM OF HUMAN IGA1 FAB FRAGMENT SHARING SAME FV AS IGG
4588, 3qjhD, 0.5041, 4.07, 0.055, 242, 110, THE CRYSTAL STRUCTURE OF THE 5C.C7 TCR
4589, 3qeuA, 0.5041, 3.83, 0.113, 195, 106, THE CRYSTAL STRUCTURE OF TCR DMF5
4590, 3mlvN, 0.5041, 4.04, 0.063, 221, 111, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH AN NOF V3 PEPTIDE
4591, 3mlsK, 0.5041, 3.98, 0.055, 224, 110, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE
4592, 3ixyH, 0.5041, 3.65, 0.118, 213, 102, THE PSEUDO-ATOMIC STRUCTURE OF DENGUE IMMATURE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF THE ANTI-FUSION LOOP ANTIBODY E53
4593, 3fo9A, 0.5041, 4.05, 0.112, 219, 107, CRYSTAL STRUCTURE OF ALDOLASE ANTIBODY 33F12 FAB  IN COMPLEX WITH HAPTEN 13-DIKETONE
4594, 3cmoX, 0.5041, 4.03, 0.084, 209, 107, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ18
4595, 2zchL, 0.5041, 4.05, 0.103, 215, 107, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN COMPLEXED WITH AN ACTIVATING ANTIBODY
4596, 2pyeE, 0.5041, 3.82, 0.075, 242, 107, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY TCR CLONE C5C1 COMPLEXED WITH MHC
4597, 2lkfA, 0.5041, 4.14, 0.126, 296, 111, LEUKOCIDIN F (HLGB) FROM STAPHYLOCOCCUS AUREUS
4598, 2b0sH, 0.5041, 3.89, 0.046, 226, 108, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH MN PEPTIDE
4599, 1za6C, 0.5041, 4.05, 0.103, 220, 107, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
4600, 1tsrB, 0.5041, 3.81, 0.049, 194, 103, P53 CORE DOMAIN IN COMPLEX WITH DNA
4601, 1s5iL, 0.5041, 3.98, 0.131, 219, 107, FAB (LNKB-2) OF MONOCLONAL ANTIBODY TO HUMAN INTERLEUKIN-2 CRYSTAL STRUCTURE
4602, 1rjlA, 0.5041, 4.07, 0.103, 212, 107, STRUCTURE OF THE COMPLEX BETWEEN OSPB-CT AND BACTERICIDAL FAB-H6831
4603, 1rihH, 0.5041, 4.01, 0.064, 221, 110, CRYSTAL STRUCTURE OF FAB 14F7 A UNIQUE ANTI-TUMOR ANTIBODY SPECIFIC FOR N-GLYCOLYL GM3
4604, 1mjjH, 0.5041, 4.04, 0.090, 209, 111, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG
4605, 1mh5A, 0.5041, 4.13, 0.103, 197, 107, THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE ANALOG
4606, 1h5bA, 0.5041, 3.78, 0.114, 113, 105, T CELL RECEPTOR VALPHA11 (AV11S5) DOMAIN
4607, 1e6oL, 0.5041, 3.78, 0.105, 210, 105, CRYSTAL STRUCTURE OF FAB13B5 AGAINST HIV-1 CAPSID PROTEIN P24
4608, 6obdL, 0.5040, 3.79, 0.095, 216, 105, CRYSTAL STRUCTURE OF ANTI-GLD52 FAB COMPLEX WITH HUMAN GLD52 PEPTIDE MIMETIC 
4609, 6jjdA, 0.5040, 4.44, 0.046, 193, 109, CRYO-EM STRUCTURE OF GIANT FRESHWATER PRAWN MACROBRACHIUM ROSENBERGII NODAVIRUS (MRNV) FULL VLP 
4610, 6dlaH, 0.5040, 3.94, 0.064, 226, 110, CRYSTAL STRUCTURES OF AN INFLUENZA A HEMAGGLUTININ ANTIBODY FAB CH65:7969D2 
4611, 5xxyL, 0.5040, 4.05, 0.084, 211, 107, COMPLEX STRUCTURE OF PD-L1 WITH ATEZOLIZUMAB FAB
4612, 5w1wI, 0.5040, 3.90, 0.162, 202, 105, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
4613, 5vkkL, 0.5040, 3.99, 0.093, 219, 107, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CD22 EPRATUZUMAB
4614, 5tdpC, 0.5040, 3.99, 0.093, 213, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-HER2 ANTIBODY 4D5 WITH REDESIGNED HEAVY AND LIGHT CHAIN INTERFACES
4615, 5mcvB, 0.5040, 3.74, 0.059, 200, 102, P53-DNA COMPLEX 3 
4616, 5ik3B, 0.5040, 4.05, 0.093, 220, 107, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E03 FAB FRAGMENT
4617, 5i1jH, 0.5040, 4.10, 0.080, 213, 112, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV3-11
4618, 5d1zE, 0.5040, 3.92, 0.075, 213, 106, ISDB NEAT1 BOUND BY CLONE D4-10
4619, 4y19E, 0.5040, 3.78, 0.075, 241, 107, IMMUNE COMPLEX
4620, 4qwwE, 0.5040, 3.74, 0.135, 212, 104, CRYSTAL STRUCTURE OF THE FAB410-BFACHE COMPLEX
4621, 4irjC, 0.5040, 3.98, 0.159, 202, 107, STRUCTURE OF THE MOUSE CD1D-4CLPHC-ALPHA-GALCER-INKT TCR COMPLEX
4622, 4djmE, 0.5040, 2.94, 0.108, 198, 93, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
4623, 3o2wL, 0.5040, 4.11, 0.093, 218, 107, CRYSTAL STRUCTURE OF THE 1E9 PHEL89SER/LEUH47TRP/METH100BPHE FAB IN COMPLEX WITH A 39A11 TRANSITION STATE ANALOG
4624, 3j8wM, 0.5040, 3.78, 0.087, 109, 103, CRYO-EM RECONSTRUCTION OF QUASI-HPV16 COMPLEX WITH H263.A2 FAB
4625, 3j8wL, 0.5040, 3.78, 0.087, 109, 103, CRYO-EM RECONSTRUCTION OF QUASI-HPV16 COMPLEX WITH H263.A2 FAB
4626, 3j8wK, 0.5040, 3.78, 0.087, 109, 103, CRYO-EM RECONSTRUCTION OF QUASI-HPV16 COMPLEX WITH H263.A2 FAB
4627, 3j8wJ, 0.5040, 3.78, 0.087, 109, 103, CRYO-EM RECONSTRUCTION OF QUASI-HPV16 COMPLEX WITH H263.A2 FAB
4628, 3j2zG, 0.5040, 3.65, 0.107, 212, 103, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
4629, 3j2zE, 0.5040, 3.65, 0.107, 212, 103, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
4630, 3j2zC, 0.5040, 3.65, 0.107, 212, 103, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
4631, 3j2zA, 0.5040, 3.65, 0.107, 212, 103, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
4632, 3j2yG, 0.5040, 3.65, 0.107, 212, 103, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
4633, 3j2yE, 0.5040, 3.65, 0.107, 212, 103, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
4634, 3j2yC, 0.5040, 3.65, 0.107, 212, 103, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
4635, 3j2yA, 0.5040, 3.65, 0.107, 212, 103, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
4636, 3hzvA, 0.5040, 3.97, 0.112, 218, 107, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.8) KDO(2.4)KDO
4637, 2qr0E, 0.5040, 3.90, 0.085, 213, 106, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
4638, 2fjgH, 0.5040, 3.94, 0.073, 218, 109, STRUCTURE OF THE G6 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
4639, 1ymhD, 0.5040, 4.04, 0.091, 218, 110, ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W
4640, 1xcqE, 0.5040, 4.03, 0.103, 220, 107, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
4641, 1tupB, 0.5040, 3.81, 0.049, 194, 103, TUMOR SUPPRESSOR P53 COMPLEXED WITH DNA
4642, 1sy6L, 0.5040, 3.75, 0.125, 213, 104, CRYSTAL STRUCTURE OF CD3GAMMAEPSILON HETERODIMER IN COMPLEX WITH OKT3 FAB FRAGMENT
4643, 1mimL, 0.5040, 3.81, 0.114, 210, 105, IGG FAB FRAGMENT (CD25-BINDING)
4644, 1bqlL, 0.5040, 3.82, 0.114, 212, 105, STRUCTURE OF AN ANTI-HEL FAB FRAGMENT COMPLEXED WITH BOBWHITE QUAIL LYSOZYME
4645, 1bbjL, 0.5040, 4.05, 0.103, 211, 107, CRYSTAL STRUCTURE OF A CHIMERIC FAB  FRAGMENT OF AN ANTIBODY BINDING TUMOUR CELLS
4646, 1bbjA, 0.5040, 4.05, 0.103, 211, 107, CRYSTAL STRUCTURE OF A CHIMERIC FAB  FRAGMENT OF AN ANTIBODY BINDING TUMOUR CELLS
4647, 1ay1L, 0.5040, 3.70, 0.106, 210, 104, ANTI TAQ FAB TP7
4648, 6fj5A, 0.5039, 3.72, 0.059, 199, 102, P53-DNA COMPLEX 5 
4649, 5xbmB, 0.5039, 3.91, 0.073, 221, 110, STRUCTURE OF SCARB2-JL2 COMPLEX 
4650, 5x2pJ, 0.5039, 4.17, 0.062, 218, 112, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMATE
4651, 5w6dD, 0.5039, 3.86, 0.100, 223, 110, CRYSTAL STRUCTURE OF BG505-SOSIP.V4.1-GT1-N137A IN COMPLEX WITH FABS 35022 AND 9H/109L
4652, 5ugyH, 0.5039, 3.90, 0.064, 221, 109, INFLUENZA HEMAGGLUTININ IN COMPLEX WITH A NEUTRALIZING ANTIBODY
4653, 5mthA, 0.5039, 3.95, 0.073, 220, 110, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACEGROUP P21 
4654, 5mcuA, 0.5039, 4.13, 0.067, 195, 105, P53-DNA COMPLEX 2 
4655, 5lspS, 0.5039, 4.05, 0.064, 216, 110, 107_A07 FAB IN COMPLEX WITH FRAGMENT OF THE MET RECEPTOR
4656, 5l0qF, 0.5039, 4.04, 0.073, 214, 110, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ADAM10 D+C DOMAIN AND A CONFORMATION SPECIFIC MAB 8C7.
4657, 5ivzC, 0.5039, 4.04, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH ARG8CIR MEDITOPE VARIANT
4658, 5i2iC, 0.5039, 3.92, 0.094, 213, 106, STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE
4659, 5cbaC, 0.5039, 3.72, 0.058, 127, 104, 3B4 IN COMPLEX WITH CXCL13 - 3B4-CXCL13
4660, 4u6hB, 0.5039, 4.06, 0.131, 217, 107, VACCINIA L1/M12B9-FAB COMPLEX
4661, 4tw1G, 0.5039, 4.29, 0.080, 290, 113, CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH
4662, 4s1rH, 0.5039, 4.12, 0.063, 235, 111, CRYSTAL STRUCTURE OF A VRC01-LINEAGE ANTIBODY 45-VRC01.H08.F-117225 IN COMPLEX WITH CLADE A/E HIV-1 GP120 CORE
4663, 4r4nL, 0.5039, 4.11, 0.093, 210, 107, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
4664, 4nrxD, 0.5039, 4.02, 0.090, 228, 111, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
4665, 4m7kL, 0.5039, 4.00, 0.103, 220, 107, CRYSTAL STRUCTURE OF ANTI-TISSUE FACTOR ANTIBODY 10H10
4666, 4kxzN, 0.5039, 3.97, 0.055, 223, 109, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
4667, 4jm4L, 0.5039, 3.98, 0.085, 214, 106, CRYSTAL STRUCTURE OF PGT 135 FAB
4668, 4f3fA, 0.5039, 3.85, 0.114, 211, 105, CRYSTAL STRUCTURE OF MSLN7-64 MORAB-009 FAB COMPLEX
4669, 4f33H, 0.5039, 4.05, 0.064, 219, 110, CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009
4670, 4djmD, 0.5039, 2.92, 0.108, 204, 93, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
4671, 4d9rE, 0.5039, 4.11, 0.054, 216, 111, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
4672, 3sgdL, 0.5039, 3.95, 0.113, 218, 106, CRYSTAL STRUCTURE OF THE MOUSE MAB 17.2
4673, 3revB, 0.5039, 3.67, 0.086, 240, 105, CRYSTAL STRUCTURE OF HUMAN ALLOREACTIVE TCR NB20
4674, 3mxvL, 0.5039, 3.97, 0.093, 212, 107, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-SHH 5E1 CHIMERA
4675, 3mv7D, 0.5039, 3.84, 0.086, 200, 105, CRYSTAL STRUCTURE OF THE TK3 TCR IN COMPLEX WITH HLA-B*3501/HPVG
4676, 3mnvC, 0.5039, 3.97, 0.112, 220, 107, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT
4677, 3j93H, 0.5039, 3.88, 0.056, 220, 108, FITTING OF FAB INTO THE CRYOEM DENSITY MAP OF EV71 PROCAPSID IN COMPLEX WITH FAB22A12
4678, 3j3zH, 0.5039, 3.88, 0.056, 220, 108, STRUCTURE OF MA28-7 NEUTRALIZING ANTIBODY FAB FRAGMENT FROM ELECTRON CRYO-MICROSCOPY OF ENTEROVIRUS 71 COMPLEXED WITH A FAB FRAGMENT
4679, 3ijhA, 0.5039, 3.95, 0.123, 217, 106, STRUCTURE OF S67-27 IN COMPLEX WITH KO
4680, 3gk8H, 0.5039, 3.88, 0.056, 220, 108, X-RAY CRYSTAL STRUCTURE OF THE FAB FROM MAB 14 MOUSE ANTIBODY AGAINST CANINE PARVOVIRUS
4681, 3bkyL, 0.5039, 3.88, 0.105, 213, 105, CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY C2H7 FAB IN COMPLEX WITH A CD20 PEPTIDE
4682, 2vxtH, 0.5039, 3.98, 0.064, 207, 109, CRYSTAL STRUCTURE OF HUMAN IL-18 COMPLEXED TO MURINE REFERENCE ANTIBODY 125-2H FAB
4683, 2vljD, 0.5039, 3.95, 0.104, 199, 106, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
4684, 2j5lB, 0.5039, 3.84, 0.114, 212, 105, STRUCTURE OF A PLASMODIUM FALCIPARUM APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX
4685, 1zeaL, 0.5039, 4.18, 0.111, 216, 108, STRUCTURE OF THE ANTI-CHOLERA TOXIN ANTIBODY FAB FRAGMENT TE33 IN COMPLEX WITH A D-PEPTIDE
4686, 1yjdH, 0.5039, 4.02, 0.073, 217, 110, CRYSTAL STRUCTURE OF HUMAN CD28 IN COMPLEX WITH THE FAB FRAGMENT OF A MITOGENIC ANTIBODY (5.11A1)
4687, 1tetL, 0.5039, 4.09, 0.112, 216, 107, CRYSTAL STRUCTURE OF AN ANTICHOLERA TOXIN PEPTIDE COMPLEX AT 2.3 ANGSTROMS
4688, 1q9lA, 0.5039, 3.97, 0.121, 219, 107, S25-2 FAB UNLIGANDED 2
4689, 1mhhB, 0.5039, 3.98, 0.101, 215, 109, ANTIBODY-ANTIGEN COMPLEX
4690, 1mhhA, 0.5039, 4.04, 0.103, 219, 107, ANTIBODY-ANTIGEN COMPLEX
4691, 1m71A, 0.5039, 3.93, 0.113, 215, 106, CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE
4692, 1kegH, 0.5039, 4.02, 0.064, 216, 110, ANTIBODY 64M-2 FAB COMPLEXED WITH DTT(6-4)TT
4693, 6ogxH, 0.5038, 4.03, 0.064, 206, 110, TERNARY COMPLEX OF OX40R (TNFRSF4) BOUND TO FAB1 AND FAB2 
4694, 6mamB, 0.5038, 4.16, 0.074, 215, 108, CLEAVED EBOLA GP IN COMPLEX WITH A BROADLY NEUTRALIZING HUMAN ANTIBODY; ADI-15946 
4695, 6flbH, 0.5038, 3.96, 0.083, 213, 109, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 2 
4696, 5ye4D, 0.5038, 4.03, 0.084, 212, 107, CRYSTAL STRUCTURE OF THE COMPLEX OF DI-ACETYLATED HISTONE H4 AND 1A9D7 FAB FRAGMENT 
4697, 5udcE, 0.5038, 4.04, 0.072, 220, 111, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
4698, 5tl5H, 0.5038, 4.00, 0.092, 221, 109, COMPLEX BETWEEN HUMAN CD27 AND ANTIBODY M2177
4699, 5swzI, 0.5038, 3.98, 0.102, 186, 108, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
4700, 5ocxL, 0.5038, 3.96, 0.113, 216, 106, CRYSTAL STRUCTURE OF ACPA E4 IN COMPLEX WITH CII-C-13-CIT 
4701, 5lqbL, 0.5038, 4.02, 0.103, 217, 107, COMPLEX STRUCTURE OF HUMAN IL2 MUTANT PROLEUKIN WITH FAB FRAGMENT OF NARA1 ANTIBODY
4702, 5i0zB, 0.5038, 3.71, 0.067, 120, 104, CRYSTAL STRUCTURE OF THE SINGLE DOMAIN CATALYTIC ANTIBODY 3D8-VH
4703, 5fhcA, 0.5038, 3.92, 0.064, 221, 110, CRYSTAL STRUCTURE OF PROTECTIVE HUMAN ANTIBODIES 100 AND 114 IN COMPLEX WITH EBOLA VIRUS FUSION GLYCOPROTEIN (GP)
4704, 5d0fA, 0.5038, 3.31, 0.050, 1526, 100, CRYSTAL STRUCTURE OF THE CANDIDA GLABRATA GLYCOGEN DEBRANCHING ENZYME (E564Q) IN COMPLEX WITH MALTOPENTAOSE
4705, 5c1mB, 0.5038, 4.00, 0.083, 118, 109, CRYSTAL STRUCTURE OF ACTIVE MU-OPIOID RECEPTOR BOUND TO THE AGONIST BU72
4706, 4yueL, 0.5038, 4.07, 0.121, 214, 107, MOUSE IL-2 BOUND TO S4B6 FAB FRAGMENT
4707, 4ydlB, 0.5038, 4.17, 0.071, 223, 112, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC18.02 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057GP120
4708, 4uifG, 0.5038, 3.81, 0.047, 120, 106, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 IN COMPLEX WITH ANTIGEN-BINDING FRAGMENTS OF HUMAN ANTIBODY 2D22
4709, 4n8cH, 0.5038, 4.02, 0.073, 220, 109, THREE-DIMENSIONAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MATRIX PROTEIN 2 OF INFLUENZA A VIRUS
4710, 4fmkA, 0.5038, 4.03, 0.102, 221, 108, CRYSTAL STRUCTURE OF MOUSE NECTIN-2 EXTRACELLULAR FRAGMENT D1-D2
4711, 4f33F, 0.5038, 4.05, 0.064, 219, 110, CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009
4712, 4f2mC, 0.5038, 3.85, 0.065, 220, 108, CRYSTAL STRUCTURE OF A TGEV CORONAVIRUS SPIKE FRAGMENT IN COMPLEX WITH THE TGEV NEUTRALIZING MONOCLONAL ANTIBODY 1AF10
4713, 3wfbH, 0.5038, 4.03, 0.073, 225, 110, REDUCED CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
4714, 3ujiH, 0.5038, 4.17, 0.072, 218, 111, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2558 IN COMPLEX WITH MN PEPTIDE
4715, 3tjhD, 0.5038, 3.80, 0.075, 239, 107, 42F3-P3A1/H2-LD COMPLEX
4716, 3sjvD, 0.5038, 3.79, 0.113, 197, 106, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
4717, 3qpqC, 0.5038, 4.10, 0.084, 215, 107, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
4718, 3opzJ, 0.5038, 3.95, 0.055, 221, 110, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
4719, 3ls5L, 0.5038, 3.86, 0.113, 215, 106, ANTI-TETRAHYDROCANNABINOL FAB FRAGMENT FREE FORM
4720, 3lh9B, 0.5038, 4.01, 0.097, 288, 103, CRYSTAL STRUCTURE OF MOUSE VPS26B(L197S/R199E) IN SPACEGROUP P41 21 2
4721, 3iy0H, 0.5038, 3.83, 0.066, 120, 106, VARIABLE DOMAINS OF THE X-RAY STRUCTURE OF FAB 14 FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS-FAB 14 COMPLEX
4722, 3c5zF, 0.5038, 3.56, 0.058, 240, 104, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
4723, 3c5zB, 0.5038, 3.56, 0.058, 240, 104, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
4724, 2oz4H, 0.5038, 4.16, 0.071, 208, 112, STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION
4725, 2nx5D, 0.5038, 3.68, 0.133, 188, 105, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
4726, 2gk0A, 0.5038, 4.07, 0.113, 217, 106, STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A TWINNED CRYSTAL IN SPACE GROUP C2
4727, 2fx8O, 0.5038, 4.07, 0.056, 214, 107, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
4728, 2fjfM, 0.5038, 4.07, 0.093, 211, 107, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
4729, 1ztxL, 0.5038, 4.07, 0.112, 212, 107, WEST NILE VIRUS ENVELOPE PROTEIN DIII IN COMPLEX WITH NEUTRALIZING E16 ANTIBODY FAB
4730, 1yedA, 0.5038, 3.87, 0.132, 219, 106, STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.4)
4731, 1q9lC, 0.5038, 3.98, 0.121, 219, 107, S25-2 FAB UNLIGANDED 2
4732, 1nakM, 0.5038, 4.00, 0.131, 217, 107, IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE))
4733, 1mvuB, 0.5038, 3.95, 0.056, 121, 107, SINGLE CHAIN FV OF C219 HEAVY CHAIN V101L MUTANT IN COMPLEX WITH SYNTHETIC EPITOPE PEPTIDE
4734, 1l4iB, 0.5038, 2.91, 0.085, 189, 94, CRYSTAL STRUCTURE OF THE PERIPLASMIC CHAPERONE SFAE
4735, 1i9rK, 0.5038, 4.05, 0.072, 219, 111, STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY
4736, 1h5bC, 0.5038, 3.62, 0.126, 113, 103, T CELL RECEPTOR VALPHA11 (AV11S5) DOMAIN
4737, 6iekE, 0.5037, 4.12, 0.063, 223, 111, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R12 
4738, 6eayL, 0.5037, 3.85, 0.076, 211, 105, STRUCTURAL BASIS FOR BROAD NEUTRALIZATION OF EBOLAVIRUSES BY AN ANTIBODY TARGETING THE GLYCOPROTEIN FUSION LOOP 
4739, 6bzvF, 0.5037, 3.99, 0.104, 214, 106, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY 19B3 
4740, 5wkhE, 0.5037, 3.96, 0.120, 244, 108, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS3
4741, 5w08K, 0.5037, 4.02, 0.055, 235, 110, A/TEXAS/50/2012(H3N2) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH K03.12 FAB
4742, 5um8D, 0.5037, 3.99, 0.108, 240, 111, CRYSTAL STRUCTURE OF HIV-1 ENVELOPE TRIMER 16055 NFL TD CC (T569G) IN COMPLEX WITH FABS 35022 AND PGT124
4743, 5szfH, 0.5037, 4.11, 0.071, 217, 112, 2A10 FAB FRAGMENT 2.54 ANGSTOMS
4744, 5swzD, 0.5037, 3.95, 0.111, 198, 108, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
4745, 5otjA, 0.5037, 3.85, 0.104, 213, 106, MONOMERIC POLCALCIN (PHL P 7) IN COMPLEX WITH TWO IDENTICAL ALLERGEN- SPECIFIC ANTIBODIES 
4746, 5kvlL, 0.5037, 4.04, 0.084, 214, 107, HUMANIZED 10G4 ANTI-LEUKOTRIENE C4 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LEUKOTRIENE C4
4747, 5hysF, 0.5037, 3.98, 0.075, 215, 107, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
4748, 5hd8F, 0.5037, 3.80, 0.154, 211, 104, CRYSTAL STRUCTURE OF DISULFIDE CROSS-LINKED D417C CLC-EC1
4749, 5e08L, 0.5037, 4.04, 0.084, 215, 107, SPECIFIC RECOGNITION OF A SINGLE-STRANDED RNA SEQUENCE BY AN ENGINEERED SYNTHETIC ANTIBODY FRAGMENT
4750, 5cmaB, 0.5037, 4.08, 0.082, 213, 110, ANTI-B7-H3 MONOCLONAL ANTIBODY CH8H9 FAB FRAGMENT
4751, 4r4nU, 0.5037, 3.98, 0.094, 210, 106, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
4752, 4r4nG, 0.5037, 4.09, 0.093, 210, 107, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
4753, 4r3sA, 0.5037, 3.99, 0.065, 114, 107, CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8)IN COMPLEX WITH MSP2 11-23
4754, 4pjgH, 0.5037, 3.72, 0.075, 240, 106, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
4755, 4pjgG, 0.5037, 3.77, 0.133, 188, 105, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
4756, 4p2qE, 0.5037, 4.11, 0.045, 245, 112, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK
4757, 4ouuA, 0.5037, 4.04, 0.121, 217, 107, ANTI-MT1-MMP MONOCLONAL ANTIBODY
4758, 4mwfH, 0.5037, 3.89, 0.063, 228, 111, STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C
4759, 4k8rC, 0.5037, 4.10, 0.093, 213, 107, AN ANTIBODY AGAINST THE C-TERMINAL DOMAIN OF PCSK9 LOWERS LDL CHOLESTEROL LEVELS IN VIVO
4760, 4gagL, 0.5037, 4.07, 0.103, 215, 107, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33 IN COMPLEX WITH ITS HCV EPITOPE (E2 RESIDUES 412-423)
4761, 4d9qE, 0.5037, 4.12, 0.054, 212, 111, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
4762, 4a63A, 0.5037, 3.75, 0.098, 205, 102, CRYSTAL STRUCTURE OF THE P73-ASPP2 COMPLEX AT 2.6A RESOLUTION
4763, 3ujtI, 0.5037, 4.09, 0.090, 207, 111, STRUCTURE OF THE FAB FRAGMENT OF AB-52 AN ANTIBODY THAT BINDS THE O- ANTIGEN OF FRANCISELLA TULARENSIS
4764, 3sgeL, 0.5037, 3.95, 0.113, 219, 106, CRYSTAL STRUCTURE OF MAB 17.2 IN COMPLEX WITH R13 PEPTIDE
4765, 3rvuC, 0.5037, 3.95, 0.094, 212, 106, STRUCTURE OF 4C1 FAB IN C2221 SPACE GROUP
4766, 3qctL, 0.5037, 4.00, 0.103, 218, 107, CRYSTAL STRUCTURE OF THE HUMANIZED APO LT3015 ANTI-LYSOPHOSPHATIDIC ACID ANTIBODY FAB FRAGMENT
4767, 3o9wC, 0.5037, 3.96, 0.157, 203, 108, RECOGNITION OF A GLYCOLIPID ANTIGEN BY THE INKT CELL TCR
4768, 3mlsJ, 0.5037, 4.03, 0.063, 226, 111, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE
4769, 3macH, 0.5037, 3.95, 0.064, 218, 109, CRYSTAL STRUCTURE OF GP41-DERIVED PROTEIN COMPLEXED WITH FAB 8062
4770, 3hntL, 0.5037, 3.98, 0.085, 214, 106, CS-35 FAB COMPLEX WITH A LINEAR TERMINAL OLIGOARABINOFURANOSYL TETRASACCHARIDE FROM LIPOARABINOMANNAN
4771, 3eyfC, 0.5037, 4.09, 0.084, 215, 107, CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9 PLUS GB PEPTIDE
4772, 2mcpL, 0.5037, 4.01, 0.103, 220, 107, REFINED CRYSTAL STRUCTURE OF THE MC/PC603 FAB-PHOSPHOCHOLINE COMPLEX AT 3.1 ANGSTROMS RESOLUTION
4773, 2fjhA, 0.5037, 4.01, 0.075, 211, 107, STRUCTURE OF THE B20-4 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
4774, 2e27L, 0.5037, 3.71, 0.069, 107, 102, CRYSTAL STRUCTURE OF FV FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY COMPLEXED WITH ABC-RING OF CIGUATOXIN
4775, 1yeeL, 0.5037, 3.96, 0.131, 219, 107, STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.5)
4776, 1tziA, 0.5037, 3.89, 0.066, 214, 106, CRYSTAL STRUCTURE OF THE FAB YADS2 COMPLEXED WITH H-VEGF
4777, 1ogaE, 0.5037, 3.71, 0.086, 240, 105, A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION.
4778, 1kemH, 0.5037, 4.02, 0.072, 218, 111, CATALYTIC ANTIBODY 28B4 FAB FRAGMENT
4779, 1fveC, 0.5037, 3.99, 0.084, 214, 107, X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING
4780, 1forL, 0.5037, 3.84, 0.105, 210, 105, STRUCTURE DETERMINATION OF AN FAB FRAGMENT THAT NEUTRALIZES HUMAN RHINOVIRUS AND ANALYSIS OF THE FAB-VIRUS COMPLEX
4781, 1e6jH, 0.5037, 4.14, 0.081, 219, 111, CRYSTAL STRUCTURE OF HIV-1 CAPSID PROTEIN (P24) IN COMPLEX WITH FAB13B5
4782, 1bbdL, 0.5037, 3.97, 0.121, 219, 107, THREE DIMENSIONAL STRUCTURE OF THE FAB FRAGMENT OF A NEUTRALIZING ANTIBODY TO HUMAN RHINOVIRUS SEROTYPE 2
4783, 6j11F, 0.5036, 3.87, 0.104, 120, 106, MERS-COV SPIKE N-TERMINAL DOMAIN AND 7D10 SCFV COMPLEX 
4784, 6igwA, 0.5036, 3.79, 0.075, 119, 106, MPZL1 MUTANT - S86G; V145G; Q146K;P147T;G148S 
4785, 6gfeM, 0.5036, 3.93, 0.085, 215, 106, HIGH-RESOLUTION STRUCTURE OF A THERAPEUTIC FULL-LENGTH ANTI-NPRA ANTIBODY WITH EXCEPTIONAL CONFORMATIONAL DIVERSITY 
4786, 6a9kL, 0.5036, 4.01, 0.121, 219, 107, CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 9C10 WITH A TRANSITION-STATE ANALOG 
4787, 5vigB, 0.5036, 4.06, 0.084, 212, 107, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z006 BOUND TO ZIKA VIRUS ENVELOPE PROTEIN DIII
4788, 5uqyG, 0.5036, 4.05, 0.093, 210, 107, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
4789, 5o14H, 0.5036, 4.13, 0.071, 221, 112, CO-CRYSTAL STRUCTURE OF A CROSS-REACTIVE BACTERICIDAL HUMAN ANTIBODY TARGETING MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN
4790, 5kanG, 0.5036, 4.06, 0.045, 231, 111, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.G.07 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
4791, 5jhlH, 0.5036, 3.98, 0.082, 216, 110, CRYSTAL STRUCTURE OF ZIKA VIRUS ENVELOPE PROTEIN IN COMPLEX WITH A FLAVIVIRUS BROADLY-PROTECTIVE ANTIBODY
4792, 5bvjC, 0.5036, 4.06, 0.103, 214, 107, THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA
4793, 4xc1L, 0.5036, 4.09, 0.056, 214, 108, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH SN-GLYCEROL 3- PHOSPHATE
4794, 4p59L, 0.5036, 4.03, 0.075, 211, 107, HER3 EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB FRAGMENT OF MOR09825
4795, 4gayL, 0.5036, 4.07, 0.103, 213, 107, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33
4796, 4ffwL, 0.5036, 3.88, 0.124, 202, 105, CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4 DPP-IV CD26) IN COMPLEX WITH FAB + SITAGLIPTIN
4797, 4dvbB, 0.5036, 3.90, 0.133, 215, 105, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF PRO-UPA ANTIBODY MAB-112
4798, 4aeiN, 0.5036, 3.87, 0.114, 217, 105, CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX
4799, 4a63G, 0.5036, 3.63, 0.108, 205, 102, CRYSTAL STRUCTURE OF THE P73-ASPP2 COMPLEX AT 2.6A RESOLUTION
4800, 3vi3E, 0.5036, 4.03, 0.093, 219, 107, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
4801, 3mxwL, 0.5036, 3.97, 0.093, 212, 107, CRYSTAL STRUCTURE SONIC HEDGEHOG BOUND TO THE 5E1 FAB FRAGMENT
4802, 3mlsH, 0.5036, 4.04, 0.063, 226, 111, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE
4803, 3mbeD, 0.5036, 3.71, 0.075, 236, 106, TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27)
4804, 3ma9H, 0.5036, 3.84, 0.056, 214, 107, CRYSTAL STRUCTURE OF GP41 DERIVED PROTEIN COMPLEXED WITH FAB 8066
4805, 3ijsA, 0.5036, 3.94, 0.123, 217, 106, STRUCTURE OF S67-27 IN COMPLEX WITH TSBP
4806, 3hr5A, 0.5036, 3.81, 0.086, 219, 105, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
4807, 3be1L, 0.5036, 3.85, 0.104, 216, 106, DUAL SPECIFIC BH1 FAB IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF HER2/ERBB-2
4808, 35c8H, 0.5036, 4.04, 0.091, 217, 110, CATALYTIC ANTIBODY 5C8 FAB-INHIBITOR COMPLEX
4809, 2pyfB, 0.5036, 3.62, 0.077, 241, 104, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY UNBOUND TCR CLONE 5-1
4810, 2brrY, 0.5036, 4.15, 0.080, 225, 112, COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34)
4811, 2adfL, 0.5036, 4.00, 0.084, 209, 107, CRYSTAL STRUCTURE AND PARATOPE DETERMINATION OF 82D6A3 AN ANTITHROMBOTIC ANTIBODY DIRECTED AGAINST THE VON WILLEBRAND FACTOR A3-DOMAIN
4812, 1ziaA, 0.5036, 2.74, 0.140, 124, 86, OXIDIZED PSEUDOAZURIN
4813, 1xedC, 0.5036, 3.35, 0.090, 105, 100, CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR PIGR
4814, 1otuF, 0.5036, 3.79, 0.154, 211, 104, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148Q MUTANT AND FAB COMPLEX
4815, 1jnlH, 0.5036, 4.02, 0.073, 216, 110, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
4816, 1cu4L, 0.5036, 4.06, 0.103, 219, 107, CRYSTAL STRUCTURE OF THE ANTI-PRION FAB 3F4 IN COMPLEX WITH ITS PEPTIDE EPITOPE
4817, 1c5dL, 0.5036, 3.93, 0.104, 213, 106, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR
4818, 1a6uH, 0.5036, 3.99, 0.064, 120, 109, B1-8 FV FRAGMENT
4819, 1a6tB, 0.5036, 4.05, 0.081, 217, 111, FAB FRAGMENT OF MAB1-IA MONOCLONAL ANTIBODY TO HUMAN RHINOVIRUS 14 NIM-IA SITE
4820, 6jjcA, 0.5035, 4.54, 0.055, 193, 110, CRYO-EM STRUCTURE OF GIANT FRESHWATER PRAWN MACROBRACHIUM ROSENBERGII NODAVIRUS (MRNV) SEMI-EMPTY VLP 
4821, 6aruB, 0.5035, 3.99, 0.084, 210, 107, STRUCTURE OF CETUXIMAB FAB MUTANT IN COMPLEX WITH EGFR EXTRACELLULAR DOMAIN 
4822, 5wjoD, 0.5035, 3.78, 0.104, 237, 106, CRYSTAL STRUCTURE OF THE UNLIGANDED PG90 TCR
4823, 5t5fL, 0.5035, 4.23, 0.102, 216, 108, NEISSERIA MENINGITIDIS FACTOR H BINDING PROTEIN IN COMPLEX WITH MONOCLONAL ANTIBODY JAR5
4824, 5muqL, 0.5035, 4.03, 0.131, 219, 107, CRYSTAL STRUCTURE OF DC8E8 FAB AT PH 7.0 CONTAINING A ZN ATOM 
4825, 5mhsD, 0.5035, 4.03, 0.084, 214, 107, T1L REOVIRUS SIGMA1 COMPLEXED WITH 5C6 FAB FRAGMENTS
4826, 5js9E, 0.5035, 3.98, 0.064, 224, 110, UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 8- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128
4827, 5girA, 0.5035, 3.96, 0.119, 206, 109, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE
4828, 5en2A, 0.5035, 4.06, 0.082, 219, 110, MOLECULAR BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF NEW WORLD HEMORRHAGIC FEVER MAMMARENAVIRUSES
4829, 4z92C, 0.5035, 3.88, 0.049, 257, 103, CRYSTAL STRUCTURE OF PARECHOVIRUS-1 VIRION
4830, 4uikH, 0.5035, 4.03, 0.082, 218, 110, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.1
4831, 4py8J, 0.5035, 4.04, 0.084, 212, 107, CRYSTAL STRUCTURE OF FAB 3.1 IN COMPLEX WITH THE 1918 INFLUENZA VIRUS HEMAGGLUTININ
4832, 4ouuL, 0.5035, 4.02, 0.121, 217, 107, ANTI-MT1-MMP MONOCLONAL ANTIBODY
4833, 4np4H, 0.5035, 4.04, 0.072, 215, 111, CLOSTRIDIUM DIFFICILE TOXIN B CROP DOMAIN IN COMPLEX WITH FAB DOMAINS OF NEUTRALIZING ANTIBODY BEZLOTOXUMAB
4834, 4nj9H, 0.5035, 4.00, 0.082, 217, 110, CRYSTAL STRUCTURE OF FAB 8B10 IN COMPLEX WITH MPTS
4835, 4mvbD, 0.5035, 3.72, 0.075, 239, 106, 42F3 PCPB7/H-2LD COMPLEX
4836, 4m7lL, 0.5035, 4.00, 0.103, 220, 107, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN TISSUE FACTOR EXTRACELLULAR DOMAIN AND ANTIBODY 10H10 FAB FRAGMENT
4837, 4jkwA, 0.5035, 4.14, 0.083, 119, 109, STRUCTURE OF THE EXTRACELLULAR DOMAIN OF BUTYROPHILIN BTN3A1 IN COMPLEX WITH ISOPENTENYL PYROPHOSPHATE (IPP)
4838, 4hdiA, 0.5035, 4.03, 0.112, 217, 107, CRYSTAL STRUCTURE OF 3E5 IGG3 FAB FROM MUS MUSCULUS
4839, 4e42B, 0.5035, 3.76, 0.087, 231, 104, STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
4840, 3vxqE, 0.5035, 3.86, 0.093, 242, 107, H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10
4841, 3vd0B, 0.5035, 3.69, 0.088, 201, 102, STRUCTURE OF P73 DNA BINDING DOMAIN TETRAMER MODULATES P73 TRANSACTIVATION
4842, 3utzA, 0.5035, 3.91, 0.104, 215, 106, ENDOGENOUS-LIKE INHIBITORY ANTIBODIES TARGETING ACTIVATED METALLOPROTEINASE MOTIFS SHOW THERAPEUTIC POTENTIAL
4843, 3revA, 0.5035, 3.91, 0.102, 201, 108, CRYSTAL STRUCTURE OF HUMAN ALLOREACTIVE TCR NB20
4844, 3qynA, 0.5035, 4.10, 0.095, 195, 105, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING 2 BASE PAIR SPACER BETWEEN HALF SITES
4845, 3nz8A, 0.5035, 4.12, 0.072, 217, 111, CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8
4846, 3d9aL, 0.5035, 4.03, 0.103, 213, 107, HIGH RESOLUTION CRYSTAL STRUCTURE STRUCTURE OF HYHEL10 FAB COMPLEXED TO HEN EGG LYSOZYME
4847, 3c09B, 0.5035, 3.86, 0.075, 175, 106, CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB (FAB72000) IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR
4848, 1yedL, 0.5035, 3.87, 0.132, 219, 106, STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.4)
4849, 1wcbL, 0.5035, 3.70, 0.117, 213, 103, PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN
4850, 1qgc4, 0.5035, 3.98, 0.103, 217, 107, STRUCTURE OF THE COMPLEX OF A FAB FRAGMENT OF A NEUTRALIZING ANTIBODY WITH FOOT AND MOUTH DISEASE VIRUS
4851, 1j8hE, 0.5035, 3.79, 0.057, 241, 106, CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR INFLUENZA HA ANTIGEN PEPTIDE AND MHC CLASS II MOLECULE HLA-DR4
4852, 1f90L, 0.5035, 3.85, 0.132, 219, 106, FAB FRAGMENT OF MONOCLONAL ANTIBODY (LNKB-2) AGAINST HUMAN INTERLEUKIN-2 IN COMPLEX WITH ANTIGENIC PEPTIDE
4853, 1dbmH, 0.5035, 4.10, 0.053, 219, 113, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
4854, 1bfoC, 0.5035, 3.97, 0.104, 214, 106, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
4855, 1a4jB, 0.5035, 4.08, 0.054, 217, 112, DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR
4856, 6ol5A, 0.5034, 4.13, 0.072, 209, 111, STRUCTURE OF IGLB12 FAB IN COMPLEX WITH ANTI-IDIOTYPE IB3 FAB 
4857, 6obdA, 0.5034, 3.84, 0.104, 216, 106, CRYSTAL STRUCTURE OF ANTI-GLD52 FAB COMPLEX WITH HUMAN GLD52 PEPTIDE MIMETIC 
4858, 6igtC, 0.5034, 3.82, 0.084, 116, 107, MPZL1 MUTANT - V145G; Q146K; P147T AND G148S 
4859, 6f2sH, 0.5034, 4.70, 0.062, 218, 113, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
4860, 6f2sF, 0.5034, 4.72, 0.062, 195, 113, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
4861, 6cdmD, 0.5034, 3.99, 0.100, 218, 110, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
4862, 6awpB, 0.5034, 4.13, 0.080, 218, 112, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH FLUVOXAMINE AT THE CENTRAL SITE
4863, 6avgB, 0.5034, 3.71, 0.144, 196, 104, CRYSTAL STRUCTURE OF THE KFJ37 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
4864, 5xcrA, 0.5034, 4.14, 0.055, 166, 110, CRYSTAL STRUCTURE OF P20.1 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
4865, 5xbmD, 0.5034, 3.71, 0.107, 209, 103, STRUCTURE OF SCARB2-JL2 COMPLEX 
4866, 5w1wN, 0.5034, 3.76, 0.135, 199, 104, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
4867, 5mx3A, 0.5034, 3.94, 0.073, 219, 110, STRUCTURE OF DC8E8 FAB CRYSTALLIZED AT PH 8.5
4868, 5mp1H, 0.5034, 4.02, 0.064, 215, 110, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
4869, 5kblA, 0.5034, 4.63, 0.068, 154, 117, CANDIDA ALBICANS SUPEROXIDE DISMUTASE 5 (SOD5) E110Q MUTANT
4870, 5hdqL, 0.5034, 3.95, 0.132, 218, 106, MNTC CO-STRUCTURE WITH MAB 305-78-7
4871, 5awnH, 0.5034, 4.09, 0.072, 219, 111, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 BROADLY NEUTRALIZING ANTIBODY 3BC176 FAB
4872, 4ydlH, 0.5034, 4.17, 0.071, 223, 112, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC18.02 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057GP120
4873, 4whtV, 0.5034, 4.02, 0.104, 212, 106, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P1 CRYSTAL FORM
4874, 4pjgF, 0.5034, 3.72, 0.066, 241, 106, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
4875, 4n90I, 0.5034, 4.09, 0.075, 214, 107, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRAIL DR5 AND FAB FRAGMENT FROM A DR5 AGONIST ANTIBODY
4876, 4jn2L, 0.5034, 4.03, 0.103, 219, 107, AN ANTIDOTE FOR DABIGATRAN
4877, 4guoB, 0.5034, 3.72, 0.088, 198, 102, STRUCTURE OF P73 DNA BINDING DOMAIN COMPLEX WITH 12 BP DNA
4878, 4gmsN, 0.5034, 4.10, 0.112, 213, 107, CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ
4879, 4fs0A, 0.5034, 4.17, 0.100, 218, 110, CRYSTAL STRUCTURE OF MUTANT F136D OF MOUSE NECTIN-2 EXTRACELLULAR FRAGMENT D1-D2
4880, 4djmG, 0.5034, 2.96, 0.097, 199, 93, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
4881, 3tzvB, 0.5034, 3.77, 0.094, 236, 106, CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE
4882, 3sdxH, 0.5034, 3.71, 0.095, 240, 105, CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
4883, 3qeuD, 0.5034, 4.02, 0.120, 202, 108, THE CRYSTAL STRUCTURE OF TCR DMF5
4884, 3mltE, 0.5034, 4.11, 0.062, 219, 112, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
4885, 3cvhL, 0.5034, 4.04, 0.084, 209, 107, HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
4886, 2xtlA, 0.5034, 3.88, 0.095, 449, 105, STRUCTURE OF THE MAJOR PILUS BACKBONE PROTEIN FROM STREPTOCOCCUS AGALACTIAE
4887, 2vlrE, 0.5034, 3.81, 0.085, 240, 106, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
4888, 2nw2B, 0.5034, 3.73, 0.113, 243, 106, CRYSTAL STRUCTURE OF ELS4 TCR AT 1.4A
4889, 2fgwL, 0.5034, 3.89, 0.085, 214, 106, X-RAY STRUCTURES OF FRAGMENTS FROM BINDING AND NONBINDING VERSIONS OF A HUMANIZED ANTI-CD18 ANTIBODY: STRUCTURAL INDICATIONS OF THE KEY ROLE OF VH RESIDUES 59 TO 65
4890, 2f19H, 0.5034, 3.84, 0.055, 221, 109, THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9 FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY
4891, 2co7B, 0.5034, 3.20, 0.147, 197, 95, SALMONELLA ENTERICA SAFA PILIN IN COMPLEX WITH THE SAFB CHAPERONE (TYPE II)
4892, 1wtlB, 0.5034, 3.87, 0.087, 108, 104, COMPARISON OF CRYSTAL STRUCTURES OF TWO HOMOLOGOUS PROTEINS: STRUCTURAL ORIGIN OF ALTERED DOMAIN INTERACTIONS IN IMMUNOGLOBULIN LIGHT CHAIN DIMERS
4893, 1uywH, 0.5034, 3.77, 0.074, 218, 108, CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
4894, 1rzgA, 0.5034, 3.88, 0.045, 223, 110, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D
4895, 1r70C, 0.5034, 4.08, 0.084, 214, 107, MODEL OF HUMAN IGA2 DETERMINED BY SOLUTION SCATTERING CURVE FITTING AND HOMOLOGY MODELLING
4896, 1egjH, 0.5034, 4.09, 0.072, 220, 111, DOMAIN 4 OF THE BETA COMMON CHAIN IN COMPLEX WITH AN ANTIBODY
4897, 6novD, 0.5033, 4.05, 0.103, 219, 107, A FAB DERIVED FROM IXEKIZUMAB 
4898, 6ey0G, 0.5033, 3.98, 0.083, 129, 109, N-TERMINAL PART (RESIDUES 30-212) OF PORM WITH THE LLAMA NANOBODY NB01
4899, 6eleA, 0.5033, 3.88, 0.065, 211, 108, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4900, 6dc7M, 0.5033, 4.17, 0.111, 218, 108, APO FAB STRUCTURE OF MOUSE MONOCLONAL ANTIBODY 8B2 
4901, 5y9cH, 0.5033, 4.06, 0.072, 210, 111, CRYSTAL STRUCTURE OF HPV58 PENTAMER IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY A12A3
4902, 5vqmH, 0.5033, 3.94, 0.055, 216, 110, CLOSTRIDIUM DIFFICILE TCDB-GTD BOUND TO PA41 FAB
4903, 5lqbH, 0.5033, 4.04, 0.081, 219, 111, COMPLEX STRUCTURE OF HUMAN IL2 MUTANT PROLEUKIN WITH FAB FRAGMENT OF NARA1 ANTIBODY
4904, 5fuzH, 0.5033, 4.01, 0.054, 222, 111, EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION OF A HUMANISED ANTI-HUMAN SERUM ALBUMIN (HSA) FV DOMAIN: AN INVESTIGATION INTO THE CORRELATION BETWEEN AFFINITY AND SERUM HALF-LIFE
4905, 5cbeC, 0.5033, 3.74, 0.058, 127, 104, E10 IN COMPLEX WITH CXCL13
4906, 4zezH, 0.5033, 3.88, 0.084, 241, 107, CRYSTAL STRUCTURE OF HCV 1406 TCR/HCV NS3: 1406-1415/HLA-A2 COMPLEX
4907, 4y2dG, 0.5033, 3.92, 0.150, 202, 107, CRYSTAL STRUCTURE OF THE MCD1D/7DW8-5/INKTCR TERNARY COMPLEX
4908, 4y2dC, 0.5033, 3.91, 0.150, 202, 107, CRYSTAL STRUCTURE OF THE MCD1D/7DW8-5/INKTCR TERNARY COMPLEX
4909, 4xcnA, 0.5033, 3.92, 0.064, 227, 109, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
4910, 4x6dE, 0.5033, 3.66, 0.096, 189, 104, CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR
4911, 4wfgD, 0.5033, 3.85, 0.105, 211, 105, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND CONDUCTIVE CONFORMATION
4912, 4ubdL, 0.5033, 4.09, 0.075, 213, 107, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
4913, 4s1dD, 0.5033, 3.85, 0.106, 211, 104, STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE
4914, 4r4nO, 0.5033, 4.05, 0.094, 210, 106, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
4915, 4pjhF, 0.5033, 3.74, 0.066, 239, 106, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-G8 TCR
4916, 4lspL, 0.5033, 3.88, 0.086, 208, 105, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC- CH31 IN COMPLEX WITH HIV-1 CLADE A/E GP120 93TH057
4917, 4kq3L, 0.5033, 3.95, 0.075, 211, 106, CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO3186
4918, 4hfwL, 0.5033, 4.02, 0.084, 212, 107, ANTI ROTAVIRUS ANTIBODY
4919, 4fn0C, 0.5033, 4.07, 0.111, 219, 108, CRYSTAL STRUCTURE OF MOUSE NECTIN-2 EXTRACELLULAR FRAGMENT D1-D2 2ND CRYSTAL FORM
4920, 4edxL, 0.5033, 4.03, 0.084, 214, 107, NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM MOUSE MAB 911
4921, 4djmB, 0.5033, 2.95, 0.108, 202, 93, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
4922, 3v6fF, 0.5033, 3.99, 0.121, 219, 107, CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6) UNBOUND
4923, 3u46H, 0.5033, 3.99, 0.100, 228, 110, CH04H/CH02L P212121
4924, 3tf7G, 0.5033, 3.77, 0.075, 224, 106, 42F3 QL9/H2-LD COMPLEX
4925, 3qjhB, 0.5033, 3.98, 0.055, 243, 110, THE CRYSTAL STRUCTURE OF THE 5C.C7 TCR
4926, 3qh3A, 0.5033, 3.94, 0.104, 194, 106, THE CRYSTAL STRUCTURE OF TCR A6
4927, 3levL, 0.5033, 4.05, 0.093, 214, 107, HIV-1 ANTIBODY 2F5 IN COMPLEX WITH EPITOPE SCAFFOLD ES2
4928, 2ojzI, 0.5033, 3.97, 0.082, 216, 110, ANTI-DNA ANTIBODY ED10
4929, 2nx5J, 0.5033, 3.75, 0.113, 243, 106, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
4930, 2mpaL, 0.5033, 4.01, 0.112, 219, 107, BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
4931, 2j1zA, 0.5033, 3.89, 0.058, 195, 103, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-N268D-F270L
4932, 2j1wA, 0.5033, 3.88, 0.058, 195, 103, HUMAN P53 CORE DOMAIN MUTANT M133L-V143A-V203A-N239Y-N268D
4933, 2ialC, 0.5033, 3.72, 0.114, 195, 105, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
4934, 1z3gL, 0.5033, 3.77, 0.135, 213, 104, CRYSTAL STRUCTURE OF COMPLEX BETWEEN PVS25 AND FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8
4935, 1uolA, 0.5033, 3.89, 0.058, 195, 103, CRYSTAL STRUCTURE OF THE HUMAN P53 CORE DOMAIN MUTANT M133L/V203A/N239Y/N268D AT 1.9 A RESOLUTION.
4936, 1t3fB, 0.5033, 4.11, 0.081, 219, 111, THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB (HUZAF) IN P21 21 21 SPACE GROUP
4937, 1rz8C, 0.5033, 4.03, 0.084, 214, 107, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 17B
4938, 1pz5A, 0.5033, 3.86, 0.114, 215, 105, STRUCTURAL BASIS OF PEPTIDE-CARBOHYDRATE MIMICRY IN AN ANTIBODY COMBINING SITE
4939, 1ogaD, 0.5033, 3.94, 0.104, 199, 106, A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION.
4940, 1mimH, 0.5033, 3.95, 0.083, 215, 109, IGG FAB FRAGMENT (CD25-BINDING)
4941, 1mi5E, 0.5033, 3.80, 0.123, 241, 106, THE CRYSTAL STRUCTURE OF LC13 TCR IN COMPLEX WITH HLAB8-EBV PEPTIDE COMPLEX
4942, 1cr9L, 0.5033, 4.04, 0.103, 219, 107, CRYSTAL STRUCTURE OF THE ANTI-PRION FAB 3F4
4943, 1clyL, 0.5033, 3.89, 0.105, 217, 105, IGG FAB (HUMAN IGG1 KAPPA) CHIMERIC FRAGMENT (CBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER
4944, 1bfoE, 0.5033, 3.97, 0.094, 214, 106, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
4945, 6oknB, 0.5032, 3.95, 0.066, 213, 106, OX40R (TNFRSF4) BOUND TO FAB 1A7 
4946, 6njmI, 0.5032, 4.10, 0.000, 218, 112, STRUCTURE OF A COMPLEX 
4947, 6i9iL, 0.5032, 4.01, 0.084, 215, 107, RIFT VALLEY FEVER VIRUS GN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FRAGMENT 
4948, 6h3hA, 0.5032, 3.92, 0.064, 222, 109, FAB FRAGMENT OF ANTIBODY AGAINST FULLERENE C60 
4949, 5mvjH, 0.5032, 4.12, 0.063, 218, 111, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
4950, 5jsaE, 0.5032, 4.05, 0.063, 224, 111, UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128
4951, 5itfB, 0.5032, 4.03, 0.091, 217, 110, CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT
4952, 5i30H, 0.5032, 3.99, 0.072, 212, 111, CRYSTAL STRUCTURE OF THE HUMAN ASTROVIRUS 2 NEUTRALIZING MONOCLONAL ANTIBODY PL-2 FAB FRAGMENT AT 1.9 A RESOLUTION
4953, 5hhmI, 0.5032, 3.86, 0.105, 196, 105, CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-F5L
4954, 5d2lJ, 0.5032, 3.64, 0.115, 226, 104, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
4955, 5c0nD, 0.5032, 4.10, 0.065, 216, 107, DEVELOPMENT OF A MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT DIABETES AND FATTY LIVER DISEASE
4956, 5c07D, 0.5032, 3.80, 0.084, 199, 107, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING YQFGPDFPIA
4957, 5ab9A, 0.5032, 3.96, 0.048, 195, 104, STRUCTURE OF THE P53 CANCER MUTANT Y220C WITH BOUND SMALL MOLECULE 7-ETHYL-3-(PIPERIDIN-4-YL)-1H-INDOLE
4958, 5a3iD, 0.5032, 4.04, 0.103, 218, 107, CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN FLD194 FAB AND TRANSMISSIBLE MUTANT H5 HAEMAGGLUTININ
4959, 4xakE, 0.5032, 4.12, 0.075, 207, 107, CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY M336 IN COMPLEX WITH MERS CO-V RBD
4960, 4pjxF, 0.5032, 3.79, 0.066, 237, 106, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-A11 TCR
4961, 4pb9H, 0.5032, 4.13, 0.072, 216, 111, STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-FRANCISELLA TULARENSIS GROEL ANTIBODY AB64
4962, 4p5sA, 0.5032, 2.66, 0.163, 105, 86, STRUCTURE OF REDUCED W45Y MUTANT OF AMICYANIN
4963, 4oz4A, 0.5032, 3.94, 0.073, 219, 110, X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.
4964, 4ongL, 0.5032, 3.95, 0.113, 214, 106, FAB FRAGMENT OF 3D6 IN COMPLEX WITH AMYLOID BETA 1-40
4965, 4hweH, 0.5032, 4.10, 0.071, 213, 112, CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT
4966, 4elmG, 0.5032, 3.81, 0.095, 171, 105, CRYSTAL STRUCTURE OF THE MOUSE CD1D-LYSOSULFATIDE-HY19.3 TCR COMPLEX
4967, 3wkmM, 0.5032, 4.13, 0.103, 214, 107, THE PERIPLASMIC PDZ TANDEM FRAGMENT OF THE RSEP HOMOLOGUE FROM AQUIFEX AEOLICUS IN COMPLEX WITH THE FAB FRAGMENT
4968, 3tt1I, 0.5032, 3.93, 0.073, 212, 110, CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
4969, 3ntcL, 0.5032, 4.05, 0.103, 219, 107, CRYSTAL STRUCTURE OF KD-247 FAB AN ANTI-V3 ANTIBODY THAT INHIBITS HIV-1 ENTRY
4970, 3mltI, 0.5032, 4.14, 0.062, 219, 112, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
4971, 3ixyG, 0.5032, 4.28, 0.080, 221, 113, THE PSEUDO-ATOMIC STRUCTURE OF DENGUE IMMATURE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF THE ANTI-FUSION LOOP ANTIBODY E53
4972, 3iu3A, 0.5032, 3.95, 0.083, 215, 109, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY BASILIXIMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN
4973, 3ijyA, 0.5032, 3.95, 0.123, 215, 106, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO
4974, 3dggB, 0.5032, 4.20, 0.080, 212, 112, CRYSTAL STRUCTURE OF FABOX108
4975, 3bdyL, 0.5032, 4.07, 0.103, 217, 107, DUAL SPECIFIC BH1 FAB IN COMPLEX WITH VEGF
4976, 2w9dL, 0.5032, 3.76, 0.135, 210, 104, STRUCTURE OF FAB FRAGMENT OF THE ICSM 18 - ANTI-PRP THERAPEUTIC ANTIBODY   AT 1.57 A RESOLUTION.
4977, 2q86A, 0.5032, 3.89, 0.140, 189, 107, STRUCTURE OF THE MOUSE INVARIANT NKT CELL RECEPTOR VALPHA14
4978, 2p5wD, 0.5032, 3.79, 0.114, 192, 105, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
4979, 2ojzH, 0.5032, 3.97, 0.082, 216, 110, ANTI-DNA ANTIBODY ED10
4980, 2j8uL, 0.5032, 3.75, 0.105, 194, 105, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION.
4981, 2g2rL, 0.5032, 4.01, 0.104, 219, 106, GREEN-FLUORESCENT ANTIBODY 11G10 IN COMPLEX WITH ITS HAPTEN (NITRO-STILBENE DERIVATIVE)
4982, 2ck0L, 0.5032, 3.96, 0.112, 216, 107, ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II COMPLEX WITH A SYNTHETIC CYCLIC PEPTIDE
4983, 1ynlH, 0.5032, 3.89, 0.055, 219, 109, IDENTIFICATION OF KEY RESIDUES OF THE NC6.8 FAB ANTIBODY FRAGMENT BINDING TO SYNTHETIC SWEETERNERS: CRYSTAL STRUCTURE OF NC6.8 CO- CRYSTALIZED WITH HIGH POTENCY SWEETENER COMPOUND SC45647
4984, 1xf5A, 0.5032, 4.07, 0.093, 220, 107, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C Y64W)IN SPACE GROUP P21212
4985, 1mexH, 0.5032, 3.87, 0.084, 211, 107, ANTIBODY CATALYSIS OF A BIMOLECULAR CYCLOADDITION REACTION
4986, 1mcpL, 0.5032, 4.02, 0.103, 220, 107, PHOSPHOCHOLINE BINDING IMMUNOGLOBULIN FAB MC/PC603. AN X-RAY DIFFRACTION STUDY AT 2.7 ANGSTROMS
4987, 1kenU, 0.5032, 3.87, 0.124, 213, 105, INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH AN ANTIBODY THAT PREVENTS THE HEMAGGLUTININ LOW PH FUSOGENIC TRANSITION
4988, 1j5oL, 0.5032, 4.05, 0.084, 214, 107, CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDED DNA TEMPLATE- PRIMER
4989, 1ggiL, 0.5032, 4.04, 0.103, 215, 107, CRYSTAL STRUCTURE OF AN HIV-1 NEUTRALIZING ANTIBODY 50.1 IN COMPLEX WITH ITS V3 LOOP PEPTIDE ANTIGEN
4990, 6jjcB, 0.5031, 4.54, 0.055, 193, 110, CRYO-EM STRUCTURE OF GIANT FRESHWATER PRAWN MACROBRACHIUM ROSENBERGII NODAVIRUS (MRNV) SEMI-EMPTY VLP 
4991, 6f2sI, 0.5031, 4.72, 0.071, 203, 113, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
4992, 6f2sA, 0.5031, 4.75, 0.071, 195, 113, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
4993, 6e14C, 0.5031, 3.07, 0.084, 205, 95, HANDOVER MECHANISM OF THE GROWING PILUS BY THE BACTERIAL OUTER MEMBRANE USHER FIMD 
4994, 6dl8H, 0.5031, 3.95, 0.046, 216, 108, CRYSTAL STRUCTURE OF AN INFLUENZA A HEMAGGLUTININ ANTIBODY FAB VARIANT CH67:1203D4 CHIMERA 
4995, 6c9uH, 0.5031, 4.04, 0.063, 205, 111, CRYSTAL STRUCTURE OF [KS3][AT3] DIDOMAIN FROM MODULE 3 OF 6- DEOXYERTHRONOLIDE B SYNTHASE IN COMPLEX WITH ANTIBODY FRAGMENT (FAB) 
4996, 6c6zD, 0.5031, 3.96, 0.094, 215, 106, CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY CDC2-C2 IN COMPLEX WITH MERS-COV S1 RBD
4997, 6bi0L, 0.5031, 4.00, 0.093, 212, 107, TRASTUZUMAB FAB N158A D185A K190A (LIGHT CHAIN) TRIPLE MUTANT.
4998, 6bgaD, 0.5031, 3.86, 0.075, 245, 106, 2B4 I-EK TCR-MHC COMPLEX WITH AFFINITY-ENHANCING VELCRO PEPTIDE 
4999, 6b0hA, 0.5031, 4.08, 0.084, 213, 107, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1262
5000, 6avfB, 0.5031, 3.85, 0.065, 242, 107, CRYSTAL STRUCTURE OF THE KFJ5 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
5001, 5uxqB, 0.5031, 3.89, 0.086, 217, 105, STRUCTURE OF ANTI-HIV TRIMER APEX ANTIBODY PGT143
